0000898174us-gaap:~~InvestmentIncomeMemberus-gaap:ForeignGovernmentDebtSecuritiesMember2021-07-012021-09-30~~MaturityUpTo30DaysMembercountry:JP2023-09-30

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, ~~2022~~2023

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number 1-11848

REINSURANCE GROUP OF AMERICA, INCORPORATED

(Exact name of Registrant as specified in its charter)


Missouri						43-1627032
(State or other jurisdiction						(IRS employer
of incorporation or organization)						identification number)

16600 Swingley Ridge Road

Chesterfield, Missouri 63017

(Address of principal executive offices)

(636) 736-7000

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes x No o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes ☒o No o☒

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer x Accelerated filer o Non-accelerated filer o

Smaller reporting company ☐ Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.01

RGA

New York Stock Exchange

~~6.20% Fixed-To-Floating Rate Subordinated Debentures due 2042~~

~~RZA~~

~~New York Stock Exchange~~

5.75% Fixed-To-Floating Rate Subordinated Debentures due 2056

RZB

New York Stock Exchange

7.125% Fixed Rate ~~Reset~~ Subordinated Debentures due 2052

RZC

New York Stock Exchange

As of October 31, ~~2022, 66,835,999~~2023, 65,905,765 shares of the registrant’s common stock were outstanding.

Table of Contents

REINSURANCE GROUP OF AMERICA, INCORPORATED AND SUBSIDIARIES

TABLE OF CONTENTS

Item       Page
   PART I – FINANCIAL INFORMATION
1
Financial Statements


Condensed Consolidated Balance Sheets (Unaudited) September 30, 2022 and December 31, 2021

3

Condensed Consolidated Statements of Income (Unaudited)
three and nine months September 30, 2022 and 2021

4

Condensed Consolidated Statements of Comprehensive Income (Unaudited) three and nine months ended September 30, 2022 and 2021

5
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) three and nine months ended September 30, 2022 and 2021
6

Condensed Consolidated Statements of Cash Flows (Unaudited) nine months ended September 30, 2022 and 2021

7

Notes to Condensed Consolidated Financial Statements (Unaudited):

8
     1. Business and Basis of Presentation
8
     2. Earnings Per Share
8
     3. Equity
9
     4. Investments
11
     5. Derivative Instruments
19
     6. Fair Value of Assets and Liabilities
25
     7. Segment Information
32
     8. Commitments, Contingencies and Guarantees
33
     9. Income Tax
34
     10. Employee Benefit Plans
35
     11. Reinsurance Ceded Receivables and Other
35
     12. Policy Claims and Benefits
36
13. Financing Activities
36
     14. New Accounting Standards
36
2
Management’s Discussion and Analysis of
Financial Condition and Results of Operations

38
3
Quantitative and Qualitative Disclosures About Market Risk

67
4
Controls and Procedures

67
   PART II – OTHER INFORMATION
1
Legal Proceedings

68
1A
Risk Factors

68
2
Unregistered Sales of Equity Securities and Use of Proceeds

68
6
Exhibits

68

Index to Exhibits

69

Signatures

70


Item		Page

	PART I – FINANCIAL INFORMATION

1	Financial Statements
	Condensed Consolidated Balance Sheets	3
	Condensed Consolidated Statements of Income	4
	Condensed Consolidated Statements of Comprehensive Income	5
	Condensed Consolidated Statements of Equity	7
	Condensed Consolidated Statements of Cash Flows	6
	Notes to Condensed Consolidated Financial Statements (Unaudited)
	Note 1 Business and Basis of Presentation	8
	Note 2 Impact of New Accounting Standard	12
	Note 3 Earnings Per Share	24
	Note 4 Equity	24
	Note 5 Future Policy Benefits	26
	Note 6 Policyholder Account Balances	35
	Note 7 Unpaid Claims and Claim Expense – Short-Duration Contracts	37
	Note 8 Market Risk Benefits	38
	Note 9 Deferred Policy Acquisition Costs	39
	Note 10 Reinsurance Ceded Receivables and Other	40
	Note 11 Investments	41
	Note 12 Derivative Instruments	49
	Note 13 Fair Value of Assets and Liabilities	55
	Note 14 Income Tax	62
	Note 15 Employee Benefit Plans	63
	Note 16 Commitments, Contingencies and Guarantees	63
	Note 17 Segment Information	64
	Note 18 Financing Activities	66
	Note 19 New Accounting Standards Not Yet Adopted	66
2	Management’s Discussion and Analysis of Financial Condition and Results of Operations	67
3	Quantitative and Qualitative Disclosure About Market Risk	97
4	Controls and Procedures	98

	PART II – OTHER INFORMATION

1	Legal Proceedings	99
1A	Risk Factors	99
2	Unregistered Sales of Equity Securities and Use of Proceeds	99
5	Other Information	99
6	Exhibits	99
	Index to Exhibits	100
	Glossary of Selected Terms	101
	Signatures	105

Table of Contents

PART I - – FINANCIAL INFORMATION

~~ITEM 1. Financial Statements~~

REINSURANCE GROUP OF AMERICA, INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(in millions, except share data)

(Unaudited)


		September 30, 2022		December 31, 2021
		(Dollars in millions, except share data)					September 30, 2023		December 31, 2022
Assets	Assets					Assets
Fixed maturity securities available-for-sale, at fair value (amortized cost of $57,630 and $55,873; allowance for credit losses of $52 and $31)		$	50,495	$	60,749
Fixed maturity securities available-for-sale, at fair value (amortized cost of $62,332 and $59,663; allowance for credit losses of $68 and $37)						Fixed maturity securities available-for-sale, at fair value (amortized cost of $62,332 and $59,663; allowance for credit losses of $68 and $37)	$	54,171	$	52,901
Equity securities, at fair value	Equity securities, at fair value	137		151		Equity securities, at fair value	133		134
Mortgage loans (net of allowance for credit losses of $43 and $35)		6,558		6,283
Mortgage loans (net of allowance for credit losses of $74 and $51)						Mortgage loans (net of allowance for credit losses of $74 and $51)	7,231		6,590
Policy loans	Policy loans	1,202		1,234		Policy loans	1,180		1,231
Funds withheld at interest	Funds withheld at interest	6,177		6,954		Funds withheld at interest	5,725		6,003
Limited partnerships and real estate joint ventures						Limited partnerships and real estate joint ventures	2,560		2,327
Short-term investments	Short-term investments	225		87		Short-term investments	141		154
Other invested assets	Other invested assets	3,246		3,070		Other invested assets	1,091		1,140
Total investments	Total investments	68,040		78,528		Total investments	72,232		70,480
Cash and cash equivalents	Cash and cash equivalents	3,512		2,948		Cash and cash equivalents	2,820		2,927
Accrued investment income	Accrued investment income	628		533		Accrued investment income	744		630
Premiums receivable and other reinsurance balances	Premiums receivable and other reinsurance balances	2,820		2,888		Premiums receivable and other reinsurance balances	3,279		3,013
Reinsurance ceded receivables and other	Reinsurance ceded receivables and other	2,456		2,580		Reinsurance ceded receivables and other	2,818		2,671
Deferred policy acquisition costs	Deferred policy acquisition costs	3,887		3,690		Deferred policy acquisition costs	4,289		4,128

Other assets	Other assets	1,362		1,008		Other assets	1,240		1,055
Total assets	Total assets	$	82,705	$	92,175	Total assets	$	87,422	$	84,904
Liabilities and Equity
Liabilities and equity						Liabilities and equity
Future policy benefits	Future policy benefits	$	33,715	$	35,782	Future policy benefits	$	36,474	$	35,689
Interest-sensitive contract liabilities	Interest-sensitive contract liabilities	30,286		26,377		Interest-sensitive contract liabilities	29,365		30,342
Market risk benefits, at fair value						Market risk benefits, at fair value	224		247
Other policy claims and benefits	Other policy claims and benefits	6,249		6,993		Other policy claims and benefits	2,654		2,480
Other reinsurance balances	Other reinsurance balances	909		613		Other reinsurance balances	750		725
Deferred income taxes	Deferred income taxes	686		2,886		Deferred income taxes	1,601		1,383
Other liabilities	Other liabilities	2,910		2,663		Other liabilities	3,751		2,906

Long-term debt	Long-term debt	4,207		3,667		Long-term debt	4,450		3,961
Collateral finance and securitization notes		—		180

Total liabilities	Total liabilities	78,962		79,161		Total liabilities	79,269		77,733
Commitments and contingent liabilities (See Note 8)
Equity:
Commitments and contingent liabilities (See Note 16)						Commitments and contingent liabilities (See Note 16)
Equity						Equity
Preferred stock – par value $0.01 per share, 10,000,000 shares authorized, no shares issued or outstanding	Preferred stock – par value $0.01 per share, 10,000,000 shares authorized, no shares issued or outstanding	—		—		Preferred stock – par value $0.01 per share, 10,000,000 shares authorized, no shares issued or outstanding	—		—
Common stock – par value $0.01 per share, 140,000,000 shares authorized, 85,310,598 shares issued at September 30, 2022 and December 31, 2021		1		1
Additional paid-in capital		2,493		2,461
Common stock – par value $0.01 per share, 140,000,000 shares authorized, 85,310,598 shares issued at September 30, 2023 and December 31, 2022						Common stock – par value $0.01 per share, 140,000,000 shares authorized, 85,310,598 shares issued at September 30, 2023 and December 31, 2022	1		1
Additional paid-in-capital						Additional paid-in-capital	2,534		2,502
Retained earnings	Retained earnings	8,820		8,563		Retained earnings	8,713		8,169
Treasury stock, at cost – 18,483,720 and 18,139,868 shares		(1,697)		(1,653)
Treasury stock, at cost – 19,438,385 and 18,634,390 shares						Treasury stock, at cost – 19,438,385 and 18,634,390 shares	(1,852)		(1,720)
Accumulated other comprehensive income (loss)	Accumulated other comprehensive income (loss)	(5,964)		3,642		Accumulated other comprehensive income (loss)	(1,333)		(1,871)
Total Reinsurance Group of America, Inc. stockholders’ equity		3,653		13,014
Total RGA, Inc. shareholders’ equity						Total RGA, Inc. shareholders’ equity	8,063		7,081
Noncontrolling interest	Noncontrolling interest	90		—		Noncontrolling interest	90		90
Total equity	Total equity	3,743		13,014		Total equity	8,153		7,171
Total liabilities and stockholders’ equity		$	82,705	$	92,175
Total liabilities and shareholders’ equity						Total liabilities and shareholders’ equity	$	87,422	$	84,904

See accompanying notes to condensed consolidated financial statements (unaudited).

Table of Contents

REINSURANCE GROUP OF AMERICA, INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(in millions, except per share amounts)

(Unaudited)


		Three months ended September 30,				Nine months ended September 30,					Three months ended September 30,				Nine months ended September 30,
		2022		2021		2022		2021			2023		2022		2023		2022
Revenues:		(Dollars in millions, except per share data)
Revenues										Revenues
Net premiums	Net premiums	$	3,247	$	3,094	$	9,632	$	9,106	Net premiums	$	4,255	$	3,247	$	10,977	$	9,632
Net investment income	Net investment income	769		796		2,333		2,367		Net investment income	922		769		2,635		2,333

Investment related gains (losses), net	Investment related gains (losses), net	(134)		58		(514)		472		Investment related gains (losses), net	(126)		(154)		(326)		(533)
Other revenues	Other revenues	184		95		432		354		Other revenues	102		188		274		438
Total revenues	Total revenues	4,066		4,043		11,883		12,299		Total revenues	5,153		4,050		13,560		11,870
Benefits and Expenses:
Benefits and expenses										Benefits and expenses
Claims and other policy benefits	Claims and other policy benefits	2,815		3,289		8,855		9,294		Claims and other policy benefits	3,959		3,048		10,035		8,857
Future policy benefits remeasurement (gains) losses										Future policy benefits remeasurement (gains) losses	(82)		226		(95)		302
Market risk benefits remeasurement (gains) losses										Market risk benefits remeasurement (gains) losses	(21)		23		(38)		29
Interest credited	Interest credited	189		177		468		541		Interest credited	223		189		647		468
Policy acquisition costs and other insurance expenses	Policy acquisition costs and other insurance expenses	396		338		1,144		1,010		Policy acquisition costs and other insurance expenses	348		341		1,028		1,021
Other operating expenses	Other operating expenses	251		229		720		683		Other operating expenses	274		251		799		720
Interest expense	Interest expense	46		41		130		129		Interest expense	72		49		188		136
Collateral finance and securitization expense		3		3		6		8
Total benefits and expenses	Total benefits and expenses	3,700		4,077		11,323		11,665		Total benefits and expenses	4,773		4,127		12,564		11,533
Income before income taxes	Income before income taxes	366		(34)		560		634		Income before income taxes	380		(77)		996		337
Provision for income taxes	Provision for income taxes	81		(12)		139		173		Provision for income taxes	91		(2)		247		109
Net income (loss)	Net income (loss)	$	285	$	(22)	$	421	$	461	Net income (loss)	289		(75)		749		228
Net income attributable to noncontrolling interest	Net income attributable to noncontrolling interest	1		—		2		—		Net income attributable to noncontrolling interest	2		1		5		2
Net income (loss) available to RGA, Inc. shareholders	Net income (loss) available to RGA, Inc. shareholders	$	284	$	(22)	$	419	$	461	Net income (loss) available to RGA, Inc. shareholders	$	287	$	(76)	$	744	$	226
Earnings per share:

Earnings per share										Earnings per share
Basic earnings per share	Basic earnings per share	$	4.24	$	(0.32)	$	6.25	$	6.78	Basic earnings per share	$	4.34	$	(1.13)	$	11.19	$	3.38
Diluted earnings per share	Diluted earnings per share	$	4.19	$	(0.32)	$	6.19	$	6.74	Diluted earnings per share	$	4.29	$	(1.13)	$	11.06	$	3.35

See accompanying notes to condensed consolidated financial statements (unaudited).

Table of Contents

REINSURANCE GROUP OF AMERICA, INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(in millions)

(Unaudited)


		Three months ended September 30,				Nine months ended September 30,					Three months ended September 30,				Nine months ended September 30,
		2022		2021		2022		2021			2023		2022		2023		2022
Comprehensive income (loss)	Comprehensive income (loss)	(Dollars in millions)								Comprehensive income (loss)
Net income (loss)		$	285	$	(22)	$	421	$	461
Net income										Net income	$	289	$	(75)	$	749	$	228
Other comprehensive income (loss), net of tax:	Other comprehensive income (loss), net of tax:									Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	Foreign currency translation adjustments	(177)		(30)		(207)		19		Foreign currency translation adjustments	(59)		(150)		83		(134)
Net unrealized investment gains (losses)	Net unrealized investment gains (losses)	(2,228)		(429)		(9,398)		(1,796)		Net unrealized investment gains (losses)	(1,780)		(2,239)		(1,163)		(9,567)

Effect of updating discount rates on future policy benefits										Effect of updating discount rates on future policy benefits	1,906		1,867		1,611		8,198
Change in instrument-specific credit risk for market risk benefits										Change in instrument-specific credit risk for market risk benefits	(6)		28		(6)		26
Defined benefit pension and postretirement plan adjustments	Defined benefit pension and postretirement plan adjustments	—		1		(1)		1		Defined benefit pension and postretirement plan adjustments	4		—		13		(1)
Total other comprehensive income (loss), net of tax	Total other comprehensive income (loss), net of tax	(2,405)		(458)		(9,606)		(1,776)		Total other comprehensive income (loss), net of tax	65		(494)		538		(1,478)
Total comprehensive income (loss)	Total comprehensive income (loss)	(2,120)		(480)		(9,185)		(1,315)		Total comprehensive income (loss)	354		(569)		1,287		(1,250)
Comprehensive income attributable to noncontrolling interest	Comprehensive income attributable to noncontrolling interest	1		—		2		—		Comprehensive income attributable to noncontrolling interest	2		1		5		2
Total comprehensive income (loss) available to RGA, Inc. shareholders		$	(2,121)	$	(480)	$	(9,187)	$	(1,315)
Total comprehensive income (loss) attributable to RGA, Inc.										Total comprehensive income (loss) attributable to RGA, Inc.	$	352	$	(570)	$	1,282	$	(1,252)

See accompanying notes to condensed consolidated financial statements (unaudited).

Table of Contents

REINSURANCE GROUP OF AMERICA, INCORPORATED AND SUBSIDIARIES

~~CONDENSED CONSOLIDATED STATEMENTS OF EQUITY~~

~~(in millions except per share amounts)~~

~~(Unaudited)~~

Three months ended September 30, 2022 and 2021
Common
Stock Additional Paid In Capital Retained
Earnings Treasury
Stock Accumulated Other Comprehensive Income (Loss) Total RGA, Inc. Stockholders’ Equity Noncontrolling Interest Total Equity
Balance, June 30, 2022 $ 1 $ 2,478 $ 8,592 $ (1,673) $ (3,559) $ 5,839 $ 90 $ 5,929
Distributions to noncontrolling interest (1) (1)
Net income 284 284 1 285
Total other comprehensive income (loss) (2,405) (2,405) (2,405)
Dividends to stockholders, $0.80 per share (54) (54) (54)
Purchase of treasury stock (27) (27) (27)
Reissuance of treasury stock 15 (2) 3 16 16
Balance, September 30, 2022 $ 1 $ 2,493 $ 8,820 $ (1,697) $ (5,964) $ 3,653 $ 90 $ 3,743

Balance, June 30, 2021 $ 1 $ 2,430 $ 8,531 $ (1,559) $ 4,041 $ 13,444 $ — $ 13,444
Net income (loss) (22) (22) (22)
Total other comprehensive income (loss) (458) (458) (458)
Dividends to stockholders, $0.73 per share (50) (50) (50)
Purchase of treasury stock (46) (46) (46)
Reissuance of treasury stock 17 (1) 1 17 17
Balance, September 30, 2021 $ 1 $ 2,447 $ 8,458 $ (1,604) $ 3,583 $ 12,885 $ — $ 12,885

Nine months ended September 30, 2022 and 2021
Common
Stock Additional Paid In Capital Retained
Earnings Treasury
Stock Accumulated Other Comprehensive Income (Loss) Total RGA, Inc. Stockholders’ Equity Noncontrolling Interest Total Equity
Balance, December 31, 2021 $ 1 $ 2,461 $ 8,563 $ (1,653) $ 3,642 $ 13,014 $ — $ 13,014
Issuance of preferred interests by subsidiary 90 90
Distributions to noncontrolling interest (2) (2)
Net income 419 419 2 421
Total other comprehensive income (loss) (9,606) (9,606) (9,606)
Dividends to stockholders, $2.26 per share (152) (152) (152)
Purchase of treasury stock (54) (54) (54)
Reissuance of treasury stock 32 (10) 10 32 32
Balance, September 30, 2022 $ 1 $ 2,493 $ 8,820 $ (1,697) $ (5,964) $ 3,653 $ 90 $ 3,743

Balance, December 31, 2020 $ 1 $ 2,406 $ 8,148 $ (1,562) $ 5,359 $ 14,352 $ — $ 14,352
Net income 461 461 461
Total other comprehensive income (loss) (1,776) (1,776) (1,776)
Dividends to stockholders, $2.13 per share (145) (145) (145)
Purchase of treasury stock (48) (48) (48)
Reissuance of treasury stock 41 (6) 6 41 41
Balance, September 30, 2021 $ 1 $ 2,447 $ 8,458 $ (1,604) $ 3,583 $ 12,885 $ — $ 12,885

~~See accompanying notes to condensed consolidated financial statements (unaudited).~~

~~Table of Contents~~

~~REINSURANCE GROUP OF AMERICA, INCORPORATED AND SUBSIDIARIES~~

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in millions)

(Unaudited)

~~(Unaudited)~~

Nine months ended September 30,
2022 2021

(Dollars in millions)
Net cash provided by (used in) operating activities $ 1,077 $ 3,821
Cash flows from investing activities:
Sales of fixed maturity securities available-for-sale 8,072 9,673
Maturities of fixed maturity securities available-for-sale 669 682
Sales of equity securities 7 26
Principal payments and sales of mortgage loans 784 728
Principal payments on policy loans 36 32
Purchases of fixed maturity securities available-for-sale (13,035) (13,698)
Purchases of equity securities (14) (21)
Cash invested in mortgage loans (1,113) (980)
Cash invested in policy loans (5) (8)
Cash invested in funds withheld at interest (8) (60)
Purchase of business, net of cash acquired of $53 — (156)
Proceeds from sale of businesses, net of cash transferred of $1 and $43 7 19
Purchases of property and equipment (19) (15)
Change in short-term investments (161) 379
Change in other invested assets (15) (93)
Net cash provided by (used in) investing activities (4,795) (3,492)
Cash flows from financing activities:
Dividends to stockholders (152) (145)
Repayment of collateral finance and securitization notes (181) (74)
Proceeds from long-term debt issuance 700 —
Debt issuance costs (10) —
Principal payments of long-term debt (153) (402)
Purchases of treasury stock (54) (48)
Change in cash collateral for derivative positions and other arrangements 99 29
Change in deposit asset on reinsurance (32) 14
Deposits on investment-type policies and contracts 5,232 857
Withdrawals on investment-type policies and contracts (1,076) (908)
Distributions to noncontrolling interest (2) —
Issuance of preferred interests by subsidiary 90 —
Net cash used in financing activities 4,461 (677)
Effect of exchange rate changes on cash (179) (33)
Change in cash and cash equivalents 564 (381)
Cash and cash equivalents, beginning of period 2,948 3,408
Cash and cash equivalents, end of period $ 3,512 $ 3,027
Supplemental disclosures of cash flow information:
Interest paid $ 106 $ 121
Income taxes paid (received), net of refunds $ 108 $ 313
Non-cash investing activities:
Transfer of invested assets $ 494 $ 1,798
Non-cash financing activities:
Non-cash deposits on reinsurance $ — $ 1,581
Purchase of a business:
Assets acquired, excluding cash acquired $ — $ 847
Liabilities assumed $ — $ (691)
Sale of businesses:
Assets disposed, net of cash transferred $ (6) $ (512)
Liabilities disposed $ 1 $ 504


	Nine months ended September 30,
	2023		2022

Net cash provided by operating activities	$	2,818	$	1,077
Cash flows from investing activities
Sales of fixed maturity securities available-for-sale	5,832		8,072
Purchases of fixed maturity securities available-for-sale	(8,751)		(13,035)
Maturities of fixed maturity securities available-for-sale	753		669
Sales of equity securities	1		7
Purchases of equity securities	(4)		(14)
Principal payments on mortgage loans	265		784
Cash invested in mortgage loans	(962)		(1,113)
Net change in policy loans	51		31
Net change in funds withheld at interest	283		(8)
Sales of limited partnerships and real estate joint ventures	328		579
Purchases of limited partnerships and real estate joint ventures	(413)		(465)
Change in short-term investments	24		(161)
Change in other invested assets	21		(129)
Purchases of property and equipment	(20)		(19)
Proceeds from sale of businesses, net of cash transferred of $1	—		7
Net cash used in investing activities	(2,592)		(4,795)
Cash flows from financing activities
Dividends to shareholders	(163)		(152)
Repayment of collateral finance and securitization notes	—		(181)
Proceeds from long-term debt issuance	900		700
Debt issuance costs	(10)		(10)
Principal payments of long-term debt	(402)		(153)
Purchases of treasury stock	(169)		(54)
Change in cash collateral for derivative positions and other arrangements	300		99
Change in deposit asset on reinsurance	41		(32)
Deposits on investment-type policies and contracts	1,884		5,232
Withdrawals on investment-type policies and contracts	(2,652)		(1,076)
Net change in noncontrolling interest	—		88
Net cash (used) provided by financing activities	(271)		4,461
Effect of exchange rate changes on cash	(62)		(179)
Change in cash and cash equivalents	(107)		564
Cash and cash equivalents, beginning of period	2,927		2,948
Cash and cash equivalents, end of period	$	2,820	$	3,512
Supplemental disclosures of cash flow information
Interest paid	$	146	$	106
Income taxes paid, net of refunds	$	240	$	108
Non-cash investing activities
Transfer of invested assets	$	1,459	$	494
Sale of businesses:
Assets disposed, net of cash transferred	$	—	$	(6)
Liabilities disposed	$	—	$	1

See accompanying notes to condensed consolidated financial statements (unaudited).

Table of Contents

REINSURANCE GROUP OF AMERICA, INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF EQUITY

(in millions except per share amounts)

(Unaudited)


	Three months ended September 30, 2023 and 2022
	Common Stock		Additional Paid In Capital		Retained Earnings		Treasury Stock		Accumulated Other Comprehensive Income (Loss)		Total RGA, Shareholders’ Equity		Noncontrolling Interest		Total Equity
Balance, June 30, 2023	$	1	$	2,522	$	8,483	$	(1,803)	$	(1,398)	$	7,805	$	90	$	7,895

Change in equity of noncontrolling interest													(2)		(2)
Net income					287						287		2		289
Total other comprehensive income (loss)									65		65				65
Dividends to shareholders, $0.85 per share					(56)						(56)				(56)

Purchase of treasury stock							(50)				(50)				(50)
Reissuance of treasury stock			12		(1)		1				12				12
Balance, September 30, 2023	$	1	$	2,534	$	8,713	$	(1,852)	$	(1,333)	$	8,063	$	90	$	8,153


Balance, June 30, 2022	$	1	$	2,478	$	8,067	$	(1,673)	$	(1,484)	$	7,389	$	90	$	7,479

Change in equity of noncontrolling interest													(1)		(1)
Net income					(76)						(76)		1		(75)
Total other comprehensive income (loss)									(494)		(494)				(494)
Dividends to shareholders, $0.80 per share					(54)						(54)				(54)

Purchase of treasury stock							(27)				(27)				(27)
Reissuance of treasury stock			15		(1)		3				17				17
Balance, September 30, 2022	$	1	$	2,493	$	7,936	$	(1,697)	$	(1,978)	$	6,755	$	90	$	6,845


	Nine months ended September 30, 2023 and 2022
	Common Stock		Additional Paid In Capital		Retained Earnings		Treasury Stock		Accumulated Other Comprehensive Income (Loss)		Total RGA, Inc. Shareholders’ Equity		Noncontrolling Interest		Total Equity
Balance, December 31, 2022	$	1	$	2,502	$	8,169	$	(1,720)	$	(1,871)	7,081		$	90	$	7,171
Change in equity of noncontrolling interest													(5)		(5)
Net income					744						744		5		749
Total other comprehensive income (loss)									538		538				538
Dividends to shareholders, $2.45 per share					(163)						(163)				(163)
Purchase of treasury stock							(169)				(169)				(169)
Reissuance of treasury stock			32		(37)		37				32				32
Balance, September 30, 2023	$	1	$	2,534	$	8,713	$	(1,852)	$	(1,333)	$	8,063	$	90	$	8,153


Balance, December 31, 2021	$	1	$	2,461	$	7,871	$	(1,653)	$	(500)	8,180		$	—	$	8,180
Issuance of preferred interests by subsidiary													90		90
Change in equity of noncontrolling interest													(2)		(2)
Net income					226						226		2		228
Total other comprehensive income (loss)									(1,478)		(1,478)				(1,478)
Dividends to shareholders, $2.26 per share					(152)						(152)				(152)
Purchase of treasury stock							(54)				(54)				(54)
Reissuance of treasury stock			32		(9)		10				33				33
Balance, September 30, 2022	$	1	$	2,493	$	7,936	$	(1,697)	$	(1,978)	$	6,755	$	90	$	6,845

See accompanying notes to condensed consolidated financial statements (unaudited).

Table of Contents

REINSURANCE GROUP OF AMERICA, INCORPORATED AND SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements

(Unaudited)

~~1. Business and Basis of Presentation~~NOTE 1 BUSINESS AND BASIS OF PRESENTATION

Business

Reinsurance Group of America, Incorporated (“RGA”) is an insurance holding company that was formed on December 31, 1992. RGA and its subsidiaries (collectively, the “Company”) is engaged in providing traditional reinsurance, which includes individual and group life and health, disability and critical illness reinsurance. The Company also provides financial solutions, which includes longevity reinsurance, asset-intensive products ~~primarily annuities,~~(primarily annuities), financial reinsurance, capital solutions and stable value products.

Basis of Presentation

The unaudited condensed consolidated financial statements of the Company have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission (“SEC”). Accordingly, these condensed consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statements and should be read in conjunction with the Company’s ~~2021~~2022 Annual Report on Form 10-K filed with the SEC on February ~~25, 2022~~24, 2023 (the ~~“2021~~“2022 Annual Report”).

In the opinion of management, all adjustments, including normal recurring adjustments necessary for a fair presentation have been included. Interim results are not necessarily indicative of the results that may be expected for the year ending December 31, ~~2022.~~2023.

Consolidation

These unaudited condensed consolidated financial statements include the accounts of RGA and its subsidiaries and all intercompany accounts and transactions have been eliminated. Entities in which the Company has significant influence over the operating and financing decisions but are not required to be consolidated are reported under the equity method of accounting.

Standards Issued and Implemented

~~2. Earnings Per Share~~In the first quarter of 2023, the Company adopted Accounting Standards Update (“ASU”): ASU 2018-12, Financial Services – Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts (“ASU 2018-12”). ASU 2018-12 updates certain requirements for the accounting for long-duration insurance contracts.

•Cash flow assumptions and measuring liability for future policy benefits – ASU 2018-12 requires the Company to review its cash flow assumptions at least annually and update, if necessary, with the impact recognized in net income in the period of the change. The liability for future policy benefits includes required adjustments at the cohort level to cap the net premium ratio at 100% and eliminate negative reserves.

Upon adoption, an adjustment was recorded to retained earnings as a result of capping the net premium ratio at 100% and eliminating negative reserves on certain issue year cohorts.

•Discount rate – The discount rate assumption is prescribed by ASU 2018-12 as an upper-medium (low credit risk) fixed-income yield and is required to be updated every quarter. The change in the liability as a result of updating the discount rate assumption is recognized in other comprehensive income (loss) (“OCI”).

Upon adoption, an adjustment was recorded to accumulated other comprehensive income (loss) (“AOCI”) as a result of remeasuring in force contract liabilities using the current upper-medium grade fixed income instrument yields as of the date of transition. The adjustment reflects the difference between discount rates locked-in at contract inception versus current discount rates at transition.

•Deferred policy acquisition costs and similar balances – Deferred policy acquisition costs (“DAC”) and other capitalized costs such as unearned revenue should be amortized on a constant level or straight-line basis over the expected term of the contracts.

Upon adoption, an adjustment was recorded to AOCI for the removal of cumulative adjustments to DAC associated with unrealized investment gains and losses previously recorded in accumulated other comprehensive income (loss).

•Market risk benefits – Market risk benefits, which are contracts or contract features that provide protection to the policyholder from capital market risk and expose the Company to other-than-nominal capital market risk, are

Table of Contents

measured at fair value. The periodic change in fair value is recognized in net income with the exception of the periodic change in fair value related to the liability’s instrument-specific credit risk, which is recognized in OCI.

Upon adoption, an adjustment was recorded to retained earnings for the difference between the fair value and carrying value of the contracts at the transition date, excluding changes in the instrument-specific credit risks, and an adjustment to AOCI for the cumulative effect of changes in the instrument-specific credit risk between contract issue date and transition date.

Change in Certain Segment Allocations

Investment income for each segment has been adjusted to reflect the impacts of adopting ASU 2018-12 and due to an update to the Company’s internally developed economic capital model. Internal excess capital charges, included in each segment’s policy acquisition costs and other insurance expenses, were also updated as a result of adopting ASU 2018-12 and updates to the Company’s internally developed economic capital model. These changes did not impact the recognition or presentation of investment income or policy acquisition costs and other insurance expenses in the condensed consolidated financial statements.

Significant Accounting Polices – Update

The Company’s significant accounting policies are discussed in Note 2 – “Significant Accounting Policies and Pronouncements” of the 2022 Annual Report. The significant accounting policies discussed below have been updated to reflect the impact of adopting ASU 2018-12.

Liability for Future Policy Benefits

Utilizing the net premium model, a liability for future policy benefits for life and long-term health business is established to meet the estimated future benefits to be paid on assumed life and health reinsurance in force less the present value of estimated future new premiums to be collected. The liability is estimated using the Company’s mortality, morbidity, and persistency assumptions that reflect the Company’s historical experience, industry data, cedant specific experience, and discount rates based on the current yields of upper-medium grade fixed income instruments. These assumptions vary with the characteristics of the reinsurance contract, the year the risk was assumed, age of the insured and other appropriate factors. The Company reviews actual and anticipated experience compared to the assumptions used to establish policy benefits on a quarterly basis and will update those assumptions if evidence suggests that they should be revised. The Company completed its annual review and any necessary updates of cash flow assumptions used to calculate the liability for future policy benefits during the third quarter of 2023 and 2022. Updates may occur in other quarters if information becomes available during the quarter that indicates an assumption update is necessary.

Liabilities for future benefits for annuities in the payout phase have been established in an amount adequate to meet the estimated future obligations on policies in force using expected mortality, discount rates and other assumptions. These assumptions vary with the characteristics of the plan of insurance, year of issue, age of insured, and other appropriate factors. The mortality assumptions are based on the Company’s historical experience, industry data and cedant specific experience.

A deferred profit liability is established when the insurance benefit extends beyond the period in which premiums are collected, and the gross premium exceeds the net premium. The deferred profit liability is amortized in proportion to insurance in force for traditional life insurance and expected future benefits for annuity contracts. The deferred profit liability is included in the liabilities for future policy benefits, and the amortization of the deferred profit liability is recognized as a reduction in claims and other policy benefits.

For the purpose of calculating the liability for future policy benefits, the Company’s reinsurance contracts for its Traditional business are grouped into annual cohorts based on the effective date of the reinsurance contract. The annual groupings are further disaggregated based on:

•How the reinsurance contracts are priced and managed;

•Geographical locations;

•Underlying currency of the contract;

•Ceding company and other factors.

Given the unique risks and highly customized nature of the Company’s financial solutions business, reinsurance contracts for the Financial Solutions business are not aggregated with other contracts for the purpose of calculating the liability for future policy benefits.

Each quarter, the Company updates its estimate of cash flows expected over the entire life of a group of contracts using actual historical experience and current future cash flow assumptions. These updated cash flows, discounted using the original contract issuance discount rates, are used to calculate the revised net premium ratio, as of the beginning of the current reporting period. The present value of these updated cash flows is compared to the carrying amount of the liability as of that same date, before updating cash flow assumptions, to determine the current period change in the liability’s estimate. This current period change in the liability is a component of the liability remeasurement gain or loss. In subsequent periods, the revised net

Table of Contents

premium ratio is used to measure the liability for future policy benefits, subject to future revisions. The Company also reviews actual and anticipated experience compared to the assumptions used to establish the liability for future policy benefits on a quarterly basis. If evidence suggests that the assumptions should be revised, the cumulative effect of the change is reflected in future policy benefits remeasurement (gains) losses in the current period. The Company has elected to lock-in claims expense assumptions at contract inception and those assumptions are not subsequently reviewed or updated.

The discount rates used to measure the liability are based on upper-medium grade fixed-income instruments (A rated credit) with similar tenor to the expected liability cash flows. The discount rate assumption is updated quarterly and used to remeasure the liability at the reporting date, with the resulting change reflected in other comprehensive income (loss). For unobservable discount rates, the Company uses estimates consistent with fair value guidance, maximizing the use of relevant, observable market prices and minimizing the use of unobservable inputs.

The Company utilizes the discount rate curve at contract inception for purposes of interest accretion and updating the net premium ratio. Interest accretion is recognized in claims and other policy benefits on the condensed consolidated statements of income. The locked-in discount curve at contract inception for contracts entered into after the adoption of ASU 2018-12 (i.e., January 1, 2021 and after) is based on the average upper-medium grade fixed-income instrument yields during the first calendar year of the reinsurance contract. The locked-in discount rates at contract inception for contracts that were effective prior to the adoption of ASU 2018-12 (i.e., prior to January 1, 2021) are the discount rate assumptions used prior to the adoption of ASU 2018-12, which were based on estimates of expected investment yields.

Included in the liability for future policy benefits are unpaid claims related to long-duration contracts and an accrual for incurred but not reported losses (“IBNR”). The Company’s IBNR accrual related to long-duration contracts is determined using case-basis estimates and lag studies of past experience. The time lag from the date of the claim or death to when the ceding company reports the claim to the Company can vary significantly by ceding company, business segment and product type, but generally averages around 3 months. Incurred but not reported claims are estimates on an undiscounted basis, using actuarial estimates of historical claims expense, adjusted for current trends and conditions. These estimates are continually reviewed and the ultimate liability may vary significantly from the amount recognized. Claims payable for incurred but not reported losses for long-duration contracts are included in the liability for future policy benefits on the condensed consolidated balance sheets. Prior to the adoption of ASU 2018-12, unpaid claims and IBNR related to long-duration contracts were included in other policy claims and benefits. Upon adoption of ASU 2018-12, the Company revised prior period amounts to conform to the current period’s presentation. See Note 2 – “Impact of New Accounting Standard” for additional information.

Interest-Sensitive Contract Liabilities and Policyholder Account Balances

Liabilities for future benefits on interest-sensitive life and investment-type contract liabilities are carried at the accumulated contract holder values without reduction for potential surrender or withdrawal charges. The Company reinsures asset-intensive products, including annuities and corporate-owned life insurance. The investment portfolios for these products are segregated for management purposes within the general account of the respective legal entity. The liabilities under asset-intensive insurance contracts or reinsurance contracts reinsured on a coinsurance basis are included in interest-sensitive contract liabilities on the condensed consolidated balance sheets. Asset-intensive contracts principally include individual fixed annuities in the accumulation phase, single premium immediate annuities, with no significant life contingency, equity-indexed annuities, individual variable annuities, corporate-owned life, and interest-sensitive whole life insurance contracts. Interest-sensitive contract liabilities are equal to (i) policy account values, which consist of an accumulation of gross premium payments; (ii) credited interest less expenses, mortality charges, and withdrawals; and (iii) fair value adjustments relating to business combinations. Liabilities for immediate annuities are calculated as the present value of the expected cash flows, with the locked-in discount rate determined such that there is no gain or loss at inception.

Equity-indexed annuity contracts reinsured by the Company allow the contract holder to elect an interest rate return or an equity market component where interest credited is based on the performance of common stock market indices, such as the S&P 500 Index®, the Dow Jones Industrial Average, or the NASDAQ. The equity market option is considered an embedded derivative, similar to a call option, which is reflected at fair value on the condensed consolidated balance sheets in interest-sensitive contract liabilities. The fair value of embedded derivatives is computed based on a projection of future equity option costs using a budget methodology, discounted back to the balance sheet date using current market indicators of volatility and interest rates. Changes in the fair value of the embedded derivatives are included as a component of interest credited on the condensed consolidated statements of income (loss).

The Company reviews its estimates of actuarial liabilities for interest-sensitive contract liabilities and compares them with its actual experience. Differences between actual experience and the assumptions used in pricing these guarantees and benefits and in the establishment of the related liabilities result in variances in profit and could result in losses. The effects of changes in such estimated liabilities are included in the results of operations in the period in which the changes occur.

Table of Contents

Market Risk Benefits

Market risk benefits are contracts or contract features that both provide protection to the contract holder from other-than-nominal capital market risk and expose the Company to other-than-nominal capital market risk. Market risk benefits are measured at fair value using an option-based valuation model based on current net amounts at risk, market data, Company experience, and other factors. Changes in fair value are recognized in net income each period with the exception of the portion of the change in fair value due to a change in the liability’s instrument-specific credit risk, which is recognized in other comprehensive income.

Market risk benefits include the following contract features on certain annuity products that provide minimum guarantees to policyholders:

•Guaranteed minimum income benefits (“GMIB”) provide the contract holder, after a specified period of time determined at the time of issuance of the variable annuity contract, with a minimum level of income (annuity) payments. Under the reinsurance treaty, the Company makes a payment to the ceding company equal to the GMIB net amount-at-risk at the time of annuitization.

•Guaranteed minimum withdrawal benefits (“GMWB”) guarantee the contract holder a return of their purchase payment via partial withdrawals, even if the account value is reduced to zero, provided that the contract holder’s cumulative withdrawals in a contract year do not exceed a certain limit. The initial guaranteed withdrawal amount is equal to the initial benefit base as defined in the contract (typically, the initial purchase payments plus applicable bonus amounts).

•Guaranteed minimum accumulation benefits (“GMAB”) provide the contract holder, after a specified period of time determined at the time of issuance of the variable annuity contract, with a minimum accumulation of their purchase payments even if the account value is reduced to zero. The initial guaranteed accumulation amount is equal to the initial benefit base as defined in the contract (typically, the initial purchase payments plus applicable bonus amounts).

•Guaranteed minimum death benefits (“GMDB”) provides the beneficiary a guaranteed minimum amount upon the death of the contract holder, regardless of the account balance.

The fair values of the GMIB, GMWB, GMDB and GMAB contract features are reflected in market risk benefits and are calculated based on actuarial and capital market assumptions related to the projected cash flows, including benefits and related contract charges over the lives of the contracts. These projected cash flows incorporate expectations concerning policyholder behavior, such as lapses, withdrawals and benefit selections, and capital market assumptions such as interest rates and equity market volatilities. In measuring the fair value of GMIBs, GMWBs, GMABs and GMDBs, the Company attributes a portion of the fees collected from the policyholder equal to the present value of expected future guaranteed minimum income, withdrawal and accumulation and death benefits (at inception). The changes in fair value are reported in market risk benefits remeasurement (gains) losses. Any additional fees represent “excess” fees and are reported in other revenues. These variable annuity guaranteed living and death benefits may be more costly than expected in volatile or declining equity markets or falling interest rate markets, causing an increase in market risk benefit liabilities.

Deferred Policy Acquisition Costs

Costs of acquiring new business, which vary with and are directly related to the production of new business, have been deferred to the extent that such costs are deemed recoverable from future premiums or gross profits. Such costs include commissions and allowances as well as certain costs of policy issuance and underwriting. Non-commission costs related to the acquisition of new and renewal insurance contracts may be deferred only if they meet the following criteria:

•Incremental direct costs of a successful contract acquisition

•Portions of employees’ salaries and benefits directly related to time spent performing specified acquisition activities for a contract that has been acquired or renewed

•Other costs directly related to the specified acquisition or renewal activities that would not have been incurred had that acquisition contract transaction not occurred

DAC related to traditional life and interest-sensitive contracts are grouped by contract type and issue year into cohorts for consistency with the groupings used in estimating the associated liability. DAC is amortized on a constant level basis for the grouped contracts over the expected term of the related contracts to approximate straight-line amortization. The constant level basis used is based on the number of policies or policy face amount of the risk assumed in the reinsurance contract. The constant level bases used for amortization are projected using mortality and actuarial assumptions for policyholder behavior that are based on the Company’s experience, industry data and other factors and are consistent with those used for the liability for future policy benefits. Changes in assumptions are reflected in DAC amortization prospectively, and actual experience relating to number of policies reinsured will likely differ from the experience previously estimated.

Table of Contents

Amortization of DAC is included in policy acquisition costs and other insurance expenses.

Reinsurance Ceded Receivables

The Company generally reports retrocession activity on a gross basis. Amounts paid or deemed to have been paid for reinsurance are reflected in reinsurance ceded receivables and other. Reinsurance ceded receivables related to long-duration contracts are estimated using mortality, morbidity, and persistency assumptions that are similar to the liability for future policy benefits ceded. The discount rate used to measure the ceded receivable is based on the current yields of an upper-medium grade fixed income instrument. Similar to the liability for future policy benefits, ceded receivables are grouped into annual cohorts based on the effective date of the reinsurance contract.

NOTE 2 IMPACT OF NEW ACCOUNTING STANDARD

As discussed in Note 1, the Company adopted ASU 2018-12 during the first quarter of 2023. The updated guidance materially changed how the Company accounts for its long-duration insurance contracts. Below is a summary of the impact of adopting ASU 2018-12:

•For the liability for future policy benefits, the net transition adjustment recorded in accumulated other comprehensive income (loss) is related to the difference in the discount rate used prior to the adoption of ASU 2018-12 and the discount rate at January 1, 2021, and the removal of shadow adjustments previously recorded in accumulated other comprehensive income (loss) for the impact of unrealized gains and losses that were included in the expected gross profits amortization calculation as of the transition date of $8,593 million, pretax.

•At transition, the Company identified certain cohorts in its Traditional segments where the present value of future expected benefits and expenses exceeded the sum of existing benefit reserve and the present value of future gross premiums, resulting in a decrease to retained earnings, net of reinsurance (and a corresponding increase in the liabilities for future policy benefits and reinsurance recoverable) of approximately $1,462 million, pretax. See “Impact of Adoption by Segment” for the transition impact by reportable segment.

•At transition, the Company identified certain cohorts, primarily longevity swaps, where the present value of future premiums exceeded the present value of future benefits resulting in a negative liability. The elimination of the negative liability at transition resulted in a decrease to retained earnings (and a corresponding increase in the liabilities for future policy benefits) of $284 million, pretax. See “Impact of Adoption by Segment” for the transition impact by reportable segment.

•For DAC, the Company removed shadow adjustments previously recorded in AOCI in the amount of $114 million, pretax, for the impact of unrealized gains and losses that were included in the pre-ASU 2018-12 expected gross profits amortization calculation as of the transition date. See “Impact of Adoption by Segment” for the transition impact by reportable segment.

•For market risk benefits, the transition adjustment of $45 million, pretax, recognized in AOCI relates to the cumulative effect of changes in the instrument-specific credit risk between contract issue date and transition date. The remaining difference of $(72) million, pretax between the fair value and carrying value of the market risk benefits at transition, excluding the amounts recorded in AOCI, was recorded as an adjustment to retained earnings as of the transition date. See “Impact of Adoption by Segment” for the transition impact by reportable segment.

Impact on Shareholders’ Equity

The following table ~~sets forth~~provides the after-tax transition impact on January 1, 2021, to the reinsurance ceded receivables, liability for future policy benefits, market risk benefits, deferred policy acquisition costs and deferred tax asset and liability for the Company's adoption of ASU 2018-12 (dollars in millions):


	January 1, 2021
	Retained Earnings		Accumulated Other Comprehensive Income (Loss)

Reinsurance ceded receivables and other	$	254	$	388
Future policy benefits	(1,746)		(8,593)
Market risk benefits	(72)		45
Deferred policy acquisition costs	—		114
Deferred tax asset (included in other assets)	8		—
Deferred tax liability (included in deferred income taxes)	311		1,778
Total	$	(1,245)	$	(6,268)

Table of Contents

Impact of Adoption by Segment

Traditional Business

The following table provides the pre-tax transition impact to the liability for future policy benefits for the Company's adoption of Financial Services – Insurance on January 1, 2021, for its Traditional business (dollars in millions):


	U.S. and Latin America – Traditional		Canada – Traditional		Europe, Middle East and Africa – Traditional		Asia Pacific – Traditional
Future policy benefits
Balance, January 1, 2021 pre-adoption	$	10,444	$	3,477	$	1,379	$	3,568
Adjustment to retained earnings (1)	896		33		70		463
Effect of changes in discount rate assumptions	4,542		2,651		320		(772)
Reclassification of claims and benefits payable (2)	1,750		203		901		1,160
Balance, January 1, 2021 post-adoption	$	17,632	$	6,364	$	2,670	$	4,419
Less: reinsurance recoverable	(1,123)		(386)		(85)		(212)
Balance, January 1, 2021 post-adoption, after reinsurance	$	16,509	$	5,978	$	2,585	$	4,207

(1)Includes adjustments for capping the net premium ratio at 100% and eliminating negative reserves on certain issue year cohorts.

(2)Amount includes certain reclassifications to conform with the revised presentation upon adoption of ASU 2018-12, such as reclassifying claims and benefits payable on long-duration contracts to liability for future policy benefits.

Financial Solutions Business

The following table provides the pre-tax transition impact to the liability for future policy benefits, market risk benefits and deferred policy acquisitions costs for the Company's adoption of Financial Services – Insurance on January 1, 2021, for its Financial Solutions business (dollars in millions):


	U.S. and Latin America – Financial Solutions		Canada – Financial Solutions		Europe, Middle East and Africa – Financial Solutions		Asia Pacific – Financial Solutions
Future policy benefits
Balance, January 1, 2021 pre-adoption	$	5,037	$	16	$	5,657	$	1,874
Adjustment to retained earnings (1)	—		20		256		8
Effect of changes in discount rate assumptions	857		9		1,011		3
Amounts previously recorded in AOCI (2)	(28)		—		—		—
Reclassification of claims and benefits payable (3)	17		4		67		2
Balance, January 1, 2021 post-adoption	$	5,883	$	49	$	6,991	$	1,887
Less: reinsurance recoverable	—		—		—		—
Balance, January 1, 2021 post-adoption, after reinsurance	$	5,883	$	49	$	6,991	$	1,887

Market risk benefits
Balance, January 1, 2021 pre-adoption	$	—	$	—	$	—	$	—
Cumulative effect of change in credit risk in AOCI	(45)		—		—		—
Cumulative effect to retained earnings	72		—		—		—
Reclassification from interest-sensitive contract liabilities	239		—		—		—
Balance, January 1, 2021 post-adoption	$	266	$	—	$	—	$	—
Less: reinsurance recoverable	—		—		—		—
Balance, January 1, 2021 post-adoption, after reinsurance	$	266	$	—	$	—	$	—

Deferred policy acquisition costs
Balance, January 1, 2021 pre-adoption	$	254	$	—	$	—	$	41
Amounts previously recorded in AOCI (2)	114		—		—		—
Balance, January 1, 2021 post-adoption	$	368	$	—	$	—	$	41

(1)Includes adjustments for capping the net premium ratio at 100% and eliminating negative reserves on certain issue year cohorts.

(2)Adjustment to remove amounts associated with unrealized gains and losses previously recorded in AOCI (i.e., “shadow adjustments”).

(3)Amount includes certain reclassifications to conform with the revised presentation upon adoption of ASU 2018-12, such as reclassifying claims and benefits payable on long-duration contracts to liability for future policy benefits.

Table of Contents

Impact to Previously Reported Amounts

The adoption of ASU 2018-12 impacted the Company’s previously reported consolidated balance sheets as of December 31, 2021 and 2022, and related statements of income, comprehensive income and equity for the each of the two years in the period ended December 31, 2022 as follows (dollars in millions). The adoption of ASU 2018-12 did not materially impact the Company’s previously reported consolidated statements of cash flows for the two years in the period ended December 31, 2022.


	As Previously Reported		Adoption of ASU 2018-12		As Adjusted
Consolidated Balance Sheets
December 31, 2022
Assets
Fixed maturity securities available-for-sale, at fair value	$	52,901	$	—	$	52,901
Equity securities, at fair value	134		—		134
Mortgage loans	6,590		—		6,590
Policy loans	1,231		—		1,231
Funds withheld at interest	6,003		—		6,003
Limited partnerships and real estate joint ventures	2,327		—		2,327
Short-term investments	154		—		154
Other invested assets	1,140		—		1,140
Total investments	70,480		—		70,480
Cash and cash equivalents	2,927		—		2,927
Accrued investment income	630		—		630
Premiums receivable and other reinsurance balances	3,013		—		3,013
Reinsurance ceded receivables and other	2,462		209		2,671
Deferred policy acquisition costs	3,974		154		4,128
Other assets	1,220		(165)		1,055
Total assets	$	84,706	$	198	$	84,904
Liabilities and equity
Future policy benefits	35,220		469		35,689
Interest-sensitive contract liabilities	30,572		(230)		30,342
Market risk benefits, at fair value	—		247		247
Other policy claims and benefits	6,571		(4,091)		2,480
Other reinsurance balances	756		(31)		725
Deferred income taxes	736		647		1,383
Other liabilities	2,655		251		2,906
Long-term debt	3,961		—		3,961

Total liabilities	80,471		(2,738)		77,733
Equity
Preferred stock	—		—		—
Common stock	1		—		1
Additional paid-in-capital	2,502		—		2,502
Retained earnings	8,967		(798)		8,169
Treasury stock, at cost	(1,720)		—		(1,720)
Accumulated other comprehensive income (loss)	(5,605)		3,734		(1,871)
Total RGA, Inc. shareholders’ equity	4,145		2,936		7,081
Noncontrolling interest	90		—		90
Total equity	4,235		2,936		7,171
Total liabilities and shareholders’ equity	$	84,706	$	198	$	84,904

Table of Contents


	As Previously Reported		Adoption of ASU 2018-12		As Adjusted
December 31, 2021
Assets
Fixed maturity securities available-for-sale, at fair value	$	60,749	$	—	$	60,749
Equity securities, at fair value	151		—		151
Mortgage loans	6,283		—		6,283
Policy loans	1,234		—		1,234
Funds withheld at interest	6,954		—		6,954
Limited partnerships and real estate joint ventures	1,996		—		1,996
Short-term investments	87		—		87
Other invested assets	1,074		—		1,074
Total investments	78,528		—		78,528
Cash and cash equivalents	2,948		—		2,948
Accrued investment income	533		—		533
Premiums receivable and other reinsurance balances	2,888		—		2,888
Reinsurance ceded receivables and other	2,580		585		3,165
Deferred policy acquisition costs	3,690		170		3,860
Other assets	1,008		11		1,019
Total assets	$	92,175	$	766	$	92,941
Liabilities and equity
Future policy benefits	35,782		11,667		47,449
Interest-sensitive contract liabilities	26,377		(258)		26,119
Market risk benefits, at fair value	—		262		262
Other policy claims and benefits	6,993		(4,883)		2,110
Other reinsurance balances	613		(56)		557
Deferred income taxes	2,886		(1,387)		1,499
Other liabilities	2,663		255		2,918
Long-term debt	3,667		—		3,667
Collateral finance and securitization notes	180		—		180
Total liabilities	79,161		5,600		84,761
Equity
Preferred stock	—		—		—
Common stock	1		—		1
Additional paid-in-capital	2,461		—		2,461
Retained earnings	8,563		(692)		7,871
Treasury stock, at cost	(1,653)		—		(1,653)
Accumulated other comprehensive income (loss)	3,642		(4,142)		(500)
Total RGA, Inc. shareholders’ equity	13,014		(4,834)		8,180
Noncontrolling interest	—		—		—
Total equity	13,014		(4,834)		8,180
Total liabilities and shareholders’ equity	$	92,175	$	766	$	92,941

Table of Contents


	As Previously Reported		Adoption of ASU 2018-12		As Adjusted
Consolidated Statements of Income
Year ended December 31, 2022
Revenues
Net premiums	$	13,078	$	—	$	13,078
Net investment income	3,161		—		3,161
Investment related gains (losses), net	(506)		(33)		(539)
Other revenues	525		2		527
Total revenues	16,258		(31)		16,227
Benefits and expenses
Claims and other policy benefits	12,046		(64)		11,982
Future policy benefits remeasurement (gains) losses	—		291		291
Market risk benefits remeasurement (gains) losses	—		10		10
Interest credited	682		—		682
Policy acquisition costs and other insurance expenses	1,499		(155)		1,344
Other operating expenses	1,009		—		1,009
Interest expense	184		—		184
Collateral finance and securitization expense	7		—		7
Total benefits and expenses	15,427		82		15,509
Income before income taxes	831		(113)		718
Provision for income taxes	204		(7)		197
Net income	$	627	$	(106)	$	521
Net income attributable to noncontrolling interest	4		—		4
Net income available to RGA, Inc. shareholders	$	623	$	(106)	$	517


	As Previously Reported		Adoption of ASU 2018-12		As Adjusted
Year ended December 31, 2021
Revenues
Net premiums	$	12,513	$	—	$	12,513
Net investment income	3,138		—		3,138
Investment related gains (losses), net	560		7		567
Other revenues	447		2		449
Total revenues	16,658		9		16,667
Benefits and expenses
Claims and other policy benefits	12,776		(1,103)		11,673
Future policy benefits remeasurement (gains) losses	—		567		567
Market risk benefits remeasurement (gains) losses	—		(58)		(58)
Interest credited	700		—		700
Policy acquisition costs and other insurance expenses	1,416		(91)		1,325
Other operating expenses	936		—		936
Interest expense	127		—		127
Collateral finance and securitization expense	12		—		12
Total benefits and expenses	15,967		(685)		15,282
Income before income taxes	691		694		1,385
Provision for income taxes	74		141		215
Net income	$	617	$	553	$	1,170
Net income attributable to noncontrolling interest	—		—		—
Net income available to RGA, Inc. shareholders	$	617	$	553	$	1,170

Table of Contents


	As Previously Reported		Adoption of ASU 2018-12		As Adjusted
Consolidated Statements of Comprehensive Income
Year ended December 31, 2022
Net income	$	627	$	(106)	$	521
Other comprehensive income (loss), net of tax
Foreign currency translation adjustments	(162)		60		(102)
Net unrealized investment gains (losses)	(9,108)		(168)		(9,276)
Effect of updating discount rates on future policy benefits	—		7,964		7,964
Change in instrument-specific credit risk for market risk benefits	—		20		20
Defined benefit pension and postretirement plan adjustments	23		—		23
Total other comprehensive income (loss), net of tax	(9,247)		7,876		(1,371)
Total comprehensive income (loss)	(8,620)		7,770		(850)
Comprehensive income (loss) attributable to noncontrolling interest	4		—		4
Total comprehensive income (loss) available to RGA, Inc.	$	(8,624)	$	7,770	$	(854)

Year ended December 31, 2021
Net income	$	617	$	553	$	1,170
Other comprehensive income (loss), net of tax
Foreign currency translation adjustments	60		(4)		56
Net unrealized investment gains (losses)	(1,799)		(34)		(1,833)
Effect of updating discount rates on future policy benefits	—		2,207		2,207
Change in instrument-specific credit risk for market risk benefits	—		(43)		(43)
Defined benefit pension and postretirement plan adjustments	22		—		22
Total other comprehensive income (loss), net of tax	(1,717)		2,126		409
Total comprehensive income (loss)	(1,100)		2,679		1,579
Comprehensive income (loss) attributable to noncontrolling interest	—		—		—
Total comprehensive income (loss) available to RGA, Inc.	$	(1,100)	$	2,679	$	1,579


	RGA, Inc. Shareholders’ Equity
	Common Stock		Additional Paid In Capital		Retained Earnings		Treasury Stock		Accumulated Other Comprehensive Income (Loss)		Total RGA, Inc. Shareholders’Equity		Noncontrolling Interest		Total Equity
Balance, December 31, 2020 as previously reported	$	1	$	2,406	$	8,148	$	(1,562)	$	5,359	$	14,352	$	—	$	14,352
Cumulative effect of modified retrospective adoption of Financial Services – Insurance on long-duration contracts					(1,187)				(6,304)		(7,491)				(7,491)
Cumulative effect of full retrospective adoption of Financial Services – Insurance on market risk benefits					(58)				36		(22)				(22)
Adjusted balance, January 1, 2021	1		2,406		6,903		(1,562)		(909)		6,839		—		6,839
Net income					1,170						1,170				1,170
Total other comprehensive income (loss)									409		409				409
Dividends to shareholders, $2.86 per share					(194)						(194)				(194)
Purchase of treasury stock							(99)				(99)				(99)
Reissuance of treasury stock			55		(8)		8				55				55
Balance, December, 31, 2021	1		2,461		7,871		(1,653)		(500)		8,180		—		8,180
Issuance of preferred interests by subsidiary													90		90
Change in equity of noncontrolling interest													(4)		(4)
Net income					517						517		4		521
Total other comprehensive income (loss)									(1,371)		(1,371)				(1,371)
Dividends to shareholders, $3.06 per share					(205)						(205)				(205)
Purchase of treasury stock							(81)				(81)				(81)
Reissuance of treasury stock			41		(14)		14				41				41
Balance, December 31, 2022	$	1	$	2,502	$	8,169	$	(1,720)	$	(1,871)	$	7,081	$	90	$	7,171

Table of Contents

Additional Transition and Other Disclosures

ASU 2018-12 expanded the disclosure requirements for long-duration contracts in the annual and interim financial statements. The following tables provide additional information regarding the transition adjustments and disaggregated rollforwards of beginning to ending balances of the liability for future policy benefits, policyholder account balances, market risk benefits and deferred policy acquisition costs for the years ended December 31, 2022 and 2021 (dollars in millions).

Liability for Future Policy Benefits


For the year ended December 31, 2022:	U.S. and Latin America – Traditional		Canada – Traditional		Europe, Middle East and Africa – Traditional		Asia Pacific – Traditional
Present Value of Expected Net Premiums
Beginning of year balance at original discount rate	$	73,447	$	21,989	$	14,440	$	37,943
Effect of changes in cash flow assumptions	(805)		189		123		1,604
Effect of actual variances from expected experience	(4)		212		835		197
Adjusted balance, beginning of year	72,638		22,390		15,398		39,744
Issuances (1)	3,329		635		1,083		3,663
Interest accrual (2)	3,423		748		500		1,032
Net premiums collected (3)	(5,182)		(950)		(1,324)		(1,989)
Derecognition (4)	—		—		—		—
Foreign currency translation	(1)		(1,493)		(1,413)		(1,944)
Ending balance at original discount rate	74,207		21,330		14,244		40,506
Effect of changes in discount rate assumptions	(6,303)		(4,899)		(2,639)		(10,927)
Balance, end of period	$	67,904	$	16,431	$	11,605	$	29,579

Present Value of Expected Future Policy Benefits
Beginning of year balance at original discount rate	$	84,075	$	25,440	$	15,664	$	41,971
Effect of changes in cash flow assumptions	(675)		191		136		1,681
Effect of actual variances from expected experience	85		212		813		234
Adjusted balance, beginning of year	83,485		25,843		16,613		43,886
Issuances (1)	3,333		635		1,083		3,667
Interest accrual (2)	3,940		958		530		1,171
Benefit payments (5)	(5,472)		(1,051)		(1,260)		(1,832)
Derecognition (4)	—		—		—		—
Foreign currency translation	(1)		(1,730)		(1,512)		(2,107)
Ending balance at original discount rate	85,285		24,655		15,454		44,785
Effect of changes in discount rate assumptions	(7,907)		(4,273)		(2,808)		(12,858)
Balance, end of period	$	77,378	$	20,382	$	12,646	$	31,927

Liability for future policy benefits	$	9,474	$	3,951	$	1,041	$	2,348
Less: reinsurance recoverable	(421)		(265)		(31)		(100)
Net liability for future policy benefits	$	9,053	$	3,686	$	1,010	$	2,248

(1)Issuances: The present value, using the original discount rate, of the expected net premiums or the expected future policy benefits related to new reinsurance contracts that became effective during the current period and new policies assumed on existing contracts.

(2)Interest accrual: The interest earned on the beginning present value of either the expected net premiums or the expected future policy benefits using the original interest rate.

(3)Net premiums collected: The portion of gross premiums collected from the ceding company that is used to fund expected benefit payments.

(4)Derecognition: Includes the effects of treaty recaptures and treaty amendments that resulted in the termination of an existing treaty and the issuance of a new treaty under the internal replacement model.

(5)Benefit payments: The release of the present value, using the original discount rate, of the expected future policy benefits due to death, lapse/withdrawal, and other benefit payments based on current assumptions.

Table of Contents


For the year ended December 31, 2021:	U.S. and Latin America – Traditional		Canada – Traditional		Europe, Middle East and Africa – Traditional		Asia Pacific – Traditional
Present Value of Expected Net Premiums
Balance, beginning of year	$	70,319	$	21,332	$	14,033	$	34,167
Effect of adoption of Financial Services – Insurance	20,758		1,785		2,599		(3,385)
Adjusted balance, beginning of year	$	91,077	$	23,117	$	16,632	$	30,782

Beginning of year balance at original discount rate	$	70,317	$	21,299	$	13,999	$	34,133
Effect of changes in cash flow assumptions	984		(45)		48		600
Effect of actual variances from expected experience	254		(24)		379		402
Adjusted balance, beginning of year	71,555		21,230		14,426		35,135
Issuances (1)	3,522		761		2,417		4,575
Interest accrual (2)	3,400		775		553		970
Net premiums collected (3)	(5,025)		(947)		(1,488)		(2,038)
Derecognition (4)	—		—		(1,167)		—
Foreign currency translation	(5)		170		(301)		(699)
Ending balance at original discount rate	73,447		21,989		14,440		37,943
Effect of changes in discount rate assumptions	15,771		(199)		1,280		(5,458)
Balance, end of period	$	89,218	$	21,790	$	15,720	$	32,485

Present Value of Expected Future Policy Benefits
Balance, beginning of year	$	80,275	$	24,587	$	15,246	$	37,335
Effect of adoption of Financial Services – Insurance	26,196		4,469		2,989		(3,694)
Adjusted balance, beginning of year	106,471		29,056		18,235		33,641

Beginning of year balance at original discount rate	$	81,172	$	24,587	$	15,281	$	37,765
Effect of changes in cash flow assumptions	1,021		(45)		42		699
Effect of actual variances from expected experience	517		(24)		422		559
Adjusted balance, beginning of year	82,710		24,518		15,745		39,023
Issuances (1)	3,537		761		2,436		4,585
Interest accrual (2)	3,916		992		598		1,107
Benefit payments (5)	(6,083)		(1,025)		(1,609)		(1,971)
Derecognition (4)	—		—		(1,176)		—
Foreign currency translation	(5)		194		(330)		(773)
Ending balance at original discount rate	84,075		25,440		15,664		41,971
Effect of changes in discount rate assumptions	19,185		1,905		1,445		(6,475)
Balance, end of period	$	103,260	$	27,345	$	17,109	$	35,496

Liability for future policy benefits	$	14,042	$	5,555	$	1,389	$	3,011
Less: reinsurance recoverable	(697)		(367)		(34)		(116)
Net liability for future policy benefits	$	13,345	$	5,188	$	1,355	$	2,895

(2)Interest accrual: The interest earned on the beginning present value of either the expected net premiums or the expected future policy benefits using the original interest rate.

(3)Net premiums collected: The portion of gross premiums collected from the ceding company that is used to fund expected benefit payments.

Table of Contents


For the year ended December 31, 2022:	U.S. and Latin America – Financial Solutions		Canada – Financial Solutions		Europe, Middle East and Africa – Financial Solutions		Asia Pacific – Financial Solutions
Present Value of Expected Net Premiums
Beginning of year balance at original discount rate	$	228	$	3,329	$	31,973	$	1,051
Effect of changes in cash flow assumptions	(31)		—		(126)		3
Effect of actual variances from expected experience	(22)		(12)		573		29
Adjusted balance, beginning of year	175		3,317		32,420		1,083
Issuances (1)	1,580		574		12,594		1,465
Interest accrual (2)	41		112		698		24
Net premiums collected (3)	(125)		(354)		(3,169)		(764)
Derecognition (4)	—		—		—		—
Foreign currency translation	—		(255)		(3,761)		(203)
Ending balance at original discount rate	1,671		3,394		38,782		1,605
Effect of changes in discount rate assumptions	(284)		(433)		(8,805)		25
Balance, end of period	$	1,387	$	2,961	$	29,977	$	1,630

Present Value of Expected Future Policy Benefits
Beginning of year balance at original discount rate	$	4,628	$	3,393	$	38,196	$	6,062
Effect of changes in cash flow assumptions	(34)		—		(140)		3
Effect of actual variances from expected experience	(46)		(24)		566		36
Adjusted balance, beginning of year	4,548		3,369		38,622		6,101
Issuances (1)	1,580		574		12,594		1,465
Interest accrual (2)	220		115		856		70
Benefit payments (5)	(525)		(351)		(3,355)		(227)
Derecognition (4)	—		—		—		—
Foreign currency translation	—		(260)		(4,387)		(848)
Ending balance at original discount rate	5,823		3,447		44,330		6,561
Effect of changes in discount rate assumptions	(617)		(432)		(9,719)		(435)
Balance, end of period	$	5,206	$	3,015	$	34,611	$	6,126

Liability for future policy benefits	$	3,819	$	54	$	4,634	$	4,496
Less: reinsurance recoverable	—		—		—		—
Net liability for future policy benefits	$	3,819	$	54	$	4,634	$	4,496

(2)Interest accrual: The interest earned on the beginning present value of either the expected net premiums or the expected future policy benefits using the original interest rate.

(3)Net premiums collected: The portion of gross premiums collected from the ceding company that is used to fund expected benefit payments.

Table of Contents


For the year ended December 31, 2021:	U.S. and Latin America – Financial Solutions		Canada – Financial Solutions		Europe, Middle East and Africa – Financial Solutions		Asia Pacific – Financial Solutions
Present Value of Expected Net Premiums
Balance, beginning of year	$	285	$	3,568	$	28,055	$	781
Effect of adoption of Financial Services – Insurance	102		343		3,634		114
Adjusted balance, beginning of year	387		3,911		31,689		895

Beginning of year balance at original discount rate	$	314	$	3,556	$	27,799	$	781
Effect of changes in cash flow assumptions	(33)		(30)		(76)		—
Effect of actual variances from expected experience	(29)		17		997		777
Adjusted balance, beginning of year	252		3,543		28,720		1,558
Issuances (1)	—		—		8,357		3,156
Interest accrual (2)	3		109		714		28
Net premiums collected (3)	(27)		(349)		(3,590)		(3,621)
Derecognition (4)	—		—		(1,669)		—
Foreign currency translation	—		26		(559)		(70)
Ending balance at original discount rate	228		3,329		31,973		1,051
Effect of changes in discount rate assumptions	28		97		668		247
Balance, end of period	$	256	$	3,426	$	32,641	$	1,298

Present Value of Expected Future Policy Benefits
Balance, beginning of year	$	4,951	$	3,584	$	33,410	$	2,645
Effect of adoption of Financial Services – Insurance	931		372		4,901		125
Adjusted balance, beginning of year	5,882		3,956		38,311		2,770

Beginning of year balance at original discount rate	$	4,951	$	3,592	$	33,410	$	2,653
Effect of changes in cash flow assumptions	(33)		6		(76)		—
Effect of actual variances from expected experience	(37)		6		1,000		777
Adjusted balance, beginning of year	4,881		3,604		34,334		3,430
Issuances (1)	—		—		8,357		3,156
Interest accrual (2)	193		112		890		63
Benefit payments (5)	(446)		(350)		(3,064)		(162)
Derecognition (4)	—		—		(1,682)		—
Foreign currency translation	—		27		(639)		(425)
Ending balance at original discount rate	4,628		3,393		38,196		6,062
Effect of changes in discount rate assumptions	575		114		1,174		250
Balance, end of period	$	5,203	$	3,507	$	39,370	$	6,312

Liability for future policy benefits	$	4,947	$	81	$	6,729	$	5,014
Less: reinsurance recoverable	—		—		—		—
Net liability for future policy benefits	$	4,947	$	81	$	6,729	$	5,014

(2)Interest accrual: The interest earned on the beginning present value of either the expected net premiums or the expected future policy benefits using the original interest rate.

(3)Net premiums collected: The portion of gross premiums collected from the ceding company that is used to fund expected benefit payments.

Table of Contents

Policyholder Account Balances

The following tables provide the balances and changes in the Company’s policyholder account balances as of and for the years ending December 31, 2022 and 2021 (dollars in millions):


For the year ended December 31, 2022:	U.S. and Latin America – Traditional		U.S. and Latin America – Financial Solutions		Asia Pacific – Financial Solutions
Balance, beginning of year	$	1,719	$	18,758	$	1,621
Deposits	24		1,289		2,521
Policy charges	(32)		(33)		(134)
Surrenders and withdrawals	(17)		(1,258)		(639)
Benefit payments	(76)		(448)		(46)
Interest credited	65		598		51
Foreign currency translation	—		—		(23)
Balance, end of period	$	1,683	$	18,906	$	3,351
Less: reinsurance recoverable	—		(1,543)		—
Balance, end of period, after reinsurance	$	1,683	$	17,363	$	3,351


For the year ended December 31, 2021:	U.S. and Latin America – Traditional		U.S. and Latin America – Financial Solutions		Asia Pacific – Financial Solutions
Balance, beginning of year	$	1,752	$	16,273	$	809
Deposits	25		3,290		868
Policy charges	(32)		(31)		(1)
Surrenders and withdrawals	(13)		(1,015)		(36)
Benefit payments	(79)		(404)		(24)
Interest credited	66		645		19
Foreign currency translation	—		—		(14)
Balance, end of period	$	1,719	$	18,758	$	1,621
Less: reinsurance recoverable	—		(1,561)		—
Balance, end of period, after reinsurance	$	1,719	$	17,197	$	1,621

Market Risk Benefits

The following tables provide the balances and changes in the Company’s liabilities for market risk benefits as of and for the years ending December 31, 2022 and 2021 (dollars in millions):


For the year ended December 31, 2022:	U.S. and Latin America – Financial Solutions
Balance, beginning of year	$	262
Balance, beginning of year, before effect of changes in the instrument-specific credit risk	254
Interest accrual	54
Attributed fees collected	28
Benefit payments	(9)
Effect of changes in future assumptions	18
Effect of changes in interest rates	(175)
Effect of changes in equity markets	48
Effect of changes in volatility	19
Other market impacts	7
Actual policyholder behavior different from expected behavior	19
Balance, end of period, before effect of changes in the instrument-specific credit risk	263
Effect of changes in the instrument-specific credit risk	(16)
Balance, end of period	247
Less: reinsurance recoverable	—
Balance, end of period, after reinsurance	$	247

Table of Contents


For the year ended December 31, 2021:	U.S. and Latin America – Financial Solutions
Balance, beginning of year	$	—
Effect of adoption of Financial Services – Insurance	266
Adjusted balance, beginning of year	266
Balance, beginning of year, before effect of changes in the instrument-specific credit risk	311
Interest accrual	3
Attributed fees collected	12
Benefit payments	(14)
Effect of changes in future assumptions	25
Effect of changes in interest rates	(51)
Effect of changes in equity markets	(49)
Effect of changes in volatility	(2)
Other market impacts	5
Actual policyholder behavior different from expected behavior	14
Balance, end of period, before effect of changes in the instrument-specific credit risk	254
Effect of changes in the instrument-specific credit risk	8
Balance, end of period	262
Less: reinsurance recoverable	—
Balance, end of period, after reinsurance	$	262

Deferred Policy Acquisition Costs

The following tables provide the balances and changes in the Company’s deferred policy acquisition costs as of and for the years ending December 31, 2022 and 2021 (dollars in millions):


For the year ended December 31, 2022:	U.S. and Latin America – Traditional		Canada – Traditional		Europe, Middle East and Africa – Traditional		Asia Pacific – Traditional
Balance, beginning of year	$	1,947	$	191	$	270	$	1,056
Capitalization	284		10		83		86
Amortization expense	(144)		(17)		(38)		(67)
Foreign currency translation	—		(13)		(21)		(32)
Balance, end of period	$	2,087	$	171	$	294	$	1,043


For the year ended December 31, 2022:	U.S. and Latin America – Financial Solutions		Canada – Financial Solutions		Europe, Middle East and Africa – Financial Solutions		Asia Pacific – Financial Solutions
Balance, beginning of year	$	312	$	—	$	—	$	81
Capitalization	87		—		—		121
Amortization expense	(58)		—		—		(13)
Foreign currency translation	—		—		—		(1)
Balance, end of period	$	341	$	—	$	—	$	188


For the year ended December 31, 2021:	U.S. and Latin America – Traditional		Canada – Traditional		Europe, Middle East and Africa – Traditional		Asia Pacific – Traditional
Balance, beginning of year	$	1,816	$	195	$	264	$	1,046
Effect of adoption of Financial Services – Insurance	—		—		—		—
Adjusted balance, beginning of year	1,816		195		264		1,046
Capitalization	254		8		42		83
Amortization expense	(123)		(13)		(24)		(55)
Foreign currency translation	—		1		(12)		(18)
Balance, end of period	$	1,947	$	191	$	270	$	1,056

Table of Contents


For the year ended December 31, 2021:	U.S. and Latin America – Financial Solutions		Canada – Financial Solutions		Europe, Middle East and Africa – Financial Solutions		Asia Pacific – Financial Solutions
Balance, beginning of year	$	254	$	—	$	—	$	41
Effect of adoption of Financial Services – Insurance	114		—		—		—
Adjusted balance, beginning of year	368		—		—		41
Capitalization	8		—		—		49
Amortization expense	(64)		—		—		(8)
Foreign currency translation	—		—		—		(1)
Balance, end of period	$	312	$	—	$	—	$	81

NOTE 3 EARNINGS PER SHARE

The following table provides the computation of basic and diluted earnings per share on net income (in millions, except per share information):

Three months ended September 30, Nine months ended September 30,
2022 2021 2022 2021
Earnings:
Net income $ 285 $ (22) $ 421 $ 461
Less: Net income attributable to noncontrolling interest 1 — 2 —
Net income available to RGA, Inc. shareholders $ 284 $ (22) $ 419 $ 461
Shares:
Weighted average outstanding shares 67 68 67 68
Equivalent shares from outstanding stock awards 1 — 1 —
Denominator for diluted calculation 68 68 68 68
Earnings per share:
Basic $ 4.24 $ (0.32) $ 6.25 $ 6.78
Diluted $ 4.19 $ (0.32) $ 6.19 $ 6.74

As a result of the net loss for the three months ended September 30, 2021, the Company is required to use basic weighted average common shares outstanding of 68 million in the calculation of diluted loss per share since the inclusion of shares for outstanding stock awards would have been anti-dilutive to the loss per share calculations.


	Three months ended September 30,				Nine months ended September 30,
	2023		2022		2023		2022
Earnings:
Net income (loss)	$	289	$	(75)	$	749	$	228
Less: Net income attributable to noncontrolling interest	2		1		5		2
Net income (loss) available to RGA, Inc. shareholders	$	287	$	(76)	$	744	$	226
Shares:
Weighted average outstanding shares	66		67		66		67
Equivalent shares from outstanding stock awards	1		1		1		1
Denominator for diluted calculation	67		68		67		68
Earnings per share:
Basic	$	4.34	$	(1.13)	$	11.19	$	3.38
Diluted	$	4.29	$	(1.13)	$	11.06	$	3.35

The calculation of common equivalent shares does not include the impact of stock awards with a conversion price that exceeds the average stock price for the earnings period as the result would be antidilutive. ~~Approximately 0.9 million and 1.5 million stock awards were excluded from the calculation of common equivalent shares during the three and nine month periods ended September 30, 2022, respectively.~~ The calculation of common equivalent shares also excludes the impact of outstanding performance contingent ~~shares,~~awards as the conditions necessary for their issuance have not been satisfied as of the end of the

~~Table of Contents~~

reporting period. Approximately 0.2 million performance contingent shares were excluded from the calculation of common equivalent shares during both the three and nine month periods ended September 30, 2022, respectively.

~~3. Equity~~NOTE 4 EQUITY

Common ~~Stock~~stock

The changes in ~~the~~ number of common stock shares issued, held in treasury and outstanding are as follows for the periods indicated:

Issued Held In Treasury Outstanding
Balance, December 31, 2021 85,310,598 18,139,868 67,170,730
Issuance of common stock — — —
Common stock acquired — 414,350 (414,350)
Stock-based compensation (1)
— (70,498) 70,498
Balance, September 30, 2022 85,310,598 18,483,720 66,826,878


	Issued	Held In Treasury	Outstanding
Balance, December 31, 2022	85,310,598	18,634,390	66,676,208

Common stock acquired	—	1,069,113	(1,069,113)
Stock-based compensation (1)	—	(265,118)	265,118
Balance, September 30, 2023	85,310,598	19,438,385	65,872,213

Issued Held In Treasury Outstanding
Balance, December 31, 2020 85,310,598 17,353,697 67,956,901
Issuance of common stock — — —
Common stock acquired — 405,644 (405,644)
Stock-based compensation (1)
— (48,566) 48,566
Balance, September 30, 2021 85,310,598 17,710,775 67,599,823


	Issued	Held In Treasury	Outstanding
Balance, December 31, 2021	85,310,598	18,139,868	67,170,730
Common Stock acquired	—	414,350	(414,350)
Stock-based compensation (1)	—	(70,498)	70,498
Balance, September 30, 2022	85,310,598	18,483,720	66,826,878

(1)Represents net shares issued from treasury pursuant to the Company’s equity-based compensation programs.

Common Stock Held in Treasury

Common stock held in treasury is accounted for at average cost. Gains resulting from the reissuance of common stock held in treasury are credited to additional paid-in capital. Losses resulting from the reissuance of common stock held in treasury are charged first to additional paid-in capital to the extent the Company has previously recorded gains on treasury share transactions, then to retained earnings.

~~On January~~

24 ~~2019, RGA’s board~~

Table of directors authorized a share repurchase program for up to $400 million of RGA’s outstanding common stock. During the nine months ended September 30, 2022, RGA repurchased 219,116 shares of common stock under this program for $25 million.Contents

On February 25, 2022, RGA’s board of directors authorized a share repurchase program for up to $400 million of RGA’s outstanding common stock. The authorization was effective immediately and does not have an expiration date. ~~In connection with this authorization, the board of directors terminated the stock repurchase authority granted in 2019.~~ During the nine months ended September 30, ~~2022,~~2023, RGA repurchased ~~195,234~~1,069,113 shares of common stock under this ~~program for $25 million.~~program.

Noncontrolling Interest

In 2022, Papara Financing LLC (“Papara”), a subsidiary of RGA Reinsurance Company, issued nonconvertible preferred interests to an unaffiliated third party. ~~Papara holds investments in mortgage loans.~~

The membership interests in Papara consist of (1) common interests, which are held by RGA Reinsurance Company and (2) preferred interests. The preferred interests total $90 million and pay an initial preferred distribution at an annual rate of 2.375% plus three month LIBOR. The applicable rate of interest is reset every five years. Distributions are paid quarterly, if declared by Papara. RGA can call the Papara preferred interests at the issue price beginning five years from the issuance date or upon the receipt of proceeds from the sale of the underlying assets.

The holders of the Papara preferred interests have the option to require redemption upon the occurrence of certain contingent events, such as the failure of Papara to pay the preferred distribution for two or more periods or to meet certain other requirements, including a minimum credit rating. If notice is given upon such an event, all other holders of equal or more subordinate classes of membership interests in Papara are entitled to receive the same form of consideration payable to the holders of the preferred interests, resulting in a deemed liquidation for accounting purposes.million. The preferred interests are included in noncontrolling interest, and net income attributable to noncontrolling interest was $2$5 million for the nine months ended September 30, ~~2022.~~

~~Table of Contents~~

2023.

Accumulated Other Comprehensive Income (Loss)

The balance of and changes in each component of accumulated other comprehensive income (loss) (“AOCI”) for the nine months ended September 30, ~~2022~~2023 and ~~2021~~2022 are as follows (dollars in millions):


		Accumulated Currency Translation Adjustments		Unrealized Appreciation (Depreciation) of Investments(1)		Pension and Postretirement Benefits		Total			Accumulated Other Comprehensive Income (Loss), Net of Income Tax
Balance, December 31, 2021		$	(9)	$	3,701	$	(50)	$	3,642
											Foreign Currency Translation Adjustments		Net Unrealized Investment Gains (Losses)(1)		Pension and Postretirement Benefits		Effect of Updating Discount Rates on Future Policy Benefits		Instrument-Specific Credit Risk for Market Risk Benefits		Total
Balance, December 31, 2022										Balance, December 31, 2022	$	(116)	$	(5,496)	$	(27)	$	3,755	$	13	$	(1,871)
Other comprehensive income (loss) before reclassifications	Other comprehensive income (loss) before reclassifications	(173)		(12,398)		(3)		(12,574)		Other comprehensive income (loss) before reclassifications	116		(1,652)		16		2,050		(8)		522
Amounts reclassified to (from) AOCI	Amounts reclassified to (from) AOCI	—		418		2		420		Amounts reclassified to (from) AOCI	—		140		1		—		—		141
Deferred income tax benefit (expense)	Deferred income tax benefit (expense)	(34)		2,582		—		2,548		Deferred income tax benefit (expense)	(33)		349		(4)		(439)		2		(125)

Balance, September 30, 2022		$	(216)	$	(5,697)	$	(51)	$	(5,964)
Balance, September 30, 2023										Balance, September 30, 2023	$	(33)	$	(6,659)	$	(14)	$	5,366	$	7	$	(1,333)


		Accumulated Currency Translation Adjustments		Unrealized Appreciation (Depreciation) of Investments(1)		Pension and Postretirement Benefits		Total			Accumulated Other Comprehensive Income (Loss), Net of Income Tax
Balance, December 31, 2020		$	(69)	$	5,500	$	(72)	$	5,359
											Foreign Currency Translation Adjustments		Net Unrealized Investment Gains (Losses)(1)		Pension and Postretirement Benefits		Effect of Updating Discount Rates on Future Policy Benefits		Instrument-Specific Credit Risk for Market Risk Benefits		Total
Balance, December 31, 2021										Balance, December 31, 2021	$	(13)	$	3,779	$	(50)	$	(4,209)	$	(7)	$	(500)
Other comprehensive income (loss) before reclassifications	Other comprehensive income (loss) before reclassifications	33		(2,136)		(5)		(2,108)		Other comprehensive income (loss) before reclassifications	(78)		(12,398)		(3)		10,487		33		(1,959)
Amounts reclassified to (from) AOCI	Amounts reclassified to (from) AOCI	—		(181)		6		(175)		Amounts reclassified to (from) AOCI	—		202		2		—		—		204
Deferred income tax benefit (expense)	Deferred income tax benefit (expense)	(14)		521		—		507		Deferred income tax benefit (expense)	(56)		2,629		—		(2,289)		(7)		277

Balance, September 30, 2021		$	(50)	$	3,704	$	(71)	$	3,583
Balance, September 30, 2022										Balance, September 30, 2022	$	(147)	$	(5,788)	$	(51)	$	3,989	$	19	$	(1,978)

(1)Includes cash flow hedges of $(351) and $(205) as of September 30, 2023 and December 31, 2022, respectively, and $(230) and $(22) as of September 30, 2022 and December 31, 2021, ~~respectively, and $(55) and $(49) as of September 30, 2021 and December 31, 2020,~~ respectively. See Note 512 – “Derivative Instruments” for additional information on cash flow hedges.

Table of Contents

The following table presents the amounts ~~reclassified from~~of AOCI ~~to the Statements of Income~~reclassifications for the three and nine months ended September 30, ~~2022~~2023 and ~~2021~~2022 (dollars in millions):


		Amount Reclassified from AOCI										Amount Reclassified from AOCI
		Three months ended September 30,				Nine months ended September 30,						Three months ended September 30,				Nine months ended September 30,				Affected Line Item in Statements of Income
Details about AOCI Components	Details about AOCI Components	2022		2021		2022		2021		Affected Line Item in Statements of Income	Details about AOCI Components	2023		2022		2023		2022
Net unrealized investment gains (losses):	Net unrealized investment gains (losses):										Net unrealized investment gains (losses):
Net unrealized gains (losses) on available-for-sale securities	Net unrealized gains (losses) on available-for-sale securities	$	(92)	$	35	$	(195)	$	218	Investment related gains (losses), net	Net unrealized gains (losses) on available-for-sale securities	$	(36)	$	(92)	$	(132)	$	(195)	Investment related gains (losses), net
Cash flow hedges – Interest rate	Cash flow hedges – Interest rate	—		(2)		(2)		(6)		(1)	Cash flow hedges – Interest rate	3		—		7		(2)		(1)
Cash flow hedges – Currency/Interest rate	Cash flow hedges – Currency/Interest rate	(3)		—		(5)		—		(1)	Cash flow hedges – Currency/Interest rate	(8)		(3)		(15)		(5)		(1)

Deferred policy acquisition costs attributed to unrealized gains and losses		(15)		(8)		(216)		(31)		(2)
Total	Total	(110)		25		(418)		181			Total	(41)		(95)		(140)		(202)
Provision for income taxes	Provision for income taxes	24		(5)		88		(38)			Provision for income taxes	13		20		36		42
Net unrealized gains (losses), net of tax	Net unrealized gains (losses), net of tax	$	(86)	$	20	$	(330)	$	143		Net unrealized gains (losses), net of tax	$	(28)	$	(75)	$	(104)	$	(160)
Amortization of defined benefit plan items:	Amortization of defined benefit plan items:										Amortization of defined benefit plan items:
Prior service cost (credit)	Prior service cost (credit)	$	—	$	—	$	1	$	1	(3)	Prior service cost (credit)	$	—	$	—	$	1	$	1	(2)
Actuarial gains (losses)	Actuarial gains (losses)	—		(3)		(3)		(7)		(3)	Actuarial gains (losses)	(1)		—		(2)		(3)		(2)
Total	Total	—		(3)		(2)		(6)			Total	(1)		—		(1)		(2)
Provision for income taxes	Provision for income taxes	—		—		—		1			Provision for income taxes	—		—		—		—
Amortization of defined benefit plans, net of tax	Amortization of defined benefit plans, net of tax	$	—	$	(3)	$	(2)	$	(5)		Amortization of defined benefit plans, net of tax	$	(1)	$	—	$	(1)	$	(2)

Total reclassifications for the period	Total reclassifications for the period	$	(86)	$	17	$	(332)	$	138		Total reclassifications for the period	$	(29)	$	(75)	$	(105)	$	(162)

(1)See Note 512 – “Derivative Instruments” for additional information on cash flow hedges.

(2)This AOCI component is included in the computation of the ~~deferred policy acquisition cost. See Note 8 – “Deferred Policy Acquisition Costs” of the 2021 Annual Report for additional details.~~

~~(3)This AOCI component is included in the computation of the~~ net periodic pension cost. See Note 1015 – “Employee Benefit Plans” for additional details.

~~Table of Contents~~

Equity Based Compensation

Equity compensation expense was $35 million and $31 million ~~and $40 million in~~for the ~~first~~ nine months ofended September 30, 2023 and 2022, ~~and 2021,~~ respectively. In the first quarter of ~~2022,~~2023, the Company granted ~~258,327~~129,146 stock appreciation rights at ~~$106.53~~$138.34 weighted average exercise price per share, ~~78,687~~185,311 performance contingent shares and ~~219,553~~105,122 restricted stock units to employees. ~~Additionally, non-employee directors were granted a total of 17,937 shares of common stock.~~ As of September 30, ~~2022, 1,652,736~~2023, 1,638,062 share awards at a weighted average strike price per share of ~~$107.03~~$114.32 were vested and exercisable with a remaining weighted average exercise period of ~~4.2~~4.1 years. As of September 30, ~~2022,~~2023, the total compensation cost of non-vested awards not yet recognized in the ~~condensed consolidated~~ financial statements was ~~$31~~$37 million. It is estimated that these costs will vest over a weighted average period of 0.7 years.

~~4. Investments~~NOTE 5 FUTURE POLICY BENEFITS

Liability for Future Policy Benefits

The Company reviews actual and anticipated experience compared to the assumptions used to establish policy benefits on a quarterly basis and will update those assumptions if evidence suggests that they should be revised. It is the Company’s policy to complete its annual assumption review during the third quarter of each year. Updates may occur in other quarters if information becomes available during the quarter that indicates an assumption update is necessary.

During the third quarter of 2023, the Company completed its annual assumption review resulting in a decrease in its total liability for future policy benefits. The decrease was primarily the result of updated mortality assumptions, which had a favorable impact on the liability for future policy benefits for the Company’s Financial Solutions business and an unfavorable impact on the Company’s Traditional business.

During the third quarter of 2022, the Company completed its annual assumption review resulting in an increase in its total liability for future policy benefits. The increase was primarily the result of updated mortality assumptions, which had an unfavorable impact on the liability for future policy benefits for the Company’s Traditional business. There were no significant changes in the assumptions used to measure the liability for future policy benefits for the Company’s Financial Solutions business.

Table of Contents

Traditional Business

The following tables provide the balances of and changes in the Company’s liability for future policy benefits for long-duration reinsurance contracts for its Traditional business, which primarily consists of individual life, group life and critical illness reinsurance for the nine months ended September 30, 2023 and 2022 (dollars in millions):


Nine months ended September 30, 2023:	U.S. and Latin America – Traditional			Canada – Traditional			Europe, Middle East and Africa – Traditional			Asia Pacific – Traditional
Present Value of Expected Net Premiums
Beginning of year balance at original discount rate	$	74,207		$	21,330		$	14,244		$	40,506
Effect of changes in cash flow assumptions	905			96			199			(180)
Effect of actual variances from expected experience	68			408			75			9
Adjusted balance, beginning of year	75,180			21,834			14,518			40,335
Issuances (1)	3,186			369			884			2,839
Interest accrual (2)	2,619			562			373			794
Net premiums collected (3)	(4,491)			(700)			(1,067)			(1,493)
Derecognition (4)	(35)			—			—			—
Foreign currency translation	5			(54)			(77)			(1,517)
Ending balance at original discount rate	76,464			22,011			14,631			40,958
Effect of changes in discount rate assumptions	(10,563)			(5,879)			(3,145)			(13,178)
Balance, end of period	$	65,901		$	16,132		$	11,486		$	27,780

Present Value of Expected Future Policy Benefits
Beginning of year balance at original discount rate	$	85,285		$	24,655		$	15,454		$	44,785
Effect of changes in cash flow assumptions	922			108			246			(171)
Effect of actual variances from expected experience	73			413			84			(40)
Adjusted balance, beginning of year	86,280			25,176			15,784			44,574
Issuances (1)	3,186			369			884			2,839
Interest accrual (2)	3,023			720			402			907
Benefit payments (5)	(4,097)			(752)			(1,033)			(1,287)
Derecognition (4)	(54)			—			—			—
Foreign currency translation	5			(60)			(77)			(1,559)
Ending balance at original discount rate	88,343			25,453			15,960			45,474
Effect of changes in discount rate assumptions	(13,185)			(5,520)			(3,402)			(15,342)
Balance, end of period	$	75,158		$	19,933		$	12,558		$	30,132

Liability for future policy benefits	$	9,257		$	3,801		$	1,072		$	2,352
Less: reinsurance recoverable	(658)			(259)			(33)			(115)
Net liability for future policy benefits	$	8,599		$	3,542		$	1,039		$	2,237

Weighted-average duration of the liability (in years)	11			14			8			15
Weighted-average interest accretion rate	4.7		%	3.7		%	3.5		%	2.7		%
Weighted-average current discount rate	5.9		%	5.4		%	6.0		%	4.9		%

(2)Interest accrual: The interest earned on the beginning present value of either the expected net premiums or the expected future policy benefits using the original interest rate.

(3)Net premiums collected: The portion of gross premiums collected from the ceding company that is used to fund expected benefit payments.

Table of Contents


Nine months ended September 30, 2022:	U.S. and Latin America – Traditional			Canada – Traditional			Europe, Middle East and Africa – Traditional			Asia Pacific – Traditional
Present Value of Expected Net Premiums
Beginning of year balance at original discount rate	$	73,447		$	21,989		$	14,440		$	37,943
Effect of changes in cash flow assumptions	(805)			115			128			1,595
Effect of actual variances from expected experience	43			(21)			423			(52)
Adjusted balance, beginning of year	72,685			22,083			14,991			39,486
Issuances (1)	2,419			546			786			2,383
Interest accrual (2)	2,541			571			370			740
Net premiums collected (3)	(3,770)			(715)			(1,005)			(1,459)
Derecognition (4)	—			—			—			—
Foreign currency translation	(1)			(1,914)			(2,412)			(3,495)
Ending balance at original discount rate	73,874			20,571			12,730			37,655
Effect of changes in discount rate assumptions	(7,148)			(4,729)			(3,006)			(11,212)
Balance, end of period	$	66,726		$	15,842		$	9,724		$	26,443

Present Value of Expected Future Policy Benefits
Beginning of year balance at original discount rate	$	84,075		$	25,440		$	15,664		$	41,971
Effect of changes in cash flow assumptions	(675)			121			141			1,715
Effect of actual variances from expected experience	135			6			412			(79)
Adjusted balance, beginning of year	83,535			25,567			16,217			43,607
Issuances (1)	2,423			546			786			2,393
Interest accrual (2)	2,924			735			393			843
Benefit payments (5)	(4,026)			(826)			(969)			(1,322)
Derecognition (4)	—			—			—			—
Foreign currency translation	—			(2,215)			(2,598)			(3,763)
Ending balance at original discount rate	84,856			23,807			13,829			41,758
Effect of changes in discount rate assumptions	(8,940)			(4,139)			(3,186)			(13,132)
Balance, end of period	$	75,916		$	19,668		$	10,643		$	28,626

Liability for future policy benefits	$	9,190		$	3,826		$	919		$	2,183
Less: reinsurance recoverable	(413)			(256)			(26)			(96)
Net liability for future policy benefits	$	8,777		$	3,570		$	893		$	2,087

Weighted-average duration of the liability (in years)	12			15			8			16
Weighted-average interest accretion rate	4.7		%	3.8		%	3.6		%	2.7		%
Weighted-average current discount rate	5.3		%	4.9		%	6.3		%	4.6		%

(2)Interest accrual: The interest earned on the beginning present value of either the expected net premiums or the expected future policy benefits using the original interest rate.

(3)Net premiums collected: The portion of gross premiums collected from the ceding company that is used to fund expected benefit payments.

Table of Contents

Significant assumptions used to compute the liability for future policy benefits for the Traditional business include mortality, morbidity, lapse rates and discount rates (both accretion and current). During the third quarter of 2023 and 2022, the Company completed its annual assumption review resulting in a $85 million and $269 million increase, excluding the effects of reinsurance, in the Company’s liability for future policy benefits for its Traditional business during 2023 and 2022, respectively. Including the effects of reinsurance, a future policy benefits remeasurement gain (loss) of $(75) million was recognized during the three and nine months ending September 30, 2023, and a future policy benefits remeasurement gain (loss) of $(329) million and $(306) million was recognized during the three and nine months ending September 30, 2022, as a result of changes in cash flow assumptions. The increase in the liability in 2023 and 2022 was primarily the result of updating the mortality assumptions used to measure the liability for future policy benefits. The Company also updated the underlying market data used to determine the current discount rate resulting in changes to the discount rate assumption used to measure the net liability for future policy benefits.

The Company’s Traditional business actual-to-expected variances, the effects of changes in cash flow assumptions and the effects of changes in discount rate assumption for the nine months ended September 30, 2023 and 2022, are summarized in the tables below:

Nine months ended September 30, 2023:

Segment

Net liability for future policy benefits at original discount rate

Changes in cash flow assumptions

Actual-to-expected variance

Impact of updating discount rate recognized in OCI

U.S. and Latin America – Traditional

$12 billion

$17 million

$5 million

$(1) billion

7.2% increase

0.2% increase

—%

9.2% decrease

Canada – Traditional

$3.4 billion

$12 million

$5 million

$(267) million

3.5% increase

0.4% increase

0.2% increase

8.0% decrease

Europe, Middle East and Africa – Traditional

$1.3 billion

$47 million

$9 million

$(88) million

9.8% increase

3.9% increase

0.7% increase

7.3% decrease

Asia Pacific – Traditional

$4.5 billion

$9 million

$(49) million

$(233) million

5.5% increase

0.2% increase

1.1% decrease

5.4% decrease

Nine months ended September 30, 2022:

Segment

Net liability for future policy benefits at original discount rate

Changes in cash flow assumptions

Actual-to-expected variance

Impact of updating discount rate recognized in OCI

U.S. and Latin America – Traditional

$11 billion

$130 million

$92 million

$(5.2) billion

3.3% increase

1.2% increase

0.9% increase

49 % decrease

Canada – Traditional

$3.2 billion

$6 million

$27 million

$(1.5) billion

6.2% decrease

0.2% increase

0.8% increase

43.9% decrease

Europe, Middle East and Africa – Traditional

$1.1 billion

$13 million

$(11) million

$(345) million

10.2% decrease

1.1% increase

0.9% decrease

28.2% decrease

Asia Pacific – Traditional

$4.1 billion

$120 million

$(27) million

$(903) million

1.9% increase

3% increase

0.7% decrease

22.4% decrease

Financial Solutions Business

The following tables provide the balances of and changes in the Company’s liability for future policy benefits, including the deferred profit liability related to the longevity business, for its Financial Solutions business, which primarily consists of longevity reinsurance, asset-intensive products, primarily annuities and financial reinsurance for the nine months ended September 30, 2023 and 2022 (dollars in millions):

Table of Contents


Nine months ended September 30, 2023:	U.S. and Latin America – Financial Solutions			Canada – Financial Solutions			Europe, Middle East and Africa – Financial Solutions			Asia Pacific – Financial Solutions
Present Value of Expected Net Premiums
Beginning of year balance at original discount rate	$	1,671		$	3,394		$	38,782		$	1,605
Effect of changes in cash flow assumptions	(69)			(54)			(561)			—
Effect of actual variances from expected experience	(20)			(5)			387			(10)
Adjusted balance, beginning of year	1,582			3,335			38,608			1,595
Issuances (1)	923			—			6,278			2,131
Interest accrual (2)	37			80			678			19
Net premiums collected (3)	(1,064)			(249)			(3,045)			(1,573)
Derecognition (4)	—			—			—			—
Foreign currency translation	2			(6)			15			(236)
Ending balance at original discount rate	1,480			3,160			42,534			1,936
Effect of changes in discount rate assumptions	(336)			(482)			(9,571)			(178)
Balance, end of period	$	1,144		$	2,678		$	32,963		$	1,758

Present Value of Expected Future Policy Benefits
Beginning of year balance at original discount rate	$	5,823		$	3,447		$	44,330		$	6,561
Effect of changes in cash flow assumptions	(91)			(76)			(595)			—
Effect of actual variances from expected experience	(28)			(13)			374			(12)
Adjusted balance, beginning of year	5,704			3,358			44,109			6,549
Issuances (1)	931			—			6,278			2,141
Interest accrual (2)	173			81			807			65
Benefit payments (5)	(405)			(248)			(2,748)			(199)
Derecognition (4)	(16)			—			—			—
Foreign currency translation	1			(5)			37			(948)
Ending balance at original discount rate	6,388			3,186			48,483			7,608
Effect of changes in discount rate assumptions	(788)			(480)			(10,552)			(997)
Balance, end of period	$	5,600		$	2,706		$	37,931		$	6,611

Liability for future policy benefits	$	4,456		$	28		$	4,968		$	4,853
Less: reinsurance recoverable	—			—			—			—
Net liability for future policy benefits	$	4,456		$	28		$	4,968		$	4,853

Weighted-average duration of the liability (in years)	8			7			9			15
Weighted-average interest accretion rate	3.5		%	3.3		%	2.3		%	1.3		%
Weighted-average current discount rate	5.9		%	5.5		%	5.3		%	2.4		%

(2)Interest accrual: The interest earned on the beginning present value of either the expected net premiums or the expected future policy benefits using the original interest rate.

(3)Net premiums collected: The portion of gross premiums collected from the ceding company that is used to fund expected benefit payments.

Table of Contents


Nine months ended September 30, 2022:	U.S. and Latin America – Financial Solutions			Canada – Financial Solutions			Europe, Middle East and Africa – Financial Solutions			Asia Pacific – Financial Solutions
Present Value of Expected Net Premiums
Beginning of year balance at original discount rate	$	228		$	3,329		$	31,973		$	1,051
Effect of changes in cash flow assumptions	(31)			—			(74)			—
Effect of actual variances from expected experience	(17)			(7)			401			125
Adjusted balance, beginning of year	180			3,322			32,300			1,176
Issuances (1)	—			581			11,256			1,325
Interest accrual (2)	1			85			513			20
Net premiums collected (3)	(18)			(269)			(2,228)			(729)
Derecognition (4)	—			—			—			—
Foreign currency translation	—			(323)			(6,761)			(359)
Ending balance at original discount rate	163			3,396			35,080			1,433
Effect of changes in discount rate assumptions	(117)			(418)			(9,639)			69
Balance, end of period	$	46		$	2,978		$	25,441		$	1,502

Present Value of Expected Future Policy Benefits
Beginning of year balance at original discount rate	$	4,628		$	3,393		$	38,196		$	6,062
Effect of changes in cash flow assumptions	(34)			—			(74)			—
Effect of actual variances from expected experience	(40)			(16)			392			125
Adjusted balance, beginning of year	4,554			3,377			38,514			6,187
Issuances (1)	—			581			11,256			1,325
Interest accrual (2)	136			87			632			53
Benefit payments (5)	(319)			(267)			(2,503)			(192)
Derecognition (4)	—			—			—			—
Foreign currency translation	—			(329)			(7,817)			(1,446)
Ending balance at original discount rate	4,371			3,449			40,082			5,927
Effect of changes in discount rate assumptions	(498)			(416)			(10,736)			(239)
Balance, end of period	$	3,873		$	3,033		$	29,346		$	5,688

Liability for future policy benefits	$	3,827		$	55		$	3,905		$	4,186
Less: reinsurance recoverable	—			—			—			—
Net liability for future policy benefits	$	3,827		$	55		$	3,905		$	4,186

Weighted-average duration of the liability (in years)	8			7			8			15
Weighted-average interest accretion rate	2.4		%	3.4		%	2.1		%	1.7		%
Weighted-average current discount rate	5.5		%	5.0		%	5.4		%	1.6		%

(2)Interest accrual: The interest earned on the beginning present value of either the expected net premiums or the expected future policy benefits using the original interest rate.

(3)Net premiums collected: The portion of gross premiums collected from the ceding company that is used to fund expected benefit payments.

Table of Contents

Significant assumptions used to compute the liability for future policy benefits for the Financial Solutions business include mortality, morbidity, lapse rates and discount rates (both accretion and current). During the third quarter of 2023 and 2022, the Company completed its annual assumption review resulting in a $78 million and $3 million decrease, excluding the effects of reinsurance, in the Company’s liability for future policy benefits for its Financial Solutions business during 2023 and 2022, respectively. Including the effects of reinsurance, a future policy benefits remeasurement gain (loss) of $78 million was recognized during the three and nine months ending September 30, 2023, and a future policy benefits remeasurement gain (loss) of $3 million was recognized during the three and nine months ending September 30, 2022, as a result of changes in cash flow assumptions. The decrease in the liability in 2023 and 2022 was primarily the result of updating the mortality assumptions used to measure the liability for future policy benefits. The Company also updated the underlying market data used to determine the current discount rate resulting in changes to the discount rate assumption used to measure the net liability for future policy benefits.

The Company’s Financial Solutions business actual-to-expected variances, the effects of changes in cash flow assumptions and the effects of changes in discount rate assumptions for the nine months ended September 30, 2023 and 2022, are summarized in the tables below:

Nine months ended September 30, 2023:

Segment

Net liability for future policy benefits at original discount rate

Changes in cash flow assumptions

Actual-to-expected variance

Impact of updating discount rate recognized in OCI

U.S. and Latin America – Financial Solutions

$4.9 billion

$(22) million

$(8) million

$(119) million

18.2% increase

0.5% decrease

0.2% decrease

2.9% decrease

Canada – Financial Solutions

$26 million

$(22) million

$(8) million

$1 million

50.9% decrease

41.5% decrease

15.1% decrease

1.9% increase

Europe, Middle East and Africa – Financial Solutions

$5.9 billion

$(34) million

$(13) million

$(67) million

7.2% increase

0.6% decrease

0.2% decrease

1.2% decrease

Asia Pacific – Financial Solutions

$5.7 billion

None

$(2) million

$(359) million

14.4% increase

—%

7.2% decrease

Nine months ended September 30, 2022:

Segment

Net liability for future policy benefits at original discount rate

Changes in cash flow assumptions

Actual-to-expected variance

Impact of updating discount rate recognized in OCI

U.S. and Latin America – Financial Solutions

$4.2 billion

$(3) million

$(23) million

$(928) million

4.4% decrease

0.1% decrease

0.5% decrease

21.1% decrease

Canada – Financial Solutions

$53 million

None

$(9) million

$(15) million

17.2% decrease

—%

14.1% decrease

23.4% decrease

Europe, Middle East and Africa – Financial Solutions

$5 billion

None

$(9) million

$(1.6) billion

19.6% decrease

—%

0.1% decrease

29.2% decrease

Asia Pacific – Financial Solutions

$4.5 billion

None

$1 million

$(311) million

10.4% decrease

—%

6.5% decrease

Table of Contents

Reconciliation and Other Disclosures

The reconciliation of the rollforward of the liability for future policy benefits to the condensed consolidated balance sheets as of September 30, 2023 and 2022 is as follows (dollars in millions):


	September 30,
	2023		2022
Liability for future policy benefits included in the rollforwards:
Traditional:
U.S. and Latin America	$	9,257	$	9,190
Canada	3,801		3,826
Europe, Middle East and Africa	1,072		919
Asia Pacific	2,352		2,183
Financial Solutions:
U.S. and Latin America	4,456		3,827
Canada	28		55
Europe, Middle East and Africa	4,968		3,905
Asia Pacific	4,853		4,186
Other long-duration contracts	126		185
Claims liability and incurred but not reported claims	5,062		4,899
Unearned revenue liability	499		549
Total liability for future policy benefits	$	36,474	$	33,724

The amount of undiscounted and discounted expected future gross premiums and expected future benefit payments for the liability for future policy benefits included in the rollforwards as of September 30, 2023 and 2022 is as follows (dollars in millions):


	September 30,
	2023				2022
	Undiscounted		Discounted		Undiscounted		Discounted
Expected future gross premiums
Traditional:
U.S. and Latin America	$	177,307	$	77,008	$	169,526	$	77,507
Canada	54,378		19,902		50,727		19,543
Europe, Middle East and Africa	24,778		13,131		22,139		11,267
Asia Pacific	90,652		35,372		85,465		33,712
Financial Solutions:
U.S. and Latin America	3,012		1,794		940		581
Canada	4,545		2,856		4,803		3,102
Europe, Middle East and Africa	68,410		36,603		48,987		28,141
Asia Pacific	3,797		2,828		2,718		2,278

Expected future benefit payments
Traditional:
U.S. and Latin America	$	188,177	$	75,158	$	179,693	$	75,916
Canada	56,423		19,933		54,039		19,668
Europe, Middle East and Africa	24,509		12,558		21,758		10,643
Asia Pacific	87,120		30,132		82,458		28,626
Financial Solutions:
U.S. and Latin America	10,233		5,600		7,041		3,873
Canada	4,285		2,706		4,697		3,033
Europe, Middle East and Africa	71,027		37,931		51,232		29,346
Asia Pacific	10,522		6,611		7,765		5,688

Table of Contents

The amount of gross premiums and interest expense recognized in the consolidated statements of income for the liability for future policy benefits included in the rollforwards for the nine months ended September 30, 2023 and 2022 is as follows (dollars in millions):


	Gross Premiums				Interest Expense
	September 30,				September 30,
	2023		2022		2023		2022
Traditional:
U.S. and Latin America	$	4,435	$	4,363	$	404	$	383
Canada	808		817		158		164
Europe, Middle East and Africa	1,058		1,033		29		23
Asia Pacific	1,959		1,880		113		103
Financial Solutions:
U.S. and Latin America	979		21		136		135
Canada	68		72		1		2
Europe, Middle East and Africa	515		468		129		119
Asia Pacific	171		172		46		33
Total	$	9,993	$	8,826	$	1,016	$	962

During the nine months ended September 30, 2023 and 2022, no material charges were incurred resulting from net premiums exceeding gross premiums.

Table of Contents

NOTE 6 POLICYHOLDER ACCOUNT BALANCES

Policyholder Account Balances

The following tables provide the balances of and changes in the Company’s liability for its policyholder account balances, reflected in interest sensitive liabilities, for the nine months ended September 30, 2023 and 2022 (dollars in millions):


Nine months ended September 30, 2023:	U.S. and Latin America – Traditional			U.S. and Latin America – Financial Solutions			Asia Pacific – Financial Solutions
Balance, beginning of year	$	1,683		$	18,906		$	3,351
Deposits	20			84			765
Policy charges	(23)			(26)			(5)
Surrenders and withdrawals	(11)			(1,517)			(93)
Benefit payments	(96)			(357)			(79)
Interest credited	49			425			82
Foreign currency translation	—			—			(43)
Balance, end of period	$	1,622		$	17,515		$	3,978
Less: reinsurance recoverable	—			(1,501)			—
Balance, end of period, after reinsurance	$	1,622		$	16,014		$	3,978

Weighted-average crediting rate	4.4		%	3.3		%	3.0		%
Net amount at risk1	$	664		$	2,410		$	—
Cash surrender value	$	1,608		$	17,479		$	3,760


Nine months ended September 30, 2022:	U.S. and Latin America – Traditional			U.S. and Latin America – Financial Solutions			Asia Pacific – Financial Solutions
Balance, beginning of year	$	1,719		$	18,758		$	1,621
Deposits	22			1,249			1,750
Policy charges	(24)			(25)			(126)
Surrenders and withdrawals	(13)			(870)			(585)
Benefit payments	(63)			(337)			(30)
Interest credited	49			452			29
Foreign currency translation	—			—			(66)
Balance, end of period	$	1,690		$	19,227		$	2,593
Less: reinsurance recoverable	—			(1,545)			—
Balance, end of period, after reinsurance	$	1,690		$	17,682		$	2,593

Weighted-average crediting rate	4.0		%	3.2		%	2.2		%
Net amount at risk1	$	681		$	2,532		$	—
Cash surrender value	$	1,675		$	19,166		$	2,468

(1) The Net amount at risk is defined as the guarantee amount less the account value as of the balance sheet date. The balance represents the amount of the claim that the Company would incur if death claims were filed on all contracts on the balance sheet date.

Information regarding the Company’s policyholder account balances as of September 30, 2023 and 2022 is as follows (dollars in millions):


	September 30,
	2023		2022
Policyholder account balances included in the rollforwards:
Traditional:
U.S. and Latin America	$	1,622	$	1,690
Financial Solutions:
U.S. and Latin America	17,515		19,227
Asia Pacific	3,978		2,593
Other policyholder account balances
U.S. and Latin America – Financial Solutions	51		71
Total policyholder account balances	$	23,166	$	23,581

Table of Contents

The balance of account values by range of guaranteed minimum crediting rates and the related range of difference, in basis points, between rates being credited to policyholders and the respective guaranteed minimums as of September 30, 2023 and 2022 is as follows (dollars in millions):


	September 30, 2023
	Range of Guaranteed Minimum Crediting Rate	At Guaranteed Minimum		1 Basis Point – 50 Basis Points Above		51 Basis Points – 100 Basis Points Above		101 Basis Points – 150 Basis Points Above		Greater Than 150 Basis Points Above		Total

U.S. and Latin America – Traditional	Less than 1.00%	$	—	$	—	$	—	$	—	$	—	$	—
	1.00 – 1.99%	—		—		—		—		—		—
	2.00 – 2.99%	—		—		—		—		—		—
	3.00 – 3.99%	—		—		—		—		—		—
	4.00% and Greater	514		108		1,000		—		—		1,622
	Total	$	514	$	108	$	1,000	$	—	$	—	$	1,622

U.S. and Latin America – Financial Solutions	Less than 1.00%	$	—	$	—	$	—	$	—	$	—	$	—
	1.00 – 1.99%	1,681		10		15		63		35		1,804
	2.00 – 2.99%	1,625		14		42		608		62		2,351
	3.00 – 3.99%	4,335		234		81		2		—		4,652
	4.00% and Greater	8,665		43		—		—		—		8,708
	Total	$	16,306	$	301	$	138	$	673	$	97	$	17,515

Asia Pacific – Financial Solutions	Less than 1.00%	$	281	$	—	$	—	$	—	$	—	$	281
	1.00 – 1.99%	699		—		—		—		—		699
	2.00 – 2.99%	827		—		—		—		—		827
	3.00 – 3.99%	1,289		—		—		—		—		1,289
	4.00% and Greater	882		—		—		—		—		882
	Total	$	3,978	$	—	$	—	$	—	$	—	$	3,978

Table of Contents


	September 30, 2022
	Range of Guaranteed Minimum Crediting Rate	At Guaranteed Minimum		1 Basis Point – 50 Basis Points Above		51 Basis Points – 100 Basis Points Above		101 Basis Points – 150 Basis Points Above		Greater Than 150 Basis Points Above		Total

U.S. and Latin America – Traditional	Less than 1.00%	$	—	$	—	$	—	$	—	$	—	$	—
	1.00 – 1.99%	—		—		—		—		—		—
	2.00 – 2.99%	—		—		—		—		—		—
	3.00 – 3.99%	—		—		—		—		—		—
	4.00% and Greater	550		1,140		—		—		—		1,690
	Total	$	550	$	1,140	$	—	$	—	$	—	$	1,690

U.S. and Latin America – Financial Solutions	Less than 1.00%	$	—	$	—	$	—	$	—	$	—	$	—
	1.00 – 1.99%	1,963		14		44		58		41		2,120
	2.00 – 2.99%	2,023		7		145		636		—		2,811
	3.00 – 3.99%	5,092		242		60		—		—		5,394
	4.00% and Greater	8,853		49		—		—		—		8,902
	Total	$	17,931	$	312	$	249	$	694	$	41	$	19,227

Asia Pacific – Financial Solutions	Less than 1.00%	$	426	$	—	$	—	$	—	$	—	$	426
	1.00 – 1.99%	782		—		—		—		—		782
	2.00 – 2.99%	609		—		—		—		—		609
	3.00 – 3.99%	769		—		—		—		—		769
	4.00% and Greater	7		—		—		—		—		7
	Total	$	2,593	$	—	$	—	$	—	$	—	$	2,593

NOTE 7 UNPAID CLAIMS AND CLAIM EXPENSE – SHORT-DURATION CONTRACTS

Rollforward of Claims and Claim Adjustment Expenses

The liability for unpaid claims for short-duration contracts is reported in other policy claims and benefits on the Company’s condensed consolidated balance sheets. Activity associated with unpaid claims is summarized below (dollars in millions):


	Nine months ended September 30,
	2023		2022
Balance, beginning of year	$	2,480	$	2,110
Less: reinsurance recoverable	(57)		(81)
Net balance, beginning of year	2,423		2,029
Incurred:
Current year	1,268		1,419
Prior years	(89)		(100)
Total incurred	1,179		1,319
Payments:
Current year	(278)		(250)
Prior years	(721)		(688)
Total payments	(999)		(938)
Other changes:
Interest accretion	25		21
Foreign exchange adjustments	(45)		(128)
Total other changes	(20)		(107)

Net balance, end of period	2,583		2,303
Plus: reinsurance recoverable	71		63
Balance, end of period	$	2,654	$	2,366

Table of Contents

Incurred claims associated with prior periods are primarily due to the development of short-duration business claims for prior years being different than were anticipated when the liabilities for unpaid claims were originally estimated. These trends have been considered in establishing the current year liability for unpaid claims.

NOTE 8 MARKET RISK BENEFITS

The following table provides the balances of and changes in the Company’s market risk benefits for the nine months ended September 30, 2023 and 2022 (dollars in millions):


	U.S. and Latin America – Financial Solutions
	Nine months ended September 30,
	2023		2022
Balance, beginning of year	$	247	$	262
Balance, beginning of year, before effect of changes in the instrument-specific credit risk	263		254
Interest accrual	9		21
Attributed fees collected	19		7
Benefit payments	1		1
Effect of changes in future assumptions	16		19
Effect of changes in interest rates	(54)		(40)
Effect of changes in equity markets	(25)		17
Effect of changes in volatility	(5)		4
Other market impacts	(11)		1
Actual policyholder behavior different from expected behavior	12		(1)
Balance, end of period, before effect of changes in the instrument-specific credit risk	225		283
Effect of changes in the instrument-specific credit risk	(9)		(24)
Balance, end of period	216		259
Less: reinsurance recoverable	—		—
Balance, end of period, after reinsurance	$	216	$	259

Net amount at risk	$	1,375	$	1,540
Weighted-average attained age of contract holders (in years)	71		66

The reconciliation of the rollforward for market risk benefits to the condensed consolidated balance sheets as of September 30, 2023 and 2022 is as follows (dollars in millions):


	September 30,						September 30,
	2023						2022
	Asset (1)		Liability		Net		Asset (1)		Liability		Net
U.S. and Latin America – Financial Solutions	$	8	$	224	$	(216)	$	—	$	259	$	(259)
Total market risk benefits	$	8	$	224	$	(216)	$	—	$	259	$	(259)

(1)Included in Other assets

Fair Value Measurement

See Note 13 – “Fair Value of Assets and Liabilities” for information about fair value measurement of assets and liabilities, except for market risk benefits.

Market risk benefits are classified within Level 3 on the fair value hierarchy. The fair value of market risk benefits is monitored through the use of attribution reports to quantify the effect of underlying sources of fair value change, including capital market inputs based on policyholder account values, interest rates and short-term and long-term implied volatility from period to period.

During the nine months ended September 30, 2023 and 2022, there were no material changes made to the inputs in the market risk benefit calculations, and nonfinancial assumptions were unchanged.

Table of Contents

NOTE 9 DEFERRED POLICY ACQUISITION COSTS

The following tables provide the balances of and changes in deferred policy acquisition costs for the Company’s Traditional business for the nine months ended September 30, 2023 and 2022 (dollars in millions):


Nine months ended September 30, 2023:	U.S. and Latin America – Traditional		Canada – Traditional		Europe, Middle East and Africa – Traditional		Asia Pacific – Traditional
Balance, beginning of year	$	2,087	$	171	$	294	$	1,043
Capitalization	183		7		75		94
Amortization expense	(111)		(9)		(28)		(44)
Foreign currency translation	1		—		(10)		(24)
Balance, end of period	$	2,160	$	169	$	331	$	1,069


Nine months ended September 30, 2022:	U.S. and Latin America – Traditional		Canada – Traditional		Europe, Middle East and Africa – Traditional		Asia Pacific – Traditional
Balance, beginning of year	$	1,947	$	191	$	270	$	1,056
Capitalization	208		5		57		66
Amortization expense	(108)		(14)		(25)		(53)
Foreign currency translation	—		(16)		(40)		(57)
Balance, end of period	$	2,047	$	166	$	262	$	1,012

The following tables provide the balances of and changes in deferred policy acquisition costs for the Company’s Financial Solutions business for the nine months ended September 30, 2023 and 2022 (dollars in millions):


Nine months ended September 30, 2023:	U.S. and Latin America – Financial Solutions		Canada – Financial Solutions		Europe, Middle East and Africa – Financial Solutions		Asia Pacific – Financial Solutions
Balance, beginning of year	$	341	$	—	$	—	$	188
Capitalization	—		—		—		89
Amortization expense	(32)		—		—		(24)
Foreign currency translation	—		—		—		(6)
Balance, end of period	$	309	$	—	$	—	$	247


Nine months ended September 30, 2022:	U.S. and Latin America – Financial Solutions		Canada – Financial Solutions		Europe, Middle East and Africa – Financial Solutions		Asia Pacific – Financial Solutions
Balance, beginning of year	$	312	$	—	$	—	$	81
Capitalization	85		—		—		92
Amortization expense	(42)		—		—		(13)
Foreign currency translation	—		—		—		(2)
Balance, end of period	$	355	$	—	$	—	$	158

Table of Contents

The reconciliation of deferred policy acquisition costs to the condensed consolidated balance sheets as of September 30, 2023 and 2022 is as follows (dollars in millions):


	September 30,
	2023		2022
Deferred policy acquisition costs included in the rollforwards:
Traditional:
U.S. and Latin America	$	2,160	$	2,047
Canada	169		166
Europe, Middle East and Africa	331		262
Asia Pacific	1,069		1,012
Financial Solutions:
U.S. and Latin America	309		355
Canada	—		—
Europe, Middle East and Africa	—		—
Asia Pacific	247		158
Other long-duration business:
Corporate and Other	4		4
Total deferred policy acquisition costs	$	4,289	$	4,004

NOTE 10 REINSURANCE CEDED RECEIVABLES AND OTHER

Retrocession reinsurance treaties do not relieve the Company from its obligations to direct writing companies. Failure of retrocessionaires to honor their obligations could result in losses to the Company. Consequently, allowances would be established for amounts deemed uncollectible. The Company regularly evaluates the financial condition of the insurance companies from which it assumes and to which it cedes reinsurance. At September 30, 2023 and December 31, 2022, no allowances were deemed necessary.

Two major reinsurance companies account for approximately 68% of reinsurance ceded receivables and other as of September 30, 2023. Retrocessions are arranged through the Company’s retrocession pools for amounts in excess of the Company’s retention limit. As of September 30, 2023, all rated retrocession pool participants followed by the A.M. Best Company were rated “A- (excellent)” or better. The Company verifies retrocession pool participants’ ratings on a quarterly basis. For a majority of the retrocessionaires that were not rated, security in the form of letters of credit or trust assets have been posted. In addition, the Company performs annual financial reviews of its retrocessionaires to evaluate financial stability and performance.

Included in the total reinsurance ceded receivables and other balance are $108 million and $183 million of claims recoverable, of which $12 million and $16 million were in excess of 90 days past due, as of September 30, 2023 and December 31, 2022, respectively. Also included in the total reinsurance ceded receivable and other is a deposit asset on reinsurance of $1.6 billion and $1.6 billion as of September 30, 2023 and December 31, 2022, respectively.

Table of Contents

NOTE 11 INVESTMENTS

Fixed Maturity Securities Available-for-Sale

The Company holds various types of fixed maturity securities available-for-sale and classifies them as corporate securities (“Corporate”), Canadian and Canadian provincial government securities (“Canadian government”), ~~residential mortgage-backed securities~~Japanese government and agencies (“~~RMBS”~~Japanese government”), asset-backed securities (“ABS”), commercial mortgage-backed securities (“CMBS”), residential mortgage-backed securities (“RMBS”), U.S. government and agencies (“U.S. government”), state and political subdivisions, and other foreign government, supranational and foreign government-sponsored enterprises (“Other foreign government”). ~~RMBS,~~ ABS, CMBS and ~~CMBS~~RMBS are collectively “structured securities.”

The following tables provide information relating to investments in fixed maturity securities by type as of September 30, ~~2022~~2023 and December 31, ~~2021~~2022 (dollars in millions):


September 30, 2022:		Amortized Cost		Allowance for Credit Losses		Unrealized Gains		Unrealized Losses		Estimated Fair Value		% of Total
September 30, 2023:														September 30, 2023:	Amortized		Allowance for		Unrealized		Unrealized		Estimated Fair		% of
															Cost		Credit Losses		Gains		Losses		Value		Total
Available-for-sale:	Available-for-sale:													Available-for-sale:
Corporate	Corporate	$	38,293	$	43	$	163	$	5,758	$	32,655	64.6	%	Corporate	$	41,463	$	55	$	170	$	6,075	$	35,503	65.5	%
Canadian government	Canadian government	3,124		—		503		41		3,586		7.1		Canadian government	3,336		—		169		157		3,348		6.2
RMBS		1,054		—		4		105		953		1.9
Japanese government														Japanese government	3,205		—		3		493		2,715		5.0
ABS	ABS	4,165		4		6		444		3,723		7.4		ABS	4,562		12		16		330		4,236		7.8
CMBS	CMBS	1,843		1		3		175		1,670		3.3		CMBS	1,959		1		2		250		1,710		3.2
RMBS														RMBS	1,172		—		3		145		1,030		1.9
U.S. government	U.S. government	1,064		—		3		204		863		1.7		U.S. government	1,346		—		—		286		1,060		2.0
State and political subdivisions	State and political subdivisions	1,254		—		9		177		1,086		2.2		State and political subdivisions	1,242		—		4		199		1,047		1.9
Other foreign government	Other foreign government	6,833		4		21		891		5,959		11.8		Other foreign government	4,047		—		23		548		3,522		6.5
Total fixed maturity securities	Total fixed maturity securities	$	57,630	$	52	$	712	$	7,795	$	50,495	100.0	%	Total fixed maturity securities	$	62,332	$	68	$	390	$	8,483	$	54,171	100.0	%


December 31, 2021:		Amortized Cost		Allowance for Credit Losses		Unrealized Gains		Unrealized Losses		Estimated Fair Value		% of Total
December 31, 2022:														December 31, 2022:	Amortized		Allowance for		Unrealized		Unrealized		Estimated Fair		% of
															Cost		Credit Losses		Gains		Losses		Value		Total
Available-for-sale:	Available-for-sale:													Available-for-sale:
Corporate	Corporate	$	35,239	$	26	$	3,084	$	194	$	38,103	62.8	%	Corporate	$	38,963	$	27	$	168	$	5,135	$	33,969	64.2	%
Canadian government	Canadian government	3,339		—		1,606		1		4,944		8.1		Canadian government	3,311		—		381		66		3,626		6.9
RMBS		1,020		—		37		7		1,050		1.7
Japanese government														Japanese government	3,033		—		4		478		2,559		4.8
ABS	ABS	4,024		—		22		41		4,005		6.6		ABS	4,324		10		4		440		3,878		7.3
CMBS	CMBS	1,790		1		66		6		1,849		3.0		CMBS	1,835		—		—		212		1,623		3.1
RMBS														RMBS	1,054		—		1		114		941		1.8
U.S. government	U.S. government	2,082		—		31		8		2,105		3.5		U.S. government	1,690		—		4		212		1,482		2.8
State and political subdivisions	State and political subdivisions	1,191		—		137		5		1,323		2.2		State and political subdivisions	1,282		—		10		173		1,119		2.1
Other foreign government	Other foreign government	7,188		4		273		87		7,370		12.1		Other foreign government	4,171		—		22		489		3,704		7.0
Total fixed maturity securities	Total fixed maturity securities	$	55,873	$	31	$	5,256	$	349	$	60,749	100.0	%	Total fixed maturity securities	$	59,663	$	37	$	594	$	7,319	$	52,901	100.0	%

The Company enters into various collateral arrangements with counterparties that require both the pledging and acceptance of fixed maturity securities as collateral. Pledged fixed maturity securities are included in fixed maturity securities available-for-sale in the condensed consolidated balance sheets. Fixed maturity securities received as collateral are held in separate custodial accounts and are not recorded on the Company’s condensed consolidated balance sheets. Subject to certain constraints, the Company is permitted by contract to sell or repledge collateral it receives; however, as of September 30, ~~2022~~2023 and December 31, ~~2021,~~2022, none of the collateral received had been sold or repledged. The Company also holds assets in trust to satisfy collateral requirements under derivative transactions and certain third-party reinsurance treaties. The following table includes fixed maturity securities pledged and received as collateral and assets in trust held to satisfy collateral requirements

~~Table of Contents~~

under derivative transactions and certain third-party reinsurance treaties as of September 30, ~~2022~~2023 and December 31, ~~2021~~2022 (dollars in millions):


		September 30, 2022				December 31, 2021					September 30, 2023				December 31, 2022
		Amortized Cost		Estimated Fair Value		Amortized Cost		Estimated Fair Value			Amortized Cost		Estimated Fair Value		Amortized Cost		Estimated Fair Value
Fixed maturity securities pledged as collateral	Fixed maturity securities pledged as collateral	$	414	$	362	$	100	$	103	Fixed maturity securities pledged as collateral	$	588	$	488	$	355	$	292
Fixed maturity securities received as collateral	Fixed maturity securities received as collateral	n/a		1,273		n/a		1,922		Fixed maturity securities received as collateral	n/a		$	1,625	n/a		$	1,428
Assets in trust held to satisfy collateral requirements	Assets in trust held to satisfy collateral requirements	31,060		26,993		28,671		31,173		Assets in trust held to satisfy collateral requirements	$	32,645	$	28,354	$	31,510	$	27,817

Table of Contents

The Company monitors its concentrations of financial instruments on an ongoing basis and mitigates credit risk by maintaining a diversified investment portfolio that limits exposure to any one issuer. The Company’s exposure to concentrations of credit risk from single issuers greater than 10% of the Company’s equity included securities of the U.S. government and its agencies and the Japanese government and its agencies, as well as the securities disclosed below, as of September 30, ~~2022~~2023 and December 31, ~~2021~~2022 (dollars in millions).


		September 30, 2022				December 31, 2021					September 30, 2023				December 31, 2022
		Amortized Cost		Estimated Fair Value		Amortized Cost		Estimated Fair Value			Amortized Cost		Estimated Fair Value		Amortized Cost		Estimated Fair Value
Fixed maturity securities guaranteed or issued by:	Fixed maturity securities guaranteed or issued by:									Fixed maturity securities guaranteed or issued by:
Government of Japan		$	2,761	$	2,440	$	3,080	$	3,063

Canadian province of Quebec	Canadian province of Quebec	1,304		1,646		1,377		2,347		Canadian province of Quebec	$	1,415	$	1,465	$	1,436	$	1,649
Canadian province of Ontario	Canadian province of Ontario	964		1,058		1,092		1,451		Canadian province of Ontario	1,001		1,014		982		1,068

The amortized cost and estimated fair value of fixed maturity securities classified as available-for-sale as of September 30, ~~2022,~~2023, are shown by contractual maturity in the table below (dollars in millions). Actual maturities can differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Structured securities are shown separately in the table below, as they are not due at a single maturity date.


		Amortized Cost		Estimated Fair Value			Amortized Cost		Estimated Fair Value
Available-for-sale:	Available-for-sale:					Available-for-sale:
Due in one year or less	Due in one year or less	$	1,480	$	1,473	Due in one year or less	$	1,623	$	1,628
Due after one year through five years	Due after one year through five years	9,448		9,138		Due after one year through five years	10,151		9,779
Due after five years through ten years	Due after five years through ten years	11,292		10,015		Due after five years through ten years	11,183		9,987
Due after ten years	Due after ten years	28,348		23,523		Due after ten years	31,682		25,801
Structured securities	Structured securities	7,062		6,346		Structured securities	7,693		6,976
Total	Total	$	57,630	$	50,495	Total	$	62,332	$	54,171

Corporate Fixed Maturity Securities

The tables below show the major sectors of the Company’s corporate fixed maturity holdings as of September 30, ~~2022~~2023 and December 31, ~~2021~~2022 (dollars in millions):

September 30, 2022: Estimated
Amortized Cost Fair Value % of Total
Finance $ 14,152 $ 12,064 36.9 %
Industrial 19,434 16,736 51.3
Utility 4,707 3,855 11.8
Total $ 38,293 $ 32,655 100.0 %
December 31, 2021: Estimated
Amortized Cost Fair Value % of Total
Finance $ 13,101 $ 14,045 36.9 %
Industrial 17,857 19,375 50.8
Utility 4,281 4,683 12.3
Total $ 35,239 $ 38,103 100.0 %

~~Table of Contents~~


September 30, 2023:			Estimated
	Amortized Cost		Fair Value		% of Total
Finance	$	15,022	$	12,842	36.1	%
Industrial	21,062		18,232		51.4
Utility	5,379		4,429		12.5

Total	$	41,463	$	35,503	100.0	%

December 31, 2022:			Estimated
	Amortized Cost		Fair Value		% of Total
Finance	$	14,551	$	12,680	37.3	%
Industrial	19,624		17,257		50.8
Utility	4,788		4,032		11.9
Total	$	38,963	$	33,969	100.0	%

Allowance for Credit Losses and Impairments – Fixed Maturity Securities Available-for-Sale

As discussed in Note 2 – “Significant Accounting Policies and Pronouncements” of the Company’s ~~2021~~2022 Annual Report, allowances for credit losses on fixed maturity securities are recognized in investment related gains (losses), net. The amount recognized represents the difference between the amortized cost of the security and the net present value of its projected future cash flows discounted at the effective interest rate implicit in the fixed maturity security prior to the allowance for credit losses. Any remaining difference between the fair value and amortized cost is recognized in OCI.

Table of Contents

The following tables present the rollforward of the allowance for credit losses in fixed maturity securities by type for the three and nine months ended September 30, ~~2022 and 2021~~2023 ~~(dollars~~and 2022 (dollars in millions):


		Nine months ended September 30, 2022
		Corporate		ABS		CMBS		Other Foreign Government		Total			Corporate		ABS		CMBS		Other Foreign Government		Total
Three months ended September 30, 2023:												Three months ended September 30, 2023:
Balance, beginning of period												Balance, beginning of period	$	62	$	12	$	1	$	—	$	75

Additional increases or decreases for credit losses on securities that had an allowance recorded in a previous period												Additional increases or decreases for credit losses on securities that had an allowance recorded in a previous period	(1)		—		—		—		(1)

Write-offs charged against the allowance												Write-offs charged against the allowance	(6)		—		—		—		(6)
Balance, end of period												Balance, end of period	$	55	$	12	$	1	$	—	$	68
Three months ended September 30, 2022:												Three months ended September 30, 2022:
Balance, beginning of period	Balance, beginning of period	$	26	$	—	$	1	$	4	$	31	Balance, beginning of period	$	43	$	5	$	1	$	6	$	55
Credit losses recognized on securities for which credit losses were not previously recorded	Credit losses recognized on securities for which credit losses were not previously recorded	26		4		—		1		31		Credit losses recognized on securities for which credit losses were not previously recorded	8		(1)		—		—		7

Reductions for securities sold during the period	Reductions for securities sold during the period	(9)		—		—		(3)		(12)		Reductions for securities sold during the period	(3)		—		—		(2)		(5)
Reductions for securities the Company intends to sell or more likely than not will be required to sell before recovery of its amortized cost	Reductions for securities the Company intends to sell or more likely than not will be required to sell before recovery of its amortized cost	(4)		—		—		—		(4)		Reductions for securities the Company intends to sell or more likely than not will be required to sell before recovery of its amortized cost	(4)		—		—		—		(4)
Additional increases or decreases for credit losses on securities that had an allowance recorded in a previous period	Additional increases or decreases for credit losses on securities that had an allowance recorded in a previous period	4		—		—		2		6		Additional increases or decreases for credit losses on securities that had an allowance recorded in a previous period	(1)		—		—		—		(1)

Balance, end of period	Balance, end of period	$	43	$	4	$	1	$	4	$	52	Balance, end of period	$	43	$	4	$	1	$	4	$	52


		Nine months ended September 30, 2021								Corporate	ABS				CMBS		Other Foreign Government				Total
Nine months ended September 30, 2023:														Nine months ended September 30, 2023:
Balance, beginning of year														Balance, beginning of year	$	27	$	10	$	—	$	—	$	37
Credit losses recognized on securities for which credit losses were not previously recorded														Credit losses recognized on securities for which credit losses were not previously recorded	44		—		1		—		45
Reductions for securities sold during the period														Reductions for securities sold during the period	(10)		—		—		—		(10)
		Corporate		ABS		CMBS		Other Foreign Government				Total
Balance, beginning of period		$	17	$	—	$	3	$	—			$	20
Additional increases or decreases for credit losses on securities that had an allowance recorded in a previous period														Additional increases or decreases for credit losses on securities that had an allowance recorded in a previous period	—		2		—		—		2
Write-offs charged against the allowance														Write-offs charged against the allowance	(6)		—		—		—		(6)
Balance, end of period														Balance, end of period	$	55	$	12	$	1	$	—	$	68
Nine months ended September 30, 2022:														Nine months ended September 30, 2022:
Balance, beginning of year														Balance, beginning of year	$	26	$	—	$	1	$	4	$	31
Credit losses recognized on securities for which credit losses were not previously recorded	Credit losses recognized on securities for which credit losses were not previously recorded	5		—		1		4				10		Credit losses recognized on securities for which credit losses were not previously recorded	26		4		—		1		31
Reductions for securities sold during the period	Reductions for securities sold during the period	(8)		—		(2)		—				(10)		Reductions for securities sold during the period	(9)		—		—		(3)		(12)
Reductions for securities the Company intends to sell or more likely than not will be required to sell before recovery of its amortized cost	Reductions for securities the Company intends to sell or more likely than not will be required to sell before recovery of its amortized cost	—		—		—		—				—		Reductions for securities the Company intends to sell or more likely than not will be required to sell before recovery of its amortized cost	(4)		—		—		—		(4)
Additional increases or decreases for credit losses on securities that had an allowance recorded in a previous period	Additional increases or decreases for credit losses on securities that had an allowance recorded in a previous period	(2)		—		(1)		—				(3)		Additional increases or decreases for credit losses on securities that had an allowance recorded in a previous period	4		—		—		2		6

Balance, end of period	Balance, end of period	$	12	$	—	$	1	$	4			$	17	Balance, end of period	$	43	$	4	$	1	$	4	$	52

Unrealized Losses for Fixed Maturity Securities Available-for-Sale

The following tables present the estimated fair value and gross unrealized losses for the ~~6,618~~7,053 and ~~1,862~~6,441 fixed maturity securities for which an allowance for credit loss has not been recorded as of September 30, ~~2022~~2023 and December 31, ~~2021,~~2022, and the estimated fair value had declined and remained below amortized cost (dollars in millions). These investments are presented by class and grade of security, as well as the length of time the related fair value has continuously remained below amortized cost.

1343

Table of Contents


	Less than 12 months				12 months or greater				Total
			Gross				Gross				Gross
September 30, 2023:	Estimated		Unrealized		Estimated		Unrealized		Estimated		Unrealized
	Fair Value		Losses		Fair Value		Losses		Fair Value		Losses
Investment grade securities:
Corporate	$	7,272	$	516	$	23,093	$	5,395	$	30,365	$	5,911
Canadian government	1,303		105		250		52		1,553		157
Japanese government	614		50		2,055		443		2,669		493
ABS	471		18		3,071		299		3,542		317
CMBS	273		12		1,358		232		1,631		244
RMBS	295		14		641		131		936		145
U.S. government	488		28		559		258		1,047		286
State and political subdivisions	120		8		807		191		927		199
Other foreign government	686		29		2,194		451		2,880		480
Total investment grade securities	11,522		780		34,028		7,452		45,550		8,232
Below investment grade securities:
Corporate	357		70		732		93		1,089		163

ABS	—		—		67		11		67		11
CMBS	—		—		2		1		2		1
Other foreign government	4		1		184		67		188		68
Total below investment grade securities	361		71		985		172		1,346		243
Total fixed maturity securities	$	11,883	$	851	$	35,013	$	7,624	$	46,896	$	8,475

Less than 12 months 12 months or greater Total
Gross Gross Gross
September 30, 2022: Estimated Unrealized Estimated Unrealized Estimated Unrealized
Fair Value Losses Fair Value Losses Fair Value Losses
Investment grade securities:
Corporate $ 25,451 $ 4,761 $ 2,283 $ 811 $ 27,734 $ 5,572
Canadian government 368 36 12 5 380 41
RMBS 678 69 128 36 806 105
ABS 2,333 296 1,054 121 3,387 417
CMBS 1,461 149 83 17 1,544 166
U.S. government 721 190 116 14 837 204
State and political subdivisions 883 161 44 16 927 177
Other foreign government 3,834 509 1,291 290 5,125 799
Total investment grade securities 35,729 6,171 5,011 1,310 40,740 7,481

Below investment grade securities:
Corporate 1,144 118 202 62 1,346 180
ABS 53 12 23 7 76 19
CMBS 22 3 18 3 40 6
Other foreign government 186 28 124 62 310 90
Total below investment grade securities 1,405 161 367 134 1,772 295
Total fixed maturity securities $ 37,134 $ 6,332 $ 5,378 $ 1,444 $ 42,512 $ 7,776


		Less than 12 months				12 months or greater				Total					Less than 12 months				12 months or greater				Total
				Gross				Gross				Gross					Gross				Gross				Gross
December 31, 2021:		Estimated		Unrealized		Estimated		Unrealized		Estimated		Unrealized
December 31, 2022:														December 31, 2022:	Estimated		Unrealized		Estimated		Unrealized		Estimated		Unrealized
		Fair Value		Losses		Fair Value		Losses		Fair Value		Losses			Fair Value		Losses		Fair Value		Losses		Fair Value		Losses
Investment grade securities:	Investment grade securities:													Investment grade securities:
Corporate	Corporate	$	4,135	$	86	$	946	$	51	$	5,081	$	137	Corporate	$	21,867	$	2,756	$	6,840	$	2,225	$	28,707	$	4,981
Canadian government	Canadian government	20		1		—		—		20		1		Canadian government	554		42		71		23		625		65
RMBS		132		3		102		4		234		7
Japanese government														Japanese government	815		86		1,694		392		2,509		478
ABS	ABS	1,747		22		589		6		2,336		28		ABS	1,596		153		1,931		269		3,527		422
CMBS	CMBS	152		2		35		2		187		4		CMBS	1,314		144		281		65		1,595		209
RMBS														RMBS	664		62		181		53		845		115
U.S. government	U.S. government	1,513		6		31		2		1,544		8		U.S. government	1,202		64		253		148		1,455		212
State and political subdivisions	State and political subdivisions	109		3		28		2		137		5		State and political subdivisions	819		124		131		50		950		174
Other foreign government	Other foreign government	2,237		33		724		37		2,961		70		Other foreign government	1,942		167		1,026		260		2,968		427
Total investment grade securities	Total investment grade securities	10,045		156		2,455		104		12,500		260		Total investment grade securities	30,773		3,598		12,408		3,485		43,181		7,083
Below investment grade securities:	Below investment grade securities:													Below investment grade securities:
Corporate	Corporate	463		13		97		44		560		57		Corporate	767		87		305		61		1,072		148

ABS	ABS	—		—		13		13		13		13		ABS	52		6		38		9		90		15
CMBS		—		—		—		—		—		—

Other foreign government	Other foreign government	136		7		75		10		211		17		Other foreign government	39		2		164		60		203		62
Total below investment grade securities	Total below investment grade securities	599		20		185		67		784		87		Total below investment grade securities	858		95		507		130		1,365		225
Total fixed maturity securities	Total fixed maturity securities	$	10,644	$	176	$	2,640	$	171	$	13,284	$	347	Total fixed maturity securities	$	31,631	$	3,693	$	12,915	$	3,615	$	44,546	$	7,308

The Company ~~has no intention~~did not intend to sell, ~~nor does~~and it ~~expect to~~was not more likely than not that it would be required to sell, the securities outlined in the tables above, as of the dates indicated. However, unforeseen facts and circumstances may cause the Company to sell fixed maturity securities in the ordinary course of managing its portfolio to meet certain diversification, credit quality and liquidity guidelines. Changes in unrealized losses are primarily driven by changes in risk-free interest rates and credit spreads.

1444

Table of Contents

Net Investment Income

Major categories of net investment income consist of the following (dollars in millions):


		Three months ended September 30,				Nine months ended September 30,					Three months ended September 30,				Nine months ended September 30,
		2022		2021		2022		2021			2023		2022		2023		2022
Fixed maturity securities available-for-sale	Fixed maturity securities available-for-sale	$	591	$	519	$	1,683	$	1,530	Fixed maturity securities available-for-sale	$	707	$	591	$	2,035	$	1,683
Equity securities	Equity securities	2		1		5		4		Equity securities	2		2		5		5
Mortgage loans	Mortgage loans	74		81		223		220		Mortgage loans	84		74		238		223
Policy loans	Policy loans	13		14		40		41		Policy loans	13		13		39		40
Funds withheld at interest	Funds withheld at interest	67		100		175		279		Funds withheld at interest	88		67		240		175
Limited partnerships and real estate joint ventures										Limited partnerships and real estate joint ventures	41		43		114		281
Short-term investments and cash and cash equivalents	Short-term investments and cash and cash equivalents	7		1		11		2		Short-term investments and cash and cash equivalents	28		7		71		11
Other invested assets – limited partnerships and real estate joint ventures		43		96		281		327
Other invested assets – all other		3		14		5		44

Other invested assets										Other invested assets	2		3		14		5
Investment income	Investment income	800		826		2,423		2,447		Investment income	965		800		2,756		2,423
Investment expense	Investment expense	(31)		(30)		(90)		(80)		Investment expense	(43)		(31)		(121)		(90)
Net investment income	Net investment income	$	769	$	796	$	2,333	$	2,367	Net investment income	$	922	$	769	$	2,635	$	2,333

Investment Related Gains (Losses), Net

Investment related gains (losses), net consist of the following (dollars in millions):


		Three months ended September 30,				Nine months ended September 30,					Three months ended September 30,				Nine months ended September 30,
		2022		2021		2022		2021			2023		2022		2023		2022
Fixed maturity securities available-for-sale:	Fixed maturity securities available-for-sale:									Fixed maturity securities available-for-sale:
Change in allowance for credit losses and impairments		$	(9)	$	(1)	$	(36)	$	2
Change in allowance for credit losses										Change in allowance for credit losses	$	7	$	3	$	(31)	$	(21)
Impairments on fixed maturities										Impairments on fixed maturities	—		(12)		(1)		(15)
Realized gains on investment activity	Realized gains on investment activity	20		45		65		265		Realized gains on investment activity	12		20		54		65
Realized losses on investment activity	Realized losses on investment activity	(106)		(9)		(236)		(52)		Realized losses on investment activity	(61)		(106)		(173)		(236)
Net gains (losses) on equity securities	Net gains (losses) on equity securities	7		8		(16)		31		Net gains (losses) on equity securities	(2)		7		(4)		(16)
Other impairment losses and change in mortgage loan allowance for credit losses		(6)		4		(9)		25
Change in fair value of certain limited partnership investments and other, net		7		27		52		170
Net gains (losses) on derivatives		(47)		(16)		(334)		31
Change in mortgage loan allowance for credit losses										Change in mortgage loan allowance for credit losses	(17)		(5)		(23)		(8)
Change in fair value of certain limited partnership investments										Change in fair value of certain limited partnership investments	25		—		32		29
Other, net										Other, net	7		7		24		26
Net losses on free-standing derivatives										Net losses on free-standing derivatives	(98)		(51)		(222)		(251)
Net gains (losses) on embedded derivatives										Net gains (losses) on embedded derivatives	1		(17)		18		(106)
Total investment related gains (losses), net	Total investment related gains (losses), net	$	(134)	$	58	$	(514)	$	472	Total investment related gains (losses), net	$	(126)	$	(154)	$	(326)	$	(533)

Securities Borrowing, Lending and Repurchase/Reverse Repurchase Agreements

The following table provides information relating to securities borrowing, lending and repurchase/reverse repurchase agreements as of September 30, ~~2022~~2023 and December 31, ~~2021~~2022 (dollars in millions):


		September 30, 2022			December 31, 2021				September 30, 2023				December 31, 2022
		Amortized Cost	Estimated Fair Value		Amortized Cost	Estimated Fair Value			Amortized Cost		Estimated Fair Value		Amortized Cost		Estimated Fair Value
Securities borrowing agreements:	Securities borrowing agreements:							Securities borrowing agreements:
Securities borrowed (1)	Securities borrowed (1)	n/a	$	630	n/a	$	420	Securities borrowed (1)	n/a		$	776	n/a		$	852
Securities pledged as collateral (2)	Securities pledged as collateral (2)	545	459		279	290		Securities pledged as collateral (2)	$	762	$	603	$	859	$	693
Securities lending agreements:	Securities lending agreements:							Securities lending agreements:
Securities loaned (2)	Securities loaned (2)	59	55		94	102		Securities loaned (2)	$	60	$	53	$	59	$	55
Securities received as collateral (3)	Securities received as collateral (3)	n/a	66		n/a	102		Securities received as collateral (3)	n/a		$	66	n/a		$	66
Repurchase/reverse repurchase agreements:	Repurchase/reverse repurchase agreements:							Repurchase/reverse repurchase agreements:
Securities pledged (2)		745	629		704	736
Cash (4)		—	—		10	10
Securities received (3)		n/a	620		n/a	728
Securities sold (2)								Securities sold (2)	$	1,344	$	1,187	$	898	$	779

Securities purchased (3)								Securities purchased (3)	n/a		$	496	n/a		$	619
Cash received ~~(5)~~(4)	Cash received ~~(5)~~(4)	66	66		—	—		Cash received ~~(5)~~(4)	$	551	$	551	$	149	$	149

(1)Securities borrowed are not reflected on the condensed consolidated balance sheets. Collateral associated with certain borrowed securities is not included within this table as the collateral pledged to the counterparty is the right to reinsurance treaty cash flows.

(2)Securities loaned, ~~and~~ pledged or sold to counterparties are included within fixed maturity securities.

(3)Securities received as collateral or purchased from counterparties are not reflected on the condensed consolidated financial statements.

(4)~~A receivable for the cash held by counterparties is included within other assets.~~

~~(5)~~A payable for the cash received by the Company is included within other liabilities.

1545

Table of Contents

The following tables present information on the remaining contractual maturity of the Company’s securities lending and repurchase agreements as of September 30, ~~2022~~2023 and December 31, ~~2021~~2022 (dollars in millions):


		September 30, 2022											September 30, 2023
		Remaining Contractual Maturity of the Agreements											Remaining Contractual Maturity of the Agreements
		Overnight and Continuous		Up to 30 Days		30 – 90 Days		Greater than 90 Days		Total			Overnight and Continuous		Up to 30 Days		30 – 90 Days		Greater than 90 Days		Total
Securities lending agreements:	Securities lending agreements:											Securities lending agreements:
Corporate	Corporate	$	—	$	—	$	—	$	42	$	42	Corporate	$	—	$	—	$	—	$	37	$	37
Canadian government												Canadian government	—		—		—		—		—

State and political subdivisions	State and political subdivisions	—		—		—		3		3		State and political subdivisions	—		—		—		11		11
Other foreign government	Other foreign government	—		—		—		10		10		Other foreign government	—		—		—		5		5
Total	Total	—		—		—		55		55		Total	—		—		—		53		53
Repurchase agreements:	Repurchase agreements:											Repurchase agreements:
Corporate	Corporate	—		—		—		278		278		Corporate	—		—		—		339		339

Japanese government												Japanese government	—		—		—		138		138
ABS												ABS	—		—		53		171		224
CMBS												CMBS	—		—		59		162		221
RMBS												RMBS	—		—		8		144		152
U.S. government												U.S. government	—		—		—		13		13

Other foreign government	Other foreign government	—		—		118		233		351		Other foreign government	—		—		—		100		100
Total	Total	—		—		118		511		629		Total	—		—		120		1,067		1,187
Total agreements	Total agreements	$	—	$	—	$	118	$	566	$	684	Total agreements	$	—	$	—	$	120	$	1,120	$	1,240


		December 31, 2021											December 31, 2022
		Remaining Contractual Maturity of the Agreements											Remaining Contractual Maturity of the Agreements
		Overnight and Continuous		Up to 30 Days		30 – 90 Days		Greater than 90 Days		Total			Overnight and Continuous		Up to 30 Days		30 – 90 Days		Greater than 90 Days		Total
Securities lending agreements:	Securities lending agreements:											Securities lending agreements:
Corporate	Corporate	$	—	$	—	$	—	$	94	$	94	Corporate	$	—	$	—	$	—	$	42	$	42
Canadian government												Canadian government	—		—		—		5		5

State and political subdivisions	State and political subdivisions	—		—		—		3		3		State and political subdivisions	—		—		—		3		3
Other foreign government	Other foreign government	—		—		—		5		5		Other foreign government	—		—		—		5		5
Total	Total	—		—		—		102		102		Total	—		—		—		55		55
Repurchase agreements:	Repurchase agreements:											Repurchase agreements:
Corporate	Corporate	—		—		—		366		366		Corporate	—		—		—		279		279

Japanese government												Japanese government	—		—		—		278		278
ABS												ABS	—		—		—		54		54
CMBS												CMBS	—		—		—		63		63
RMBS												RMBS	—		—		—		10		10

Other foreign government	Other foreign government	—		—		—		370		370		Other foreign government	—		—		—		95		95
Total	Total	—		—		—		736		736		Total	—		—		—		779		779
Total agreements	Total agreements	$	—	$	—	$	—	$	838	$	838	Total agreements	$	—	$	—	$	—	$	834	$	834

Table of Contents

Mortgage Loans

As of September 30, ~~2022,~~2023, mortgage loans were geographically dispersed throughout the U.S. with the largest concentrations in California ~~(13.1%~~(12.9%), Texas (11.4%) and Washington ~~(8.2%~~(7.8%), in addition to loans secured by properties in Canada ~~(3.1%~~(3.7%) and the United Kingdom ~~(2.3%~~(2.4%). The recorded investment in mortgage loans presented below is gross of unamortized deferred loan origination fees and expenses and allowance for credit losses.

The following table presents the distribution of the Company’s recorded investment in mortgage loans by property type as of September 30, ~~2022~~2023 and December 31, ~~2021~~2022 (dollars in millions):

September 30, 2022 December 31, 2021
Property type: Carrying Value % of Total Carrying Value % of Total
Office $ 1,727 26.1 % $ 1,683 26.6 %
Retail 2,317 35.0 2,090 33.0
Industrial 1,431 21.6 1,249 19.7
Apartment 751 11.4 801 12.7
Other commercial 387 5.9 506 8.0
Recorded investment 6,613 100.0 % 6,329 100.0 %
Unamortized balance of loan origination fees and expenses (12) (11)
Allowance for credit losses (43) (35)
Total mortgage loans $ 6,558 $ 6,283

~~Table of Contents~~


	September 30, 2023				December 31, 2022
Property type:	Carrying Value		% of Total		Carrying Value		% of Total
Office	$	1,716	23.4	%	$	1,706	25.6	%
Retail	2,445		33.4		2,290		34.4
Industrial	1,820		24.9		1,518		22.8
Apartment	870		11.9		763		11.5
Other commercial	469		6.4		376		5.7
Recorded investment	7,320		100.0	%	6,653		100.0	%
Unamortized balance of loan origination fees and expenses	(15)				(12)
Allowance for credit losses	(74)				(51)
Total mortgage loans	$	7,231			$	6,590

The following table presents the maturities of the Company’s recorded investment in mortgage loans as of September 30, ~~2022~~2023 and December 31, ~~2021~~2022 (dollars in millions):


		September 30, 2022				December 31, 2021					September 30, 2023				December 31, 2022
		Recorded Investment		% of Total		Recorded Investment		% of Total			Recorded Investment		% of Total		Recorded Investment		% of Total
Due within five years	Due within five years	$	2,504	37.8	%	$	2,660	42.0	%	Due within five years	$	3,150	42.9	%	$	2,652	39.9	%
Due after five years through ten years	Due after five years through ten years	3,047		46.0		2,593		41.0		Due after five years through ten years	3,248		44.4		2,930		44.0
Due after ten years	Due after ten years	1,062		16.2		1,076		17.0		Due after ten years	922		12.7		1,071		16.1
Total	Total	$	6,613	100.0	%	$	6,329	100.0	%	Total	$	7,320	100.0	%	$	6,653	100.0	%

The following tables set forth certain key credit quality indicators of the Company’s recorded investment in mortgage loans as of September 30, ~~2022~~2023 and December 31, ~~2021~~2022 (dollars in millions):


		Recorded Investment															Recorded Investment
		Debt Service Ratios						Construction Loans									Debt Service Ratios								Construction loans
		>1.20x		1.00x – 1.20x		<1.00x				Total			% of Total		>1.20x				1.00x – 1.20x			<1.00x					Total			% of Total
September 30, 2022:
September 30, 2023:																September 30, 2023:
Loan-to-Value Ratio	Loan-to-Value Ratio															Loan-to-Value Ratio
0% – 59.99%	0% – 59.99%	$	3,334	$	226	$	74	$	27		$	3,661		55.3	%	0% – 59.99%	$	3,947		$	301		$	53	$	45		$	4,346		59.3	%
60% – 69.99%	60% – 69.99%	1,946		181		113		—			2,240			33.9		60% – 69.99%	1,929			154			29		—			2,112			28.9
70% – 79.99%	70% – 79.99%	434		34		35		—			503			7.6		70% – 79.99%	518			35			33		—			586			8.0
80% or greater	80% or greater	84		—		125		—			209			3.2		80% or greater	105			43			128		—			276			3.8
Total	Total	$	5,798	$	441	$	347	$	27		$	6,613		100.0	%	Total	$	6,499		$	533		$	243	$	45		$	7,320		100.0	%


		Recorded Investment															Recorded Investment
		Debt Service Ratios						Construction Loans									Debt Service Ratios								Construction loans
		>1.20x		1.00x – 1.20x		<1.00x				Total			% of Total		>1.20x				1.00x – 1.20x			<1.00x					Total			% of Total
December 31, 2021:
December 31, 2022:																December 31, 2022:
Loan-to-Value Ratio	Loan-to-Value Ratio															Loan-to-Value Ratio
0% – 59.99%	0% – 59.99%	$	3,111	$	238	$	51	$	6		$	3,406		53.8	%	0% – 59.99%	$	3,466		$	215		$	56	$	18		$	3,755		56.4	%
60% – 69.99%	60% – 69.99%	1,906		190		46		—			2,142			33.8		60% – 69.99%	1,894			119			71		—			2,084			31.3
70% – 79.99%	70% – 79.99%	520		41		12		—			573			9.1		70% – 79.99%	475			49			91		—			615			9.3
80% or greater	80% or greater	148		—		60		—			208			3.3		80% or greater	81			—			118		—			199			3.0
Total	Total	$	5,685	$	469	$	169	$	6		$	6,329		100.0	%	Total	$	5,916		$	383		$	336	$	18		$	6,653		100.0	%

Table of Contents

The following table sets forth credit quality grades by year of origination of the Company’s recorded investment in mortgage loans as of September 30, ~~2022~~2023 and December 31, ~~2021~~2022 (dollars in millions):


		Recorded Investment															Recorded Investment
		Year of Origination															Year of Origination
		2022		2021		2020		2019		2018		Prior		Total			2023		2022		2021		2020		2019		Prior		Total
September 30, 2022:
September 30, 2023:																September 30, 2023:
Internal credit quality grade:	Internal credit quality grade:															Internal credit quality grade:
High investment grade	High investment grade	$	619	$	697	$	331	$	568	$	417	$	1,538	$	4,170	High investment grade	$	336	$	686	$	670	$	334	$	520	$	1,851	$	4,397
Investment grade	Investment grade	460		284		245		323		279		629		2,220		Investment grade	599		615		281		219		326		608		2,648
Average	Average	—		6		—		26		66		89		187		Average	—		—		6		18		23		200		247
Watch list		—		—		—		—		—		—		—

In or near default	In or near default	—		—		—		—		—		36		36		In or near default	—		—		—		—		—		28		28
Total	Total	$	1,079	$	987	$	576	$	917	$	762	$	2,292	$	6,613	Total	$	935	$	1,301	$	957	$	571	$	869	$	2,687	$	7,320

~~Table of Contents~~


		Recorded Investment															Recorded Investment
		Year of Origination															Year of Origination
		2021		2020		2019		2018		2017		Prior		Total			2022		2021		2020		2019		2018		Prior		Total
December 31, 2021:
December 31, 2022:																December 31, 2022:
Internal credit quality grade:	Internal credit quality grade:															Internal credit quality grade:
High investment grade	High investment grade	$	725	$	402	$	645	$	461	$	344	$	1,534	$	4,111	High investment grade	$	698	$	684	$	327	$	561	$	422	$	1,565	$	4,257
Investment grade	Investment grade	367		272		331		301		296		502		2,069		Investment grade	586		284		248		279		252		531		2,180
Average	Average	6		—		27		39		5		32		109		Average	—		6		—		39		52		83		180
Watch list		—		—		—		—		—		4		4

In or near default	In or near default	—		—		—		—		—		36		36		In or near default	—		—		—		—		—		36		36
Total	Total	$	1,098	$	674	$	1,003	$	801	$	645	$	2,108	$	6,329	Total	$	1,284	$	974	$	575	$	879	$	726	$	2,215	$	6,653

The following table presents the current and past due composition of the Company’s recorded investment in mortgage loans as of September 30, ~~2022~~2023 and December 31, ~~2021 (dollars in millions):~~2022.


		September 30, 2022		December 31, 2021			September 30, 2023		December 31, 2022
Current	Current	$	6,577	$	6,329	Current	$	7,292	$	6,617
31 – 60 days past due		17		—

Greater than 90 days		19		—

Greater than 90 days past due						Greater than 90 days past due	28		36
Total	Total	$	6,613	$	6,329	Total	$	7,320	$	6,653

The following table presents information regarding the Company’s allowance for credit losses for mortgage loans for the three and nine months ended September 30, ~~2022~~2023 and ~~2021~~2022 (dollars in millions):


		Three months ended September 30,				Nine months ended September 30,					Three months ended September 30,				Nine months ended September 30,
		2022		2021		2022		2021			2023		2022		2023		2022
Balance, beginning of period	Balance, beginning of period	$	38	$	45	$	35	$	64	Balance, beginning of period	$	57	$	38	$	51	$	35
Change in allowance for credit losses	Change in allowance for credit losses	5		(6)		8		(25)		Change in allowance for credit losses	17		5		23		8

Balance, end of period	Balance, end of period	$	43	$	39	$	43	$	39	Balance, end of period	$	74	$	43	$	74	$	43

~~For~~During the nine months ended September 30, 2023, the Company modified six mortgage loans for borrowers experiencing financial difficulty providing interest only payments and maturity extensions. The total recorded investment before allowance for credit losses for the modified loans were $68 million as of September 30, 2023. During the nine months ended September 30, 2022, the Company restructured 3three mortgage loans to interest only payments, one of which was paid in full as ~~a result~~ of ~~lower occupancy levels.~~December 31, 2022. The total recorded investment before allowance for credit losses for mortgage loans ~~which~~that were modified and met the criteria of Troubled Debt Restructuring (“TDR”)~~, is~~ was $77 million as of September 30, 2022. ~~For~~

During the nine months ended September 30, ~~2021,~~2023, the Company ~~did not have any significant~~converted two mortgage loans totaling $36 million to owned properties as a result of foreclosures. The Company had $41 million and $19 million for mortgage loans that were ~~modified and met the criteria of a TDR. The Company has a mortgage loan in the amount of $19 million that was~~ on a nonaccrual status as of September 30, ~~2022. The Company had no mortgage loans that were on a nonaccrual status as of September 30, 2021.~~2023 and 2022, respectively. The Company did not acquire any impaired mortgage loans during the nine months ended September 30, ~~2022~~2023 and ~~2021.~~2022.

Table of Contents

Policy Loans

The majority of policy loans are associated with one client. These policy loans present no credit risk as the amount of the loan cannot exceed the obligation due to the ceding company upon the death of the insured or surrender of the underlying policy. The provisions of the treaties in force and the underlying policies determine the policy loan interest rates. The Company earns a spread between the interest rate earned on policy loans and the interest rate credited to corresponding liabilities.

Funds Withheld at Interest

As of September 30, ~~2022, $4.0~~2023, $3.5 billion of the funds withheld at interest balance is primarily associated with two clients. For reinsurance agreements written on a modco basis and certain agreements written on a coinsurance funds withheld basis, assets equal to the net statutory reserves are withheld and legally owned and managed by the ceding company and are reflected as funds withheld at interest. In the event of a ceding company’s insolvency, the Company would need to assert a claim on the assets supporting its reserve liabilities. However, the risk of loss to the Company is mitigated by its ability to offset amounts it owes the ceding company for claims or allowances against amounts owed to the Company from the ceding company.

Limited Partnerships and Real Estate Joint Ventures

~~Table~~The carrying values of ~~Contents~~limited partnerships and real estate joint ventures as of September 30, 2023 and December 31, 2022 are as follows (dollars in millions):


	September 30, 2023		December 31, 2022
Limited partnerships – equity method	$	930	$	934
Limited partnerships – fair value	818		683
Limited partnerships – cost method	68		49
Real estate joint ventures	744		661
Total limited partnerships and real estate joint ventures	$	2,560	$	2,327

Other Invested Assets

Other invested assets include ~~limited partnership interests, joint ventures (other than operating joint ventures),~~ lifetime mortgages and derivative contracts. Other invested assets also includes FHLB common stock, ~~and~~ unit-linked investments, and real estate held for investment, which are included in “Other” in the table below. As of September 30, ~~2022~~2023 and December 31, ~~2021,~~2022, the allowance for credit losses for lifetime mortgages was not material. The carrying values of other invested assets as of September 30, ~~2022~~2023 and December 31, ~~2021~~2022 are as follows (dollars in millions):


		September 30, 2022		December 31, 2021			September 30, 2023		December 31, 2022
Limited partnership interests and real estate joint ventures		$	2,196	$	1,996

Lifetime mortgages	Lifetime mortgages	786		758		Lifetime mortgages	$	900	$	868
Derivatives	Derivatives	161		175		Derivatives	75		170
Other	Other	103		141		Other	116		102
Total other invested assets	Total other invested assets	$	3,246	$	3,070	Total other invested assets	$	1,091	$	1,140

~~5. Derivative Instruments~~

~~Accounting for Derivative Instruments and Hedging Activities~~NOTE 12 DERIVATIVE INSTRUMENTS

See Note 2 – “Significant Accounting Policies and Pronouncements” of the Company’s ~~2021~~2022 Annual Report for a detailed discussion of the accounting treatment for derivative instruments, including embedded derivatives. See Note 613 – “Fair Value of Assets and Liabilities” for additional disclosures related to the fair value hierarchy for derivative instruments, including embedded derivatives.

~~Types of Derivatives Used by the Company~~

Commonly used derivative instruments include, but are not necessarily limited to: credit default swaps, ~~financial~~equity futures, equity options, foreign currency swaps, foreign currency forwards, interest rate swaps, interest rate options, interest rate futures, total return swaps, synthetic guaranteed investment contracts (“GICs”), consumer price index (“CPI”) swaps, forward bond purchase commitments, ~~total return swaps,~~ other derivatives and embedded derivatives.

For detailed information on these derivative instruments and the related strategies, see Note 5 – “Derivative Instruments” of the Company’s ~~2021~~2022 Annual Report.

Table of Contents

Summary of Derivative Positions

Derivatives, except for embedded derivatives, are included in other invested assets or other liabilities, at fair value. Embedded derivative assets and liabilities on modco or funds withheld arrangements are included on the condensed consolidated balance sheets with the host contract in funds withheld at interest or other liabilities, at fair value. Embedded derivative liabilities on indexed annuity ~~and variable annuity~~ products are included on the condensed consolidated balance sheets with the host contract in interest-sensitive contract liabilities, at fair value. The following table presents the notional amounts and gross fair value of derivative instruments prior to taking into account the netting effects of master netting agreements as of September 30, ~~2022~~2023 and December 31, ~~2021~~2022 (dollars in millions):


		September 30, 2023						December 31, 2022
	Primary Underlying Risk	Notional		Carrying Value/Fair Value				Notional		Carrying Value/Fair Value
		Amount		Assets		Liabilities		Amount		Assets		Liabilities
Derivatives not designated as hedging instruments:
Interest rate swaps	Interest rate	$	1,622	$	7	$	24	$	1,271	$	2	$	2
Interest rate options	Interest rate	6,555		30		—		7,756		34		—
Total return swaps	Interest rate	500		42		30		500		18		—
Interest rate futures	Interest rate	95		—		—		96		—		—
Equity futures	Equity	245		—		—		164		—		—
Foreign currency swaps	Foreign currency	150		32		—		150		18		—
Foreign currency forwards	Foreign currency	826		—		24		766		50		—
CPI swaps	CPI	445		12		2		496		20		3
Credit default swaps	Credit	1,515		3		38		1,523		2		21
Equity options	Equity	282		14		—		358		38		—
Synthetic GICs	Interest rate	16,535		—		—		17,411		—		—
Embedded derivatives in:
Modco or funds withheld arrangements		—		378		368		—		363		371
Indexed annuity products		—		—		441		—		—		530
Total non-hedging derivatives		28,770		518		927		30,491		545		927
Derivatives designated as hedging instruments:
Interest rate swaps	Foreign currency/Interest rate	2,340		6		180		1,310		3		113
Foreign currency swaps	Foreign currency	104		—		7		114		—		—
Foreign currency forwards	Foreign currency	1,146		22		1		1,019		38		1
Forward bond purchase commitments	Interest rate	1,073		—		159		407		—		96
Total hedging derivatives		4,663		28		347		2,850		41		210
Total derivatives		$	33,433	$	546	$	1,274	$	33,341	$	586	$	1,137

Table of Contents

September 30, 2022 December 31, 2021
Primary Underlying Risk Notional Carrying Value/Fair Value Notional Carrying Value/Fair Value
Amount Assets Liabilities Amount Assets Liabilities
Derivatives not designated as hedging instruments:
Interest rate swaps Interest rate $ 1,048 $ 2 $ 7 $ 1,273 $ 66 $ 1
Interest rate options Interest rate 5,312 40 — — — —
Total return swaps Interest rate 500 — 2 — — —
Financial futures Equity 215 — — 240 — —
Foreign currency swaps Foreign currency 150 27 — 150 1 —
Foreign currency forwards Foreign currency 776 — 34 395 2 4
CPI swaps CPI 462 25 8 563 34 7
Credit default swaps Credit 1,723 6 50 1,321 29 1
Equity options Equity 296 49 — 472 29 —
Synthetic GICs Interest rate 17,485 — — 16,143 — —
Embedded derivatives in:
Modco or funds withheld arrangements — 316 256 — 227 62
Indexed annuity products — — 550 — — 693
Variable annuity products — — 139 — — 162
Total non-hedging derivatives 27,967 465 1,046 20,557 388 930
Derivatives designated as hedging instruments:
Interest rate swaps Foreign currency/Interest rate 1,335 4 140 941 4 33
Foreign currency swaps Foreign currency 114 — 7 153 1 —
Foreign currency forwards Foreign currency 1,028 67 — 1,320 14 11
Forward bond purchase commitments Interest rate 407 — 109 545 14 1
Total hedging derivatives 2,884 71 256 2,959 33 45
Total derivatives $ 30,851 $ 536 $ 1,302 $ 23,516 $ 421 $ 975

Fair Value Hedges

The Company designates and reports ~~certain foreign currency swaps to hedge~~ the ~~foreign currency fair value exposure of foreign currency denominated assets~~following as fair value hedges when they meet the requirements of the general accounting principles for Derivatives and ~~Hedging~~Hedging: .(i) certain foreign currency swaps to hedge the foreign currency fair value exposure of foreign currency denominated assets; and (ii) interest rate swaps to convert fixed rate liabilities to floating rate liabilities. The gain or loss on the hedged item attributable to a change in foreign currency or interest rates and the offsetting gain or loss on the related foreign currency or interest rate swaps ~~as of~~for the three and nine months ended September 30, ~~2022~~2023 and ~~2021~~2022 were as follows (dollars in millions):


Type of Fair Value Hedge	Type of Fair Value Hedge	Hedged Item	Gains (Losses) Recognized for Derivatives		Gains (Losses) Recognized for Hedged Items		Type of Fair Value Hedge	Hedged Item	Investment Related Gains (Losses), Net				Interest Credited
			Investment Related Gains (Losses)						Derivatives		Hedged Items		Derivatives		Hedged Items
For the three months ended September 30, 2023:							For the three months ended September 30, 2023:
Interest rate swaps							Interest rate swaps	Interest-sensitive contract liabilities	$	—	$	—	$	(2)	$	2
Foreign currency swaps							Foreign currency swaps	Foreign-denominated fixed maturity securities	(4)		3		—		—
For the three months ended September 30, 2022:	For the three months ended September 30, 2022:						For the three months ended September 30, 2022:

Foreign currency swaps	Foreign currency swaps	Foreign-denominated fixed maturity securities	$	(7)	$	8	Foreign currency swaps	Foreign-denominated fixed maturity securities	(7)		8		—		—
For the three months ended September 30, 2021:
For the nine months ended September 30, 2023:							For the nine months ended September 30, 2023:
Interest rate swaps							Interest rate swaps	Interest-sensitive contract liabilities	—		—		(2)		2
Foreign currency swaps	Foreign currency swaps	Foreign-denominated fixed maturity securities	$	(4)	$	4	Foreign currency swaps	Foreign-denominated fixed maturity securities	(7)		5		—		—
For the nine months ended September 30, 2022:	For the nine months ended September 30, 2022:						For the nine months ended September 30, 2022:

Foreign currency swaps	Foreign currency swaps	Foreign-denominated fixed maturity securities	$	(8)	$	13	Foreign currency swaps	Foreign-denominated fixed maturity securities	(8)		13		—		—
For the nine months ended September 30, 2021:
Foreign currency swaps		Foreign-denominated fixed maturity securities	$	(6)	$	7

Cash Flow Hedges

Certain derivative instruments are designated as cash flow hedges when they meet the requirements of the general accounting principles for Derivatives and Hedging. The Company designates and accounts for the following as cash flow hedges: (i) certain interest rate swaps, in which the cash flows of assets and liabilities are variable based on a benchmark rate; (ii) certain interest rate swaps, in which the cash flows of assets are denominated in different currencies, commonly referred to as cross-currency swaps; (iii) certain interest rate swaps, in which floating rate assets are converted to fixed rate assets; and ~~(iii)~~(iv) forward bond purchase commitments.

~~Table of Contents~~

The following ~~tables present~~table presents the components of AOCI, before income tax, and the condensed consolidated income statement classification where the gain or loss is recognized related to cash flow hedges for the three and nine months ended September 30, ~~2022~~2023 and ~~2021~~2022 (dollars in millions):


		Three months ended September 30,					Three months ended September 30,
		2022		2021			2023		2022
Balance, beginning of period	Balance, beginning of period	$	(206)	$	(40)	Balance, beginning of period	$	(228)	$	(206)
Gains (losses), net deferred in other comprehensive income (loss)	Gains (losses), net deferred in other comprehensive income (loss)	(27)		(17)		Gains (losses), net deferred in other comprehensive income (loss)	(128)		(27)

Amounts reclassified to investment income		3		—
Amounts reclassified to net investment income						Amounts reclassified to net investment income	8		3
Amounts reclassified to interest expense	Amounts reclassified to interest expense	—		2		Amounts reclassified to interest expense	(3)		—
Balance, end of period	Balance, end of period	$	(230)	$	(55)	Balance, end of period	$	(351)	$	(230)

		Nine months ended September 30,					Nine months ended September 30,
		2022		2021			2023		2022
Balance, beginning of period	Balance, beginning of period	$	(22)	$	(49)	Balance, beginning of period	$	(205)	$	(22)
Gains (losses), net deferred in other comprehensive income (loss)	Gains (losses), net deferred in other comprehensive income (loss)	(215)		(12)		Gains (losses), net deferred in other comprehensive income (loss)	(154)		(215)

Amounts reclassified to investment income		5		—
Amounts reclassified to net investment income						Amounts reclassified to net investment income	15		5
Amounts reclassified to interest expense	Amounts reclassified to interest expense	2		6		Amounts reclassified to interest expense	(7)		2
Balance, end of period	Balance, end of period	$	(230)	$	(55)	Balance, end of period	$	(351)	$	(230)

As of September 30, ~~2022,~~2023, approximately $8$17 million of before-tax deferred net ~~gains~~losses recorded in AOCI are expected to be reclassified to net investment income during the next twelve months. ~~As of September 30, 2022, approximately $1~~For the same time period, $11 million of before-tax deferred net ~~losses~~gains on derivative instruments recorded in AOCI are expected to be reclassified to interest expense during the next twelve months.

Table of Contents

The following table presents the effect of derivatives in cash flow hedging relationships on the condensed consolidated statements of income and the condensed consolidated statements of comprehensive income for the three and nine months ended September 30, ~~2022~~2023 and ~~2021~~2022 (dollars in millions):

Derivative Type Gains (Losses) Deferred in OCI Gains (Losses) Reclassified into Income from AOCI
Investment Income Interest Expense
For the three months ended September 30, 2022:
Interest rate $ (20) $ — $ —
Foreign currency/interest rate (7) (3) —
Total $ (27) $ (3) $ —
For the three months ended September 30, 2021:
Interest rate $ (12) $ — $ (2)
Foreign currency/interest rate (5) — —
Total $ (17) $ — $ (2)
For the nine months ended September 30, 2022:
Interest rate $ (190) $ — $ (2)
Foreign currency/interest rate (25) (5) —
Total $ (215) $ (5) $ (2)
For the nine months ended September 30, 2021:
Interest rate $ (6) $ — $ (6)
Foreign currency/interest rate (6) — —
Total $ (12) $ — $ (6)

~~Table of Contents~~


Derivative Type	Gains (Losses) Deferred in OCI		Gains (Losses) Reclassified into Income from AOCI
			Net Investment Income		Interest Expense
For the three months ended September 30, 2023:
Interest rate	$	(113)	$	(4)	$	3
Foreign currency/interest rate	(15)		(4)		—
Total	$	(128)	$	(8)	$	3
For the three months ended September 30, 2022:
Interest rate	$	(20)	$	—	$	—
Foreign currency/interest rate	(7)		(3)		—
Total	$	(27)	$	(3)	$	—

For the nine months ended September 30, 2023:
Interest rate	$	(107)	$	(4)	$	7
Foreign currency/interest rate	(47)		(11)		—
Total	$	(154)	$	(15)	$	7
For the nine months ended September 30, 2022:
Interest rate	$	(190)	$	—	$	(2)
Foreign currency/interest rate	(25)		(5)		—
Total	$	(215)	$	(5)	$	(2)

For the three and nine months ended September 30, ~~2022~~2023 and ~~2021,~~2022, there were no material amounts reclassified into earnings relating to instances in which the Company discontinued cash flow hedge accounting because the forecasted transaction did not occur by the anticipated date or within the additional time period permitted by the authoritative guidance for the accounting for derivatives and hedging.

Hedges of Net Investments in Foreign Operations

The Company uses foreign currency swaps and foreign currency forwards to hedge a portion of its net investment in certain foreign operations against adverse movements in exchange rates. The following table illustrates the Company’s net investments in foreign operations (“NIFO”) hedges and the gains (losses) deferred in OCI for the three and nine months ended September 30, ~~2022~~2023 and ~~2021~~2022 (dollars in millions):


		Derivative Gains (Losses) Deferred in OCI									Derivative Gains (Losses) Deferred in OCI
		Three months ended September 30,				Nine months ended September 30,					Three months ended September 30,				Nine months ended September 30,
Type of NIFO Hedge	Type of NIFO Hedge	2022		2021		2022		2021		Type of NIFO Hedge	2023		2022		2023		2022
Foreign currency swaps	Foreign currency swaps	$	—	$	2	$	1	$	(1)	Foreign currency swaps	$	—	$	—	$	—	$	1
Foreign currency forwards	Foreign currency forwards	66		28		88		4		Foreign currency forwards	29		66		8		88
Total	Total	$	66	$	30	$	89	$	3	Total	$	29	$	66	$	8	$	89

The cumulative foreign currency translation gain recorded in AOCI related to these hedges was ~~$226~~$218 million and ~~$137~~$210 million atas of September 30, ~~2022~~2023 and December 31, ~~2021,~~2022, respectively. If a hedged foreign operation was sold or substantially liquidated, the amounts in AOCI would be reclassified to the condensed consolidated statements of income. A pro rata portion would be reclassified upon partial sale of a hedged foreign operation. There were no sales or substantial liquidations of net investments in foreign operations that would have required the reclassification of gains or losses from AOCI into investment income during the periods presented.

Non-qualifying Derivatives and Derivatives for Purposes Other Than Hedging

The Company uses various other derivative instruments for risk management purposes that either do not qualify or have not been elected for hedge accounting treatment. The gain or loss related to the change in fair value for these derivative instruments is recognized in investment related gains (losses), net, except where otherwise noted.

2252

Table of Contents

A summary of the effect of non-hedging derivatives, including embedded derivatives, on the Company’s condensed consolidated statements of income for the three and nine months ended September 30, ~~2022~~2023 and ~~2021~~2022 is as follows (dollars in millions):


			Three months ended September 30,						Gains (Losses) for the three months ended September 30,
Type of Non-hedging Derivative	Type of Non-hedging Derivative	Income Statement Location of Gain (Loss)	2022		2021		Type of Non-hedging Derivative	Income Statement Location of Gains (Losses)	2023		2022
Interest rate swaps	Interest rate swaps	Investment related gains (losses), net	$	(33)	$	(4)	Interest rate swaps	Investment related gains (losses), net	$	(64)	$	(33)
Interest rate options	Interest rate options	Investment related gains (losses), net	18		—		Interest rate options	Investment related gains (losses), net	16		18
Total return swaps	Total return swaps	Investment related gains (losses), net	(1)		—		Total return swaps	Investment related gains (losses), net	(8)		(1)
Financial futures		Investment related gains (losses), net	7		—
Interest rate futures							Interest rate futures	Investment related gains (losses), net	—		2
Equity futures							Equity futures	Investment related gains (losses), net	11		5
Foreign currency swaps	Foreign currency swaps	Investment related gains (losses), net	9		3		Foreign currency swaps	Investment related gains (losses), net	8		9
Foreign currency forwards	Foreign currency forwards	Investment related gains (losses), net	(55)		(2)		Foreign currency forwards	Investment related gains (losses), net	(37)		(55)
CPI swaps	CPI swaps	Investment related gains (losses), net	7		12		CPI swaps	Investment related gains (losses), net	—		7
Credit default swaps	Credit default swaps	Investment related gains (losses), net	(12)		(12)		Credit default swaps	Investment related gains (losses), net	(26)		(12)
Equity options	Equity options	Investment related gains (losses), net	8		3		Equity options	Investment related gains (losses), net	3		8

Subtotal	Subtotal		(52)		—		Subtotal		(97)		(52)
Embedded derivatives in:	Embedded derivatives in:						Embedded derivatives in:
Modco or funds withheld arrangements	Modco or funds withheld arrangements	Investment related gains (losses), net	(17)		21		Modco or funds withheld arrangements	Investment related gains (losses), net	1		(17)

Indexed annuity products	Indexed annuity products	Interest credited	18		(15)		Indexed annuity products	Interest credited	3		18
Variable annuity products		Investment related gains (losses), net	21		(37)
Total non-hedging derivatives	Total non-hedging derivatives		$	(30)	$	(31)	Total non-hedging derivatives		$	(93)	$	(51)

			Nine months ended September 30,						Gains (Losses) for the nine months ended September 30,
Type of Non-hedging Derivative	Type of Non-hedging Derivative	Income Statement Location of Gain (Loss)	2022		2021		Type of Non-hedging Derivative	Income Statement Location of Gains (Losses)	2023		2022
Interest rate swaps	Interest rate swaps	Investment related gains (losses), net	$	(129)	$	(41)	Interest rate swaps	Investment related gains (losses), net	$	(74)	$	(129)
Interest rate options	Interest rate options	Investment related gains (losses), net	12		—		Interest rate options	Investment related gains (losses), net	(10)		12
Total return swaps	Total return swaps	Investment related gains (losses), net	(1)		—		Total return swaps	Investment related gains (losses), net	—		(1)
Financial futures		Investment related gains (losses), net	38		(19)
Interest rate futures							Interest rate futures	Investment related gains (losses), net	2		5
Equity futures							Equity futures	Investment related gains (losses), net	(8)		33
Foreign currency swaps	Foreign currency swaps	Investment related gains (losses), net	27		15		Foreign currency swaps	Investment related gains (losses), net	20		27
Foreign currency forwards	Foreign currency forwards	Investment related gains (losses), net	(154)		(11)		Foreign currency forwards	Investment related gains (losses), net	(130)		(154)
CPI swaps	CPI swaps	Investment related gains (losses), net	25		33		CPI swaps	Investment related gains (losses), net	7		25
Credit default swaps	Credit default swaps	Investment related gains (losses), net	(103)		20		Credit default swaps	Investment related gains (losses), net	(5)		(103)
Equity options	Equity options	Investment related gains (losses), net	29		(18)		Equity options	Investment related gains (losses), net	(22)		29

Subtotal	Subtotal		(256)		(21)		Subtotal		(220)		(256)
Embedded derivatives in:	Embedded derivatives in:						Embedded derivatives in:
Modco or funds withheld arrangements	Modco or funds withheld arrangements	Investment related gains (losses), net	(106)		87		Modco or funds withheld arrangements	Investment related gains (losses), net	18		(106)
Indexed annuity products							Indexed annuity products	Interest credited	14		98
Total non-hedging derivatives							Total non-hedging derivatives		$	(188)	$	(264)

Indexed annuity products		Interest credited	98		(14)
Variable annuity products		Investment related gains (losses), net	23		(36)
Total non-hedging derivatives			$	(241)	$	16

2353

Table of Contents

Credit Derivatives

The following table presents the estimated fair value, maximum amount of future payments and weighted average years to maturity of credit default swaps sold by the Company at September 30, ~~2022~~2023 and December 31, ~~2021~~2022 (dollars in millions):


		September 30, 2022					December 31, 2021						September 30, 2023					December 31, 2022
Rating Agency Designation of Referenced Credit Obligations(1)	Rating Agency Designation of Referenced Credit Obligations(1)	Estimated Fair Value of Credit Default Swaps		Maximum Amount of Future Payments under Credit Default Swaps(2)		Weighted Average Years to Maturity(3)	Estimated Fair Value of Credit Default Swaps		Maximum Amount of Future Payments under Credit Default Swaps(2)		Weighted Average Years to Maturity(3)	Rating Agency Designation of Referenced Credit Obligations(1)	Estimated Fair Value of Credit Default Swaps		Maximum Amount of Future Payments under Credit Default Swaps(2)		Weighted Average Years to Maturity(3)	Estimated Fair Value of Credit Default Swaps		Maximum Amount of Future Payments under Credit Default Swaps(2)		Weighted Average Years to Maturity(3)
AAA/AA+/AA/AA-/A+/A/A-	AAA/AA+/AA/AA-/A+/A/A-											AAA/AA+/AA/AA-/A+/A/A-
Single name credit default swaps	Single name credit default swaps	$	(40)	$	433	18.8	$	28	$	600	14.2	Single name credit default swaps	$	(36)	$	420	18.3	$	(18)	$	428	18.7
Subtotal		(40)		433		18.8	28		600		14.2

BBB+/BBB/BBB-	BBB+/BBB/BBB-											BBB+/BBB/BBB-
Single name credit default swaps	Single name credit default swaps	—		150		3.6	1		141		2.4	Single name credit default swaps	3		155		2.9	1		155		3.3
Credit default swaps referencing indices	Credit default swaps referencing indices	(1)		1,115		6.7	—		565		5.1	Credit default swaps referencing indices	(1)		915		4.7	—		915		6.2
Subtotal	Subtotal	(1)		1,265		6.3	1		706		4.6	Subtotal	2		1,070		4.4	1		1,070		5.8
BB+/BB/BB-	BB+/BB/BB-											BB+/BB/BB-
Single name credit default swaps	Single name credit default swaps	(3)		25		3.4	(1)		15		3.5	Single name credit default swaps	(1)		25		2.4	(2)		25		3.2
Subtotal		(3)		25		3.4	(1)		15		3.5

Total	Total	$	(44)	$	1,723	9.4	$	28	$	1,321	9.0	Total	$	(35)	$	1,515	8.2	$	(19)	$	1,523	9.4

(1)The rating agency designations are based on ratings from Standard and Poor’s (“S&P”).

(2)Assumes the value of the referenced credit obligations is zero.

(3)The weighted average years to maturity of the credit default swaps is calculated based on weighted average notional amounts.

Netting Arrangements and Credit Risk

Certain of the Company’s derivatives are subject to enforceable master netting arrangements and reported as a net asset or liability in the condensed consolidated balance sheets. The Company nets all derivatives that are subject to such arrangements.

The Company has elected to include all derivatives, except embedded derivatives, in the table below, irrespective of whether they are subject to an enforceable master netting arrangement or a similar agreement. See Note 411 – “Investments” for information regarding the Company’s securities borrowing, lending and repurchase/reverse repurchase agreements.

The following table provides information relating to the netting of the Company’s derivative instruments as of September 30, ~~2022~~2023 and December 31, ~~2021~~2022 (dollars in millions):


		Gross Amounts Recognized		Gross Amounts Offset in the Balance Sheet		Net Amounts Presented in the Balance Sheet		Financial Instruments/ Collateral (1)		Net Amount			Gross Amounts Recognized		Gross Amounts Offset in the Balance Sheet		Net Amounts Presented in the Balance Sheet		Financial Instruments/Collateral (1)		Net Amount
September 30, 2022:
September 30, 2023:												September 30, 2023:
Derivative assets	Derivative assets	$	220	$	(59)	$	161	$	(161)	$	—	Derivative assets	$	168	$	(93)	$	75	$	(75)	$	—
Derivative liabilities	Derivative liabilities	357		(59)		298		(298)		—		Derivative liabilities	465		(93)		372		(372)		—
December 31, 2021:
December 31, 2022:												December 31, 2022:
Derivative assets	Derivative assets	$	194	$	(19)	$	175	$	(175)	$	—	Derivative assets	223		(53)		170		(170)		—
Derivative liabilities	Derivative liabilities	58		(19)		39		(39)		—		Derivative liabilities	236		(53)		183		(183)		—

(1)Includes initial margin posted to a central clearing partner for financial instruments and excludes the excess of collateral received/pledged from/to the counterparty.

The Company may be exposed to credit-related losses in the event of non-performance by counterparties to derivative financial instruments. Generally, the credit exposure of the Company’s derivative contracts is limited to the fair value and accrued interest of non-collateralized derivative contracts in an asset position at the reporting date. As of September 30, ~~2022,~~2023, the Company had credit exposure of ~~$14~~$13 million.

Derivatives may be exchange-traded or they may be privately negotiated contracts, which are referred to as over-the-counter (“OTC”) derivatives. Certain of the Company’s OTC derivatives are cleared and settled through central clearing counterparties (“OTC cleared”) and others are bilateral contracts between two counterparties. The Company manages its credit risk related to OTC derivatives by entering into transactions with creditworthy counterparties, maintaining collateral arrangements and through the use of master netting agreements that provide for a single net payment to be made by one counterparty to another at each due date and upon termination. The Company is only exposed to the default of the central clearing counterparties for OTC cleared derivatives, and these transactions require initial and daily variation margin collateral postings. Exchange-traded

~~Table of Contents~~

derivatives are settled on a daily basis, thereby reducing the credit risk exposure in the event of non-performance by counterparties to such financial instruments.

~~6. Fair Value~~

Table of ~~Assets and Liabilities~~Contents

NOTE 13 FAIR VALUE OF ASSETS AND LIABILITIES

Fair Value Measurement

General accounting principles for Fair Value Measurements and Disclosures define fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. These principles also establish a three-level fair value hierarchy that requires an entity to maximize the use of observable inputs and to minimize the use of unobservable inputs when measuring fair value:

Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities. Active markets are defined through various characteristics for the measured asset/liability, such as having many transactions and narrow bid/ask spreads.

Level 2 – Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or market standard valuation techniques and assumptions that use significant inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the related assets or liabilities and include those whose value is determined using market standard valuation techniques described above. Prices are determined using valuation methodologies such as discounted cash flow models and other similar techniques that require management’s judgment or estimation in developing inputs that are consistent with those other market participants would use when pricing similar assets and liabilities.

For a discussion of the Company’s valuation methodologies for assets and liabilities measured at fair value and the fair value hierarchy, see Note 6 – “Fair Value of Assets and Liabilities” in the Notes to Consolidated Financial Statements included in the Company’s ~~2021~~2022 Annual Report.

~~Table~~See Note 8 – “Market Risk Benefits” for information about fair value measurement of ~~Contents~~market risk benefits.

Assets and Liabilities by Hierarchy Level

Assets and liabilities measured at fair value on a recurring basis as of September 30, ~~2022~~2023 and December 31, ~~2021~~2022 are summarized below (dollars in millions):


September 30, 2022:				Fair Value Measurements Using:
September 30, 2023:										September 30, 2023:			Fair Value Measurements Using:
		Total		Level 1		Level 2		Level 3			Total		Level 1		Level 2		Level 3
Assets:(1)	Assets:(1)									Assets:(1)
Fixed maturity securities – available-for-sale:
Fixed maturity securities available-for-sale:										Fixed maturity securities available-for-sale:
Corporate	Corporate	$	32,655	$	—	$	28,369	$	4,286	Corporate	$	35,503	$	—	$	30,888	$	4,615
Canadian government	Canadian government	3,586		—		3,586		—		Canadian government	3,348		—		3,348		—
RMBS		953		—		952		1
Japanese government										Japanese government	2,715		—		2,715		—
ABS	ABS	3,723		—		2,599		1,124		ABS	4,236		—		2,968		1,268
CMBS	CMBS	1,670		—		1,607		63		CMBS	1,710		—		1,654		56
RMBS										RMBS	1,030		—		1,029		1
U.S. government	U.S. government	863		767		87		9		U.S. government	1,060		972		81		7
State and political subdivisions	State and political subdivisions	1,086		—		1,058		28		State and political subdivisions	1,047		—		1,027		20
Other foreign government	Other foreign government	5,959		—		5,926		33		Other foreign government	3,522		—		3,489		33
Total fixed maturity securities – available-for-sale		50,495		767		44,184		5,544
Total fixed maturity securities available-for-sale										Total fixed maturity securities available-for-sale	54,171		972		47,199		6,000
Equity securities	Equity securities	137		73		—		64		Equity securities	133		65		—		68
Funds withheld at interest – embedded derivatives	Funds withheld at interest – embedded derivatives	(197)		—		—		(197)		Funds withheld at interest – embedded derivatives	(359)		—		—		(359)
Funds withheld at interest	Funds withheld at interest	52		—		—		52		Funds withheld at interest	51		—		—		51
Cash equivalents	Cash equivalents	2,114		2,114		—		—		Cash equivalents	1,579		1,578		1		—
Short-term investments	Short-term investments	196		141		48		7		Short-term investments	107		34		65		8
Other invested assets:	Other invested assets:									Other invested assets:
Derivatives	Derivatives	161		—		161		—		Derivatives	75		—		75		—

Other	Other	23		—		23		—		Other	18		—		18		—
Total other invested assets (1)		184		—		184		—
Total other invested assets										Total other invested assets	93		—		93		—

Total	Total	$	52,981	$	3,095	$	44,416	$	5,470	Total	$	55,775	$	2,649	$	47,358	$	5,768
Liabilities:	Liabilities:									Liabilities:
Interest-sensitive contract liabilities – embedded derivatives	Interest-sensitive contract liabilities – embedded derivatives	$	689	$	—	$	—	$	689	Interest-sensitive contract liabilities – embedded derivatives	$	441	$	—	$	—	$	441
Other liabilities:	Other liabilities:									Other liabilities:
Funds withheld at interest – embedded derivatives	Funds withheld at interest – embedded derivatives	(256)		—		—		(256)		Funds withheld at interest – embedded derivatives	(369)		—		—		(369)
Derivatives	Derivatives	298		—		298		—		Derivatives	372		—		372		—
Total										Total	$	444	$	—	$	372	$	72

Total		$	731	$	—	$	298	$	433

Table of Contents

(1)~~Other invested assets included in the fair value hierarchy exclude~~Excludes limited ~~partnership interests~~partnerships that are measured at estimated fair value using the ~~net asset value (“NAV”)~~NAV per share (or its equivalent) as a practical expedient. As of September 30, ~~2022,~~2023, the fair value of such investments was ~~$656~~$818 million.


December 31, 2021:				Fair Value Measurements Using:
December 31, 2022:										December 31, 2022:			Fair Value Measurements Using:
		Total		Level 1		Level 2		Level 3			Total		Level 1		Level 2		Level 3
Assets:(1)	Assets:(1)									Assets:(1)
Fixed maturity securities – available-for-sale:
Fixed maturity securities available-for-sale:										Fixed maturity securities available-for-sale:
Corporate	Corporate	$	38,103	$	—	$	34,215	$	3,888	Corporate	$	33,969	$	—	$	29,670	$	4,299
Canadian government	Canadian government	4,944		—		4,944		—		Canadian government	3,626		—		3,626		—
RMBS		1,050		—		1,049		1
Japanese government										Japanese government	2,559		—		2,559		—
ABS	ABS	4,005		—		2,908		1,097		ABS	3,878		—		2,603		1,275
CMBS	CMBS	1,849		—		1,768		81		CMBS	1,623		—		1,555		68
RMBS										RMBS	941		—		931		10
U.S. government	U.S. government	2,105		1,993		100		12		U.S. government	1,482		1,388		85		9
State and political subdivisions	State and political subdivisions	1,323		—		1,290		33		State and political subdivisions	1,119		—		1,093		26
Other foreign government	Other foreign government	7,370		—		7,337		33		Other foreign government	3,704		—		3,669		35
Total fixed maturity securities – available-for-sale		60,749		1,993		53,611		5,145
Total fixed maturity securities available-for-sale										Total fixed maturity securities available-for-sale	52,901		1,388		45,791		5,722
Equity securities	Equity securities	151		101		—		50		Equity securities	134		68		—		66
Funds withheld at interest – embedded derivatives	Funds withheld at interest – embedded derivatives	104		—		—		104		Funds withheld at interest – embedded derivatives	(371)		—		—		(371)
Funds withheld at interest	Funds withheld at interest	83		—		—		83		Funds withheld at interest	54		—		—		54
Cash equivalents	Cash equivalents	1,138		1,138		—		—		Cash equivalents	1,535		1,535		—		—
Short-term investments	Short-term investments	64		—		36		28		Short-term investments	121		54		54		13
Other invested assets:	Other invested assets:									Other invested assets:
Derivatives	Derivatives	175		—		175		—		Derivatives	170		—		170		—

Other	Other	52		—		52		—		Other	23		—		23		—

Total other invested assets (1)		227		—		227		—

Total other invested assets										Total other invested assets	193		—		193		—
Total	Total	$	62,516	$	3,232	$	53,874	$	5,410	Total	$	54,567	$	3,045	$	46,038	$	5,484
Liabilities:	Liabilities:									Liabilities:
Interest-sensitive contract liabilities – embedded derivatives	Interest-sensitive contract liabilities – embedded derivatives	$	855	$	—	$	—	$	855	Interest-sensitive contract liabilities – embedded derivatives	$	530	$	—	$	—	$	530
Other liabilities:	Other liabilities:									Other liabilities:
Funds withheld at interest – embedded derivatives	Funds withheld at interest – embedded derivatives	(61)		—		—		(61)		Funds withheld at interest – embedded derivatives	(363)		—		—		(363)
Derivatives	Derivatives	39		—		39		—		Derivatives	183		—		183		—

Total	Total	$	833	$	—	$	39	$	794	Total	$	350	$	—	$	183	$	167

(1)~~Other invested assets included in the fair value hierarchy exclude~~Excludes limited ~~partnership interests~~partnerships that are measured at estimated fair value using the NAV per share (or its equivalent) as a practical expedient. As of December 31, ~~2021,~~2022, the fair value of such investments was ~~$581~~$683 million.

2656

Table of Contents

Quantitative Information Regarding Internally Priced Assets and Liabilities

The following table presents quantitative information about significant unobservable inputs used in Level 3 fair value measurements that are developed internally by the Company as of September 30, ~~2022~~2023 and December 31, ~~2021~~2022 (dollars in millions):


		Estimated Fair Value				Valuation Technique	Unobservable Inputs		Range (Weighted Average)				Estimated Fair Value					Valuation Technique		Unobservable Inputs	Range (Weighted Average)
		September 30, 2022		December 31, 2021				September 30, 2022		December 31, 2021	September 30, 2023				December 31, 2022				September 30, 2023		December 31, 2022
Assets:	Assets:													Assets:
Corporate	Corporate	$	26	$	49	Market comparable securities	Liquidity premium		1%		0-1% (1%)	Corporate	$	82		$	25	Market comparable securities		Liquidity premium	0-2% (1%)	1%
							EBITDA Multiple		5.0x-5.3x (5.2x)		5.2x-7.0x (6.4x)									EBITDA Multiple	5.3x-7.6x (7.2x)	5.3x
ABS	ABS	196		205		Market comparable securities	Liquidity premium		0-18% (2%)		2-18% (4%)	ABS	266			274		Market comparable securities		Liquidity premium	0-18% (2%)	0-18% (2%)
U.S. government	U.S. government	9		12		Market comparable securities	Liquidity premium		0-1% (1%)		0-1% (1%)	U.S. government	7			9		Market comparable securities		Liquidity premium	0-1% (1%)	0-1% (1%)

Equity securities	Equity securities	8		5		Market comparable securities	EBITDA Multiple		6.9x-11.2x (9.1x)		6.9x-10.6x (8.0x)	Equity securities	20			9		Market comparable securities		Liquidity premium	4%	N/A
																				EBITDA Multiple	8.4x-11.2x (10.8x)	8.4x-11.2x (9.6x)
Funds withheld at interest – embedded derivatives	Funds withheld at interest – embedded derivatives	39		182		Total return swap	Mortality		0-100% (3%)		0-100% (3%)	Funds withheld at interest – embedded derivatives	(17)			(34)		Total return swap		Mortality	0-100% (3%)	0-100% (3%)
							Lapse		0-35% (12%)		0-35% (18%)									Lapse	0-35% (16%)	0-35% (17%)
							Withdrawal		0-5% (4%)		0-5% (4%)									Withdrawal	0-5% (4%)	0-5% (4%)
							CVA		0-5% (0%)		0-5% (0%)									CVA	0-5% (0%)	0-5% (0%)
							Crediting rate		1-4% (2%)		1-4% (2%)									Crediting rate	1-4% (2%)	1-4% (2%)

Liabilities:	Liabilities:											Liabilities:
Interest-sensitive contract liabilities – embedded derivatives – indexed annuities	Interest-sensitive contract liabilities – embedded derivatives – indexed annuities	550		693		Discounted cash flow	Mortality		0-100% (3%)		0-100% (2%)	Interest-sensitive contract liabilities – embedded derivatives – indexed annuities	441			530		Discounted cash flow		Mortality	0-100% (3%)	0-100% (3%)
							Lapse		0-35% (11%)		0-35% (16%)									Lapse	0-35% (15%)	0-35% (16%)
							Withdrawal		0-5% (3%)		0-5% (3%)									Withdrawal	0-5% (4%)	0-5% (3%)
							Option budget projection		1-4% (2%)		1-4% (2%)									Option budget projection	1-4% (2%)	1-4% (2%)
Interest-sensitive contract liabilities – embedded derivatives – variable annuities		139		162		Discounted cash flow	Mortality		0-100% (2%)		0-100% (2%)
							Lapse		0-25% (4%)		0-25% (4%)
							Withdrawal		0-7% (6%)		0-7% (5%)
							CVA		0-5% (1%)		0-5% (1%)
							Long-term volatility		0-27% (13%)		0-27% (14%)

2757

Table of Contents

Changes in Level 3 Assets and Liabilities

Assets and liabilities transferred into Level 3 are due to a lack of observable market transactions and price information. Transfers out of Level 3 are primarily the result of the Company obtaining observable pricing information or a ~~third party~~third-party pricing quotation that appropriately reflects the fair value of those assets and liabilities.

For further information on the Company’s valuation processes, see Note 6 – ~~“Fair~~“Fair Value of Assets and Liabilities” in the Notes to Consolidated Financial Statements included in the Company’s ~~2021~~2022 Annual Report.

The reconciliations for all assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) are as follows (dollars in millions):


For the three months ended September 30, 2022:		Fixed maturity securities – available-for-sale												Funds withheld at interest –embedded derivatives, net(1)					Funds withheld at interest			Interest-sensitive contract liabilities – embedded derivatives
Three months ended September 30, 2023:																					Three months ended September 30, 2023:				Fixed maturity securities available-for-sale																								Funds withheld at interest –embedded derivatives, net (1)					Funds withheld at interest							Interest-sensitive contract liabilities – embedded derivatives
		Corporate		Foreign govt		Structured securities		U.S. and local govt		Equity securities		Short-term investments				Funds withheld at interest –embedded derivatives, net(1)					Funds withheld at interest			Interest-sensitive contract liabilities – embedded derivatives						Corporate			Foreign govt			Structured securities			U.S. and local govt			Equity securities			Cash equivalents							Short-term investments						Funds withheld at interest –embedded derivatives, net (1)		Funds withheld at interest			Interest-sensitive contract liabilities – embedded derivatives
Fair value, beginning of period	Fair value, beginning of period	$	4,238	$	36	$	1,247	$	43	$	47	$	21				$	(744)	Fair value, beginning of period			$	4,654						$	35		$	1,397		$	29		$	68		$	—		$	6	$	9			$	53					$	(472)
Total gains/losses (realized/unrealized)	Total gains/losses (realized/unrealized)																										Total gains/losses (realized/unrealized)
Included in earnings, net:	Included in earnings, net:																								Included in earnings, net:
Net investment income	Net investment income	1		—		—		—		—		—		—					(3)					—		Net investment income				1			—			1			—			—			—					—					—				—					—
Investment related gains (losses), net	Investment related gains (losses), net	—		—		—		(1)		10		—		(17)					—			20			Investment related gains (losses), net			4			—			—			—			—			—					—					1				—					—

Interest credited	Interest credited	—		—		—		—		—		—		—					—			18			Interest credited			—			—			—			—			—			—					—					—				—					3

Included in other comprehensive income (loss)	Included in other comprehensive income (loss)	(164)		(3)		(81)		(1)		—		—		—					(5)			—			Included in other comprehensive income (loss)			(84)			(2)			(16)			(2)			—			—					—					—				(2)					—

Purchases(2)	Purchases(2)	445		—		60		—		10		6		—					—			1			Purchases (2)			170			—			29			—			—			—					9					—				—					3
Sales(2)	Sales(2)	(29)		—		(7)		(3)		(3)		—		—					—			—			Sales (2)			(19)			—			(10)			—			—			—					—					—				—					—
Settlements(2)	Settlements(2)	(150)		—		(52)		(1)		—		—		—					(2)			16			Settlements (2)			(164)			—			(76)			—			—			—					(1)					—				—					25
Transfers into Level 3	Transfers into Level 3	20		—		67		—		—		—		—					—			—			Transfers into Level 3			53			—			—			—			—			—					—					—				—					—
Transfers out of Level 3	Transfers out of Level 3	(75)		—		(46)		—		—		(20)		—					—			—			Transfers out of Level 3			—			—			—			—			—			—					(6)					—				—					—
Fair value, end of period	Fair value, end of period	$	4,286	$	33	$	1,188	$	37	$	64	$	7	$	59				$	52		$	(689)		Fair value, end of period			$	4,615		$	33		$	1,325		$	27		$	68		$	—				$	8				$	10			$	51				$	(441)
Total gains/losses (realized/unrealized) recorded for the period relating to those Level 3 assets and liabilities that were still held at the end of the period	Total gains/losses (realized/unrealized) recorded for the period relating to those Level 3 assets and liabilities that were still held at the end of the period																				Total gains/losses (realized/unrealized) recorded for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
Included in earnings, net:	Included in earnings, net:																								Included in earnings, net:
Net investment income	Net investment income	$	1	$	—	$	—	$	—	$	—	$	—	$	—				$	(3)		$	—		Net investment income			$	1		$	—		$	1		$	—		$	—		$	—				$	—				$	—			$	—				$	—
Investment related gains (losses), net	Investment related gains (losses), net	(4)		—		1		—		8		—		(17)					—			19			Investment related gains (losses), net			—			—			—			—			—			—					—					1				—					—

Interest credited	Interest credited	—		—		—		—		—��		—		—					—			2			Interest credited			—			—			—			—			—			—					—					—				—					(22)
Included in other comprehensive income (loss)	Included in other comprehensive income (loss)	(158)		(3)		(83)		(1)		—		—		—					(5)			—			Included in other comprehensive income (loss)			(81)			(2)			(16)			(2)			—			—					—					—				(2)					—

(1)Funds withheld at interest – embedded derivative assets and liabilities are presented net for purposes of the rollforward.

(2)The amount reported within purchases, sales and settlements is the purchase price (for purchases) and the sales/settlement proceeds (for sales and settlements) based upon the actual date purchased or sold/settled. Items purchased and sold/settled in the same period are excluded from the rollforward. The Company had no issuances during the period.

2858

Table of Contents


For the nine months ended September 30, 2022:		Fixed maturity securities – available-for-sale												Funds withheld at interest –embedded derivatives, net(1)			Funds withheld at interest				Interest-sensitive contract liabilities – embedded derivatives
Nine months ended September 30, 2023:																			Nine months ended September 30, 2023:				Fixed maturity securities available-for-sale																					Funds withheld at interest –embedded derivatives, net (1)				Funds withheld at interest								Interest-sensitive contract liabilities – embedded derivatives
		Corporate		Foreign govt		Structured securities		U.S. and local govt		Equity securities		Short-term investments				Funds withheld at interest –embedded derivatives, net(1)			Funds withheld at interest					Interest-sensitive contract liabilities – embedded derivatives			Corporate			Foreign govt			Structured securities			U.S. and local govt			Equity securities			Cash equivalents								Short-term investments								Interest-sensitive contract liabilities – embedded derivatives
Fair value, beginning of period	Fair value, beginning of period	$	3,888	$	33	$	1,179	$	45	$	50	$	28				Fair value, beginning of period				$	4,299			$	35		$	1,353		$	35		$	66		$	—		$	13		$		(8)			$	54					$	(530)
Total gains/losses (realized/unrealized)	Total gains/losses (realized/unrealized)																						Total gains/losses (realized/unrealized)
Included in earnings, net:	Included in earnings, net:																						Included in earnings, net:
Net investment income	Net investment income	4		—		—		—		—		—		—						(13)				—	Net investment income		3			—			4			—			—			—				—					—				(3)				—
Investment related gains (losses), net	Investment related gains (losses), net	(6)		—		(5)		(1)		4		1		(106)			—				22		Investment related gains (losses), net		4			—			(1)			—			(2)			—			(1)				18					—					—

Interest credited	Interest credited	—		—		—		—		—		—		—			—				98		Interest credited		—			—			—			—			—			—			—				—					—					14

Included in other comprehensive income (loss)	Included in other comprehensive income (loss)	(465)		(13)		(226)		(5)		—		(1)		—			(12)				—		Included in other comprehensive income (loss)		(93)			(2)			28			(2)			—			—			—				—					1					—

Purchases(2)	Purchases(2)	1,381		—		362		—		14		27		—			3				(4)		Purchases (2)		680			—			144			—			8			1			10				—					1					13
Sales(2)	Sales(2)	(153)		—		(58)		(4)		(4)		—		—			—				—		Sales (2)		(51)			—			(14)			—			(4)			—			—				—					—					—
Settlements(2)	Settlements(2)	(329)		—		(111)		(4)		—		(28)		—			(9)				50		Settlements (2)		(282)			—			(198)			(1)			—			—			(1)				—					(2)					62
Transfers into Level 3	Transfers into Level 3	77		13		112		10		—		—		—			—				—		Transfers into Level 3		61			—			64			—			—			—			6				—					—					—
Transfers out of Level 3	Transfers out of Level 3	(111)		—		(65)		(4)		—		(20)		—			—				—		Transfers out of Level 3		(6)			—			(55)			(5)			—			(1)			(19)				—					—					—
Fair value, end of period	Fair value, end of period	$	4,286	$	33	$	1,188	$	37	$	64	$	7	$	59		$	52			$	(689)	Fair value, end of period		$	4,615		$	33		$	1,325		$	27		$	68		$	—		$	8			$	10				$	51				$	(441)
Total gains/losses (realized/unrealized) recorded for the period relating to those Level 3 assets and liabilities that were still held at the end of the period	Total gains/losses (realized/unrealized) recorded for the period relating to those Level 3 assets and liabilities that were still held at the end of the period																						Total gains/losses (realized/unrealized) recorded for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
Included in earnings, net:	Included in earnings, net:																						Included in earnings, net:
Net investment income	Net investment income	$	3	$	—	$	—	$	—	$	—	$	—	$	—		$	(13)			$	—	Net investment income		$	3		$	—		$	4		$	—		$	—		$	—		$	—			$	—				$	(3)				$	—
Investment related gains (losses), net	Investment related gains (losses), net	(12)		—		(4)		—		2		—		(106)							19		Investment related gains (losses), net		(2)			—			(2)			—			(2)			—			(1)				18					—					—

Interest credited	Interest credited	—		—		—		—		—		—		—			—				47		Interest credited		—			—			—			—			—			—			—				—					—					(47)
Included in other comprehensive income (loss)	Included in other comprehensive income (loss)	(459)		(13)		(227)		(5)		—		—		—			(12)				—		Included in other comprehensive income (loss)		(94)			(2)			27			(2)			—			—			—				—					1					—

(1)Funds withheld at interest – embedded derivative assets and liabilities are presented net for purposes of the rollforward.

2959

Table of Contents


For the three months ended September 30, 2021:		Fixed maturity securities – available-for-sale												Funds withheld at interest – embedded derivatives			Funds withheld at interest and other			Interest-sensitive contract liabilities – embedded derivatives
Three months ended September 30, 2022:																						Three months ended September 30, 2022:		Fixed maturity securities available-for-sale																											Funds withheld at interest –embedded derivatives, net (1)					Funds withheld at interest								Interest-sensitive contract liabilities – embedded derivatives
		Corporate		Foreign govt		Structured securities		U.S. and local govt		Equity securities		Short-term investments				Funds withheld at interest – embedded derivatives				Funds withheld at interest and other			Interest-sensitive contract liabilities – embedded derivatives								Corporate				Foreign govt				Structured securities				U.S. and local govt				Equity securities							Cash equivalents						Short-term investments							Interest-sensitive contract liabilities – embedded derivatives
Fair value, beginning of period	Fair value, beginning of period	$	3,208	$	41	$	653	$	21	$	63	$	—									Fair value, beginning of period			$	4,238		$	36			$	1,247			$	43			$	47			$	—			$	21			$	76				$	62				$	(584)
Total gains/losses (realized/unrealized)	Total gains/losses (realized/unrealized)																								Total gains/losses (realized/unrealized)
Included in earnings, net:	Included in earnings, net:																								Included in earnings, net:
Net investment income	Net investment income	1		—		—		—		—		—		—					2			—					Net investment income			1				—				—				—				—				—					—				—				(3)					—
Investment related gains (losses), net	Investment related gains (losses), net	1		—		—		—		8		—		20			—			(37)					Investment related gains (losses), net		—				—				—				(1)				10				—				—					(17)				—					—

Interest credited	Interest credited	—		—		—		—		—		—		—			—			(14)					Interest credited		—				—				—				—				—				—				—					—				—					18

Included in other comprehensive income (loss)	Included in other comprehensive income (loss)	(1)		(2)		1		—		—		—		—			(2)			—					Included in other comprehensive income (loss)		(164)				(3)				(81)				(1)				—				—				—					—				(5)					—

Purchases~~(1)~~(2)	Purchases~~(1)~~(2)	436		—		245		—		8		26		(2)			5			(8)					Purchases~~(1)~~(2)		445				—				60				—				10				—				6					—				—					1
Sales~~(1)~~(2)	Sales~~(1)~~(2)	(5)		—		(3)		—		(22)		—		—			—			—					Sales~~(1)~~(2)		(29)				—				(7)				(3)				(3)				—				—					—				—					—
Settlements~~(1)~~(2)	Settlements~~(1)~~(2)	(75)		—		(51)		—		—		—		—			(1)			21					Settlements~~(1)~~(2)		(150)				—				(52)				(1)				—				—				—					—				(2)					15
Transfers into Level 3	Transfers into Level 3	—		—		21		—		—		—		—			—			—					Transfers into Level 3		20				—				67				—				—				—				—					—				—					—
Transfers out of Level 3	Transfers out of Level 3	(8)		—		—		—		—		—		—			—			—					Transfers out of Level 3		(75)				—				(46)				—				—				—				(20)					—				—					—
Fair value, end of period	Fair value, end of period	$	3,557	$	39	$	866	$	21	$	57	$	26	$	143		$	85		$	(918)				Fair value, end of period		$	4,286			$	33			$	1,188			$	37			$	64			$	—			$	7				$	59			$	52				$	(550)
Total gains/losses (realized/unrealized) recorded for the period relating to those Level 3 assets and liabilities that were still held at the end of the period	Total gains/losses (realized/unrealized) recorded for the period relating to those Level 3 assets and liabilities that were still held at the end of the period																								Total gains/losses (realized/unrealized) recorded for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
Included in earnings, net:	Included in earnings, net:																								Included in earnings, net:
Net investment income	Net investment income	$	1	$	—	$	—	$	—	$	—	$	—	$	—		$	2		$	—				Net investment income		$	1			$	—			$	—			$	—			$	—			$	—			$	—				$	—			$	(3)				$	—
Investment related gains (losses), net	Investment related gains (losses), net	1		—		—		—		4		—		21			—			(39)					Investment related gains (losses), net		(4)				—				1				—				8				—				—					(17)				—					—

Interest credited	Interest credited	—		—		—		—		—		—		—			—			(35)					Interest credited		—				—				—				—				—				—				—					—				—					2
Included in other comprehensive income (loss)	Included in other comprehensive income (loss)	(1)		(2)		1		—		—		—		—			(2)			—					Included in other comprehensive income (loss)		(158)				(3)				(83)				(1)				—				—				—					—				(5)					—

(1)Funds withheld at interest – embedded derivative assets and liabilities are presented net for purposes of the rollforward.

For the nine months ended September 30, 2021: Fixed maturity securities – available-for-sale Funds
withheld at interest – embedded derivatives Funds
withheld at interest and other Interest-sensitive contract
liabilities – embedded derivatives
Corporate Foreign govt Structured securities U.S. and local govt Equity securities Short-term investments
Fair value, beginning of period $ 3,029 $ 17 $ 254 $ 23 $ 53 $ 15 $ 58 $ 56 $ (907)
Total gains/losses (realized/unrealized)
Included in earnings, net:
Net investment income 4 — — — — — — (4) —
Investment related gains (losses), net 2 — — — 19 — 87 — (36)
Interest credited — — — — — — — — (13)
Included in other comprehensive income (loss) (34) (3) 5 — — — 1 (2) —
Purchases(1)
976 25 673 — 8 26 (2) 37 (25)
Sales(1)
(25) — (5) — (23) — — — —
Settlements(1)
(416) — (136) (2) — (10) (1) (2) 63
Transfers into Level 3 29 — 75 — — — — — —
Transfers out of Level 3 (8) — — — — (5) — — —
Fair value, end of period $ 3,557 $ 39 $ 866 $ 21 $ 57 $ 26 $ 143 $ 85 $ (918)
Total gains/losses (realized/unrealized) recorded for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
Included in earnings, net:
Net investment income $ 3 $ — $ — $ — $ — $ — $ — $ (4) $ —
Investment related gains (losses), net — — — — 14 — 87 — (42)
Interest credited — — — — — — — — (76)
Included in other comprehensive income (loss) (32) (3) 5 — — — 1 (2) —

3060

Table of Contents


Nine months ended September 30, 2022:	Fixed maturity securities available-for-sale														Funds withheld at interest –embedded derivatives, net (1)		Funds withheld at interest		Interest-sensitive contract liabilities – embedded derivatives
	Corporate		Foreign govt		Structured securities		U.S. and local govt		Equity securities		Cash equivalents		Short-term investments
Fair value, beginning of period	$	3,888	$	33	$	1,179	$	45	$	50	$	—	$	28	$	165	$	83	$	(693)
Total gains/losses (realized/unrealized)
Included in earnings, net:
Net investment income	4		—		—		—		—		—		—		—		(13)		—
Investment related gains (losses), net	(6)		—		(5)		(1)		4		—		1		(106)		—		—

Interest credited	—		—		—		—		—		—		—		—		—		98

Included in other comprehensive income (loss)	(465)		(13)		(226)		(5)		—		—		(1)		—		(12)		—

Purchases (2)	1,381		—		362		—		14		—		27		—		3		(4)
Sales (2)	(153)		—		(58)		(4)		(4)		—		—		—		—		—
Settlements (2)	(329)		—		(111)		(4)		—		—		(28)		—		(9)		49
Transfers into Level 3	77		13		112		10		—		—		—		—		—		—
Transfers out of Level 3	(111)		—		(65)		(4)		—		—		(20)		—		—		—
Fair value, end of period	$	4,286	$	33	$	1,188	$	37	$	64	$	—	$	7	$	59	$	52	$	(550)
Total gains/losses (realized/unrealized) recorded for the period relating to those Level 3 assets and liabilities that were still held at the end of the period
Included in earnings, net:
Net investment income	$	3	$	—	$	—	$	—	$	—	$	—	$	—	$	—	$	(13)	$	—
Investment related gains (losses), net	(12)		—		(4)		—		2		—		—		(106)		—		19


Interest credited	—		—		—		—		—		—		—		—		—		47
Included in other comprehensive income (loss)	(459)		(13)		(227)		(5)		—		—		—		—		(12)		—

(1)Funds withheld at interest – embedded derivative assets and liabilities are presented net for purposes of the rollforward.

Nonrecurring Fair Value Measurements

The Company has certain assets subject to measurement at fair value on a nonrecurring basis, in periods subsequent to their initial recognition if they are determined to be impaired. During the nine months ended September 30, 2023 and2022, ~~and 2021,~~ the Company did not have any material assets that were measured at fair value due to impairment.

Fair Value of Financial Instruments Carried at Other Than Fair Value

The following table presents the carrying values and estimated fair values of the Company’s financial instruments, which were not measured at fair value on a recurring basis, as of September 30, ~~2022~~2023 and December 31, ~~2021~~2022 (dollars in millions). For additional information regarding the methods and significant assumptions used by the Company to estimate these fair values, see Note 6 – “Fair Value of Assets and Liabilities” in the Notes to Consolidated Financial Statements included in the Company’s ~~2021~~2022 Annual Report. This table excludes any payables or receivables for collateral under repurchase/reverse repurchase agreements and other transactions. The estimated fair value of the excluded amount approximates carrying value as they equal the amount of cash collateral received/paid.

Table of Contents

September 30, 2022:
Carrying Value (1)
Estimated
Fair Value Fair Value Measurement Using:
Level 1 Level 2 Level 3
Assets:
Mortgage loans $ 6,558 $ 5,902 $ — $ — $ 5,902
Policy loans 1,202 1,202 — 1,202 —
Funds withheld at interest 6,343 6,051 — — 6,051
Cash and cash equivalents 1,398 1,398 1,398 — —
Short-term investments 29 29 29 — —
Other invested assets 904 671 4 66 601
Accrued investment income 628 628 — 628 —
Liabilities:
Interest-sensitive contract liabilities $ 23,141 $ 22,450 $ — $ — $ 22,450
Other liabilities – funds withheld at interest 1,610 1,383 — — 1,383
Long-term debt 4,207 3,955 — — 3,955
Collateral finance and securitization notes — — — — —
December 31, 2021:
Carrying Value (1)
Estimated
Fair Value Fair Value Measurement Using:
Level 1 Level 2 Level 3
Assets:
Mortgage loans $ 6,283 $ 6,580 $ — $ — $ 6,580
Policy loans 1,234 1,234 — 1,234 —
Funds withheld at interest 6,747 7,075 — — 7,075
Cash and cash equivalents 1,810 1,810 1,810 — —
Short-term investments 23 23 23 — —
Other invested assets 910 907 6 70 831
Accrued investment income 533 533 — 533 —
Liabilities:
Interest-sensitive contract liabilities $ 18,625 $ 19,540 $ — $ — $ 19,540
Other liabilities – funds withheld at interest 1,658 1,657 — — 1,657
Long-term debt 3,667 3,886 — — 3,886
Collateral finance and securitization notes 180 153 — — 153


September 30, 2023:	Carrying Value (1)		Estimated Fair Value		Fair Value Measurement Using:
					Level 1		Level 2		Level 3
Assets:
Mortgage loans	$	7,231	$	6,559	$	—	$	—	$	6,559
Policy loans	1,180		1,180		—		1,180		—
Funds withheld at interest	6,034		5,570		—		—		5,570
Limited partnerships – cost method	68		70		—		—		70
Cash and cash equivalents	1,241		1,241		1,241		—		—
Short-term investments	34		34		34		—		—
Other invested assets	972		744		4		59		681
Accrued investment income	744		744		—		744		—
Liabilities:
Interest-sensitive contract liabilities	$	22,598	21,867		$	—	$	—	$	21,867
Other liabilities – funds withheld at interest	1,566		1,264		—		—		1,264
Long-term debt	4,450		4,113		—		—		4,113


December 31, 2022:
Assets:
Mortgage loans	$	6,590	$	6,109	$	—	$	—	$	6,109
Policy loans	1,231		1,231		—		1,231		—
Funds withheld at interest	6,319		5,884		—		—		5,884
Limited partnerships – cost method	49		52		—		—		52
Cash and cash equivalents	1,392		1,392		1,392		—		—
Short-term investments	33		33		33		—		—
Other invested assets	947		758		4		65		689
Accrued investment income	630		630		—		630		—
Liabilities:
Interest-sensitive contract liabilities	$	23,493	$	23,065	$	—	$	—	$	23,065
Other liabilities – funds withheld at interest	1,596		1,321		—		—		1,321
Long-term debt	3,961		3,670		—		—		3,670

(1)Carrying values presented herein may differ from those in the Company’s condensed consolidated balance sheets because certain items within the respective financial statement captions may be measured at fair value on a recurring basis.

NOTE 14 INCOME TAX

The Inflation Reduction Act of 2022 (“the Act”) was enacted in the U.S. The Act includes law changes relating to tax, climate change, energy and health care. In particular, for tax years ending after December 31, 2022, the Act imposes a 15% minimum tax on adjusted financial statement income for “applicable corporations” with average financial statement income exceeding $1 billion for the previous 3-year period ending in 2022 or after. Based on the current guidance, the Company is not an applicable corporation for 2023. The Act also imposes a 1% excise tax on stock buybacks of a publicly traded corporation. The Act is not expected to have a material impact to the Company’s tax expense.

The effective tax rate for the three and nine months ending September 30, 2023, was 24.2% and 24.9% on pre-tax income. The tax rate was higher than the U.S. statutory rate primarily due to income earned in foreign jurisdictions and adjustments to the valuation allowance. These increases were partially offset with tax benefits received in certain foreign jurisdictions.

The effective tax rate for the three and nine months ending September 30, 2022, was 2.7% and 32.5%. The Company’s effective tax rate for the three and nine months ending September 30, 2022, differed from the U.S. statutory rate of 21% primarily due to U.S. taxation on foreign earnings, income earned in jurisdictions with tax rates greater than the U.S. statutory rate, and adjustments to valuation allowances which were partially offset with adjustments related to tax returns filed during the quarter.

Table of Contents

~~7. Segment Information~~NOTE 15 EMPLOYEE BENEFIT PLANS

The ~~accounting policies~~components of ~~the segments are the same as those described in Note 2~~ ~~– “Significant Accounting Policies and Pronouncements” in the Notes to Consolidated Financial Statements~~net periodic benefit cost, included in other operating expenses on the Company’s ~~2021 Annual Report. The Company measures segment performance primarily based on profit or loss from operations before~~condensed consolidated statements of income, ~~taxes. There are no intersegment reinsurance transactions~~for the three and ~~the Company does not have any material long-lived assets.~~

~~The Company allocates capital to its segments based on an internally developed economic capital model, the purpose of which is to measure the risk in the business~~nine months ended September 30, 2023 and to provide a basis upon which capital is deployed. The economic capital model considers the unique and specific nature of the risks inherent in the Company’s businesses. As a result of the economic capital allocation process, a portion of investment income is attributed to the segments based on the level of allocated capital. In addition, the segments are charged for excess capital utilized above the allocated economic capital basis. This charge is included in policy acquisition costs and other insurance expenses.

The Company has geographic-based and business-based operational segments. Geographic-based operations are further segmented into traditional and financial solutions businesses. Information related to revenues, income (loss) before income taxes and total assets of the Company for each reportable segment are summarized below2022 were as follows (dollars in millions).:

Three months ended September 30, Nine months ended September 30,
Revenues: 2022 2021 2022 2021
U.S. and Latin America:
Traditional $ 1,867 $ 1,795 $ 5,602 $ 5,248
Financial Solutions 315 374 845 1,125
Total 2,182 2,169 6,447 6,373
Canada:
Traditional 358 354 1,087 1,063
Financial Solutions 27 25 79 77
Total 385 379 1,166 1,140
Europe, Middle East and Africa:
Traditional 457 454 1,380 1,370
Financial Solutions 142 174 458 459
Total 599 628 1,838 1,829
Asia Pacific:
Traditional 705 663 2,079 1,963
Financial Solutions 171 95 235 303
Total 876 758 2,314 2,266
Corporate and Other 24 109 118 691
Total $ 4,066 $ 4,043 $ 11,883 $ 12,299


	Pension Benefits				Other Benefits
	Three months ended September 30,				Three months ended September 30,
	2023		2022		2023		2022
Service cost	$	3	$	5	$	—	$	1
Interest cost	3		1		1		—
Expected return on plan assets	(3)		(3)		—		—
Amortization of prior service cost (credit)	—		—		—		—
Amortization of prior actuarial losses	1		—		—		—

Net periodic benefit cost	$	4	$	3	$	1	$	1

Three months ended September 30, Nine months ended September 30,
Income (loss) before income taxes: 2022 2021 2022 2021
U.S. and Latin America:
Traditional $ 204 $ (126) $ 247 $ (329)
Financial Solutions 70 128 175 397
Total 274 2 422 68
Canada:
Traditional 32 44 54 100
Financial Solutions 4 — 21 10
Total 36 44 75 110
Europe, Middle East and Africa:
Traditional 1 (91) (3) (171)
Financial Solutions 31 85 149 228
Total 32 (6) 146 57
Asia Pacific:
Traditional 118 (96) 227 (67)
Financial Solutions (2) 6 (124) 65
Total 116 (90) 103 (2)
Corporate and Other (92) 16 (186) 401
Total $ 366 $ (34) $ 560 $ 634

~~Table of Contents~~

Assets: September 30, 2022 December 31, 2021
U.S. and Latin America:
Traditional $ 20,640 $ 20,572
Financial Solutions 25,598 29,028
Total 46,238 49,600
Canada:
Traditional 4,994 5,091
Financial Solutions 42 18
Total 5,036 5,109
Europe, Middle East and Africa:
Traditional 4,341 4,670
Financial Solutions 4,375 7,165
Total 8,716 11,835
Asia Pacific:
Traditional 9,072 10,048
Financial Solutions 10,023 7,678
Total 19,095 17,726
Corporate and Other 3,620 7,905
Total $ 82,705 $ 92,175


	Pension Benefits				Other Benefits
	Nine months ended September 30,				Nine months ended September 30,
	2023		2022		2023		2022
Service cost	$	10	$	13	$	1	$	2
Interest cost	8		4		2		1
Expected return on plan assets	(8)		(9)		—		—
Amortization of prior service cost (credit)	—		—		(1)		(1)
Amortization of prior actuarial losses	2		2		—		1

Net periodic benefit cost	$	12	$	10	$	2	$	3

~~8. Commitments, Contingencies and Guarantees~~NOTE 16 COMMITMENTS, CONTINGENCIES AND GUARANTEES

Commitments

Funding of Investments

The Company’s commitments to fund investments as of September 30, ~~2022~~2023 and December 31, ~~2021~~2022, are presented in the following table (dollars in millions):


		September 30, 2022		December 31, 2021			September 30, 2023		December 31, 2022
Limited partnership interests and joint ventures		$	1,052	$	1,031
Limited partnerships and real estate joint ventures						Limited partnerships and real estate joint ventures	$	1,082	$	937
Mortgage loans	Mortgage loans	118		152		Mortgage loans	70		137
Bank loans and private placements	Bank loans and private placements	744		768		Bank loans and private placements	674		682
Lifetime mortgages	Lifetime mortgages	76		41		Lifetime mortgages	55		59

The Company anticipates that the majority of its current commitments will be invested over the next five years; however, these commitments could become due any time at the request of the counterparties. Bank loans and private placements are included in fixed maturity securities available-for-sale.

The Company has an immaterial liability, included in other liabilities, for expected credit losses associated with unfunded commitments as of September 30, ~~2022~~2023 and December 31, ~~2021.~~2022.

Funding Agreements

Federal Home Loan Bank ~~(“FHLB”)~~ of Des Moines

The Company is a member of the FHLB and, through membership, has issued funding agreements to the FHLB in exchange for cash advances. As of September 30, ~~2022~~2023 and December 31, ~~2021,~~2022, the Company had ~~$1.3~~$1.2 billion and ~~$1.4~~$1.3 billion ~~respectively,~~ of FHLB funding agreements ~~outstanding.~~outstanding, respectively. The Company is required to provide collateral in excess of the funding agreement amounts outstanding, considering any discounts to the securities posted and prepayment penalties.

Funding Agreement Backed Notes

The Company’s Funding Agreement Backed Notes (“FABN”) program allows RGA Global Funding, a special-purpose, unaffiliated statutory trust, to offer its senior secured medium-term notes to investors. RGA Global Funding uses the net proceeds from each sale to purchase one or more funding agreements from the Company. As of September 30, ~~2022~~2023 and December 31, ~~2021,~~2022, the Company had $900 million ~~and $500 million, respectively,~~ of FABN agreements outstanding and are included within interest-sensitive contract liabilities.

Table of Contents

Contingencies

Litigation

The Company is subject to litigation and regulatory investigations or actions from time to time. Based on current knowledge, management does not believe that loss contingencies arising from pending legal, regulatory and governmental matters will have a material adverse effect on the financial condition, results of operations or cash flows of the Company. However, in light of the ~~normal course~~inherent uncertainties involved in future or pending legal, regulatory and governmental matters, some of ~~its business; however,~~which are beyond the ~~Company currently has no~~Company’s control, and indeterminate or potentially substantial amount of damages sought in any such matters, an adverse outcome could be material ~~litigation.~~to the Company’s financial condition, results of operations or cash flows for any particular reporting period. A legal reserve is established when the Company is notified of an arbitration demand, litigation or ~~litigation~~regulatory action or is notified that

~~Table of Contents~~

an arbitration demand, litigation or ~~litigation~~regulatory action is imminent, it is probable that the Company will incur a loss as a result and the amount of the probable loss is reasonably capable of being estimated.

Other Contingencies

The Company indemnifies its directors and officers as provided in its charters and by-laws. Since this indemnity generally is not subject to limitation with respect to duration or amount, the Company does not believe that it is possible to determine the maximum potential amount due under this indemnity in the future.

Guarantees

Statutory Reserve Support

Certain RGA subsidiaries have committed to provide statutory reserve support to third parties, in exchange for a fee, by funding loans if certain defined events occur. Such statutory reserves are required under the U.S. Valuation of Life Policies Model Regulation (commonly referred to as Regulation XXX for term life insurance policies and Regulation A-XXX for universal life secondary guarantees).

In addition, certain subsidiaries have also committed to provide capital support to a third party, in exchange for a fee, by agreeing to assume real estate leases in the event of a severe and prolonged decline in the commercial lease market. Upon assumption of a lease, the Company would recognize a right to use asset and lease obligation.

As of September 30, ~~2022,~~2023, the Company does not believe that it will be required to provide any funding under these commitments as the occurrence of the defined events is considered remote. The following table presents the maximum potential obligation for these commitments as of September 30, ~~2022~~2023 (dollars in millions):


Commitment Period:		Maximum Potential Obligation
Commitment Period				Commitment Period	Maximum Potential Obligation
2034	2034	$	1,243	2034	$	1,243
2035	2035	2,616		2035	1,907
2036	2036	3,599		2036	3,599
2037	2037	6,850		2037	6,850
2038	2038	2,300		2038	800
2039	2039	7,350		2039	8,751
2041				2041	720
2046	2046	3,000		2046	3,000

~~Other Guarantees~~

~~RGA has issued guarantees~~NOTE 17 SEGMENT INFORMATION

The accounting policies of the segments are the same as those described in Note 2 – “Significant Accounting Policies and Pronouncements” in the Notes to ~~third parties~~Consolidated Financial Statements included in the Company’s 2022 Annual Report. The Company measures segment performance primarily based on ~~behalf~~profit or loss from operations before income taxes. There are no intersegment reinsurance transactions and the Company does not have any material long-lived assets.

The Company allocates capital to its segments based on an internally developed economic capital model, the purpose of ~~its subsidiaries for~~which is to measure the ~~payment of amounts due under certain securities borrowing~~risk in the business and repurchase arrangements, financing arrangements and office lease obligations, whereby, if a subsidiary fails to meet an obligation, RGA or one of its other subsidiaries will make a payment to fulfill the obligation. Additionally, in limited circumstances, treaty guarantees are granted to ceding companies in order to provide ~~them additional security, particularly~~a basis upon which capital is deployed. The economic capital model considers the unique and specific nature of the risks inherent in ~~cases where RGA’s subsidiary~~the Company’s businesses. As a result of the economic capital allocation process, a portion of investment income is ~~relatively new, unrated, or not of a significant size, relative~~attributed to the ~~ceding company. Liabilities supported by the treaty guarantees, before consideration of any legally offsetting amounts due from the guaranteed party are reflected~~segments based on the ~~Company’s condensed consolidated balance sheets~~level of allocated capital. In addition, the segments are charged for excess capital utilized above the allocated economic capital basis. This charge is included in ~~future~~ policy ~~benefits. Potential guaranteed amounts of future payments will vary depending on production levels~~acquisition costs and underwriting results. Guarantees related to securities borrowing and repurchase arrangements provide additional security to third parties should a subsidiary fail to provide securities when due. RGA’s guarantees issued as of September 30, 2022 and December 31, 2021, are reflected in the following table (dollars in millions):other insurance expenses.

September 30, 2022 December 31, 2021
Treaty guarantees $ 1,732 $ 2,208
Treaty guarantees, net of assets in trust 1,003 1,281
Securities borrowing and repurchase arrangements 161 134

~~9. Income Tax~~

For the three and nine months ended September 30, 2022, the effective tax rate on pre-tax income was 22.3% and 25.0%, respectively. The Company’s effective tax rate for the three and nine months ended September 30, 2022, differed from the U.S. statutory rate of 21% primarily due to U.S. Subpart F income on foreign earnings, U.S. Global Intangible low-taxed income (“GILTI”), and income earned in jurisdictions with tax rates greater than the U.S. statutory rate, which were partially offset with adjustments related to tax returns filed during the quarter.

For the three and nine months ended September 30, 2021, the effective tax rate on pre-tax income was 34.3% and 27.3%, respectively. The Company’s effective tax rate for both tax periods was higher than the U.S. statutory rate of 21% primarily as

3464

Table of Contents

~~a result~~The Company has geographic-based and business-based operational segments. Geographic-based operations are further segmented into Traditional and Financial Solutions businesses. Information related to revenues, income (loss) before income taxes and total assets of ~~corporate rate changes and income earned in jurisdictions with tax rates higher than the U.S., losses in jurisdictions for which~~ the Company ~~received no benefits and adjustments from tax returns filed.~~

~~10. Employee Benefit Plans~~

~~The components of net periodic benefit cost, included in other operating expenses on the Company’s condensed consolidated statements of income,~~ for ~~the three and nine months ended September 30, 2022 and 2021 were as follows~~each reportable segment are summarized below (dollars in millions):

Pension Benefits Other Benefits
Three months ended September 30, Three months ended September 30,
2022 2021 2022 2021
Service cost $ 5 $ 4 $ 1 $ —
Interest cost 1 1 — —
Expected return on plan assets (3) (3) — —
Amortization of prior service cost (credit) — — — —
Amortization of prior actuarial losses — 2 — 1
Net periodic benefit cost $ 3 $ 4 $ 1 $ 1


	Three months ended September 30,				Nine months ended September 30,
Revenues:	2023		2022		2023		2022
U.S. and Latin America:
Traditional	$	1,949	$	1,855	$	5,693	$	5,552
Financial Solutions	1,115		292		1,908		811
Total	3,064		2,147		7,601		6,363
Canada:
Traditional	366		359		1,098		1,095
Financial Solutions	26		27		79		82
Total	392		386		1,177		1,177
Europe, Middle East and Africa:
Traditional	471		456		1,382		1,372
Financial Solutions	160		142		459		460
Total	631		598		1,841		1,832
Asia Pacific:
Traditional	801		720		2,282		2,124
Financial Solutions	130		171		397		234
Total	931		891		2,679		2,358
Corporate and Other	135		28		262		140
Total	$	5,153	$	4,050	$	13,560	$	11,870

Pension Benefits Other Benefits
Nine months ended September 30, Nine months ended September 30,
2022 2021 2022 2021
Service cost $ 13 $ 13 $ 2 $ 2
Interest cost 4 3 1 1
Expected return on plan assets (9) (8) — —
Amortization of prior service cost (credit) — — (1) (1)
Amortization of prior actuarial losses 2 5 1 2
Net periodic benefit cost $ 10 $ 13 $ 3 $ 4

~~11. Reinsurance Ceded Receivables and Other~~

Retrocession reinsurance treaties do not relieve the Company from its obligations to direct writing companies. Failure of retrocessionaires to honor their obligations could result in losses to the Company. Consequently, allowances would be established for amounts deemed uncollectible. At September 30, 2022 and December 31, 2021, no allowances were deemed necessary. The Company regularly evaluates the financial condition of the insurance companies from which it assumes and to which it cedes reinsurance.

Retrocessions are arranged through the Company’s retrocession pools for amounts in excess of the Company’s retention limit. As of September 30, 2022 and December 31, 2021, all rated retrocession pool participants followed by the A.M. Best Company were rated “A- (excellent)” or better. The Company verifies retrocession pool participants’ ratings on a quarterly basis. For a majority of the retrocessionaires that were not rated, security in the form of letters of credit or trust assets has been posted. In addition, the Company performs annual financial reviews of its retrocessionaires to evaluate financial stability and performance.

The following table presents information for the Company’s reinsurance ceded receivable assets, including the respective amount and A.M. Best rating for each reinsurer representing in excess of five percent of the total as of September 30, 2022 or December 31, 2021 (dollars in millions):

September 30, 2022 December 31, 2021
Reinsurer A.M. Best Rating Amount % of Total Amount % of Total
Reinsurer A A- $ 1,607 65.4 % $ 1,626 63.0 %
Reinsurer B A+ 406 16.5 423 16.4
Reinsurer C A+ 194 7.9 212 8.2
Reinsurer D A 54 2.2 59 2.3
Reinsurer E A+ 40 1.6 44 1.7
Reinsurer F A++ 33 1.3 42 1.6
Other reinsurers 122 5.1 174 6.8
Total $ 2,456 100.0 % $ 2,580 100.0 %

Included in the total reinsurance ceded receivables and other balance were $202 million and $203 million of claims recoverable, of which $15 million and $10 million were in excess of 90 days past due, as of September 30, 2022 and December 31, 2021, respectively. Also included in the total reinsurance ceded receivable and other is a deposit asset on reinsurance of $1,607 million and $1,626 million as of September 30, 2022 and December 31, 2021, respectively.


	Three months ended September 30,				Nine months ended September 30,
Income (loss) before income taxes:	2023		2022		2023		2022
U.S. and Latin America:
Traditional	$	105	$	(69)	$	288	$	81
Financial Solutions	108		53		290		153
Total	213		(16)		578		234
Canada:
Traditional	6		12		70		54
Financial Solutions	30		6		46		22
Total	36		18		116		76
Europe, Middle East and Africa:
Traditional	(60)		5		(29)		43
Financial Solutions	84		34		195		126
Total	24		39		166		169
Asia Pacific:
Traditional	134		(73)		302		94
Financial Solutions	(16)		47		(9)		(63)
Total	118		(26)		293		31
Corporate and Other	(11)		(92)		(157)		(173)
Total	$	380	$	(77)	$	996	$	337

3565

Table of Contents

~~12. Policy Claims and Benefits~~

~~Rollforward of Claims and Claim Adjustment Expenses~~

The liability for unpaid claims is reported in future policy benefits and other policy claims and benefits on the Company’s condensed consolidated balance sheets. Activity associated with unpaid claims is summarized below (dollars in millions):

Nine Months Ended September 30,
2022 2021
Balance, beginning of period $ 8,053 $ 7,556
Less: reinsurance recoverable (556) (641)
Net balance, beginning of period 7,497 6,915
Incurred:
Current year 10,532 9,948
Prior years (155) (159)
Total incurred 10,377 9,789
Payments:
Current year (4,545) (3,712)
Prior years (5,971) (5,229)
Total payments (10,516) (8,941)
Other changes:
Interest accretion 23 30
Foreign exchange adjustments (499) (135)
Total other changes (476) (105)
Net balance, end of period 6,882 7,658
Plus: reinsurance recoverable 456 538
Balance, end of period $ 7,338 $ 8,196

Incurred claims associated with prior periods are primarily due to events, related to long-duration business, which were incurred in prior periods but were reported in the current period, and to a lesser extent, the development of short-duration business claims for prior years being different than were anticipated when the liabilities for unpaid claims were originally estimated. These trends have been considered in establishing the current year liability for unpaid claims.


Assets:	September 30, 2023		December 31, 2022
U.S. and Latin America:
Traditional	$	22,527	$	22,612
Financial Solutions	24,117		25,203
Total	46,644		47,815
Canada:
Traditional	4,936		4,826
Financial Solutions	221		177
Total	5,157		5,003
Europe, Middle East and Africa:
Traditional	3,649		3,652
Financial Solutions	6,247		5,215
Total	9,896		8,867
Asia Pacific:
Traditional	9,894		9,254
Financial Solutions	13,362		12,023
Total	23,256		21,277
Corporate and Other	2,469		1,942
Total	$	87,422	$	84,904

~~13. Financing Activities~~NOTE 18 FINANCING ACTIVITIES

On ~~September 15, 2022, RGA announced a cash tender offer for any and all of its outstanding 6.20% Fixed-to-Floating Rate Subordinated Debentures~~June 8, 2023, the Company issued 6.0% fixed rate senior notes due 2042 (the “2042 Debentures”) at a price of $25.20 for each $25 principal amount of the 2042 Debentures. The tender offer expired on September 22, 2022, and a total of $151 million, or approximately 38%, of the aggregate principal amount of the 2042 Debentures were tendered. The Company intends to redeem the remaining debentures in accordance with the indenture governing the 2042 Debentures.

~~On September 23, 2022, RGA issued 7.125% fixed-rate reset subordinated debentures due October 15, 2052,~~2033 with a face amount of ~~$700 million. This security has been registered with the Securities and Exchange Commission. The net proceeds were approximately $690~~$400 million, ~~and a portion~~which was used ~~in part~~ to ~~pay for~~repay upon maturity the ~~tender offer~~$400 million 4.70% Senior Notes that matured on September 15, 2023. Capitalized issuance costs were $4 million.

On March 23, 2023, Chesterfield Reinsurance Company, a subsidiary of ~~the 2042 Debentures. The remaining proceeds will be used for future redemptions~~RGA, issued 7.125% Surplus Notes due 2043, with a face amount of ~~any remaining 2042 Debentures, and general corporate purposes.~~$500 million. Capitalized issue costs were ~~approximately $10~~$6 million.

The ~~remaining amount~~loan is expected to be repaid over the term of the ~~$850 million Series A Floating Rate Insured Notes issued by the Company’s subsidiary, Timberlake Financial, LLC, which was approximately $185 million, were redeemed~~loan based on ~~August 29, 2022,~~available funds and ~~are no longer outstanding as~~regulatory approval. As of September 30, ~~2022.~~2023, the amount outstanding is $500 million.

On March 13, 2023, the Company entered into a new syndicated revolving credit facility with a five year term and an overall capacity of $850 million, replacing its existing $850 million syndicated revolving credit facility, which was scheduled to mature in August 2023. The Company may borrow cash and may obtain letters of credit in multiple currencies under this facility.

~~14. New Accounting Standards~~NOTE 19 NEW ACCOUNTING STANDARDS NOT YET ADOPTED

Changes to the general accounting principles are established by the Financial Accounting Standards Board (“FASB”) in the form of accounting standards updates to the FASB Accounting Standards Codification™. ~~Accounting~~There are no accounting standards ~~updates~~ not ~~listed below were assessed and determined to be either not~~yet adopted that are applicable or are expected to have more than a minimal impact on the Company’s condensed consolidated financial statements.

~~Table of Contents~~

~~Standards Adopted~~

For information on the adoption of recent accounting guidance and their impact, if any, on the Company’s results of operations and financial position, see Note 2 – “Significant Accounting Policies and Pronouncements” of the Company’s 2021 Annual Report.

~~Standards Not Yet Adopted~~

~~In the first quarter of 2023, the Company will adopt Accounting Standards Update (“ASU”): ASU 2018-12,~~ ~~Financial Services – Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts (“ASU 2018-12”).~~ ~~ASU 2018-12 updates certain requirements for the accounting for long-duration insurance contracts.~~

•~~Cash flow assumptions and measuring liability for future policy benefits~~ ~~– ASU 2018-12 requires the Company to review its cash flow assumptions at least annually and update, when necessary, with the impact recognized in net income in the period of the change.~~

~~Upon adoption, there will be an adjustment to retained earnings as a result of capping the net premium ratio at 100% and eliminating negative reserves on certain issue year cohorts.~~

•~~Discount rat~~e – The discount rate assumption is prescribed by ASU 2018-12 as an upper-medium (low credit risk) fixed-income yield and is required to be updated every quarter. The change in the liability as a result of updating the discount rate assumption is recognized in other comprehensive income (loss) (“OCI”).

Upon adoption, there will be an adjustment to accumulated other comprehensive income (loss) as a result of remeasuring in force contract liabilities using current upper-medium grade fixed income instrument yields. The adjustment will largely reflect the difference between discount rates locked-in at contract inception versus current discount rates at transition.

•~~Deferred policy acquisition costs and similar balances~~ ~~– Deferred policy acquisition costs (“DAC”) and other capitalized costs such as unearned revenue are amortized on a constant level or straight-line basis over the expected term of the contracts.~~

Upon adoption, the Company expects an adjustment to accumulated other comprehensive income (loss) for the removal of cumulative adjustments to DAC associated with unrealized gains and losses previously recorded in accumulated other comprehensive income (loss).

•~~Market risk benefits~~ – Market risk benefits, which are contracts or contract features that provide protection to the policyholder from capital market risk and expose the Company to other-than-nominal capital market risk, are measured at fair value. The periodic change in fair value is recognized in net income with the exception of the periodic change in fair value related to the instrument-specific credit risk, which is recognized in OCI.

Upon adoption, the Company expects an impact to (1) accumulated other comprehensive income (loss) for the cumulative effect of changes in the instrument-specific credit risk between contract issue date and transition date and (2) retained earnings for the difference between fair value and carrying value at the transition date, excluding the changes in the instrument-specific credit risk.

The updated guidance for the cash flow assumptions, discount rate and deferred policy acquisition costs will be applied on a modified retrospective method as of the earliest period included in the financial statements; that is, to contracts in force as of January 1, 2021. The guidance for market risk benefits will be applied retrospectively as of January 1, 2021.

The Company estimates the adoption of the new guidance will decrease previously reported retained earnings by approximately $1.0 billion to $1.3 billion, net of tax, and accumulated other comprehensive income (loss) by approximately $5.1 billion to $7.1 billion, net of tax, as of the transition date of January 1, 2021. In addition, the Company estimates the adoption of the new guidance will decrease previously reported retained earnings by approximately $0.5 billion to $0.8 billion, net of tax, and accumulated other comprehensive income (loss) by approximately $3.2 billion to $5.2 billion, net of tax, as of December 31, 2021. All amounts assume a tax rate of 24 percent. While the Company has substantially completed the necessary updates to its valuation models and other systems to implement the standard, the Company’s implementation of the new guidance is ongoing. The actual impact of adoption, including the actual tax rate, will be updated as the model validation, system testing and parallel runs continue through the remainder of 2022; therefore, the Company’s estimates are subject to change.

3766

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Cautionary Note Regarding Forward-Looking Statements

This ~~report~~document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and federal securities laws including, among others, statements relating to projections of the future operations, strategies, earnings, revenues, income or loss, ratios, financial performance and growth potential of the Company. Forward-looking statements often contain words and phrases such as “anticipate,” “assume,” “believe,” “continue,” “could,” “estimate,” “expect,” ~~“anticipate,~~“if,” “intend,” “likely,” “may,” ~~“could,~~“plan,” ~~“intend,~~“potential,” ~~“intent,” “belief,” “estimate,~~“pro forma,” “project,” ~~“plan,~~“should,” ~~“predict,~~“will,” ~~“foresee,~~“would,” ~~“likely,” “will”~~ and other words and terms of similar ~~expressions.~~meaning or that are otherwise tied to future periods or future performance, in each case in all derivative forms. Forward-looking statements are based on management’s current expectations and beliefs concerning future developments and their potential effects on the Company. Forward-looking statements are not a guarantee of future performance and are subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results, performance, and achievements could differ materially from those set forth in, contemplated by or underlying the forward-looking statements.

The effects of the COVID-19 pandemic and the response thereto on economic conditions, the financial markets and insurance risks, and the resulting effects on the Company’s financial results, liquidity, capital resources, financial metrics, investment portfolio and stock price, could cause actual results and events to differ materially from those expressed or implied by forward-looking statements. Additionally, numerous other important factors (whether related to, resulting from or exacerbated by the COVID-19 pandemic or otherwise)Factors that could also cause results ~~and~~or events to differ, possibly materially, from those expressed or implied by forward-looking statements, ~~including, without limitation:~~include, among others: (1) adverse changes in mortality (whether related to COVID-19 or otherwise), morbidity, lapsation or claims experience, (2) inadequate risk analysis and underwriting, (3) adverse capital and credit market conditions and their impact on the Company’s liquidity, access to capital and cost of capital, (4) changes in the Company’s financial strength and credit ratings and the effect of such changes on the Company’s future results of operations and financial condition, (5) the availability and cost of collateral necessary for regulatory reserves and capital, (6) requirements to post collateral or make payments due to declines in the market value of assets subject to the Company’s collateral arrangements, (7) action by regulators who have authority over the Company’s reinsurance operations in the jurisdictions in which it operates, (8) the effect of the Company parent’s status as an insurance holding company and regulatory restrictions on its ability to pay principal of and interest on its debt obligations, (9) general economic conditions or a prolonged economic downturn affecting the demand for insurance and reinsurance in the Company’s current and planned markets, (10) the impairment of other financial institutions and its effect on the Company’s business, (11) fluctuations in U.S. or foreign currency exchange rates, interest rates, or securities and real estate markets, (12) market or economic conditions that adversely affect the value of the Company’s investment securities or result in the impairment of all or a portion of the value of certain of the Company’s investment securities that in turn could affect regulatory capital, (13) market or economic conditions that adversely affect the Company’s ability to make timely sales of investment securities, (14) risks inherent in the Company’s risk management and investment strategy, including changes in investment portfolio yields due to interest rate or credit quality changes, (15) the fact that the determination of allowances and impairments taken on the Company’s investments is highly subjective, (16) the stability of and actions by governments and economies in the markets in which the Company operates, including ongoing uncertainties regarding the amount of U.S. sovereign debt and the credit ratings thereof, (17) the Company’s dependence on third parties, including those insurance companies and reinsurers to which the Company cedes some reinsurance, third-party investment managers and others, (18) financial performance of the Company’s clients, (19) the threat of natural disasters, catastrophes, terrorist attacks, pandemics, epidemics or ~~pandemics~~other major public health issues anywhere in the world where the Company or its clients do business, (20) competitive factors and competitors’ responses to the Company’s initiatives, (21) development and introduction of new products and distribution opportunities, (22) execution of the Company’s entry into new markets, (23) integration of acquired blocks of business and entities, (24) interruption or failure of the Company’s telecommunication, information technology or other operational systems, or the Company’s failure to maintain adequate security to protect the confidentiality or privacy of personal or sensitive data and intellectual property stored on such systems, (25) adverse developments with respect to litigation, arbitration or ~~arbitration results,~~regulatory investigations or actions (26) the adequacy of reserves, resources and accurate information relating to settlements, awards and terminated and discontinued lines of business, (27) changes in laws, regulations, and accounting standards applicable to the Company or its business, including Long Duration Targeted Improvement accounting changes and (28) other risks and uncertainties described in this document and in the Company’s other filings with the Securities and Exchange Commission (“SEC”).

Forward-looking statements should be evaluated together with the many risks and uncertainties that affect the Company’s business, including those mentioned in this document and described in the periodic reports the Company files with the SEC. These forward-looking statements speak only as of the date on which they are made. The Company does not undertake any obligation to update ~~these~~the forward-looking statements, even though the Company’s situation may change in the future. For a discussion of these risks and uncertainties that could cause actual results to differ materially from those contained in the forward-looking statements, you are advised to see Item 1A – “Risk Factors” in the ~~Company’s 2021~~2022 Annual Report, ~~on Form 10-K,~~ as may be supplemented by Item 1A – “Risk Factors” in the Company’s subsequent Quarterly Reports on Form 10-Q.

3867

Table of Contents

Overview

The Company is among the leading global providers of life reinsurance and financial solutions, with ~~$3.3~~$3.5 trillion of life reinsurance in force and assets of ~~$82.7~~$87.4 billion as of September 30, ~~2022.~~2023. Traditional reinsurance includes individual and group life and health, disability, and critical illness reinsurance. Financial ~~solutions~~Solutions includes longevity reinsurance, asset-intensive reinsurance, capital solutions, including financial reinsurance and stable value products. The Company derives revenues primarily from renewal premiums from existing reinsurance treaties, new business premiums from existing or new reinsurance treaties, fee income from ~~financial solutions~~Financial Solutions business and income earned on invested assets.

Historically, the Company’s primary business has been traditional life reinsurance, which involves reinsuring life insurance policies that are often in force for the remaining lifetime of the underlying individuals insured, with premiums earned typically over a period of 10 to 30 years. To a lesser extent, the Company also reinsures health business typically reinsured for one to three years. Each year, however, a portion of the business under existing treaties terminates due to, among other things, lapses or voluntary surrenders of underlying policies, deaths of insureds, and the exercise of recapture options by ceding companies. The Company has expanded its ~~financial solutions~~Financial Solutions business, including significant asset-intensive and longevity risk transactions, which allow its clients to take advantage of growth opportunities and manage their capital, longevity and investment risk.

For its traditional ~~life~~ business, the Company’s profitability largely depends on the volume and amount of death- and health-related claims incurred and the ability to adequately price the risks it assumes. While death claims are reasonably predictable over a period of many years, claims become less predictable over shorter periods and are subject to significant fluctuation from quarter to quarter and year to year. For longevity business, the Company’s profitability depends on the lifespan of the underlying contract holders and the investment performance for certain contracts. Additionally, the Company generates profits on investment spreads associated with the reinsurance of investment type contracts and generates fees from financial reinsurance transactions, which are typically shorter duration than its traditional life reinsurance business. The Company believes its sources of liquidity are sufficient to cover potential claims payments on both a short-term and long-term basis.

As is customary in the reinsurance business, clients continually update, refine, and revise reinsurance information provided to the Company. Such revised information is used by the Company in preparation of its condensed consolidated financial statements and the financial effects resulting from the incorporation of revised data are reflected in the current period.

In the first quarter of 2023, the Company adopted Accounting Standards Update (“ASU”): ASU 2018-12, Financial Services – Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts (“ASU 2018-12”). ASU 2018-12 updates certain requirements for the accounting for long-duration insurance contracts. See Note 2 – “Impact of New Accounting Standard” in the Notes to Condensed Consolidated Financial Statements for additional information.

Segment Presentation

The Company has geographic-based and business-based operational segments. Geographic-based operations are further segmented into ~~traditional~~Traditional and ~~financial solutions~~Financial Solutions businesses. The Company allocates capital to its segments based on an internally developed economic capital model, the purpose of which is to measure the risk in the business and to provide a consistent basis upon which capital is deployed. The economic capital model considers the unique and specific nature of the risks inherent in RGA’s businesses.

As a result of the economic capital allocation process, a portion of investment income is credited to the segments based on the level of allocated capital. In addition, the segments are charged for excess capital utilized above the allocated economic capital basis. This charge is included in policy acquisition costs and other insurance expenses. Segment investment performance varies with the composition of investments and the relative allocation of capital to the operating segments.

Segment revenue levels can be significantly influenced by currency fluctuations, large transactions, mix of business and reporting practices of ceding companies, and therefore may fluctuate from period to period. Although reasonably predictable over a period of years, segment claims experience can be volatile over shorter periods. See “Results of Operations by Segment” below for further information about the Company’s segments.

3968

Table of Contents

Critical Accounting Policies

The preparation of financial statements in conformity with GAAP requires the application of accounting policies that often involve a significant degree of judgment. Management, on an ongoing basis, reviews estimates and assumptions used in the preparation of financial statements. If management determines that modifications in assumptions and estimates are appropriate given current facts and circumstances, results of operations and financial position as reported in the condensed consolidated financial statements could change significantly.

Management believes the critical accounting policies relating to the following areas are most dependent on the application of estimates and assumptions:

Premiums receivable;

Deferred policy acquisition costs;

Liabilities for future policy benefits and incurred but not reported claims;

Valuation of investments, allowance for credit losses and impairments to specific investments;

Valuation of embedded ~~derivatives;~~derivatives and market risk benefits; and

Income taxes.

A discussion of each of the critical accounting policies may be found in the Company’s ~~2021~~2022 Annual Report under “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies.” The critical accounting polices related to Deferred Policy Acquisition Costs, estimating the Company’s Liability for Future Policy Benefits and Valuation of Embedded Derivatives and Market Risk Benefits presented below have been updated to reflect the adoption of ASU 2018-12.

Deferred Policy Acquisition Costs

ASU 2018-12 simplified the accounting for deferred policy acquisition costs by eliminating the requirement to test deferred policy acquisition costs for impairment or recoverability, an interest component is no longer accrued, and the requirement to adjust deferred policy acquisition costs for unrealized gains and losses (i.e., “shadow adjustments”) has been eliminated. ASU 2018-12 also clarified that deferred policy acquisition costs should only include costs that have been incurred and estimates of future contract renewal costs shall no longer be included, and capitalized costs should be amortized using a simplified method that approximates straight line amortization. As a result of these simplifications, the Company no longer considers the accounting for deferred policy acquisition costs to be a critical accounting policy.

Liabilities for Future Policy Benefits and Incurred but Not Reported Claims

The liability for future policy benefits is estimated using the Company’s mortality, morbidity, and persistency assumptions that reflect the Company’s historical experience, industry data, cedant specific experience, and discount rates based on the current yields of upper-medium grade fixed income instruments (A rated credit). These assumptions vary with the characteristics of the reinsurance contract, the year the risk was assumed, age of the insured and other appropriate factors.

The liability for annuities in the payout phase is calculated using expected mortality, discount rates and other assumptions. These assumptions vary with the characteristics of the plan of insurance, year of issue, age of insured, and other appropriate factors. The mortality assumptions are based on the Company’s experience as well as industry experience and standards.

•How the reinsurance contracts are priced and managed;

•Geographical locations;

•Underlying currency of the contract;

•Ceding company and other factors.

Given the unique risks and highly customized nature the Company’s financial reinsurance business, reinsurance contracts for the Financial Solutions business are not aggregated with other contracts for the purpose of calculating the liability for future policy benefits.

With the exception of claim expense assumptions, the Company reviews actual and anticipated experience compared to the assumptions used to establish policy benefits on a quarterly basis and will update those assumptions if evidence suggests the assumptions should be revised. During the third quarter of 2023, the Company completed its annual assumption review resulting in a decrease in its total liability for future polity benefits. The decrease was primarily the result of updated mortality

Table of Contents

assumptions, which had a favorable impact on the liability for future policy benefits for the Company’s Financial Solutions business and an unfavorable impact on the Company’s Traditional business. Updates may occur in other quarters if information becomes available during the quarter that indicates an assumption update is necessary. The Company has elected to lock-in claims expense assumptions at contract inception and those assumptions are not subsequently reviewed or updated.

The discount rates used to estimate the liability are based on upper-medium grade fixed-income instruments (A rated credit) with similar tenor to the expected liability cash flows. The discount rate assumption is updated quarterly and used to remeasure the liability at the reporting date, with the resulting change reflected in other comprehensive income (loss). For unobservable discount rates, the Company uses estimates consistent with fair value guidance, maximizing the use of relevant, observable market prices and minimizing the use of unobservable inputs.

Valuation of Market Risk Benefits and Embedded Derivatives

The Company reinsures certain annuity products that contain terms that are deemed to be market risk benefits or embedded derivatives, primarily variable annuities with guaranteed minimum benefits and equity-indexed annuities.

Variable annuities with guaranteed minimum benefits have been identified as market risk benefits. Market risk benefits are contracts or contract features that both provide protection to the contract holder from other-than-nominal capital market risk and expose the Company to other-than-nominal capital market risk. Market risk benefits are measured at fair value using an option-based valuation model based on current net amounts at risk, market data, Company experience, and other factors. Changes in fair value are recognized in net income each period with the exception of the portion of the change in fair value due to a change in the liability’s credit valuation adjustment (“CVA”), which is recognized in other comprehensive income (loss).

The Company reinsures certain annuity products that contain terms that are deemed to be embedded derivatives, primarily equity-indexed annuities and variable annuities with guaranteed minimum benefits. The Company assesses each identified embedded derivative to determine whether it is required to be bifurcated under the general accounting principles for Derivatives and Hedging. If the instrument would not be reported in its entirety at fair value and it is determined that the terms of the embedded derivative are not clearly and closely related to the economic characteristics of the host contract, and that a separate instrument with the same terms would qualify as a derivative instrument, the embedded derivative is bifurcated from the host contract and accounted for as a freestanding derivative. Such embedded derivatives are carried on the consolidated balance sheets at fair value with the host contract.

Additionally, reinsurance treaties written on a modified coinsurance or funds withheld basis are subject to the general accounting principles for Derivatives and Hedging related to embedded derivatives. The majority of the Company’s funds withheld at interest balances are associated with its reinsurance of annuity contracts, the majority of which are subject to the general accounting principles for Derivatives and Hedging related to embedded derivatives. Management believes the embedded derivative feature in each of these reinsurance treaties is similar to a total return swap on the assets held by the ceding companies.

The valuation of the various embedded derivatives requires complex calculations based on actuarial and capital markets inputs and assumptions related to estimates of future cash flows and interpretations of the primary accounting guidance continue to evolve in practice. The valuation of embedded derivatives is sensitive to the investment credit spread environment. Changes in investment credit spreads are also affected by the application of a credit valuation adjustment (“CVA”). The fair value calculation of an embedded derivative in an asset position utilizes a CVA based on the ceding company’s credit risk. Conversely, the fair value calculation of an embedded derivative in a liability position utilizes a CVA based on the Company’s credit risk. Generally, an increase in investment credit spreads, ignoring changes in the CVA, will have a negative impact on the fair value of the embedded derivative (decrease in income).

Table of Contents

Consolidated Results of Operations

~~Impacts~~Results from Operations – 2023 compared to 2022

The following table summarizes net income for the periods presented.


	Three months ended September 30,						Nine months ended September 30,
(Dollars in millions, except per share data)	2023		2022		2023 vs 2022		2023		2022		2023 vs 2022
Revenues
Net premiums	$	4,255	$	3,247	$	1,008	$	10,977	$	9,632	$	1,345
Net investment income	922		769		153		2,635		2,333		302




Investment related losses, net	(126)		(154)		28		(326)		(533)		207
Other revenues	102		188		(86)		274		438		(164)
Total revenues	5,153		4,050		1,103		13,560		11,870		1,690
Benefits and expenses
Claims and other policy benefits	3,959		3,048		911		10,035		8,857		1,178
Future policy benefits remeasurement (gains) losses	(82)		226		(308)		(95)		302		(397)
Market risk benefits remeasurement (gains) losses	(21)		23		(44)		(38)		29		(67)
Interest credited	223		189		34		647		468		179
Policy acquisition costs and other insurance expenses	348		341		7		1,028		1,021		7
Other operating expenses	274		251		23		799		720		79
Interest expense	72		49		23		188		136		52
Total benefits and expenses	4,773		4,127		646		12,564		11,533		1,031
Income before income taxes	380		(77)		457		996		337		659
Provision for income taxes	91		(2)		93		247		109		138
Net income	$	289	$	(75)	$	364	$	749	$	228	$	521
Net income (loss) attributable to noncontrolling interest	2		1		1		5		2		3
Net income (loss) available to RGA, Inc. shareholders	$	287	$	(76)	$	363	$	744	$	226	$	518
Earnings per share
Basic earnings per share	$	4.34	$	(1.13)	$	5.47	$	11.19	$	3.38	$	7.81
Diluted earnings per share	$	4.29	$	(1.13)	$	5.42	$	11.06	$	3.35	$	7.71

Three months ended September 30, 2023 compared to three months ended September 30, 2022

The increase in income for the three months ended September 30, 2023, was primarily the result of:

•During the third quarter of ~~the COVID-19 Pandemic~~

~~Although global COVID-19 related deaths have begun to decline,~~2023, the Company ~~continues~~completed its annual assumption review resulting in a future policy benefits remeasurement gain of $3 million compared to ~~experience increased claim costs, primarily~~a future policy benefits remeasurement loss of $326 million in the ~~first~~third quarter of 2022, as a result of the COVID-19 global pandemic. However, the Company cannot reliably predict the future impact the ongoing pandemic will have on its business, results of operations and financial condition as the ultimate amount and timing of claims the Company will experience as a result of the COVID-19 pandemic will depend on many variables and uncertainties. These variables and uncertainties will depend on, the severity of new variants of the virus, vaccination effectiveness, country-specific circumstances, and COVID-19’s indirect impact on mortality and morbidity.2022. See Note 5 – “Future Policy Benefits” for additional information.

~~To date, general population COVID-19 deaths have been heavily concentrated~~•An increase in ~~individuals aged 70 and older and with pre-existing comorbidities; however, many populations have seen~~net investment income attributable to an increase in ~~younger age deaths, particularly~~the average invested asset base and higher interest rates earned on new investments.

•A $1 million increase in ~~areas where healthcare facilities were unable~~investment related losses associated with the changes in the fair value of embedded derivatives on modco/funds withheld treaties for the three month period ended September 30, 2023, compared to ~~provide adequate care. The Company’s insured population has lower exposure~~a decrease of $17 million for the three month period ended September 30, 2022.

•A remeasurement gain of $21 million in the current period related to ~~older ages than~~market risk benefits compared to a remeasurement loss of $23 million in the ~~general population and covers a generally healthier population due~~prior year.

Nine months ended September 30, 2023 compared to ~~underwriting and socioeconomic factors of those purchasing insurance. In addition, the Company’s longevity business may act as a modest offset to excess life insurance claims at older ages.~~nine months ended September 30, 2022

The Company’s COVID-19 projection and financial impact models continue to be updated and refined based on latest external data and the Company’s claim experience to date and are subject to the many variables and uncertainties noted above. During the first nine months of 2022, the U.S. continues to be the key driver of mortality claim costs followed by Asia and Canada. Forincrease in income for the nine months ended September 30, ~~2022,~~2023, was primarily the Company estimates it has incurred approximately $388 million of COVID-19 related life and health claim costs, including amounts incurred but not reported, with approximately $295 million of that amount being associated with the U.S. and Latin America Traditional segment. During the three months ended September 30, 2022, mortality claims relatedresult of:

•An increase in net investment income attributable to ~~COVID-19 continued to decline across all segments; however, the Company experienced~~ an increase in ~~medical hospitalization claims for at-home sickness benefits related to COVID-19 in Japan. Changes to~~ the ~~definition of qualifying at-home sickness benefits at the end of September~~average invested asset base and ~~a reduction in general population infections in Japan is expected to reduce future at-home benefit expenses in future periods.~~

The Company has maintained the range of COVID-19 mortality claim cost estimates relative to the level of general population deaths for the U.S., UK and Canada. The Company estimates that every additional 10,000 population deaths in the U.S., UK or Canada as a result of COVID-19 would result in the following corresponding excess mortality claims of approximately

higher interest rates earned on new investments.

•$1018 million ~~to $20 million~~improvement in investment related losses associated with changes in the ~~U.S.;~~

•$4fair value of embedded derivative on modco/funds withheld treaties for the nine month period ended September 30, 2023, compared to a decrease of $106 million ~~to $8 million in~~for the ~~UK; and~~

•~~$10 million to $20 million in Canada.~~

nine month period ended September 30, 2022.

4071

Table of Contents

~~Results from Operations~~ – ~~2022 compared to 2021~~

~~The following table summarizes net income for the periods presented.~~

Three months ended September 30, Nine months ended September 30,
2022 2021 2022 vs 2021 2022 2021 2022 vs 2021
Revenues: (Dollars in millions, except per share data)
Net premiums $ 3,247 $ 3,094 $ 153 $ 9,632 $ 9,106 $ 526
Investment income, net of related expenses 769 796 (27) 2,333 2,367 (34)
Investment related gains (losses), net (134) 58 (192) (514) 472 (986)
Other revenues 184 95 89 432 354 78
Total revenues 4,066 4,043 23 11,883 12,299 (416)
Benefits and Expenses:
Claims and other policy benefits 2,815 3,289 (474) 8,855 9,294 (439)
Interest credited 189 177 12 468 541 (73)
Policy acquisition costs and other insurance expenses 396 338 58 1,144 1,010 134
Other operating expenses 251 229 22 720 683 37
Interest expense 46 41 5 130 129 1
Collateral finance and securitization expense 3 3 — 6 8 (2)
Total benefits and expenses 3,700 4,077 (377) 11,323 11,665 (342)
Income before income taxes
366 (34) 400 560 634 (74)
Provision for income taxes 81 (12) 93 139 173 (34)
Net income 285 (22) 307 421 461 (40)
Net income attributable to noncontrolling interest $ 1 $ — 1 $ 2 $ — 2
Net income available to RGA, Inc. shareholders $ 284 $ (22) $ 306 $ 419 $ 461 $ (42)
Earnings per share:
Basic earnings per share $ 4.24 $ (0.32) $ 4.56 $ 6.25 $ 6.78 $ (0.53)
Diluted earnings per share $ 4.19 $ (0.32) $ 4.51 $ 6.19 $ 6.74 $ (0.55)

~~Three months ended September 30, 2022 compared to three months ended September 30, 2021~~

~~The increase in income for the three months ended September 30, 2022, was primarily the result of:~~

•~~Decrease in mortality~~Favorable claims experience in the U.S. and Latin America ~~EMEA~~ and Asia ~~Pacific traditional segments, due to fewer claims~~Traditional segment during the nine month period ended September 30, 2023 and future policy benefits remeasurement gains as a result of favorable assumption updates during the third quarter of 2023. The unfavorable experience in the prior period, included in future policy benefits remeasurement (gains) losses, was primarily attributable to higher than expected claims as a result of COVID-19 incurred in the ~~COVID-19 pandemic.~~first quarter of 2022 and unfavorable assumption updates in the third quarter of 2022.

•~~An increase~~A decrease in other ~~revenues primarily attributable~~revenue, which was the result of a recapture fee received in the prior year related to a U.S. Capital Solutions transaction, and reduced surrender and market value ~~adjustments~~adjustment charges ~~of $104 million due to higher lapses~~ on a single premium annuity block of business in ~~Asia, which were partially offset by an increase in policy acquisition costs and other reinsurance expenses.~~Asia.

•~~The decrease in mortality claims was partially offset by:~~

◦~~Changes in the fair value~~A remeasurement gain of ~~derivative instruments, excluding embedded derivatives, included in investment~~$38 million related ~~gains (losses), net. During the three month period ended September 30, 2022, the fair value of these instruments decreased by $52 million, compared~~ to ~~a decrease of $0 million during the three months ended September 30, 2021.~~

◦Changes in the fair value of embedded derivatives, associated with modco/funds withheld treaties, decreased investment related gains by $16 million for the three months ended September 30, 2022, compared to an increase of $21 million for the three month period ended September 30, 2021.

◦$86 million, pre-tax, of net realized losses, included in investment related gains (losses), net associated with portfolio repositioning, compared to $36 million of net realized gains recognized in the prior year.

◦The average yield earned on investments, excluding spread related business, was 4.40% and 4.95% for the three month periods ended September 30, 2022 and 2021, respectively. Investment yield decreased for the three months ended September 30, 2022, in comparison to the same period in the prior year, primarily due to decreased variable income from limited partnerships and real estate joint ventures.

~~Table of Contents~~

~~Nine months ended September 30, 2022 compared to nine months ended September 30, 2021~~

~~The decrease in income~~market risk benefits for the nine months ended September 30, ~~2022, was primarily the result of:~~

•Changes in the fair value of derivative instruments, excluding embedded derivatives, included in investment related gains (losses), net. During the nine months ended September 30, 2022, the fair value of these instruments decreased by $256 million,2023, compared to a ~~decrease~~remeasurement loss of ~~$21 million during the nine months ended September 30, 2021.~~

•~~Changes in the fair value of embedded derivatives, associated with modco/funds withheld treaties, decreased investment related gains by $106~~$29 million for the nine months ended September 30, ~~2022, compared to an increase of $87 million for the nine months ended September 30, 2021.~~

•$171 million, pre-tax, of net realized losses, included in investment related gains (losses), net associated with portfolio repositioning, compared to $213 million of net realized gains recognized in the prior year.

•The prior year benefited from a one-time adjustment of $162 million, pretax, associated with prior periods that includes $92 million, pretax, to correct the accounting for equity method limited partnerships to reflect unrealized gains in investment income, net of related expenses that were previously included in accumulated other comprehensive income (loss), and a $70 million, pretax, correction reflected in other investment related gains (losses), net to adjust the carrying value of certain limited partnerships from cost less impairments to a fair value approach, using the net asset value (“NAV”) per share or its equivalent.

•The decreases in investment income and investment related gains (losses) were partially offset by a decrease in mortality claims in the U.S. and Latin America, EMEA and Asia Pacific traditional segments, as a result of fewer claims attributable to the COVID-19 pandemic.2022.

Foreign currency fluctuations can result in variances in the financial statement line items. Foreign currency exchange fluctuations increased (decreased) income before taxes for the three and nine ~~month periods~~months ended September 30, ~~2022,~~2023, by ~~$11~~$1 million and ~~$24~~$(21) million, respectively, primarily due to the ~~impact of the~~strengthening and weakening of the ~~Japanese Yen~~Canadian Dollar compared to the U.S. ~~Dollar.~~dollar. Unless otherwise stated, all amounts discussed below are net of foreign currency fluctuations.

Premiums and business growth

The increase in premiums ~~during~~for the three and nine ~~month period~~months ended September 30, ~~2022, is~~2023, was primarily due to single premium pension risk transfer (“PRT”) transactions completed in the first and third quarters of 2023. The PRT single premiums received were offset by an increase in reserves. The remaining increase in premiums for the three and nine months ended September 30, 2023, was attributable to organic growth on existing treaties and new business ~~production.~~production, measured by the face amount of life reinsurance in force, of $265.5 billion and $316.4 billion during the nine months ended September 30, 2023 and 2022, respectively. Consolidated assumed life reinsurance in force ~~decreased from $3,468.6~~increased to $3,499.4 billion as of September 30, ~~2021, to~~2023, from $3,272.6 billion as of September 30, 2022, due to new business production and changes in foreign exchange rates partially offset by new business production. The Company added new business production, measured by face amount of reinsurance in force, of $316.4 billion and $305.4 billion during the nine months ended September 30, 2022 and 2021, respectively.rates.

~~Investment~~Net investment income ~~net of related expenses~~ and investment related gains (losses), net

The ~~decrease~~increase in net investment income ~~net of related expenses is~~was primarily attributable to ~~the aforementioned accounting correction associated with equity method limited partnerships recorded in the first quarter of 2021, partially offset by~~ an increase in the average invested asset ~~base:~~base and interest rates earned on new investments, partially offset by a decrease in variable investment income associated with joint venture and limited partnership investments:

•The average invested assets at amortized cost, excluding spread related business, ~~was~~totaled $35.9 billion and $34.5 billion ~~for the nine months ended September 30,~~in 2023 and 2022, ~~compared to $33.0 billion for the nine months ended September 30, 2021.~~respectively.

•The average yield earned on investments, excluding spread related business, was ~~4.78%~~4.72% and ~~5.08%~~4.40% for the three month periods ended September 30, 2023 and 2022, respectively, and 4.62% and 4.78% for the nine months ended September 30, 2023 and 2022, ~~and 2021,~~ respectively. ~~Investment~~The increase in yield ~~decreased~~for the three months ended September 30, 2023, compared to the prior year was attributable to higher interest rates. The decrease in yield for the nine months ended September 30, ~~2022, in comparison~~2023, compared to ~~the same periods in~~ the prior year ~~primarily due~~was attributable to ~~decreased~~lower variable investment income ~~from~~associated with joint ventures and limited partnerships ~~and real estate joint ventures.~~

partially offset by higher interest rates.

The average yield will vary from ~~year~~period to ~~year~~period depending on several variables, including the prevailing ~~risk-fee~~risk-free interest rate and credit spread environment, prepayment fees and make-whole premiums, changes in the mix of the underlying investments and cash and cash equivalents balances. Variable investment income from joint ventures and limited partnerships ~~including unrealized gains and losses on certain limited partnerships,~~ will also vary from ~~year~~period to ~~year~~period and ~~can be~~is highly ~~variable based~~dependent on ~~equity-market performance and~~ the timing of dividends and distributions on certain investments. Investment income is allocated to the operating segments based upon average assets and related capital levels deemed appropriate to support segment operations.

The decrease in investment related ~~gains (losses),~~losses, net is primarily attributable to the following:

•During the three and nine months ended September 30, ~~2022,~~2023, the Company repositioned its portfolio generating net capital losses of ~~$86~~$49 million and ~~$171~~$119 million, respectively, compared to net capital ~~gains~~losses of ~~$36~~$86 million and ~~$213~~$171 million during the three and nine months ended September 30, ~~2021,~~2022, respectively.

~~Table~~•Changes in the fair value of ~~Contents~~embedded derivatives associated with modco/funds withheld treaties increased by $1 million and $18 million for the three and nine months ended September 30, 2023, respectively, compared to decreases of $17 million and $106 million for the three and nine months ended September 30, 2022, respectively.

•The Company uses various derivative instruments such as interest rate swaps, credit default swaps and foreign exchange forwards for risk management purposes that either do not qualify or have not been elected for hedge accounting treatment. Changes in the fair value of these instruments are included in investment related gains (losses), net. During the three and nine months ~~periods~~ ended September 30, ~~2022,~~2023, the fair value of these instruments decreased by ~~$52~~ $98

Table of Contents

million and ~~$256~~$222 million, respectively, compared to ~~an increase (decrease)~~decreases of $0$51 million and ~~$(21)~~$251 million during the first three and nine months of 2022. See Note 12 – “Derivative Instruments” for additional information.

The effective tax rate was 24.2% and 24.9% for the three and nine months ended September 30, ~~2021, respectively. See Note 5 – “Derivative Instruments” in the Notes~~2023, respectively, compared to ~~Condensed Consolidated Financial Statements for additional information.~~

•~~Changes in the fair value of embedded derivatives, associated with modco/funds withheld treaties, decreased investment related gains (losses), net by $16 million~~2.7% and ~~$106 million~~32.5% for the three and nine ~~month periods ended September 30, 2022, respectively, compared to an increase of $21 million and $87 million for the three and nine month periods ended September 30, 2021.~~

•The Company incurred $15 million and $45 million of impairments and change in allowance for credit losses during the three and nine month periods ended September 30, 2022, respectively, compared to a decrease of $3 million and $27 million of impairments and change in allowance for credit losses during the three and nine month periods ended September 30, 2021, respectively.

•Investment related gains (losses), net for the first nine months of 2021, included the adjustment previously discussed to investments in limited partnerships considered to be investment companies, which should have been recognized in prior periods, of $70 million pre-tax to adjust the carrying value from cost less impairments to the fair value approach, using the net asset value (“NAV”) per share or its equivalent.

~~The effective tax rate on a consolidated basis was 22.3% and 34.3% for the three~~ months ended September 30, ~~2022 and 2021, respectively, and 25.0% and 27.3% for the nine months ended September 30, 2022 and 2021, respectively.~~2022. See Note 914 – “Income Tax” ~~in the Notes to Condensed Consolidated Financial Statements~~ for additional information on the Company’s consolidated effective tax ~~rates.~~rate.

Impact of certain derivatives and market risk benefits

The Company recognizes in consolidated income any changes in the fair value of embedded derivatives on modco or funds withheld treaties and equity index annuities (“EIAs”) ~~and variable annuities~~. In addition, the Company recognizes the changes in fair value of market risk benefits associated with guaranteed minimum benefit ~~riders.~~riders in market risk benefits remeasurement gains (losses). The Company utilizes freestanding derivatives to minimize the income statement volatility due to changes in the fair value of ~~embedded derivatives~~market risk benefits associated with guaranteed minimum benefit riders. The following table presents the effect of embedded derivatives, market risk benefits and related freestanding derivatives on income before income taxes for the periods indicated (dollars in millions):

Three Months Ended September 30, Nine Months Ended September 30,
2022 2021 2022 vs 2021 2022 2021 2022 vs 2021
Modco/Funds withheld:
Unrealized gains (losses) $ (16) $ 21 $ (37) $ (106) $ 87 $ (193)
Deferred acquisition costs/retrocession 10 (8) 18 61 (31) 92
Net effect (6) 13 (19) (45) 56 (101)
EIAs:
Unrealized gains (losses) 10 4 6 54 36 18
Deferred acquisition costs/retrocession (5) (2) (3) (24) (18) (6)
Net effect 5 2 3 30 18 12
Guaranteed minimum benefit riders:
Unrealized gains (losses) 21 (37) 58 23 (36) 59
Related freestanding derivatives, net of deferred acquisition costs/retrocession (29) 5 (34) (56) (28) (28)
Net effect (8) (32) 24 (33) (64) 31
Total net effect after freestanding derivatives $ (9) $ (17) $ 8 $ (48) $ 10 $ (58)


	Three months ended September 30,						Nine months ended September 30,
	2023		2022		2023 vs. 2022		2023		2022		2023 vs. 2022
Modco/Funds withheld:
Change in fair value of funds withheld embedded derivatives	$	1	$	(17)	$	18	$	18	$	(106)	$	124
EIAs:
Embedded derivatives – interest credited	7		10		(3)		11		54		(43)
Market Risk Benefits:
Market risk benefits remeasurement gains (losses)	21		(23)		44		38		(29)		67
Related freestanding derivatives	(42)		(12)		(30)		(82)		(39)		(43)
Net effect	(21)		(35)		14		(44)		(68)		24
Total net effect after freestanding derivatives	$	(13)	$	(42)	$	29	$	(15)	$	(120)	$	105

4373

Table of Contents

Results of Operations by Segment

U.S. and Latin America Operations

The U.S. and Latin America operations consist of two major segments: Traditional and Financial Solutions. The Traditional segment primarily specializes in the reinsurance of individual ~~mortality risk,~~mortality-risk, health and long-term care and to a lesser extent, group reinsurance. The Financial Solutions segment consists of Asset-Intensive and Capital Solutions. Asset-Intensive within the Financial Solutions segment includes coinsurance of annuities, ~~and~~ corporate-owned life insurance policies, pension risk transfer (“PRT”) group annuity contracts and, to a lesser extent, fee-based synthetic guaranteed investment contracts, which include investment-only, stable value contracts. Capital Solutions within the Financial Solutions segment primarily involves assisting ceding companies in meeting applicable regulatory requirements by enhancing the ceding companies’ financial strength and regulatory surplus position through relatively low risk reinsurance and other transactions. Typically, these transactions do not qualify as reinsurance under GAAP, due to the low-risk nature of the transactions, therefore only the related net fees are reflected in other revenues on the condensed consolidated statements of ~~income~~.income.

The following table summarizes income before income taxes for the Company’s U.S. and Latin America operations for the periods presented:


		Three Months Ended September 30,						Nine Months Ended September 30,							Three months ended September 30,						Nine months ended September 30,
(dollars in millions)	(dollars in millions)	2022		2021		2022 vs 2021		2022		2021		2022 vs 2021		(dollars in millions)	2023		2022		2023 vs 2022		2023		2022		2023 vs 2022
Revenues:
Revenues														Revenues
Net premiums	Net premiums	$	1,653	$	1,564	$	89	$	4,854	$	4,589	$	265	Net premiums	$	2,566	$	1,653	$	913	$	6,111	$	4,854	$	1,257
Investment income, net of related expenses		484		536		(52)		1,512		1,510		2
Net investment income														Net investment income	494		468		26		1,426		1,447		(21)
Investment related gains (losses), net	Investment related gains (losses), net	(14)		7		(21)		(153)		38		(191)		Investment related gains (losses), net	(61)		(33)		(28)		(111)		(172)		61
Other revenues	Other revenues	59		62		(3)		234		236		(2)		Other revenues	65		59		6		175		234		(59)
Total revenues	Total revenues	2,182		2,169		13		6,447		6,373		74		Total revenues	3,064		2,147		917		7,601		6,363		1,238
Benefits and expenses:
Benefits and expenses														Benefits and expenses
Claims and other policy benefits	Claims and other policy benefits	1,440		1,718		(278)		4,684		4,957		(273)		Claims and other policy benefits	2,462		1,561		901		5,745		4,644		1,101
Future policy benefits remeasurement (gains) losses														Future policy benefits remeasurement (gains) losses	(45)		155		(200)		(19)		226		(245)
Market risk benefits remeasurement (gains) losses														Market risk benefits remeasurement (gains) losses	(21)		23		(44)		(38)		29		(67)
Interest credited	Interest credited	148		166		(18)		390		497		(107)		Interest credited	156		148		8		454		390		64
Policy acquisition costs and other insurance expenses	Policy acquisition costs and other insurance expenses	261		231		30		778		700		78		Policy acquisition costs and other insurance expenses	231		217		14		690		667		23
Other operating expenses	Other operating expenses	59		52		7		173		151		22		Other operating expenses	68		59		9		191		173		18
Total benefits and expenses	Total benefits and expenses	1,908		2,167		(259)		6,025		6,305		(280)		Total benefits and expenses	2,851		2,163		688		7,023		6,129		894
Income before income taxes		$	274	$	2	$	272	$	422	$	68	$	354
Income (loss) before income taxes														Income (loss) before income taxes	$	213	$	(16)	$	229	$	578	$	234	$	344

The increase in income before income taxes in the third quarter of 2022 was primarily driven by favorable claims experience in the individual mortality line of business, as well as an increase of $42 million due to termination and utilization assumption updates related to individual health disabled life reserves. The increase income was partially offset by lower investment income, as well as higher investment related losses and a decrease in the fair value of the embedded derivative associated with modco/funds withheld treaties within Financial Solutions. The increaseincreases in income before income taxes for the third quarter and first nine months of ~~2022 is also attributable~~2023 were primarily the result of favorable impacts of assumption updates in 2023 as compared to the prior year, favorable claims experience ~~within~~in the ~~individual mortality line~~U. S. Traditional lines of business, ~~as well as the aforementioned individual health disabled life reserve assumption update. Partially offsetting the nine month increases were decreases~~fluctuations in investment related gains (losses) ~~as well as a decrease~~due to changes in the fair value of ~~the~~market risk benefits, net of hedging, and embedded ~~derivative~~derivatives associated with modco/funds withheld treaties ~~within~~in the Financial ~~Solutions.~~Solutions segment, partially offset by a recapture fee earned on a terminated Capital Solutions transaction in the second quarter of 2022.

4474

Table of Contents

Traditional Reinsurance


		Three Months Ended September 30,								Nine Months Ended September 30,
For the three months ended September 30,																		For the three months ended September 30,	Three months ended September 30,								Nine months ended September 30,
(dollars in millions)	(dollars in millions)	2022			2021			2022 vs 2021		2022			2021			2022 vs 2021		(dollars in millions)	2023			2022			2023 vs 2022		2023			2022			2023 vs 2022
Revenues:
Revenues																		Revenues
Net premiums	Net premiums	$	1,640		$	1,550		$	90	$	4,812		$	4,547		$	265	Net premiums	$	1,746		$	1,640		$	106	$	5,111		$	4,812		$	299
Investment income, net of related expenses		214			245			(31)		727			685			42
Net investment income																		Net investment income	195			201			(6)		568			676			(108)
Investment related gains (losses), net	Investment related gains (losses), net	8			(5)			13		42			2			40		Investment related gains (losses), net	2			8			(6)		—			42			(42)
Other revenues	Other revenues	5			5			—		21			14			7		Other revenues	6			6			—		14			22			(8)
Total revenues	Total revenues	1,867			1,795			72		5,602			5,248			354		Total revenues	1,949			1,855			94		5,693			5,552			141
Benefits and expenses:
Benefits and expenses																		Benefits and expenses
Claims and other policy benefits	Claims and other policy benefits	1,398			1,670			(272)		4,552			4,828			(276)		Claims and other policy benefits	1,611			1,520			91		4,650			4,491			159
Future policy benefits remeasurement (gains) losses																		Future policy benefits remeasurement (gains) losses	(20)			160			(180)		11			252			(241)
Market risk benefits remeasurement (gains) losses																		Market risk benefits remeasurement (gains) losses	—			—			—		—			—			—
Interest credited	Interest credited	18			17			1		52			52			—		Interest credited	19			18			1		55			52			3
Policy acquisition costs and other insurance expenses	Policy acquisition costs and other insurance expenses	203			195			8		619			583			36		Policy acquisition costs and other insurance expenses	184			182			2		546			544			2
Other operating expenses	Other operating expenses	44			39			5		132			114			18		Other operating expenses	50			44			6		143			132			11
Total benefits and expenses	Total benefits and expenses	1,663			1,921			(258)		5,355			5,577			(222)		Total benefits and expenses	1,844			1,924			(80)		5,405			5,471			(66)
Income (loss) before income taxes	Income (loss) before income taxes	$	204		$	(126)		$	330	$	247		$	(329)		$	576	Income (loss) before income taxes	$	105		$	(69)		$	174	$	288		$	81		$	207
Key metrics:
Key metrics																		Key metrics
Life reinsurance in force	Life reinsurance in force									$1,662.7 billion			$1,619.9 billion					Life reinsurance in force									$1,693.1 billion			$1,662.7 billion
Claims and other policy benefits as a percentage of net premiums (“loss ratios”)		85.2		%	107.7		%			94.6		%	106.2		%
Future policy benefits remeasurement (gains) losses																		Future policy benefits remeasurement (gains) losses
Effect of changes in cash flow assumptions																		Effect of changes in cash flow assumptions	$	17		$	170				$	17		$	170
Effect of actual variances from expected experience																		Effect of actual variances from expected experience	$	(37)		$	(10)				$	(6)		$	82
Loss ratio (1)																		Loss ratio (1)	91.1		%	102.4		%			91.2		%	98.6		%
Policy acquisition costs and other insurance expenses as a percentage of net premiums	Policy acquisition costs and other insurance expenses as a percentage of net premiums	12.4		%	12.6		%			12.9		%	12.8		%			Policy acquisition costs and other insurance expenses as a percentage of net premiums	10.5		%	11.1		%			10.7		%	11.3		%
Other operating expenses as a percentage of net premiums	Other operating expenses as a percentage of net premiums	2.7		%	2.5		%			2.7		%	2.5		%			Other operating expenses as a percentage of net premiums	2.9		%	2.7		%			2.8		%	2.7		%

(1)Includes Claims and other policy benefits and Future policy benefits remeasurement (gains) losses

The increase in income before income taxes infor the third quarter ~~for~~and the ~~U.S. and Latin America Traditional segment~~first nine months of 2023 was primarily the result of favorable ~~claims experience within~~impacts from assumption updates in the individual mortality business, as well as the aforementioned assumption update for individual health disabled life reserves, partially offset by less favorable investment income. The increase in income before taxes for the first nine months was primarily the resultthird quarter of favorable claims experience within the individual mortality business, the individual health disabled life reserve adjustment and favorable investment income, partially offset by less favorable claims experience within the U.S. group and Latin American businesses. The impact of COVID-19 claims was significantly less both quarter to date and year to date2023 as compared to the ~~same periods~~third quarter of 2022 and favorable claims experience across all businesses, driven in ~~2021.~~

large part by COVID-19 claims in the first quarter of 2022.

Revenues

•The increase in net premiums ~~for the third quarter~~ was primarily due to organic growth as well as new sales. The increase in net premiums for the nine month period was primarily due to organic growth and new sales of $184 million, as well as $45 million in restructuring of a transaction that was previously recognized as a deposit contract in Latin America and $36 million related to the partial recapture of a large reinsurance transaction in the second quarter of 2021.business treaties. The segment added new life business production, measured by face amount of life reinsurance in force, of ~~$37.3~~$106.4 billion and ~~$33.9 billion during the third quarter of 2022 and 2021, respectively, and~~ $109.5 ~~billion and $98.1~~ billion during the first nine months of 2023 and 2022, respectively. Also contributing to the increase in net premiums was the recapture of a retrocession treaty, effective April 1, 2023, which resulted in a reduction in ceded premium in the second and ~~2021, respectively.~~third quarters of 2023.

•The decrease in net investment income ~~for~~during the ~~three month period~~nine months ended September 30, ~~2022,~~2023, was primarily due to ~~lower variable investment income. The increase~~a decrease in ~~net investment income for the nine month period was primarily the result of higher yields and asset bases in the current year partially offset by lower~~ variable investment income.

Benefits and expenses

•The ~~decreases~~decrease in ~~the loss ratio~~future policy benefits remeasurement losses for the ~~three~~third quarter and first nine months ~~ended September 30, 2022,~~of 2023 was attributable to a remeasurement loss as result of the Company’s 2023 annual assumption review of $17 million as compared to a remeasurement loss of $170 million in the ~~same periods~~third quarter of 2022, and favorable claims experience relative to the prior-year, primarily in ~~2021, were~~the U.S. Individual Life business and, in large part, related to COVID-19 claims in the first quarter of 2022.

•The decrease in policy acquisition costs and other insurance expenses as a percentage of net premiums is less than 1% and is primarily due to ~~favorable COVID-19~~varying allowance levels within coinsurance type arrangements and ~~non-COVID-19 experience, mainly within~~ the ~~Individual Mortality line~~mix of business. While the cause of death is not yet available for all claims, the Company estimates that approximately $295 million of claims for the nine months ended September 30, 2022, were attributable to COVID-19.

new business between coinsurance versus yearly renewable term.

4575

Table of Contents

Financial Solutions


For the three months ended September 30,	For the three months ended September 30,	2022						2021						2022 vs 2021						For the three months ended September 30,	2023						2022						2023 vs 2022
		Asset-Intensive		Capital Solutions		Total		Asset-Intensive		Capital Solutions		Total		Asset-Intensive		Capital Solutions		Total
(dollars in millions)	(dollars in millions)																			(dollars in millions)	Asset-Intensive		Capital Solutions		Total		Asset-Intensive		Capital Solutions		Total		Asset-Intensive		Capital Solutions		Total
Revenues:
Revenues																				Revenues
Net premiums	Net premiums	$	13	$	—	$	13	$	14	$	—	$	14	$	(1)	$	—	$	(1)	Net premiums	$	820	$	—	$	820	$	13	$	—	$	13	$	807	$	—	$	807
Investment income, net of related expenses		270		—		270		290		1		291		(20)		(1)		(21)
Net investment income																				Net investment income	298		1		299		265		2		267		33		(1)		32
Investment related gains (losses), net	Investment related gains (losses), net	(22)		—		(22)		12		—		12		(34)		—		(34)		Investment related gains (losses), net	(63)		—		(63)		(41)		—		(41)		(22)		—		(22)
Other revenues	Other revenues	29		25		54		31		26		57		(2)		(1)		(3)		Other revenues	35		24		59		29		24		53		6		—		6
Total revenues	Total revenues	290		25		315		347		27		374		(57)		(2)		(59)		Total revenues	1,090		25		1,115		266		26		292		824		(1)		823
Benefits and expenses:
Benefits and expenses																				Benefits and expenses
Claims and other policy benefits	Claims and other policy benefits	42		—		42		48		—		48		(6)		—		(6)		Claims and other policy benefits	851		—		851		41		—		41		810		—		810
Future policy benefits remeasurement (gains) losses																				Future policy benefits remeasurement (gains) losses	(25)		—		(25)		(5)		—		(5)		(20)		—		(20)
Market risk benefits remeasurement (gains) losses																				Market risk benefits remeasurement (gains) losses	(21)		—		(21)		23		—		23		(44)		—		(44)
Interest credited	Interest credited	130		—		130		149		—		149		(19)		—		(19)		Interest credited	137		—		137		130		—		130		7		—		7
Policy acquisition costs and other insurance expenses	Policy acquisition costs and other insurance expenses	58		—		58		34		2		36		24		(2)		22		Policy acquisition costs and other insurance expenses	45		2		47		36		(1)		35		9		3		12
Other operating expenses	Other operating expenses	12		3		15		10		3		13		2		—		2		Other operating expenses	14		4		18		11		4		15		3		—		3
Total benefits and expenses	Total benefits and expenses	242		3		245		241		5		246		1		(2)		(1)		Total benefits and expenses	1,001		6		1,007		236		3		239		765		3		768
Income before income taxes	Income before income taxes	$	48	$	22	$	70	$	106	$	22	$	128	$	(58)	$	—	$	(58)	Income before income taxes	$	89	$	19	$	108	$	30	$	23	$	53	$	59	$	(4)	$	55

For the nine months ended September 30, 2022 2021 2022 vs 2021
Asset-Intensive Capital Solutions Total Asset-Intensive Capital Solutions Total Asset-Intensive Capital Solutions Total
(dollars in millions)
Revenues:
Net premiums $ 42 $ — $ 42 $ 42 $ — $ 42 $ — $ — $ —
Investment income, net of related expenses 783 2 785 823 2 825 (40) — (40)
Investment related gains (losses), net (195) — (195) 36 — 36 (231) — (231)
Other revenues 87 126 213 142 80 222 (55) 46 (9)
Total revenues 717 128 845 1,043 82 1,125 (326) 46 (280)
Benefits and expenses:
Claims and other policy benefits 132 — 132 129 — 129 3 — 3
Interest credited 338 — 338 445 — 445 (107) — (107)
Policy acquisition costs and other insurance expenses 157 2 159 113 4 117 44 (2) 42
Other operating expenses 33 8 41 27 10 37 6 (2) 4
Total benefits and expenses 660 10 670 714 14 728 (54) (4) (58)
Income before income taxes $ 57 $ 118 $ 175 $ 329 $ 68 $ 397 $ (272) $ 50 $ (222)

~~Asset-Intensive Reinsurance~~


For the nine months ended September 30,	2023						2022						2023 vs 2022
(dollars in millions)	Asset-Intensive		Capital Solutions		Total		Asset-Intensive		Capital Solutions		Total		Asset-Intensive		Capital Solutions		Total
Revenues
Net premiums	$	1,000	$	—	$	1,000	$	42	$	—	$	42	$	958	$	—	$	958
Net investment income	856		2		858		767		4		771		89		(2)		87
Investment related gains (losses), net	(111)		—		(111)		(214)		—		(214)		103		—		103
Other revenues	86		75		161		86		126		212		—		(51)		(51)
Total revenues	1,831		77		1,908		681		130		811		1,150		(53)		1,097
Benefits and expenses
Claims and other policy benefits	1,095		—		1,095		153		—		153		942		—		942
Future policy benefits remeasurement (gains) losses	(30)		—		(30)		(26)		—		(26)		(4)		—		(4)
Market risk benefits remeasurement (gains) losses	(38)		—		(38)		29		—		29		(67)		—		(67)
Interest credited	399		—		399		338		—		338		61		—		61
Policy acquisition costs and other insurance expenses	138		6		144		122		1		123		16		5		21
Other operating expenses	38		10		48		32		9		41		6		1		7
Total benefits and expenses	1,602		16		1,618		648		10		658		954		6		960
Income before income taxes	$	229	$	61	$	290	$	33	$	120	$	153	$	196	$	(59)	$	137

The ~~decreases~~increase in income before income taxes for the U.S. and Latin America Financial ~~Solutions’ Asset-intensive~~Solutions segment for the three and nine months ended September 30, ~~2022, were~~2023, was primarily due to the ~~decrease~~change in the fair value of embedded derivatives on funds withheld at interest, the change in market risk benefits remeasurement gains (losses), net of the change in the fair value of the ~~embedded~~associated free standing derivatives, ~~related to modco/funds withheld treaties~~ and higher net investment ~~related losses, net~~income due to increases in ~~coinsurance portfolios.~~interest rates.

The increase in premiums for the three and nine months ended September 30, 2023, was primarily due to single premium pension risk transfer (“PRT”) transactions completed in the first and third quarters of 2023. The PRT single premiums received were offset by an increase in reserves.

The book value of the invested asset base ~~at amortized cost,~~ supporting ~~this segment~~asset-intensive transactions decreased to $23.0 billion as of September 30, 2023, from $24.2 billion as of September 30, ~~2022, from $24.6 billion as of September 30, 2021.~~2022.

•The decrease in the asset base was primarily due to ~~$1.1~~$2.2 billion ofin net run off inof existing in force transactions, partially offset by ~~$0.9~~$1.0 billion from new transactions.

Table of Contents

•As of September 30, 2023 and 2022, ~~and 2021, $4.3~~$3.8 billion and ~~$4.7~~$4.3 billion, respectively, of the invested assets were funds withheld at interest, of which greater than 90% was associated with two clients.

~~Table~~As of ~~Contents~~

September 30, 2023 and 2022, the amount of reinsurance assumed in Capital Solutions transactions, as measured by pre-tax statutory surplus, risk based capital and other financial structures was $25.9 billion and $25.3 billion, respectively.

Impact of certain derivatives and market risk benefits

The Company recognizes in consolidated income any changes in the fair value of embedded derivatives on modco or funds withheld treaties and equity indexed annuities (“EIAs”). In addition, the Company recognizes the changes in fair value of market risk benefits associated with guaranteed minimum benefit riders. The Company utilizes freestanding derivatives to minimize the income statement volatility due to changes in the fair value of market risk benefits associated with guaranteed minimum benefit riders.

Income from the asset-intensive business tends to be volatile due to changes in the fair value of certain derivatives, including embedded derivatives associated with reinsurance treaties structured on a modco or funds withheld basis, ~~as well as~~ embedded derivatives associated with the Company’s reinsurance of ~~equity-indexed annuities~~EIAs, and ~~variable annuities~~changes in the fair value of market risk benefits associated with guaranteed minimum benefit riders. Fluctuations occur period to period primarily due to changing investment conditions including, but not limited to, interest rate movements (including risk-free rates and credit spreads), implied volatility ~~the Company’s own credit risk~~ and equity market performance, all of which are factors in the calculations of the fair value. Therefore, management believes it is helpful to distinguish between the effects of changes in these derivatives, net of related hedging activity, and the primary factors that drive profitabilityvalue of the ~~underlying treaties, namely investment income, fee income (included in other revenues),~~assets and ~~interest credited. These fluctuations are considered unrealized by management and do not affect current cash flows, crediting rates or spread performance on the underlying treaties.~~liabilities.

The following table summarizes the asset-intensive results and quantifies the impact of these embedded derivatives and market risk benefits for the periods presented. Revenues before certain derivatives, benefits and expenses before certain derivatives, and income before income taxes and certain derivatives should not be viewed as substitutes for GAAP revenues, GAAP benefits and expenses, and GAAP income before income taxes.


(dollars in millions)	(dollars in millions)	Three months ended September 30,				Nine months ended September 30,				(dollars in millions)	Three months ended September 30,				Nine months ended September 30,
		2022		2021		2022		2021			2023		2022		2023		2022
Revenues:
Revenues										Revenues
Total revenues	Total revenues	$	290	$	347	$	717	$	1,043	Total revenues	$	1,090	$	266	$	1,831	$	681
Less:	Less:									Less:
Embedded derivatives – modco/funds withheld treaties	Embedded derivatives – modco/funds withheld treaties	(23)		26		(147)		85		Embedded derivatives – modco/funds withheld treaties	(1)		(23)		18		(147)
Guaranteed minimum benefit riders and related free standing derivatives		8		(34)		(20)		(99)
Revenues before certain derivatives		305		355		884		1,057
Benefits and expenses:
Derivatives hedging market risk benefits										Derivatives hedging market risk benefits	(44)		(12)		(86)		(39)
Revenues before certain derivatives and market risk benefits										Revenues before certain derivatives and market risk benefits	1,135		301		1,899		867
Benefits and expenses										Benefits and expenses
Total benefits and expenses	Total benefits and expenses	242		241		660		714		Total benefits and expenses	1,001		236		1,602		648
Less:	Less:									Less:
Embedded derivatives – modco/funds withheld treaties		(10)		8		(61)		31
Guaranteed minimum benefit riders and related free standing derivatives		16		(2)		13		(35)
Equity-indexed annuities	Equity-indexed annuities	(5)		(2)		(30)		(18)		Equity-indexed annuities	(7)		(10)		(11)		(54)
Benefits and expenses before certain derivatives		241		237		738		736
Market risk benefits remeasurement (gains) losses										Market risk benefits remeasurement (gains) losses	(21)		23		(38)		29
Benefits and expenses before certain derivatives and market risk benefits										Benefits and expenses before certain derivatives and market risk benefits	1,029		223		1,651		673
Income before income taxes:	Income before income taxes:									Income before income taxes:
Income before income taxes		48		106		57		329
Income (loss) before income taxes										Income (loss) before income taxes	89		30		229		33
Less:	Less:									Less:
Embedded derivatives – modco/funds withheld treaties	Embedded derivatives – modco/funds withheld treaties	(13)		18		(86)		54		Embedded derivatives – modco/funds withheld treaties	(1)		(23)		18		(147)
Guaranteed minimum benefit riders and related free standing derivatives		(8)		(32)		(33)		(64)
Market risk benefits remeasurement (gains) losses and related free standing derivatives										Market risk benefits remeasurement (gains) losses and related free standing derivatives	(23)		(35)		(48)		(68)
Equity-indexed annuities	Equity-indexed annuities	5		2		30		18		Equity-indexed annuities	7		10		11		54
Income before income taxes and certain derivatives	Income before income taxes and certain derivatives	$	64	$	118	$	146	$	321	Income before income taxes and certain derivatives	$	106	$	78	$	248	$	194

Embedded Derivatives – Modco/Funds Withheld Treaties – Represents the change in the fair value of embedded derivatives on funds withheld at interest associated with treaties written on a modco or funds withheld basis. ~~The fair value changes of embedded derivatives are reflected in revenues, while the related impact on deferred acquisition expenses is reflected in benefits and expenses.~~ The Company’s utilization of a credit valuation adjustment did not have a material effect on the change in fair value of these embedded derivatives for the three and nine months ended September 30, ~~2022~~2023 and ~~2021.~~2022.

The change in fair value of the embedded derivatives related to modco/funds withheld treaties, ~~net of deferred acquisition costs~~ increased (decreased) income before income taxes by ~~$(13)~~$(1) million and ~~$18~~$(23) million for the third quarter and ~~$(86)~~$18 million and ~~$54~~$(147) million for the nine months ended September 30, ~~2022~~2023 and ~~2021,~~2022, respectively. The decrease in ~~revenue~~income for the third quarter was due to rising interest rates, offset by tightening credit spreads. The decrease in income for the third quarter of 2022 was due to widening credit spreads. The increase in income for the nine months ended September 30, 2023, was due to tightening credit spreads, and the decrease in income for the nine months ended September 30, 2022, was ~~primarily driven by the impact of~~due to higher risk-free interest rates ~~of $(11) million~~ and ~~$(98) million and the impact of widening~~wider credit spreads of $(12) million and $(69) million, respectively, on the fair value calculation. The revenue for the third quarter ended September 30, 2021, was primarily due to the impact of lower interest rates of $26 million. The revenue for the nine months ended September 30, 2021, was primarily driven by tightening credit spreads of $74 million.spreads.

4777

Table of Contents

~~Guaranteed Minimum Benefit Riders~~Market Risk Benefits – Represents the impact related to market risk benefits, which consist of guaranteed minimum benefits associated with the Company’s reinsurance of variable ~~annuities. The fair value changes of~~and equity-indexed annuities, including the ~~guaranteed minimum benefits along with the changes in fair value of the~~associated free standing derivatives (interest rate swaps, financial futures and equity options), purchased by the Company to ~~substantially~~economically hedge the liability are reflected in revenues, while the related impact on deferred acquisition expenses is reflected in benefits and expenses. Changes in fair values of the embedded derivatives on guaranteed minimum benefits are net of an increase (decrease) in investment related gains (losses), net of $27 million and $7 million for the third quarters of 2022 and 2021, respectively, and $15 million and $(56) million for the nine months ended September 30, 2022 and 2021, respectively, associated with the Company’s utilization of a credit valuation adjustment.

market risk benefit. The change in fair value of the ~~guaranteed minimum~~market risk benefits, ~~after allowing for~~net of the changes in the associated free standing derivatives, ~~(decreased)~~decreased income before income taxes by ~~$(8)~~$23 million and ~~$(32)~~$48 million for the ~~third quarter~~three and ~~$(33)~~nine months ended September 30, 2023, respectively, due to increasing interest rates. The decrease in income of $35 million and ~~$(64)~~$68 million for the three and nine months ended September 30, 2022, ~~and 2021, respectively.~~

•~~The increase in revenue for the three months ended September 30, 2022,~~respectively, was primarily driven by a $27 million increase in the credit valuation adjustment, which has the impact of decreasing the fair value of the guaranteed minimum benefit liability, partially offset by assumption updates of $(19) million, which included a change in the benchmark rate to the secured overnight financing rate. The increase in revenue was offset by the related increase in deferred acquisition expenses of $16 million.

•The decrease in revenue for the three months ended September 30, 2021, was primarily driven by a $(37) million impact from the annual update of best estimate actuarial assumptions for future mortality improvement.

•~~The decrease in income for the nine months ended September 30, 2022, was primarily~~also due to ~~higher~~increasing interest rates of $(8) million, net of hedging and the $(19) million assumption update in the current quarter, partially offset by a $15 million increase in the credit valuation adjustment which has the impact of decreasing the value of the guaranteed minimum benefit liability.

•The decrease in revenue for the nine months ended September 30, 2021, was primarily driven by a $(56) million decrease in the credit valuation adjustment which has the impact of increasing the fair value of the guaranteed minimum benefit liability and a $(37) million impact from the annual update of best estimate actuarial assumptions for future mortality improvement.rates.

Equity-Indexed Annuities – Represents changes in the liability for equity-indexed annuities in excess of changes in account ~~value, after adjustments for related deferred acquisition expenses.~~value. The change in fair value of embedded derivative liabilities associated with equity-indexed annuities increased income before income taxes by $5$7 million and $2$10 million for the ~~third quarters of 2022~~three and ~~2021, respectively, and $30 million and $18 million for the~~ nine months ended September 30, ~~2022~~2023 and ~~2021, respectively. The increase in income~~$11 million and $54 million for the ~~third quarter~~three and ~~first~~ nine months ofended September 30, 2023 and 2022, ~~was primarily~~respectively, due to an increase in risk free interest rates which has the impact of lowering the fair value of the liability.

Discussion and analysis before certain derivatives and market risk benefits

The changes in derivatives and market risk benefits discussed above are considered unrealized by management and do not affect current cash flows, crediting rates or spread performance on the underlying treaties. Fluctuations occur period to period primarily due to changing investment conditions including, but not limited to, interest rate movements (including benchmark rates and credit spreads), ~~credit valuation adjustments,~~ implied volatility and equity market performance, all of which are factors in the calculations of fair value. Therefore, management believes it is helpful to distinguish between the effects of changes in these derivatives and market risk benefits as the primary factors that drive profitability of the underlying treaties ~~namely~~are investment income, fee income (included in other revenues) and interest credited.

~~Discussion and analysis before certain derivatives:~~

•Income before income taxes and certain derivatives ~~decreased~~and market risk benefits increased by ~~$54~~$29 million and ~~$175~~$55 million for the three and nine months ended September 30, ~~2022, respectively,~~2023, as compared to the same periods in ~~2021. The decrease for the three months ended September 30,~~ 2022, ~~was~~ primarily due to ~~a $(33) million decrease in~~higher investment ~~related gains (losses),~~income, net in coinsurance and funds withheld ~~portfolios. Additionally,~~portfolios due to increases in interest rates and remeasurement gain as a result of the ~~prior period included income from a retrocession transaction executed~~assumption update completed in the third quarter of ~~$13 million. The decrease~~2023.

•Revenue before certain derivatives and market risk benefits increased by $834 million and $1,032 million for the three and nine months ended September 30, ~~2022,~~2023, as compared to the same periods in 2022. The increase in the third quarter of 2023 and nine months ended was primarily due to ~~$(121)~~PRT single premiums and higher investment income due to an increase in interest rates. PRT premiums are offset by a corresponding increase in future policy benefits.

•Benefits and expenses before certain derivatives and market risk benefits increased by $805 million ~~lower investment related gains (losses), net~~and $977 million for the three and nine months ended September 30, 2023, as compared to the same periods in ~~coinsurance~~2022. The increase in the three and ~~funds withheld portfolios. Additionally,~~nine months ended September 30, 2023, was primarily due to the ~~prior period included a one-time fee~~establishment of ~~$34 million~~liabilities for future policy benefits associated with ~~a new transaction, $13 million of income from a retrocession transaction, and favorable prior year policyholder experience including impacts from COVID-19 of $13 million.~~PRT transactions.

4878

Table of Contents

•Revenue before certain derivatives decreased by $50 million and by $173 million for the three and nine months ended September 30, 2022, respectively, as compared to the same periods in 2021. The decrease for the three months ended September 30, 2022, was primarily due to a $(25) million decrease in investment related gains (losses), net in coinsurance and funds withheld portfolios and a $(31) million changes in the fair value of equity options associated with the reinsurance of EIAs. The decrease for the nine months ended September 30, 2022, was primarily due to $(102) million change in fair value of equity options associated with the reinsurance of EIAs and $(84) million lower investment related gains (losses), net in coinsurance and funds withheld portfolios. The effect on investment income related to equity options is substantially offset by a corresponding change in interest credited.

•Benefits and expenses before certain derivatives increased by $4 million and $2 million for the three and nine months ended September 30, 2022, as compared to the same period in 2021. The increase in the third quarter of 2022 was primarily due to $8 million higher amortization of deferred acquisition costs associated with investment related gains (losses), net in coinsurance and funds withheld portfolios and a $15 million increase in other insurance expenses related to a funds withheld transaction which is retroceded to a third party. These expense increases were partially offset by $29 million lower interest credited associated with reinsurance of EIAs. The increase in the first nine months of 2022 was due to $37 million higher amortization of deferred acquisition costs associated with investment related gains (losses), net in coinsurance and funds withheld portfolios and a $52 million increase related to a funds withheld transaction which is retroceded to a third party. Additionally, the prior period included favorable policyholder experience including impacts from COVID-19 of $13 million. These increases were offset by $99 million lower interest credited associated with the reinsurance of EIAs. The effect on interest credited related to equity options is substantially offset by a corresponding increase in investment income.

~~Capital Solutions~~

Income before income taxes for the U.S. and Latin America Capital Solutions’ business increased $0 million, and $50 million, or 73.5%, for the three and nine months ended September 30, 2022, as compared to the same periods in 2021. The increase in the nine month period was primarily due to a recapture fee earned on a terminated transaction. Fees earned from this business can vary significantly depending on the size of the transactions and the timing of their completion and therefore can fluctuate from period to period.

•At September 30, 2022 and 2021, the amount of reinsurance assumed from client companies, as measured by pre-tax statutory surplus, risk based capital and other financial structures was $25.3 billion and $22.0 billion, respectively.

Canada Operations

~~The Company conducts reinsurance business in Canada primarily through RGA Canada, which assists clients with capital management activity and mortality and morbidity risk management.~~ The Canada operations are primarily engaged in ~~Traditional~~traditional reinsurance, which consists mainly of traditional individual life reinsurance, and to a lesser extent creditor, group life and health, critical illness and disability reinsurance. Creditor insurance covers the outstanding balance on personal, mortgage or commercial loans in the event of death, disability or critical illness and is generally shorter in duration than traditional individual life insurance. The Canada Financial Solutions segment consists of longevity and capital solutions.


		Three Months Ended September 30,						Nine Months Ended September 30,							Three months ended September 30,						Nine months ended September 30,
(dollars in millions)	(dollars in millions)	2022		2021		2022 vs 2021		2022		2021		2022 vs 2021		(dollars in millions)	2023		2022		2023 vs 2022		2023		2022		2023 vs 2022
Revenues:
Revenues														Revenues
Net premiums	Net premiums	$	317	$	311	$	6	$	983	$	938	$	45	Net premiums	$	324	$	317	$	7	$	972	$	983	$	(11)
Investment income, net of related expenses		64		65		(1)		177		188		(11)
Net investment income														Net investment income	63		65		$	(2)	187		188		(1)
Investment related gains (losses), net	Investment related gains (losses), net	2		1		1		(3)		3		(6)		Investment related gains (losses), net	—		2		(2)		6		(3)		9
Other revenues	Other revenues	2		2		—		9		11		(2)		Other revenues	5		2		3		12		9		3
Total revenues	Total revenues	385		379		6		1,166		1,140		26		Total revenues	392		386		6		1,177		1,177		—
Benefits and expenses:
Benefits and expenses														Benefits and expenses
Claims and other policy benefits	Claims and other policy benefits	291		278		13		919		860		59		Claims and other policy benefits	302		294		8		895		910		(15)
Future policy benefits remeasurement (gains) losses														Future policy benefits remeasurement (gains) losses	(7)		7		(14)		(12)		(1)		(11)
Market risk benefits remeasurement (gains) losses														Market risk benefits remeasurement (gains) losses	—		—		—		—		—		—
Interest credited	Interest credited	—		—		—		—		—		—		Interest credited	1		—		1		1		—		1
Policy acquisition costs and other insurance expenses	Policy acquisition costs and other insurance expenses	47		47		—		140		139		1		Policy acquisition costs and other insurance expenses	47		56		(9)		140		160		(20)
Other operating expenses	Other operating expenses	11		10		1		32		31		1		Other operating expenses	13		11		2		37		32		5
Total benefits and expenses	Total benefits and expenses	349		335		14		1,091		1,030		61		Total benefits and expenses	356		368		(12)		1,061		1,101		(40)
Income before income taxes		$	36	$	44	$	(8)	$	75	$	110	$	(35)
Income (loss) before income taxes														Income (loss) before income taxes	$	36	$	18	$	18	$	116	$	76	$	40

•The ~~decreases~~increase in income before income taxes for the three and nine months ended September 30, 2023, was primarily due to future policy benefits remeasurement gains as compared to future policy benefits remeasurement losses for the same period in 2022 and favorable experience on the Financial Solutions segment as compared to the same ~~periods~~period in ~~2021, were~~2022. The increase in income for the nine months ended September 30, 2023, was primarily due to ~~unfavorable claims~~higher future policy benefits remeasurement gains, an increase in investment related gains (losses), net, and overall favorable experience, as compared to the same period in ~~the individual mortality and group lines of business and lower investment income, partially offset by favorable longevity experience.~~2022.

~~Table of Contents~~

•Foreign currency fluctuations can result in variances in the financial statement line items. Foreign currency fluctuations resulted in ~~a decrease~~decreases in income before ~~incomes~~income taxes of $1 million and $2$6 million for the three and nine months ended September 30, ~~2022, respectively.~~2023. Unless otherwise stated, all amounts discussed below are net of foreign currency fluctuations.

Table of Contents

Traditional Reinsurance


		Three Months Ended September 30,								Nine Months Ended September 30,									Three months ended September 30,								Nine months ended September 30,
(dollars in millions)	(dollars in millions)	2022			2021			2022 vs 2021		2022			2021			2022 vs 2021		(dollars in millions)	2023			2022			2023 vs 2022		2023			2022			2023 vs 2022
Revenues:
Revenues																		Revenues
Net premiums	Net premiums	$	293		$	289		$	4	$	911		$	870		$	41	Net premiums	$	302		$	293		$	9	$	904		$	911		$	(7)
Investment income, net of related expenses		63			65			(2)		176			188			(12)
Net investment income																		Net investment income	62			64			(2)		184			184			—
Investment related gains (losses), net	Investment related gains (losses), net	2			1			1		(3)			3			(6)		Investment related gains (losses), net	—			2			(2)		6			(3)			9
Other revenues	Other revenues	—			(1)			1		3			2			1		Other revenues	2			—			2		4			3			1
Total revenues	Total revenues	358			354			4		1,087			1,063			24		Total revenues	366			359			7		1,098			1,095			3
Benefits and expenses:
Benefits and expenses																		Benefits and expenses
Claims and other policy benefits	Claims and other policy benefits	270			255			15		865			798			67		Claims and other policy benefits	284			272			12		836			844			(8)
Future policy benefits remeasurement (gains) losses																		Future policy benefits remeasurement (gains) losses	16			9			7		18			8			10
Market risk benefits remeasurement (gains) losses																		Market risk benefits remeasurement (gains) losses	—			—			—		—			—			—
Interest credited	Interest credited	—			—			—		—			—			—		Interest credited	1			—			1		1			—			1
Policy acquisition costs and other insurance expenses	Policy acquisition costs and other insurance expenses	46			46			—		138			137			1		Policy acquisition costs and other insurance expenses	46			56			(10)		138			159			(21)
Other operating expenses	Other operating expenses	10			9			1		30			28			2		Other operating expenses	13			10			3		35			30			5
Total benefits and expenses	Total benefits and expenses	326			310			16		1,033			963			70		Total benefits and expenses	360			347			13		1,028			1,041			(13)
Income (loss) before income taxes	Income (loss) before income taxes	$	32		$	44		$	(12)	$	54		$	100		$	(46)	Income (loss) before income taxes	$	6		$	12		$	(6)	$	70		$	54		$	16
Key metrics:
Key metrics																		Key metrics
Life reinsurance in force	Life reinsurance in force									$448.7 billion			$463.1 billion					Life reinsurance in force									$477.2 billion			$448.7 billion
Claims and other policy benefits as a percentage of net premiums (“loss ratios”)		92.2		%	88.2		%			95.0		%	91.7		%
Future policy benefits remeasurement (gains) losses																		Future policy benefits remeasurement (gains) losses
Effect of changes in cash flow assumptions																		Effect of changes in cash flow assumptions	$	13		$	6				$	13		$	6
Effect of actual variances from expected experience																		Effect of actual variances from expected experience	$	3		$	3				$	5		$	2
Loss ratio (1)																		Loss ratio (1)	99.3		%	95.9		%			94.5		%	93.5		%
Policy acquisition costs and other insurance expenses as a percentage of net premiums	Policy acquisition costs and other insurance expenses as a percentage of net premiums	15.7		%	15.9		%			15.1		%	15.7		%			Policy acquisition costs and other insurance expenses as a percentage of net premiums	15.2		%	19.1		%			15.3		%	17.5		%
Other operating expenses as a percentage of net premiums	Other operating expenses as a percentage of net premiums	3.4		%	3.1		%			3.3		%	3.2		%			Other operating expenses as a percentage of net premiums	4.3		%	3.4		%			3.9		%	3.3		%

(1)Includes Claims and other policy benefits and Future policy benefits remeasurement (gains) losses

The ~~decreases~~decrease in income before income taxes for the three ~~and~~months ended September 30, 2023, was primarily due to higher future policy benefits remeasurement losses as compared to the same period in 2022. The increase in income before income taxes for the nine months ended September 30, ~~2022, were~~2023, was primarily due favorable experience and higher investment related gains (losses),net, partially offset by higher future policy benefits remeasurement losses as compared to the same period in 2022.

Revenues

•The increase in total revenues for the three months ended September 30, 2023 was primarily due to ~~unfavorable claims experience~~an increase in net premiums as compared to the ~~individual mortality~~same period in 2022 and ~~group lines~~the increase in total revenues for the nine months ended September 30, 2023 was primarily due to investment related gains as compared to investment related losses for the same period in 2022 partially offset by lower net premiums as compared to the same period in 2022.

•The increase in net premiums for the three months ended September 30, 2023, is primarily due to organic growth, partially offset by foreign currency fluctuations. The decrease in net premiums for the nine months ended September 30, 2023 is due to foreign currency fluctuations. Excluding the impact of ~~business and lower investment income.~~

~~Revenues~~foreign currency fluctuations the increase in net premiums is primarily due to organic growth.

•The segment added new life business production, measured by face amount of life reinsurance in force, of ~~$10.8~~$33.0 billion and ~~$11.5 billion for the third quarter of 2022 and 2021, respectively, and~~ $36.3 ~~billion, and $34.2~~ billion during the first nine months of 2023 and 2022, ~~and 2021,~~ respectively.

•The decreases in net investment income for the three and nine months ended September 30, 2022, were primarily due to decreased variable investment income, partially offset by an increase in the invested asset base.

Benefits and expenses

•The increase in ~~the~~ loss ~~ratio~~ratios for the three and nine months ended September 30, ~~2022,~~2023, are primarily due to higher future policy remeasurement losses as compared to the same period in ~~2021, was primarily~~2022.

•During the third quarter of 2023, the Company completed its annual assumption review resulting in a future policy benefits remeasurement loss of $13 million compared to a future policy benefits remeasurement loss of $6 million in the third quarter of 2022 due to ~~more unfavorable claims experience in the individual~~updating mortality line of business and unfavorable claims experience in the group line of business in 2022. The increase in the loss ratio for the nine months ended September 30, 2022, as compared to the same period in 2021, was primarily due to more unfavorable claims experience in the individual mortality line of business in 2022. While the cause of death is not yet available for all claims, the Company estimates that approximately $26 million of claims for the nine months ended September 30, 2022, were attributable to COVID-19.

assumptions.

5080

Table of Contents

~~Financial Solutions~~

Three Months Ended September 30, Nine Months Ended September 30,
(dollars in millions) 2022 2021 2022 vs 2021 2022 2021 2022 vs 2021
Revenues:
Net premiums $ 24 $ 22 $ 2 $ 72 $ 68 $ 4
Investment income, net of related expenses 1 — 1 1 — 1
Investment related gains (losses), net — — — — — —
Other revenues 2 3 (1) 6 9 (3)
Total revenues 27 25 2 79 77 2
Benefits and expenses:
Claims and other policy benefits 21 23 (2) 54 62 (8)
Interest credited — — — — — —
Policy acquisition costs and other insurance expenses 1 1 — 2 2 —
Other operating expenses 1 1 — 2 3 (1)
Total benefits and expenses 23 25 (2) 58 67 (9)
Income (loss) before income taxes $ 4 $ — $ 4 $ 21 $ 10 $ 11

•The ~~increases~~decrease in ~~income before income taxes~~policy acquisition costs for the three and nine months ended September 30, ~~2022, were~~2023, is primarily ~~a result of slightly favorable mortality experience on longevity business as~~due to lower allowances and ceded expenses.

Financial Solutions


	Three months ended September 30,						Nine months ended September 30,
(dollars in millions)	2023		2022		2023 vs 2022		2023		2022		2023 vs 2022
Revenues
Net premiums	$	22	$	24	$	(2)	$	68	$	72	$	(4)
Net investment income	1		1		—		3		4		(1)
Investment related gains (losses), net	—		—		—		—		—		—
Other revenues	3		2		1		8		6		2
Total revenues	26		27		(1)		79		82		(3)
Benefits and expenses
Claims and other policy benefits	18		22		(4)		59		66		(7)
Future policy benefits remeasurement (gains) losses	(23)		(2)		(21)		(30)		(9)		(21)
Market risk benefits remeasurement (gains) losses	—		—		—		—		—		—
Interest credited	—		—		—		—		—		—
Policy acquisition costs and other insurance expenses	1		—		1		2		1		1
Other operating expenses	—		1		(1)		2		2		—
Total benefits and expenses	(4)		21		(25)		33		60		(27)
Income (loss) before income taxes	$	30	$	6	$	24	$	46	$	22	$	24
Key metrics
Future policy benefits remeasurement (gains) losses
Effect of changes in cash flow assumptions	$	(22)	$	—			$	(22)	$	—
Effect of actual variances from expected experience	$	(1)	$	(2)			$	(8)	$	(9)

The increase in income for the three and nine months ended September 30, 2023, compared to the same periods in ~~2021.~~2022, was the result of a future policy remeasurement gain of $22 million due to a change in mortality assumptions.

Europe, Middle East and Africa Operations

The Europe, Middle East and Africa (“EMEA”) operations include business primarily generated by offices in France, Germany, Ireland, Italy, the Middle East, the Netherlands, Poland, South Africa, Spain and the United Kingdom (“UK”). EMEA consists of two major segments: Traditional and Financial Solutions. The Traditional segment primarily provides reinsurance through yearly renewable term and coinsurance agreements on a variety of life, health and critical illness products. Reinsurance agreements may be facultative or automatic agreements covering primarily individual risks and, in some markets, group risks. The Financial Solutions segment consists of reinsurance and other transactions associated with longevity closed blocks, payout annuities, capital management solutions and financial reinsurance.


		Three Months Ended September 30,						Nine Months Ended September 30,							Three months ended September 30,						Nine months ended September 30,
(dollars in millions)	(dollars in millions)	2022		2021		2022 vs 2021		2022		2021		2022 vs 2021		(dollars in millions)	2023		2022		2023 vs 2022		2023		2022		2023 vs 2022
Revenues:
Revenues														Revenues
Net premiums	Net premiums	$	548	$	528	$	20	$	1,673	$	1,562	$	111	Net premiums	$	565	$	548	$	17	$	1,647	$	1,673	$	(26)
Investment income, net of related expenses		58		73		(15)		170		215		(45)
Net investment income														Net investment income	79		55		24		216		162		54
Investment related gains (losses), net	Investment related gains (losses), net	(9)		23		(32)		(15)		41		(56)		Investment related gains (losses), net	(21)		(9)		(12)		(36)		(15)		(21)
Other revenues	Other revenues	2		4		(2)		10		11		(1)		Other revenues	8		4		4		14		12		2
Total revenues	Total revenues	599		628		(29)		1,838		1,829		9		Total revenues	631		598		33		1,841		1,832		9
Benefits and expenses:
Benefits and expenses														Benefits and expenses
Claims and other policy benefits	Claims and other policy benefits	498		559		(61)		1,487		1,559		(72)		Claims and other policy benefits	524		506		18		1,469		1,504		(35)
Future policy benefits remeasurement (gains) losses														Future policy benefits remeasurement (gains) losses	10		(4)		14		—		(14)		14
Market risk benefits remeasurement (gains) losses														Market risk benefits remeasurement (gains) losses	—		—		—		—		—		—
Interest credited	Interest credited	(5)		(2)		(3)		(22)		(1)		(21)		Interest credited	(2)		(5)		3		(4)		(22)		18
Policy acquisition costs and other insurance expenses	Policy acquisition costs and other insurance expenses	33		37		(4)		98		96		2		Policy acquisition costs and other insurance expenses	27		21		6		70		66		4
Other operating expenses	Other operating expenses	41		40		1		129		118		11		Other operating expenses	48		41		7		140		129		11
Total benefits and expenses	Total benefits and expenses	567		634		(67)		1,692		1,772		(80)		Total benefits and expenses	607		559		48		1,675		1,663		12
Income before income taxes		$	32	$	(6)	$	38	$	146	$	57	$	89
Income (loss) before income taxes														Income (loss) before income taxes	$	24	$	39	$	(15)	$	166	$	169	$	(3)

Table of Contents

•The ~~increase~~decrease in income before income taxes for the three months ended September 30, 2023, as compared to the same period in 2022, was primarily due to higher losses from future policy benefits remeasurement and unfavorable mortality experience in select markets. The decrease for the nine months ended September 30, 2023, as compared to the same period in 2022, was primarily ~~the result of increased net premiums and~~due to higher losses from future policy benefits remeasurement, unfavorable mortality experience with some offset from favorable ~~claims experience, partially offset by decreases in net investment income and investment related gains (losses), net.~~longevity experience.

•Foreign currency fluctuations can result in variances in the financial statement line items. Foreign currency ~~exchange~~ fluctuations resulted in ~~decreases~~a $2 million increase and $4 million decrease in income before income taxes ~~of $5 million and $12 million~~ for the three and nine months ended September 30, ~~2022, respectively, as compared to the same periods in 2021.~~2023. Unless otherwise stated, all amounts discussed below are net of foreign currency fluctuations.

~~Table of Contents~~

Traditional Reinsurance

Three Months Ended September 30, Nine Months Ended September 30,
(dollars in millions) 2022 2021 2022 vs 2021 2022 2021 2022 vs 2021
Revenues:
Net premiums $ 436 $ 432 $ 4 $ 1,314 $ 1,303 $ 11
Investment income, net of related expenses 21 22 (1) 65 66 (1)
Investment related gains (losses), net — — — — — —
Other revenues — — — 1 1 —
Total revenues 457 454 3 1,380 1,370 10
Benefits and expenses:
Claims and other policy benefits 394 482 (88) 1,198 1,365 (167)
Interest credited — — — — — —
Policy acquisition costs and other insurance expenses 32 35 (3) 94 91 3
Other operating expenses 30 28 2 91 85 6
Total benefits and expenses 456 545 (89) 1,383 1,541 (158)
Income (loss) before income taxes $ 1 $ (91) $ 92 $ (3) $ (171) $ 168
Key metrics:
Life reinsurance in force $671.3 billion $852.8 billion
Claims and other policy benefits as a percentage of net premiums (“loss ratios”) 90.4 % 111.6 % 91.2 % 104.8 %
Policy acquisition costs and other insurance expenses as a percentage of net premiums 7.3 % 8.1 % 7.2 % 7.0 %
Other operating expenses as a percentage of net premiums 6.9 % 6.5 % 6.9 % 6.5 %

The increase in income before income taxes for the three and nine months ended September 30, 2022, as compared to the same periods in 2021, were primarily due to an improvement in individual life mortality experience and increased net premiums in the first nine months of 2022.

~~Revenues~~


	Three months ended September 30,								Nine months ended September 30,
(dollars in millions)	2023			2022			2023 vs 2022		2023			2022			2023 vs 2022
Revenues
Net premiums	$	447		$	436		$	11	$	1,314		$	1,314		$	—
Net investment income	23			18			5		69			55			14
Investment related gains (losses), net	—			—			—		—			—			—
Other revenues	1			2			(1)		(1)			3			(4)
Total revenues	471			456			15		1,382			1,372			10
Benefits and expenses
Claims and other policy benefits	429			409			20		1,202			1,182			20
Future policy benefits remeasurement (gains) losses	43			(7)			50		47			(5)			52
Market risk benefits remeasurement (gains) losses	—			—			—		—			—			—
Interest credited	—			—			—		—			—			—
Policy acquisition costs and other insurance expenses	25			19			6		64			61			3
Other operating expenses	34			30			4		98			91			7
Total benefits and expenses	531			451			80		1,411			1,329			82
Income (loss) before income taxes	$	(60)		$	5		$	(65)	$	(29)		$	43		$	(72)
Key metrics
Life reinsurance in force									$814.5 billion			$671.3 billion
Future policy benefits remeasurement (gains) losses
Effect of changes in cash flow assumptions	$	47		$	13				$	47		$	13
Effect of actual variances from expected experience	$	(4)		$	(20)				$	—		$	(18)
Loss ratio (1)	105.6		%	92.2		%			95.1		%	89.6		%
Policy acquisition costs and other insurance expenses as a percentage of net premiums	5.6		%	4.4		%			4.9		%	4.6		%
Other operating expenses as a percentage of net premiums	7.6		%	6.9		%			7.5		%	6.9		%

•(1)~~The increases in net premiums for the three~~Includes Claims and ~~nine months ended September 30, 2022, as compared to the same periods in 2021, were due to an in increase in business volume on new~~other policy benefits and ~~existing treaties.~~Future policy benefits remeasurement (gains) losses

•The segment added new life business production, measured by face amount of reinsurance in force, of $38.2 billion and $32.0 billion during the third quarter of 2022 and 2021, respectively, and $133.8 billion and $147.4 billion during the nine months ended September 30, 2022 and 2021, respectively.

~~Benefits and expenses~~

•The decreases in the loss ratio for the third quarter and first nine months of 2022 were due to improved mortality experience. While the cause of death is not available for all claims, the Company estimates for the nine months ended September 30, 2022, that approximately $15 million of claims were primarily attributable to COVID-19.

~~Financial Solutions~~

Three Months Ended September 30, Nine Months Ended September 30,
(dollars in millions) 2022 2021 2022 vs 2021 2022 2021 2022 vs 2021
Revenues:
Net premiums $ 112 $ 96 $ 16 $ 359 $ 259 $ 100
Investment income, net of related expenses 37 51 (14) 105 149 (44)
Investment related gains (losses), net (9) 23 (32) (15) 41 (56)
Other revenues 2 4 (2) 9 10 (1)
Total revenues 142 174 (32) 458 459 (1)
Benefits and expenses:
Claims and other policy benefits 104 77 27 289 194 95
Interest credited (5) (2) (3) (22) (1) (21)
Policy acquisition costs and other insurance expenses 1 2 (1) 4 5 (1)
Other operating expenses 11 12 (1) 38 33 5
Total benefits and expenses 111 89 22 309 231 78
Income (loss) before income taxes $ 31 $ 85 $ (54) $ 149 $ 228 $ (79)

~~Table of Contents~~

The decreases in income before income taxes for the three and nine months ended September 30, ~~2022,~~2023, as compared to the same periods in ~~2021,~~2022, were primarily due to ~~decreases in investment income, net of related expenses, investment related gains (losses), net~~increased claims and ~~unfavorable claims experience, partially offset by increases~~increased future policy benefits remeasurement losses.

Revenues

•The increase in net ~~premiums.~~premiums for the three months ended September 30, 2023, was primarily due to foreign currency fluctuations. Net premiums for the first nine months of 2023 were unchanged compared to the same period last year. Excluding the impact of foreign currency fluctuations, business volume on new and existing treaties increased in the first nine months of 2023.

~~Revenues~~•The segment added new life business production, measured by face amount of life reinsurance in force, of $97.6 billion and $133.8 billion during the nine months ended September 30, 2023 and 2022, respectively.

Benefits and expenses

•The increases in ~~net premiums~~the loss ratios for the third quarter and first nine months of 2023 were primarily due to an update of mortality assumptions primarily in the UK and a worsening in mortality experience primarily in the UK and South Africa.

•During the third quarter of 2023, the Company completed its annual assumption review resulting in a future policy benefits remeasurement loss of $47 million compared to a future policy benefits remeasurement loss of $13 million in the third quarter of 2022 due to updating mortality assumptions.

Table of Contents

Financial Solutions


	Three months ended September 30,						Nine months ended September 30,
(dollars in millions)	2023		2022		2023 vs 2022		2023		2022		2023 vs 2022
Revenues
Net premiums	$	118	$	112	$	6	$	333	$	359	$	(26)
Net investment income	56		37		19		147		107		40
Investment related gains (losses), net	(21)		(9)		(12)		(36)		(15)		(21)
Other revenues	7		2		5		15		9		6
Total revenues	160		142		18		459		460		(1)
Benefits and expenses
Claims and other policy benefits	95		97		(2)		267		322		(55)
Future policy benefits remeasurement (gains) losses	(33)		3		(36)		(47)		(9)		(38)
Market risk benefits remeasurement (gains) losses	—		—		—		—		—		—
Interest credited	(2)		(5)		3		(4)		(22)		18
Policy acquisition costs and other insurance expenses	2		2		—		6		5		1
Other operating expenses	14		11		3		42		38		4
Total benefits and expenses	76		108		(32)		264		334		(70)
Income (loss) before income taxes	$	84	$	34	$	50	$	195	$	126	$	69
Key metrics
Future policy benefits remeasurement (gains) losses
Effect of changes in cash flow assumptions	$	(34)	$	—			$	(34)	$	—
Effect of actual variances from expected experience	$	1	$	3			$	(13)	$	(9)

The increases in income before income taxes for the three and nine months ended September 30, ~~2022, as compared to the same periods in 2021,~~2023, were primarily due to ~~increased volumes of~~increases in net investment income and higher future policy benefits remeasurement gains. The first nine months also had favorable claims experience related to closed longevity blocks, partially offset by decreased net premiums.

Revenues

•The decrease in net premiums for the first nine months was primarily due to an increase in the ceded premium on closed block ~~business.~~longevity transactions.

•The ~~decreases~~increase in net investment income ~~for the three and nine months ended September 30, 2022, as compared~~was primarily related to ~~the same periods in 2021, were primarily due to lower~~higher yield and ~~lower~~higher income associated with unit-linked policies which fluctuate with market performance and are offset by ~~a decrease~~an increase in interest credited related to the unit-linked liabilities.

•The ~~decreases~~increase in investment related ~~gains (losses), net~~losses for the ~~three~~third quarter and first nine ~~month periods were primarily due~~months was attributable to fluctuations in the fair market value of CPI swap derivatives due to changes in future inflation ~~expectations and lower~~expectations. The increase in investment related ~~gains~~losses for the nine months ended September 30, 2023, was also attributable to higher investment related losses on fixed-income ~~securities, respectively.~~securities.

Benefits and expenses

•The ~~increases~~decrease in claims and other policy benefits for the ~~three and~~first nine months ~~ended September 30, 2022, as compared to the same periods in 2021, were~~of 2023 was the result of favorable longevity experience and an increased ~~volumes~~level of external retrocession coverage on closed block longevity ~~block business.~~transactions.

•During the third quarter of 2023, the Company completed its annual assumption review resulting in a future policy benefits remeasurement gain of $34 million. There were no changes to assumptions in the prior period.

Table of Contents

Asia Pacific Operations

The Asia Pacific operations include business generated by its offices principally in Australia, China, Hong Kong, India, Japan, Malaysia, New Zealand, Singapore, South Korea and Taiwan. The Traditional segment’s principal types of reinsurance include individual and group life and health, critical illness, disability and superannuation. Reinsurance agreements may be facultative or automatic agreements covering primarily individual risks, and in some markets, group risks. Superannuation is the Australian government mandated compulsory retirement savings program. Superannuation funds accumulate retirement funds for employees, and, in addition, typically offer life and disability insurance coverage. The Financial Solutions segment includes financial reinsurance, asset-intensive and certain disability and life blocks.


		Three Months Ended September 30,						Nine Months Ended September 30,							Three months ended September 30,						Nine months ended September 30,
(dollars in millions)	(dollars in millions)	2022		2021		2022 vs 2021		2022		2021		2022 vs 2021		(dollars in millions)	2023		2022		2023 vs 2022		2023		2022		2023 vs 2022
Revenues:
Revenues														Revenues
Net premiums	Net premiums	$	729	$	691	$	38	$	2,122	$	2,017	$	105	Net premiums	$	800	$	729	$	71	$	2,247	$	2,122	$	125
Investment income, net of related expenses		115		70		45		281		196		85
Net investment income														Net investment income	177		128		49		533		320		213
Investment related gains (losses), net	Investment related gains (losses), net	(90)		(15)		(75)		(279)		11		(290)		Investment related gains (losses), net	(65)		(90)		25		(162)		(279)		117
Other revenues	Other revenues	122		12		110		190		42		148		Other revenues	19		124		(105)		61		195		(134)
Total revenues	Total revenues	876		758		118		2,314		2,266		48		Total revenues	931		891		40		2,679		2,358		321
Benefits and expenses:
Benefits and expenses														Benefits and expenses
Claims and other policy benefits	Claims and other policy benefits	586		734		(148)		1,765		1,918		(153)		Claims and other policy benefits	671		687		(16)		1,926		1,799		127
Future policy benefits remeasurement (gains) losses														Future policy benefits remeasurement (gains) losses	(40)		68		(108)		(64)		91		(155)
Market risk benefits remeasurement (gains) losses														Market risk benefits remeasurement (gains) losses	—		—		—		—		—		—
Interest credited	Interest credited	38		12		26		80		42		38		Interest credited	54		38		16		154		80		74
Policy acquisition costs and other insurance expenses	Policy acquisition costs and other insurance expenses	80		50		30		203		156		47		Policy acquisition costs and other insurance expenses	67		68		(1)		192		194		(2)
Other operating expenses	Other operating expenses	56		52		4		163		152		11		Other operating expenses	61		56		5		178		163		15
Total benefits and expenses	Total benefits and expenses	760		848		(88)		2,211		2,268		(57)		Total benefits and expenses	813		917		(104)		2,386		2,327		59
Income before income taxes		$	116	$	(90)	$	206	$	103	$	(2)	$	105
Income (loss) before income taxes														Income (loss) before income taxes	$	118	$	(26)	$	144	$	293	$	31	$	262

•The increases in income before ~~income~~ taxes for the three and nine months ended September 30, 2023, as compared to the same periods in 2022, were primarily due to ~~favorable claims experience, increases~~increased net investment income related to an increase in the asset base from new asset-intensive transactions, increased net premiums and ~~net~~lower investment ~~income, partially offset by unfavorable fluctuations in the fair value of derivatives within the Financial Solutions business.~~related losses, and favorable underwriting results.

•Foreign currency fluctuations can result in variances in the financial statement line items. Foreign currency fluctuations resulted in ~~an increase~~increases of $1 million and decreases of $4 million in income before income taxes ~~of $14 million and $33 million for~~during the three and nine months ended September 30, ~~2022, as compared to the same periods in 2021.~~2023. Unless otherwise stated, all amounts discussed below are net of foreign currency fluctuations.

5384

Table of Contents

Traditional Reinsurance


		Three Months Ended September 30,								Nine Months Ended September 30,									Three months ended September 30,								Nine months ended September 30,
(dollars in millions)	(dollars in millions)	2022			2021			2022 vs 2021		2022			2021			2022 vs 2021		(dollars in millions)	2023			2022			2023 vs 2022		2023			2022			2023 vs 2022
Revenues:
Revenues																		Revenues
Net premiums	Net premiums	$	660		$	626		$	34	$	1,950		$	1,851		$	99	Net premiums	$	737		$	660		$	77	$	2,076		$	1,950		$	126
Investment income, net of related expenses		38			33			5		104			100			4
Net investment income																		Net investment income	60			51			9		183			144			39
Investment related gains (losses), net	Investment related gains (losses), net	3			—			3		8			(1)			9		Investment related gains (losses), net	1			4			(3)		6			9			(3)
Other revenues	Other revenues	4			4			—		17			13			4		Other revenues	3			5			(2)		17			21			(4)
Total revenues	Total revenues	705			663			42		2,079			1,963			116		Total revenues	801			720			81		2,282			2,124			158
Benefits and expenses:
Benefits and expenses																		Benefits and expenses
Claims and other policy benefits	Claims and other policy benefits	498			682			(184)		1,577			1,778			(201)		Claims and other policy benefits	604			627			(23)		1,746			1,644			102
Future policy benefits remeasurement (gains) losses																		Future policy benefits remeasurement (gains) losses	(39)			68			(107)		(62)			91			(153)
Market risk benefits remeasurement (gains) losses																		Market risk benefits remeasurement (gains) losses	—			—			—		—			—			—
Interest credited	Interest credited	—			—			—		—			—			—		Interest credited	—			—			—		—			—			—
Policy acquisition costs and other insurance expenses	Policy acquisition costs and other insurance expenses	37			31			6		126			115			11		Policy acquisition costs and other insurance expenses	46			47			(1)		136			146			(10)
Other operating expenses	Other operating expenses	52			46			6		149			137			12		Other operating expenses	56			51			5		160			149			11
Total benefits and expenses	Total benefits and expenses	587			759			(172)		1,852			2,030			(178)		Total benefits and expenses	667			793			(126)		1,980			2,030			(50)
Income (loss) before income taxes	Income (loss) before income taxes	$	118		$	(96)		$	214	$	227		$	(67)		$	294	Income (loss) before income taxes	$	134		$	(73)		$	207	$	302		$	94		$	208
Key metrics:
Key metrics																		Key metrics
Life reinsurance in force	Life reinsurance in force									$479.4 billion			$526.0 billion					Life reinsurance in force									$501.8 billion			$479.4 billion
Claims and other policy benefits as a percentage of net premiums (“loss ratios”)		75.5		%	108.9		%			80.9		%	96.1		%
Future policy benefits remeasurement (gains) losses																		Future policy benefits remeasurement (gains) losses
Effect of changes in cash flow assumptions																		Effect of changes in cash flow assumptions	$	(2)		$	140				$	(2)		$	117
Effect of actual variances from expected experience																		Effect of actual variances from expected experience	$	(37)		$	(72)				$	(60)		$	(26)
Loss ratio (1)																		Loss ratio (1)	76.7		%	105.3		%			81.1		%	89.0		%
Policy acquisition costs and other insurance expenses as a percentage of net premiums	Policy acquisition costs and other insurance expenses as a percentage of net premiums	5.6		%	5.0		%			6.5		%	6.2		%			Policy acquisition costs and other insurance expenses as a percentage of net premiums	6.2		%	7.1		%			6.6		%	7.5		%
Other operating expenses as a percentage of net premiums	Other operating expenses as a percentage of net premiums	7.9		%	7.3		%			7.6		%	7.4		%			Other operating expenses as a percentage of net premiums	7.6		%	7.7		%			7.7		%	7.6		%

(1)Includes Claims and other policy benefits and Future policy benefits remeasurement (gains) losses

The increases in income before income taxes for the three and nine months ended September 30, ~~2022, as compared to the same periods in 2021,~~2023, were primarily the result of ~~an increase in net premiums~~higher total revenue and favorable ~~claims experience.~~underwriting results.

Revenues

•The increases in net premiums ~~for the three and nine months ended September 30, 2022, as compared to the same periods in 2021,~~ were primarily due to continued business growth in the segment.

•The segment added new life business production, measured by face amount of life reinsurance in force, of ~~$14.4~~$25.7 billion and ~~$7.1 billion during the third quarter of 2022 and 2021, respectively, and~~ $36.7 ~~billion and $25.6~~ billion during the nine months ended September 30, 2023 and 2022, ~~and 2021,~~ respectively.

•The increases in net investment income were attributable to increase in investment yield due to an increase in interest rates.

Benefits and expenses

•The ~~decreases~~decrease in the loss ratio for the three and nine months ended September 30, ~~2022,~~2023, as compared to the same ~~periods~~period in ~~2021 were~~2022, was primarily due to favorable claims ~~experience across~~experience.

•During the ~~segment~~third quarter of 2023, the Company completed its annual assumption review resulting in a future policy benefits remeasurement gain of $2 million compared to a future policy benefits remeasurement loss of $140 million in the third quarter of 2022 due to improved COVID-19 experience, primarily in India, and favorable claims experience, primarily in Hong Kong. While the cause of death is not yet available for all claims, the Company estimates for the nine months ended September 30, 2022, that approximately $19 million of claims were attributable to COVID-19 which includes medical hospitalization claims in Japan for at-home sickness benefits related to COVID-19.updating mortality assumptions.

~~Financial Solutions~~

Three Months Ended September 30, Nine Months Ended September 30,
(dollars in millions) 2022 2021 2022 vs 2021 2022 2021 2022 vs 2021
Revenues:
Net premiums $ 69 $ 65 $ 4 $ 172 $ 166 $ 6
Investment income, net of related expenses 77 37 40 177 96 81
Investment related gains (losses), net (93) (15) (78) (287) 12 (299)
Other revenues 118 8 110 173 29 144
Total revenues 171 95 76 235 303 (68)
Benefits and expenses:
Claims and other policy benefits 88 52 36 188 140 48
Interest credited 38 12 26 80 42 38
Policy acquisition costs and other insurance expenses 43 19 24 77 41 36
Other operating expenses 4 6 (2) 14 15 (1)
Total benefits and expenses 173 89 84 359 238 121
Income (loss) before income taxes $ (2) $ 6 $ (8) $ (124) $ 65 $ (189)

5485

Table of Contents

Financial Solutions


	Three months ended September 30,						Nine months ended September 30,
(dollars in millions)	2023		2022		2023 vs 2022		2023		2022		2023 vs 2022
Revenues
Net premiums	$	63	$	69	$	(6)	$	171	$	172	$	(1)
Net investment income	117		77		40		350		176		174
Investment related gains (losses), net	(66)		(94)		28		(168)		(288)		120
Other revenues	16		119		(103)		44		174		(130)
Total revenues	130		171		(41)		397		234		163
Benefits and expenses
Claims and other policy benefits	67		60		7		180		155		25
Future policy benefits remeasurement (gains) losses	(1)		—		(1)		(2)		—		(2)
Market risk benefits remeasurement (gains) losses	—		—		—		—		—		—
Interest credited	54		38		16		154		80		74
Policy acquisition costs and other insurance expenses	21		21		—		56		48		8
Other operating expenses	5		5		—		18		14		4
Total benefits and expenses	146		124		22		406		297		109
Income (loss) before income taxes	$	(16)	$	47	$	(63)	$	(9)	$	(63)	$	54
Key metrics
Future policy benefits remeasurement (gains) losses
Effect of changes in cash flow assumptions	$	—	$	—			$	—	$	—
Effect of actual variances from expected experience	$	(1)	$	—			$	(2)	$	—

The ~~decreases~~decrease in income (loss) before income taxes ~~for~~during the third quarter of 2023 and ~~first~~the nine months ofended September 30, 2023, as compared to the same periods in 2022, ~~were primarily~~was due to ~~unfavorable fluctuations~~the impact of higher surrender fess and market value adjustments, reflected in other revenues, from a single premium annuity transaction recognized in the ~~fair value of derivatives.~~ prior year.

The invested asset base supporting asset-intensive transactions increased to $14.4 billion as of September 30, 2023, from $11.6 billion as of September 30, ~~2022, from $8.1 billion as of September 30, 2021.~~2022. The increase in the asset base compared to ~~2021~~September 30, 2022, was primarily due to ~~$3.4~~approximately $2.0 billion in additional assets from recently executed transactions and net organic growth of ~~$0.1~~$0.8 billion from existing ~~in force~~in-force blocks. The amount of reinsurance assumed from client companies, as measured by pre-tax statutory surplus, risk based capital and other financial reinsurance structures was ~~$1.0~~$1.1 billion and ~~$1.4~~$1.0 billion for the ~~periods~~nine months ended September 30, ~~2022~~2023 and ~~2021,~~2022, respectively. Fees earned from this business can vary significantly depending on the size, complexity and timing of the transactions and, therefore, can fluctuate from period to period.

Revenues

•The decreases in net premiums for the three and nine months ended September 30, 2023, as compared to the same periods in 2022, were the result of lower contributions from single premium asset-intensive transactions, partially offset by contributions from recently executed asset-intensive transactions.

•The increase in net investment income was due to a growing asset base and improved yields from increased interest rates.

•The decrease in investment related losses, net during the quarter ended September 30, 2023, as compared to the same period in 2022, was attributable to investment losses associated with higher lapses in the prior year. The decrease in investment related losses, net for the first nine months of 2023, as compared to 2022, was attributable to an increase in the fair value of derivatives of $98 million and investment losses associated with higher lapses in the prior year. Investment losses associated with higher lapses in the prior year were offset by surrender fees and market value adjustment charges, as described below.

•The decreases in other revenue for the three and nine months ended September 30, 2023, as compared to the same periods in 2022, were due to surrender fees and market value adjustment charges associated with higher lapses in the prior year.

Benefits and expenses

•The increases in claims and other policy benefits for the three and nine months ended September 30, ~~2022, as compared to 2021, was primarily attributable to medical hospitalization claims in Japan for at-home sickness benefits related to COVID-19 of $21 million and $26 million, respectively.~~

•~~The increases in investment income for the three and nine months ended September 30, 2022,~~2023, as compared to the same periods in ~~2021,~~2022, were ~~primarily due to~~ the ~~increase in the asset base.~~result of recently executed asset-intensive transactions.

•

~~The decreases in investment related gains (losses), net for the third quarter and nine months ended September 30, 2022, were primarily due to the decrease in fair value~~Table of ~~derivatives of $54 million and $249 million, respectively, due to the weakening of the Japanese yen, higher interest rates and widening credit spreads.~~Contents

•The increases in other revenues for the third quarter and nine months ended September 30, 2022, were primarily attributable to surrender and market value adjustment charges on a single premium annuity block of business of $104 million and $126 million, respectively, due to higher lapses, which was partially offset by an increase in policy acquisition costs and other reinsurance expenses of $24 million and $31 million, and a decrease in investment related gains (losses), net of $(23) million and $(37) million, respectively.

Corporate and Other

Corporate and Other revenues primarily include investment income from unallocated invested assets, investment related gains and losses and service fees. Corporate and Other expenses consist of the offset to capital charges allocated to the operating segments within the policy acquisition costs and other insurance income line item, unallocated overhead and executive costs, interest expense related to debt, and the investment income and expense associated with the Company’s ~~Funding Agreement Backed Notes (“FABN”) program,~~ collateral finance and securitization transactions and service business expenses. Additionally, Corporate and Other includes results from certain wholly-owned subsidiaries ~~such as RGAX, and joint ventures~~ that, among other activities, develop and market technology, and provide consulting and outsourcing solutions for the insurance and reinsurance industries. The Company ~~invests~~continues to invest in this area in an effort to both support its clients and accelerate the development of ~~new~~innovative solutions and services to increase consumer engagement within the life insurance industry and hence generate new future revenue streams.


															Three months ended September 30,						Nine months ended September 30,
(dollars in millions)	(dollars in millions)	Three months ended September 30,						Nine months ended September 30,						(dollars in millions)	2023		2022		2023 vs 2022		2023		2022		2023 vs 2022
		2022		2021		2022 vs 2021		2022		2021		2022 vs 2021
Revenues:
Revenues														Revenues
Net premiums	Net premiums	$	—	$	—	$	—	$	—	$	—	$	—	Net premiums	$	—	$	—	$	—	$	—	$	—	$	—
Investment income, net of related expenses		48		52		(4)		193		258		(65)
Net investment income														Net investment income	109		53		56		273		216		57
Investment related gains (losses), net	Investment related gains (losses), net	(23)		42		(65)		(64)		379		(443)		Investment related gains (losses), net	21		(24)		45		(23)		(64)		41
Other revenues	Other revenues	(1)		15		(16)		(11)		54		(65)		Other revenues	5		(1)		6		12		(12)		24
Total revenues	Total revenues	24		109		(85)		118		691		(573)		Total revenues	135		28		107		262		140		122
Benefits and expenses:
Benefits and expenses														Benefits and expenses
Claims and other policy benefits	Claims and other policy benefits	—		—		—		—		—		—		Claims and other policy benefits	—		—		—		—		—		—
Future policy benefits remeasurement (gains) losses														Future policy benefits remeasurement (gains) losses	—		—		—		—		—		—
Market risk benefits remeasurement (gains) losses														Market risk benefits remeasurement (gains) losses	—		—		—		—		—		—
Interest credited	Interest credited	8		1		7		20		3		17		Interest credited	14		8		6		42		20		22
Policy acquisition costs and other insurance income		(25)		(27)		2		(75)		(81)		6
Policy acquisition costs and other insurance expenses														Policy acquisition costs and other insurance expenses	(24)		(21)		(3)		(64)		(66)		2
Other operating expenses	Other operating expenses	84		75		9		223		231		(8)		Other operating expenses	84		84		—		253		223		30
Interest expense	Interest expense	46		41		5		130		129		1		Interest expense	72		49		23		188		136		52
Collateral finance and securitization expense		3		3		—		6		8		(2)
Total benefits and expenses	Total benefits and expenses	116		93		23		304		290		14		Total benefits and expenses	146		120		26		419		313		106
Income (loss) before income taxes		$	(92)	$	16	$	(108)	$	(186)	$	401	$	(587)
Loss before income taxes														Loss before income taxes	$	(11)	$	(92)	$	81	$	(157)	$	(173)	$	16

The ~~decreases~~decrease in ~~income~~loss before income taxes for the three ~~and nine month periods~~months ended September 30, ~~2022, were~~2023, was primarily ~~due~~attributable to aan increase in net investment income, increase in investment related gains (losses), net, partially offset by an increase in interest expense. The decrease in ~~total revenues and higher interest credited.~~

~~Table of Contents~~

•~~Net investment~~loss before income taxes for the nine months ended September 30, ~~2021, includes a one-time adjustment of $92 million of pre-tax unrealized gains on certain limited partnerships, for which the Company uses the equity method of accounting, from AOCI~~2023, was primarily attributable to ~~net investment income. The unrealized gains should have been recognized directly~~an increase in net investment income, increase in ~~the same prior periods they were reported as earnings by the investees. Excluding this adjustment, the~~investment related gains (losses), net, increase in interest credited, increase in other operating expenses and increase in interest expense.

Revenues

•The increases in net investment income for the three and nine ~~month periods~~months ended September 30, ~~2022, is~~2023, were attributable to higher ~~investment income on Corporate invested assets due to~~yields and a higher unallocated invested asset base. ~~Higher investment income includes income earned on assets associated with the Company’s FABN program, which is partially offset by higher interest credited related to the program.~~

•Investment related gains (losses), net for the first nine months of 2021 includes an adjustment to investments in limited partnerships considered to be investment companies, which should have been recognized in prior periods, of $70 million to adjust the carrying value from cost less impairments to the fair value approach, using the net asset value (“NAV”) per share or its equivalent. The ~~remaining decrease~~increase in investment related gains (losses), net for the ~~third quarter and first nine~~three months ~~of 2022 as~~ended September 30, 2023, was primarily attributable to unrealized gains on limited partnerships in the current period compared to ~~the prior year is attributable to~~net losses on sales of fixed maturity securities in the ~~current period compared~~prior period. The decrease in investment related losses, net for the nine months ended September 30, 2023, was primarily attributable to ~~gains~~a decrease in ~~the prior period, lower unrealized gains~~net losses on ~~limited partnerships, changes in allowances and impairments on mortgage loans and available-for-sale securities and changes in the fair value~~sales of ~~equity securities, partially offset by increases in the fair value of derivatives as a result of fluctuations in foreign exchange rates, interest rates and equity markets.~~fixed maturity securities.

•The ~~decrease~~increase in other revenues was primarily due to ~~a decline~~an increase in the cash surrender value on corporate-owned life insurance for the three and nine ~~month period~~months ended September 30, ~~2022,~~2023, compared to a decrease in value in the prior year.

Expenses

•The increase in interest credited for the nine months ended September 30, 2023, was primarily attributable to an increase in ~~value for the prior year, as well as gains~~interest rates on the sales of subsidiaries in the prior period of $11 million. Further, foreign currency losses reduced other revenues for the three and nine month periods ended September 30, 2022, as compared to the prior period.FHLB funding agreements.

•The increase in other operating expenses for the ~~three month period~~nine months ended September 30, ~~2022,~~2023, was primarily attributable to ~~higher~~an increase in incentive compensation ~~and information technology expenditures.~~ expense.

•The ~~decrease~~increases in ~~other operating expenses~~interest expense for the three and nine ~~month period~~months ended September 30, ~~2022, was~~2023, were primarily attributable to ~~a decrease~~an increase in ~~compensation expense.~~outstanding debt.

Table of Contents

Liquidity and Capital Resources

Overview

The Company believes that cash flows from the source of funds available to it will provide sufficient cash flows for the next twelve months to satisfy the current liquidity requirements of the Company under various scenarios that include the potential risk of early recapture of reinsurance treaties, market ~~and economic uncertainties, including interest rates and inflation,~~events and higher than expected ~~claims associated with COVID-19 primarily during the first quarter of 2022.~~claims. The Company performs periodic liquidity stress testing to ensure its asset portfolio includes sufficient high quality liquid assets that could be utilized to bolster its liquidity position under stress scenarios. These assets could be utilized as collateral for secured borrowing transactions with various third parties or by selling the securities in the open market if needed. The Company’s liquidity requirements have been and will continue to be funded through net cash flows from operations. However, in the event of significant unanticipated cash requirements beyond normal liquidity needs, the Company has multiple liquidity alternatives available based on market conditions and the amount and timing of the liquidity need. These alternatives include the sale of invested assets subject to market conditions, borrowings under committed credit facilities, secured borrowings, and if necessary, issuing long-term debt, preferred securities or common equity.

Current Market Environment

The Company’s average investment yield, excluding spread related business, for the ~~nine~~three months ended September 30, ~~2022,~~2023, was ~~4.78% or 30~~4.72%, 32 basis points ~~lower than~~above the same period in ~~2021 due~~2022 primarily attributable to ~~decreased~~higher interest rates and an increase in variable investment income associated with joint ventures and limited partnerships. The average yield will vary from year to year depending on several variables, including the prevailing risk-fee interest rate and credit spread environment, prepayment fees and make-whole premiums, changes in the mix of the underlying investments and cash and cash equivalents balances. Variable investment income from joint ventures and limited partnerships ~~partially offset by increased variable income~~will also vary from ~~real estate joint ventures. The Company’s insurance liabilities, in particular its annuity products, are sensitive~~year to ~~changing market factors.~~year and is highly dependent on the timing of dividends and distributions on certain investments. Gross unrealized gains on fixed maturity securities available-for-sale decreased from ~~$5.3~~$0.6 billion at December 31, ~~2021,~~2022, to ~~$0.7~~$0.4 billion at September 30, ~~2022, due to increased interest rates. Similarly,~~2023. Additionally, gross unrealized losses increased from ~~$0.3~~$7.3 billion at December 31, ~~2021,~~2022, to ~~$7.8~~$8.5 billion at September 30, ~~2022.~~2023.

The Company continues to be in a position to hold any investment security showing an unrealized loss until recovery, provided it remains comfortable with the credit of the issuer. The Company does not rely on short-term funding or commercial paper and to date it has experienced no liquidity pressure, nor does it anticipate such pressure in the foreseeable future.

The Company projects its reserves to be sufficient and it would not expect to ~~write down deferred acquisition costs or~~ be required to take any actions to augment capital, even if interest rates remain at current levels for the next five years, assuming all other factors remain constant. ~~While interest rates have recently increased,~~To mitigate disintermediation risk, the Company ~~continues~~purchased swaptions to ~~feel~~protect it against a material increase in interest rates. While the Company has felt the pressures of sustained low interest rates, followed by the recent significant increase in risk-free rates, and volatile equity markets, its business and ~~may continue to do so; however, its underlying business is~~results of operations are not overly sensitive to these risks. Mortality and morbidity risks continue to be the most significant risk for the Company. Although

~~Table of Contents~~

management believes the Company’s current capital base is adequate to support its business at current operating levels, it continues to monitor new business opportunities and any associated new capital needs that could arise from the changing financial ~~landscape~~landscape.

The Holding Company

RGA is an insurance holding company whose primary uses of liquidity include, but are not limited to, the immediate capital needs of its operating companies, dividends paid to its shareholders, repurchase of common stock and interest payments on its indebtedness. The primary sources of RGA’s liquidity include proceeds from its capital-raising efforts, interest income on undeployed corporate investments, interest income received on surplus notes with RGA Reinsurance Company (“RGA Reinsurance”), RGA Life and Annuity Insurance Company ~~(formerly Reinsurance Company of Missouri, Incorporated)~~(“RGA Life and Annuity”) and Rockwood Reinsurance Company (“Rockwood Re”) and dividends from operating subsidiaries. As the Company continues its growth efforts, RGA will continue to be dependent upon these sources of liquidity. The following tables provide comparative information for RGA (dollars in millions):


		Three months ended September 30,				Nine months ended September 30,					Three months ended September 30,				Nine months ended September 30,
		2022		2021		2022		2021			2023		2022			2023		2022
Interest and dividend income	Interest and dividend income	$	135	$	303	$	287	$	367	Interest and dividend income	$	134	$	135		$	205	$	287
Interest expense	Interest expense	45		47		128		150		Interest expense	53		45			153		128
Capital contributions to subsidiaries	Capital contributions to subsidiaries	5		5		17		12		Capital contributions to subsidiaries	8		5			20		17
Issuance of unaffiliated debt	Issuance of unaffiliated debt	690		—		690		—		Issuance of unaffiliated debt	—		690			400		690
Dividends to shareholders	Dividends to shareholders	54		50		152		145		Dividends to shareholders	56		54			163		152

Purchase of treasury stock	Purchase of treasury stock	25		46		50		48		Purchase of treasury stock	50		25			150		50

September 30, 2022 December 31, 2021
Cash and invested assets $ 931 $ 621

Table of Contents


	September 30, 2023		December 31, 2022
Cash and invested assets	$	537	$	903

See Item 15, Schedule II – “Condensed Financial Information of the Registrant” in the ~~2021~~2022 Annual Report for additional financial information related to RGA.

The undistributed earnings of substantially all of the Company’s foreign subsidiaries have been reinvested indefinitely in those non-U.S. operations, as described in Note 9 – “Income Tax” in the Notes to Consolidated Financial Statements in the ~~2021~~2022 Annual Report. As U.S. Tax Reform generally ~~eliminates~~eliminated U.S. federal income taxes on dividends from foreign subsidiaries, the Company does not expect to incur material income taxes if these funds are repatriated.

RGA endeavors to maintain a capital structure that provides financial and operational flexibility to its subsidiaries, credit ratings that support its competitive position in the financial services marketplace, and shareholder returns. As part of the Company’s capital deployment strategy, it has in recent years repurchased shares of RGA common stock and paid dividends to RGA shareholders, as authorized by the board of directors.

On January 24, 2019, RGA’s board of directors authorized a share repurchase program for up to $400 million of RGA’s outstanding common stock. During the nine months ended September 30, 2022, RGA repurchased 219,116 shares of common stock under this program for $25 million.

On February 25, 2022, RGA’s board of directors authorized a share repurchase program for up to $400 million of RGA’s outstanding common stock. The authorization was effective immediately and does not have an expiration date. In connection with this authorization, the board of directors terminated the stock repurchase authority granted in 2019. During the nine months ended September 30, ~~2022,~~2023, RGA repurchased ~~195,234~~1,069,113 shares of common stock under this program for ~~$25 million.~~$150 million, and as of September 30, 2023, $200 million may be purchased under this program.

The pace of repurchase activity depends on various factors such as the level of available cash, an evaluation of the costs and benefits associated with alternative uses of excess capital, such as acquisitions and in force reinsurance transactions, and RGA’s stock price.

Details underlying dividend and share repurchase program activity were as follows ~~(dollars in~~(in millions, except share data):

Nine months ended September 30,
2022 2021
Dividends to shareholders $ 152 $ 145
Purchase of treasury stock (1)
50 46
Total amount paid to shareholders $ 202 $ 191
Number of treasury shares purchased (1)
414 406
Average price per share $ 120.67 $ 113.40
1Excludes shares utilized to execute and settle certain stock incentive awards.

~~Table of Contents~~


	Nine months ended September 30,
	2023		2022
Dividends to shareholders	$	163	$	152
Purchase of common stock (1)	150		50
Total amount paid to shareholders	$	313	$	202

Number of common shares purchased (1)	1,069,113		414,350
Average price per share	$	140.30	$	120.67

(1)

Excludes shares utilized to execute and settle certain stock incentive awards.

In October ~~2022,~~2023, RGA’s board of directors declared a quarterly dividend of ~~$0.80~~$0.85 per share. All future payments of dividends are at the discretion of RGA’s board of directors and will depend on the Company’s earnings, capital requirements, insurance regulatory conditions, operating conditions, and other such factors as the board of directors may deem relevant. The amount of dividends that RGA can pay will depend in part on the operations of its reinsurance subsidiaries. See Note 34 – “Equity” in the Notes to Condensed Consolidated Financial Statements for information on the Company’s share repurchase program.

Debt

Certain of the Company’s debt agreements contain financial covenant restrictions related to, among others, liens, the issuance and disposition of stock of restricted subsidiaries, minimum requirements of consolidated net worth, maximum ratios of debt to capitalization and change of control provisions. The Company renewed its syndicated credit facility in the first quarter of 2023. Under the terms of the new facility the Company is required to maintain a minimum consolidated net worth, as defined in the debt agreements, ~~of $5.3~~$5.8 billion ~~calculated as of~~effective with the ~~last day of each fiscal quarter.~~June 30, 2023, covenant calculations. Also, consolidated indebtedness, calculated as of the last day of each fiscal quarter, cannot exceed 35% of the sum of the Company’s consolidated indebtedness plus adjusted ~~consolidated stockholders’~~RGA Inc’s shareholders’ equity. A material ongoing covenant default could require immediate payment of the amount due, including principal, under the various agreements. Additionally, the Company’s debt agreements contain cross-acceleration covenants, which would make outstanding borrowings immediately payable in the event of a material uncured covenant default under any of the agreements, including, but not limited to, non-payment of indebtedness when due for an amount in excess of the amounts set forth in those agreements, bankruptcy proceedings, or any other event that results in the acceleration of the maturity of indebtedness.

Table of Contents

As of September 30, ~~2022~~2023 and December 31, ~~2021,~~2022, the Company had ~~$4.2~~$4.5 billion and ~~$3.7~~$4.0 billion, respectively, in outstanding borrowings under its debt agreements and was in compliance with all covenants under those agreements. As of September 30, ~~2022~~2023 and December 31, ~~2021,~~2022, the average ~~net~~ interest rate on long-term debt outstanding was ~~4.89%~~5.10% and ~~4.42%~~4.71%, respectively. The ability of the Company to make debt principal and interest payments depends on the earnings and surplus of subsidiaries, investment earnings on undeployed capital proceeds, available liquidity at the holding company, and the Company’s ability to raise additional funds.

The Company enters into derivative agreements with counterparties that reference either the Company’s debt rating or its financial strength rating. If either rating is downgraded in the future, it could trigger certain terms in the Company’s derivative agreements, which could negatively affect overall liquidity. For the majority of the Company’s derivative agreements, there is a termination event should the long-term senior debt ratings drop below either BBB+ (S&P) or Baa1 (Moody’s) or the financial strength ratings drop below either A- (S&P) or A3 (Moody’s).

The Company may borrow up to $850 million in cash and obtain letters of credit in multiple currencies on its revolving credit facility that matures in ~~August 2023.~~March 2028. As of September 30, ~~2022,~~2023, the Company had no cash borrowings outstanding and ~~$7 million in~~no issued, but undrawn, letters of credit under this facility.

On ~~December 13, 2021,~~June 8, 2023, the Company issued 6.0% fixed rate senior notes due 2033 with a face amount of $400 million, which were used to repay upon maturity the $400 million 4.70% Senior Notes that matured on September 15, 2023. Capitalized issuance costs were $4 million.

On March 23, 2023, Chesterfield Reinsurance Company, a subsidiary of RGA, ~~Reinsurance~~ issued ~~4.00%~~7.125% Surplus Notes due ~~in 2051~~2043, with a face amount of $500 million. ~~The net proceeds were approximately $494 million and will be used for general corporate purposes.~~

On September 15, 2022, RGA announced a cash tender offer for any and all of its outstanding 6.20% Fixed-to-Floating Rate Subordinated Debentures due 2042 (the “2042 Debentures”) at a price of $25.20 for each $25 principal amount of 2042 Debentures. The tender offer expired on September 22, 2022, and a total of $151 million or approximately 38%, of the aggregate principal amount of the 2042 Debentures were tendered. The Company intends to redeem the remaining debentures in accordance with the indenture governing the 2042 Debentures.

On September 23, 2022, RGA issued 7.125% fixed-rate reset subordinated debentures due October 15, 2052, with a face amount of $700 million. This security has been registered with the Securities and Exchange Commission. The net proceeds were approximately $690 million and a portion was used in part to pay for the tender offer of the 2042 Debentures. The remaining proceeds will be used for future redemptions of the remaining 2042 Debentures in accordance with the indenture governing the 2042 Debentures, and general corporate purposes. Capitalized issue costs were approximately ~~$10~~$6 million.

Based on the historic cash flows and the current financial results of the Company, management believes RGA’s cash flows will be sufficient to enable RGA to meet its obligations for at least the next ~~twelve~~12 months.

Credit and Committed Facilities

~~At September 30, 2022,~~On March 13, 2023, The Company entered into a new syndicated revolving credit facility with a five year term and an overall capacity of $850 million. The new facility replaced the ~~Company maintained an~~existing $850 million syndicated revolving credit facility, ~~and certain committed letter of credit facilities aggregating~~which was scheduled to ~~$928 million.~~mature in August 2023. See Note 13 – “Debt” in the Notes to Consolidated Financial Statements in the ~~2021~~2022 Annual Report for further information about these facilities.

~~Table of Contents~~

The Company has obtained bank letters of credit in favor of various affiliated and unaffiliated insurance companies from which the Company assumes business. These letters of credit represent guarantees of performance under the reinsurance agreements and allow ceding companies to take statutory reserve credits. Certain of these letters of credit contain financial covenant restrictions similar to those described in the “Debt” discussion above. At September 30, ~~2022,~~2023, there were approximately ~~$158~~$53 million of outstanding bank letters of credit in favor of third parties. Additionally, in accordance with applicable regulations, the Company utilizes letters of credit to secure statutory reserve ~~credits~~credit when it retrocedes business to its affiliated subsidiaries. The Company cedes business to its affiliates to help reduce the amount of regulatory capital required in certain jurisdictions, such as the U.S. and ~~the~~ UK. The Company believes the capital required to support the business in the affiliates reflects more realistic expectations than the original jurisdiction of the business, where capital requirements are often considered to be quite conservative. As of September 30, ~~2022, $1.5 billion~~2023, $768 million in letters of credit from various banks were outstanding, but undrawn, backing reinsurance between the various subsidiaries of the Company.

Cash Flows

The Company’s principal cash inflows from its reinsurance operations include premiums and deposit funds received from ceding companies. The primary liquidity concerns with respect to these cash flows are early recapture of the reinsurance contract by the ceding company and lapses of annuity products reinsured by the Company. The Company’s principal cash inflows from its invested assets result from investment income and the maturity and sales of invested assets. The primary liquidity concerns with respect to these cash inflows relates to the risk of default by debtors and interest rate volatility. The Company manages these risks very closely. See “Investments” below.

Additional sources of liquidity to meet unexpected cash outflows in excess of operating cash inflows and current cash and equivalents on hand also includes drawing funds under a revolving credit facility, under which the Company had availability of ~~$843~~$850 million as of September 30, ~~2022.~~2023. The Company also has ~~$641~~$766 million of funds available through collateralized borrowings from the FHLB as of September 30, ~~2022.~~2023. As of September 30, ~~2022,~~2023, the Company could have borrowed these additional amounts without violating any of its existing debt covenants.

The Company’s principal cash outflows relate to the payment of claims liabilities, interest credited, operating expenses, income taxes, dividends to shareholders, purchases of treasury stock, and principal and interest under debt and other financing

Table of Contents

obligations. The Company seeks to limit its exposure to loss on any single insured and to recover a portion of benefits paid by ceding reinsurance to other insurance enterprises or reinsurers under excess coverage and coinsurance contracts (See Note 2 – “Significant Accounting Policies and Pronouncements” in the Notes to Consolidated Financial Statements in the ~~2021~~2022 Annual Report). The Company performs annual financial reviews of its retrocessionaires to evaluate financial stability and performance. The Company has never experienced a material default in connection with retrocession arrangements, nor has it experienced any difficulty in collecting claims recoverable from retrocessionaires; however, no assurance can be given as to the future performance of such retrocessionaires nor to the recoverability of future claims. The Company’s management believes its cash and cash equivalents along with its current sources of liquidity are adequate to meet its cash requirements for the next ~~twelve months, despite the uncertainty associated with the pandemic.~~

~~Table of Contents~~

12 months.

Summary of Primary Sources and Uses of Liquidity and Capital

The Company’s primary sources and uses of liquidity and capital are summarized as ~~follows:~~follows (dollars in millions):


			For the nine months ended September 30,
			2022		2021				For the nine months ended September 30,
			(Dollars in millions)						2023		2022
Sources:	Sources:						Sources:
		Net cash provided by operating activities	$	1,076	$	3,821		Net cash provided by operating activities	$	2,818	$	1,077

								Proceeds from long-term debt issuance	900		700
		Proceeds from long-term debt issuance	700		—
								Change in cash collateral for derivative positions and other arrangements	300		99
		Change in cash collateral for derivative positions and other arrangements	99		29			Change in deposit asset on reinsurance	41		—
		Change in deposit asset on reinsurance	—		14			Net deposits to investment-type policies and contracts	—		4,156
		Net deposits from investment-type policies and contracts	4,156		—			Net change in noncontrolling interest	—		88
		Issuance of preferred interests by subsidiary	90		—
		Total sources	6,121		3,864			Total sources	4,059		6,120

Uses:	Uses:						Uses:
		Net cash used in investing activities	4,794		3,492			Net cash used in investing activities	2,592		4,795
		Dividends to stockholders	152		145			Dividends to shareholders	163		152
		Repayment of collateral finance and securitization notes	181		74			Repayment of collateral finance and securitization notes	—		181
		Debt issuance costs	10		—			Debt issuance costs	10		10
		Principal payments of long-term debt	153		402			Principal payments of long-term debt	402		153
								Purchases of treasury stock	169		54
		Purchases of treasury stock	54		48
								Change in deposit asset on reinsurance	—		32
								Net withdrawals from investment-type policies and contracts	768		—
		Change in deposit asset on reinsurance	32		—			Effect of exchange rate changes on cash	62		179
		Net withdrawals from investment-type policies and contracts	—		51			Total uses	4,166		5,556
		Distributions to noncontrolling interest	2		—
		Effect of exchange rate changes on cash	179		33
		Total uses	5,557		4,245
Net change in cash and cash equivalents	Net change in cash and cash equivalents		$	564	$	(381)	Net change in cash and cash equivalents		$	(107)	$	564

Cash Flows from Operations – The principal cash inflows from the Company’s reinsurance activities come from premiums, investment and fee income, annuity considerations and deposit funds. The principal cash outflows relate to the liabilities associated with various life and health insurance, annuity and disability products, operating expenses, income tax payments and interest on outstanding debt obligations. The primary liquidity concern with respect to these cash flows is the risk of shortfalls in premiums and investment income, particularly in periods with abnormally high claims levels.

Cash Flows from Investments – The principal cash inflows from the Company’s investment activities come from repayments of principal on invested assets, proceeds from maturities of invested assets, sales of invested assets and settlements of freestanding derivatives. The principal cash outflows relate to purchases of investments, issuances of policy loans and settlements of freestanding derivatives. The Company typically has a net cash outflow from investing activities because cash inflows from insurance operations are reinvested in accordance with its asset/liability management discipline to fund insurance liabilities. The Company closely monitors and manages these risks through its credit risk management process. The primary liquidity concerns with respect to these cash flows are the risk of default by debtors and market disruption, which could make it difficult for the Company to sell investments.

Financing Cash Flows – The principal cash inflows from the Company’s financing activities come from issuances of RGA debt and equity securities, and deposit funds associated with universal life and other investment type policies and contracts. The principal cash outflows come from repayments of debt, payments of dividends to ~~stockholders,~~shareholders, purchases of treasury stock, and withdrawals associated with universal life and other investment type policies and contracts. A primary liquidity concern with respect to these cash flows is the risk of early contractholder and policyholder withdrawal.

Contractual Obligations

There were no ~~other~~ material changes in the Company’s contractual obligations from those reported in the ~~2021~~2022 Annual Report, except for the following:

•The Company’s contractual obligations associated with long term debt, including principal and interest, increased from $7.1 billion at December 31, 2021 to $9.1 billion at September 30, 2022, primarily due to the issuance of 7.125% fixed-rate reset subordinated debentures due October 15, 2052, with a face amount of $700 million on September 23, 2022.

6091

Table of Contents

•The Company’s contractual obligations associated with ~~interest sensitive contract liabilities~~other investment related commitments increased from ~~$43.4~~$1.0 billion at December 31, ~~2021~~2022 to ~~$49.8~~$1.4 billion at September 30, ~~2022,~~2023, primarily ~~due~~relating to ~~large asset intensive transactions completed during the nine months ended September 30, 2022. The majority of these commitments are expected to occur beyond five years.~~

•The remaining amount of the $850 million Series A Floating Rate Insured Notes issued by the Company’s subsidiary, Timberlake Financial, LLC, which was approximately $185 million, were redeemed on August 29, 2022,increases in securities borrowing, lending and ~~are no longer outstanding as of September 30, 2022.~~repurchase/reverse repurchase agreements. See Note 11 Investments for further details.

Asset / Liability Management

The Company actively manages its cash and invested assets using an approach that is intended to balance quality, diversification, asset/liability matching, liquidity and investment return. The goals of the investment process are to optimize after-tax, risk-adjusted investment income and after-tax, risk-adjusted total return while managing the assets and liabilities on a cash flow and duration basis.

The Company has established target asset portfolios for its operating segments, which represent the investment strategies intended to profitably fund its liabilities within acceptable risk parameters. These strategies include objectives and limits for effective duration, yield curve sensitivity and convexity, liquidity, asset sector concentration and credit quality.

The Company’s asset-intensive products are primarily supported by investments in fixed maturity securities reflected on the Company’s balance sheet and under funds withheld arrangements with the ceding company. Investment guidelines are established to structure the investment portfolio based upon the type, duration and behavior of products in the liability portfolio so as to achieve targeted levels of profitability. The Company manages the asset-intensive business to provide a targeted spread between the interest rate earned on investments and the interest rate credited to the underlying interest-sensitive contract liabilities. The Company periodically reviews models projecting different interest rate scenarios and their effect on profitability. Certain of these asset-intensive agreements, primarily in the U.S. and Latin America Financial Solutions operating segment, are generally funded by fixed maturity securities that are withheld by the ceding company.

The Company’s liquidity position (cash and cash equivalents and ~~short-term~~short term investments) was ~~$3.7~~$3.0 billion and ~~$3.0~~$3.1 billion at September 30, ~~2022~~2023 and December 31, ~~2021,~~2022, respectively. Liquidity needs are determined from valuation analyses conducted by operational units and are driven by product portfolios. Periodic evaluations of demand liabilities and short-term liquid assets are designed to adjust specific portfolios, as well as their durations and maturities, in response to anticipated liquidity needs.

See “Securities Borrowing, Lending and Repurchase/Reverse Repurchase Agreements” in Note 4 11 – “Investments” in the Notes to Condensed Consolidated Financial Statements for information related to the Company’s securities borrowing, lending and repurchase/reverse repurchase ~~agreements.~~programs. In addition to its security agreements with third parties, certain RGA’s subsidiaries have entered into intercompany securities lending agreements to more efficiently source securities for lending to third parties and to provide for more efficient regulatory capital management.

The Company is a member of the FHLB and holds ~~$66~~$60 million of FHLB common stock, which is included in other invested assets on the Company’s condensed consolidated balance sheets.

The Company has entered into funding agreements with the FHLB under guaranteed investment contracts whereby the Company has issued the funding agreements in exchange for cash and for which the FHLB has been granted a blanket lien on the Company’s commercial and residential mortgage-backed securities and commercial mortgage loans used to collateralize the Company’s obligations under the funding agreements. The Company maintains control over these pledged assets, and may use, commingle, encumber or dispose of any portion of the collateral as long as there is no event of default and the remaining qualified collateral is sufficient to satisfy the collateral maintenance level. The funding agreements and the related security agreements represented by this blanket lien provide that upon any event of default by the Company, the FHLB’s recovery is limited to the amount of the Company’s liability under the outstanding funding agreements. The amount of the Company’s liability for the funding agreements with the FHLB ~~under guaranteed investment contracts~~ was ~~$1.3 billion and $1.4~~$1.2 billion at September 30, ~~2022~~2023 and $1.3 billion at December 31, ~~2021, respectively,~~2022, which is included in interest-sensitive contract liabilities on the Company’s condensed consolidated balance sheets. The advances on these agreements are collateralized primarily by commercial and residential mortgage-backed securities, commercial mortgage loans, and U.S. Treasury and government agency securities. The amount of collateral exceeds the liability and is dependent on the type of assets collateralizing the guaranteed investment contracts.

~~Table of Contents~~

Investments

Management of Investments

The Company’s investment and derivative strategies involve matching the characteristics of its reinsurance products and other obligations. The Company seeks to closely approximate the interest rate sensitivity of the assets with estimated interest rate sensitivity of the reinsurance liabilities. The Company achieves its income objectives through strategic and tactical asset allocations, applying security and derivative strategies within asset/liability and disciplined risk management frameworks. Derivative strategies are employed within the Company’s risk management framework to help manage duration, currency, and other risks in assets and/or liabilities and to replicate the credit characteristics of certain assets.

Table of Contents

The Company’s portfolio management groups work with the Enterprise Risk Management function to develop the investment policies for the assets of the Company’s domestic and international investment portfolios. All investments held by the Company, directly or in a funds withheld at interest reinsurance arrangement, are monitored for conformance with the Company’s stated investment policy limits as well as any limits prescribed by the applicable jurisdiction’s insurance laws and regulations. See Note 411 – “Investments” in the Notes to Condensed Consolidated Financial Statements for additional information regarding the Company’s investments.

Portfolio Composition

The Company had total cash and invested assets of ~~$71.6~~$75.1 billion and ~~$81.5~~$73.4 billion as of September 30, ~~2022~~2023 and December 31, ~~2021,~~2022, respectively, as illustrated below (dollars in millions):


		September 30, 2022		% of Total		December 31, 2021		% of Total			September 30, 2023		% of Total		December 31, 2022		% of Total
Fixed maturity securities available-for-sale	Fixed maturity securities available-for-sale	$	50,495	70.6	%	$	60,749	74.6	%	Fixed maturity securities available-for-sale	$	54,171	72.1	%	$	52,901	72.0	%
Equity securities	Equity securities	137		0.2		151		0.2		Equity securities	133		0.2		134		0.2
Mortgage loans	Mortgage loans	6,558		9.2		6,283		7.7		Mortgage loans	7,231		9.6		6,590		9.0
Policy loans	Policy loans	1,202		1.7		1,234		1.5		Policy loans	1,180		1.6		1,231		1.7
Funds withheld at interest	Funds withheld at interest	6,177		8.6		6,954		8.5		Funds withheld at interest	5,725		7.6		6,003		8.2
Limited partnerships and real estate joint ventures										Limited partnerships and real estate joint ventures	2,560		3.4		2,327		3.2
Short-term investments	Short-term investments	225		0.3		87		0.1		Short-term investments	141		0.2		154		0.2
Other invested assets	Other invested assets	3,246		4.5		3,070		3.8		Other invested assets	1,091		1.5		1,140		1.5
Cash and cash equivalents	Cash and cash equivalents	3,512		4.9		2,948		3.6		Cash and cash equivalents	2,820		3.8		2,927		4.0
Total cash and invested assets	Total cash and invested assets	$	71,552	100.0	%	$	81,476	100.0	%	Total cash and invested assets	$	75,052	100.0	%	$	73,407	100.0	%

Investment Yield

The following table presents consolidated average invested assets at amortized cost, net investment income, investment yield, variable investment income (“VII”), and investment yield excluding VII, which can vary significantly from period to period (dollars in millions). The table excludes spread related business. Spread related business is primarily associated with contracts on which the Company earns an interest rate spread between assets and liabilities. To varying degrees, fluctuations in the yield on other spread related business is generally subject to corresponding adjustments to the interest credited on the liabilities.

Three months ended September 30, Nine months ended September 30,
2022 2021   Increase/
  (Decrease) 2022 2021   Increase/
  (Decrease)
Average invested assets at amortized cost $ 34,579 $ 33,361 $ 1,218 $ 34,494 $ 33,021 $ 1,473
Net investment income $ 374 $ 405 $ (31) $ 1,228 $ 1,251 $ (23)
Annualized investment yield (ratio of net investment income to average invested assets at amortized cost) 4.40 % 4.95 % (55) bps 4.78 % 5.08 % (30) bps
VII (included in net investment income) $ 38 $ 102 $ (64) $ 249 $ 342 $ (93)
Annualized investment yield excluding VII (ratio of net investment income, excluding VII, to average invested assets, excluding assets with only VII, at amortized cost) 4.12 % 3.85 % 27 bps 3.96 % 3.83 % 13 bps

~~Table of Contents~~


	Three months ended September 30,								Nine months ended September 30,
	2023			2022			Increase/ (Decrease)		2023			2022			Increase/ (Decrease)
Average invested assets at amortized cost	$	37,051		$	34,579		$	2,472	$	35,934		$	34,494		$	1,440
Net investment income	$	430		$	374		$	56	$	1,238		$	1,228		$	10
Annualized investment yield (ratio of net investment income to average invested assets at amortized cost)	4.72		%	4.40		%	32 bps		4.62		%	4.78		%	(16) bps
VII (included in net investment income)	$	39		$	38		$	1	$	95		$	249		$	(154)
Annualized investment yield excluding VII (ratio of net investment income, excluding VII, to average invested assets, excluding assets with only VII, at amortized cost)	4.51		%	4.12		%	39 bps		4.46		%	3.96		%	50 bps

Investment yield ~~decreased~~increased for the three months ended September 30, ~~2022,~~2023, in comparison to the same period in the prior year, primarily due to the recent increase in interest rates. Investment yield decreased for the nine months ended September 30, 2023, in comparison to the same period in the prior year, primarily due to decreased variable income from limited partnerships and real estate joint ventures, which are included in other invested assets on the condensed consolidated balance sheets. Investment yield decreased for the nine months ended September 30, 2022, in comparison to the same period in the prior year, primarily due to decreased variable income from limited partnerships partially offset by increased ~~variable income~~yield from ~~real estate joint ventures. Investment yield excluding variable investment income increased for~~ the ~~three and nine months ended September 30, 2022,~~recent increase in ~~comparison to the same periods in the prior year, primarily due to the rising~~ interest ~~rate environment.~~rates.

Fixed Maturity Securities Available-for-Sale

See “Fixed Maturity Securities Available-for-Sale” in Note 411 – “Investments” in the Notes to Condensed Consolidated Financial Statements for tables that provide the amortized cost, allowance for credit losses, unrealized gains and losses and estimated fair value of these securities by type as of September 30, ~~2022~~2023 and December 31, ~~2021.~~

The Company holds various types of fixed maturity securities available-for-sale and classifies them as corporate securities (“Corporate”), Canadian and Canadian provincial government securities (“Canadian government”), residential mortgage-backed securities (“RMBS”), asset-backed securities (“ABS”), commercial mortgage-backed securities (“CMBS”), U.S. government and agencies (“U.S. government”), state and political subdivisions, and other foreign government, supranational and foreign government-sponsored enterprises (“Other foreign government”). RMBS, ABS, and CMBS are collectively “structured securities.” As of September 30, 2022 and December 31, 2021, approximately 93.1% and 94.0%, respectively, of the Company’s consolidated investment portfolio of fixed maturity securities were investment grade.2022.

Important factors in the selection of investments include diversification, quality, yield, call protection and total rate of return potential. The relative importance of these factors is determined by market conditions and the underlying reinsurance liability and existing portfolio characteristics. As of September 30, 2023 and December 31, 2022, approximately 94.0% and 94.3%, respectively, of the Company’s consolidated investment portfolio of fixed maturity securities were investment grade.

Table of Contents

The Company owns floating rate securities that represent approximately ~~7.6%~~8.0% and ~~5.3%~~7.4% of the total fixed maturity securities as of September 30, ~~2022~~2023 and December 31, ~~2021,~~2022, respectively. These investments have a higher degree of income variability than the other fixed income holdings in the portfolio due to fluctuations in interest payments. The Company holds floating rate investments to match specific floating rate liabilities primarily reflected in the condensed consolidated balance sheets as collateral finance notes, as well as to enhance asset management strategies.

The largest asset class in which fixed maturity securities were invested was corporate securities, which represented approximately ~~64.6%~~65.5% and ~~62.8%~~64.2% of total fixed maturity securities as of September 30, ~~2022~~2023 and December 31, ~~2021.~~2022, respectively. See “Corporate Fixed Maturity Securities” in Note 411 – “Investments” in the Notes to Condensed Consolidated Financial Statements for tables showing the major sector types, which comprise the corporate fixed maturity holdings as of September 30, ~~2022~~2023 and December 31, ~~2021.~~2022.

As of September 30, ~~2022~~2023 and December 31, ~~2021,~~2022, the Company’s investments in Canadian government securities represented ~~7.1%~~6.2% and ~~8.1%~~6.9%, respectively, of the fair value of total fixed maturity securities. These assets are primarily high quality, long duration provincial strip bonds, the valuation of which is closely linked to the interest rate curve. These assets are longer in duration and held primarily for asset/liability management to meet Canadian regulatory requirements.

As of September 30, 2023 and December 31, 2022, the Company’s investments in Japanese government securities represented 5.0% and 4.8%, respectively, of the fair value of total fixed maturity securities. These assets are primarily long duration government bonds matching the liability profile of the Company’s Japanese business.

The Company references rating agency designations in some of its investments disclosures. These designations are based on the ratings from nationally recognized statistical rating organizations, primarily Moody’s, S&P and Fitch. Structured securities held by the Company’s insurance subsidiaries that maintain the NAIC statutory basis of accounting utilize the NAIC rating methodology. The NAIC assigns designations to publicly traded as well as privately placed securities. The designations assigned by the NAIC range from class 1 to class 6, with designations in classes 1 and 2 generally considered investment grade (BBB or higher rating agency designation). NAIC designations in classes 3 through 6 are generally considered below investment grade (BB or lower rating agency designation). If no rating is available from a rating agency or the NAIC, then an internally developed rating is used.

~~Table of Contents~~

The quality of the Company’s available-for-sale fixed maturity securities portfolio, as measured at fair value and by the percentage of fixed maturity securities invested in various ratings categories, relative to the entire available-for-sale fixed maturity securities portfolio, as of September 30, ~~2022~~2023 and December 31, ~~2021~~2022 was as follows (dollars in millions):


			September 30, 2022						December 31, 2021								September 30, 2023						December 31, 2022
NAIC Designation	NAIC Designation	Rating Agency Designation	Amortized Cost		Estimated Fair Value		% of Total		Amortized Cost		Estimated Fair Value		% of Total		NAIC Designation	Rating Agency Designation	Amortized Cost		Estimated Fair Value		% of Total		Amortized Cost		Estimated Fair Value		% of Total
1	1	AAA/AA/A	$	33,881	$	30,062	59.6	%	$	33,540	$	36,725	60.5	%	1	AAA/AA/A	$	38,876	$	33,799	62.4	%	$	36,217	$	32,295	61.1	%
2	2	BBB	19,931		16,924		33.5		18,684		20,379		33.5		2	BBB	19,959		17,134		31.6		20,188		17,580		33.2
3	3	BB	3,044		2,843		5.6		2,620		2,668		4.4		3	BB	2,902		2,780		5.1		2,734		2,607		5.0
4	4	B	625		583		1.2		876		863		1.4		4	B	439		368		0.7		397		331		0.6
5	5	CCC and lower	107		62		0.1		96		79		0.1		5	CCC and lower	104		81		0.2		103		71		0.1
6	6	In or near default	42		21		—		57		35		0.1		6	In or near default	52		9		—		24		17		—
		Total	$	57,630	$	50,495	100.0	%	$	55,873	$	60,749	100.0	%		Total	$	62,332	$	54,171	100.0	%	$	59,663	$	52,901	100.0	%

The Company’s fixed maturity portfolio includes structured securities. The following table shows the types of structured securities the Company held as of September 30, ~~2022~~2023 and December 31, ~~2021~~2022 (dollars in millions):


		September 30, 2022						December 31, 2021							September 30, 2023						December 31, 2022
		Amortized Cost		Estimated Fair Value		% of Total		Amortized Cost		Estimated Fair Value		% of Total			Amortized Cost		Estimated Fair Value		% of Total		Amortized Cost		Estimated Fair Value		% of Total
RMBS:
Agency		$	489	$	442	7.0	%	$	551	$	582	8.4	%
Non-agency		565		511		8.1		469		468		6.8
Total RMBS		1,054		953		15.1		1,020		1,050		15.2
ABS:	ABS:													ABS:
Collateralized loan obligations (“CLOs”)	Collateralized loan obligations (“CLOs”)	1,788		1,650		26.0		1,761		1,752		25.4		Collateralized loan obligations (“CLOs”)	$	2,022	$	1,967	28.2	%	$	1,825	$	1,702	26.4	%
ABS, excluding CLOs	ABS, excluding CLOs	2,377		2,073		32.6		2,263		2,253		32.6		ABS, excluding CLOs	2,540		2,269		32.5		2,499		2,176		33.8
Total ABS	Total ABS	4,165		3,723		58.6		4,024		4,005		58.0		Total ABS	4,562		4,236		60.7		4,324		3,878		60.2
CMBS	CMBS	1,843		1,670		26.3		1,790		1,849		26.8		CMBS	1,959		1,710		24.5		1,835		1,623		25.2
RMBS:														RMBS:
Agency														Agency	454		388		5.6		476		427		6.6
Non-agency														Non-agency	718		642		9.2		578		514		8.0
Total RMBS														Total RMBS	1,172		1,030		14.8		1,054		941		14.6
Total	Total	$	7,062	$	6,346	100.0	%	$	6,834	$	6,904	100.0	%	Total	$	7,693	$	6,976	100.0	%	$	7,213	$	6,442	100.0	%

The Company’s RMBS portfolio includes agency-issued pass-through securities and collateralized mortgage obligations. Agency-issued pass-through securities are guaranteed or otherwise supported by the Federal Home Loan Mortgage Corporation, Federal National Mortgage Association, or the Government National Mortgage Association. The principal risks inherent in holding RMBS are prepayment and extension risks, which will affect the timing

Table of when cash will be received and are dependent on the level of mortgage interest rates. Prepayment risk is the unexpected increase in principal payments from the expected, primarily as a result of owner refinancing. Extension risk relates to the unexpected slowdown in principal payments from the expected. In addition, non-agency RMBS face credit risk should the borrower be unable to pay the contractual interest or principal on their obligation. The Company monitors its mortgage-backed securities to mitigate exposure to the cash flow uncertainties associated with these risks.Contents

The Company’s ABS portfolio primarily consists of CLOs, aircraft and single-family rentals. The principal risks in holding ABS are structural, credit, capital market and interest rate risks. Structural risks include the securities’ cash flow priority in the capital structure and the inherent prepayment sensitivity of the underlying collateral. Credit risks include the adequacy and ability to realize proceeds from the collateral. Credit risks are mitigated by credit enhancements that include excess spread, over-collateralization and subordination. Capital market risks include general level of interest rates and the liquidity for these securities in the marketplace.

The Company’s CMBS portfolio primarily consists of large pool securitizations that are diverse by property type, borrower and geographic dispersion. The principal risks in holding CMBS are structural and credit risks. Structural risks include the securities’ cash flow priority in the capital structure and the inherent prepayment sensitivity of the underlying collateral. Credit risks include the adequacy and ability to realize proceeds from the collateral. The Company focuses on investment grade rated tranches that provide additional credit support beyond the equity protection in the underlying loans. These assets are viewed as an attractive alternative to other fixed income asset classes.

~~Table~~The Company’s RMBS portfolio includes agency-issued pass-through securities and collateralized mortgage obligations. Agency-issued pass-through securities are guaranteed or otherwise supported by the Federal Home Loan Mortgage Corporation, Federal National Mortgage Association, or the Government National Mortgage Association. The principal risks inherent in holding RMBS are prepayment and extension risks, which will affect the timing of ~~Contents~~

when cash will be received and are dependent on the level of mortgage interest rates. Prepayment risk is the unexpected increase in principal payments from the expected, primarily as a result of owner refinancing. Extension risk relates to the unexpected slowdown in principal payments from the expected. In addition, non-agency RMBS face credit risk should the borrower be unable to pay the contractual interest or principal on their obligation. The Company monitors its mortgage-backed securities to mitigate exposure to the cash flow uncertainties associated with these risks.

As of September 30, ~~2022~~2023 and December 31, ~~2021,~~2022, the Company had ~~$7,795 million~~$8.5 billion and ~~$349 million,~~$7.3 billion, respectively, of gross unrealized losses related to its fixed maturity securities. The Company monitors its fixed maturity securities to determine impairments in value and evaluates factors such as financial condition of the issuer, payment performance, compliance with covenants, general market and industry sector conditions, current intent and ability to hold securities, and various other subjective factors. Based on management’s judgment, an allowance for credit losses in the amount that fair value is less than the amortized cost is recorded for securities determined to have expected credit losses.

Mortgage Loans

The Company’s mortgage loan portfolio consists of U.S., Canada and UK based investments primarily in commercial offices, light industrial properties and retail locations. The mortgage loan portfolio is diversified by geographic region and property type as discussed further under “Mortgage Loans” in Note 411 – “Investments” in the Notes to Condensed Consolidated Financial Statements. Most of the mortgage loans in the Company’s portfolio range in size up to $30 million, with the average mortgage loan investment as of September 30, ~~2022,~~2023, totaling approximately $9$10 million.

As of September 30, ~~2022~~2023 and December 31, ~~2021,~~2022, the Company’s recorded investment in mortgage loans, gross of unamortized deferred loan origination fees and expenses and allowance for credit losses, were distributed geographically as follows (dollars in millions):


		September 30, 2022				December 31, 2021					September 30, 2023				December 31, 2022
		Recorded Investment		% of Total		Recorded Investment		% of Total			Recorded Investment		% of Total		Recorded Investment		% of Total
U.S. Region:	U.S. Region:									U.S. Region:
West	West	$	2,377	36.0	%	$	2,270	36.0	%	West	$	2,726	37.2	%	$	2,420	36.4	%
South	South	2,257		34.1		2,135		33.7		South	2,427		33.2		2,215		33.3
Midwest	Midwest	1,142		17.3		1,166		18.4		Midwest	1,197		16.4		1,147		17.2
Northeast	Northeast	479		7.2		419		6.6		Northeast	522		7.1		474		7.1
Subtotal - U.S.	Subtotal - U.S.	6,255		94.6		5,990		94.7		Subtotal - U.S.	6,872		93.9		6,256		94.0
Canada	Canada	208		3.1		193		3.0		Canada	274		3.7		239		3.6
United Kingdom	United Kingdom	150		2.3		144		2.3		United Kingdom	174		2.4		158		2.4
Other		—		—		2		—

Total	Total	$	6,613	100.0	%	$	6,329	100.0	%	Total	$	7,320	100.0	%	$	6,653	100.0	%

See “Allowance for Credit Losses and Impairments” in Note 2 – “Significant Accounting Policies and Pronouncements” of the Company’s ~~2021~~2022 Annual Report and “Mortgage Loans” in Note 411 – “Investments” in the Notes to Condensed Consolidated Financial Statements for information regarding the Company’s policy for allowance for credit losses on mortgage loans.

Table of Contents

Allowance for Credit Losses and Impairments

The Company’s determination of whether a decline in value necessitates the recording of an allowance for credit losses includes an analysis of whether the issuer is current on its contractual payments, evaluating whether it is probable that the Company will be able to collect all amounts due according to the contractual terms of the security and analyzing the overall ability of the Company to recover the amortized cost of the investment. See “Allowance for Credit Losses and Impairments” in Note 2 – “Significant Accounting Policies and Pronouncements” of the Company’s ~~2021~~2022 Annual Report for additional information. The table below summarizes investment related gains (losses), net related to allowances for credit losses and impairments for the three and nine months ended September 30, ~~2022~~2023 and ~~2021~~2022 (dollars in millions).


		Three months ended September 30,				Nine months ended September 30,
		2022		2021		2022		2021			Three months ended September 30,				Nine months ended September 30,
											2023		2022		2023		2022
Change in allowance for credit losses on fixed maturity securities	Change in allowance for credit losses on fixed maturity securities	$	(3)	$	1	$	21	$	(2)	Change in allowance for credit losses on fixed maturity securities	$	7	$	3	$	(31)	$	(21)
Impairments on fixed maturity securities	Impairments on fixed maturity securities	12		—		15		—		Impairments on fixed maturity securities	—		(12)		(1)		(15)
Other impairment losses and changes in provision		1		2		1		—
Change in mortgage loan allowance for credit losses	Change in mortgage loan allowance for credit losses	5		(6)		8		(25)		Change in mortgage loan allowance for credit losses	(17)		(5)		(23)		(8)
Total		$	15	$	(3)	$	45	$	(27)

Other impairment losses										Other impairment losses	(4)		(1)		(4)		(1)
Investment related gains (losses) related to credit losses and impairments										Investment related gains (losses) related to credit losses and impairments	$	(14)	$	(15)	$	(59)	$	(45)

The ~~decrease~~change in allowance for credit losses ~~and increase in impairments~~ on fixed maturity securities for the three months ended September 30, 2023, was primarily related to write offs charged against allowance. The change in allowance for credit losses on fixed maturity securities for the nine months ended September 30, 2023, was primarily related to the March 2023 banking crisis. The change in allowance for credit losses on fixed maturity securities for the three and nine months ended September 30, 2022, ~~corresponds~~corresponded to the reversal of previously recorded allowances due to intent to sell primarily related to high-yield securities. The increase in ~~allowance for credit losses on fixed maturity securities for the nine months ended September 30, 2022, was primarily related to high yield securities. The increase in~~ mortgage loan allowance for credit ~~loss~~losses for the three and nine months ended September 30, ~~2022, reflects~~2023, was primarily due to growth in the ~~impact of market conditions including occupancy rates.~~

~~Table of Contents~~

asset base and updated model assumptions that take into account economic factors. For the three months ended September 30, 2023, the decrease in other impairment losses was due to real estate held for investment.

See “Unrealized Losses for Fixed Maturity Securities Available-for-Sale” in Note 411 – “Investments” in the Notes to Condensed Consolidated Financial Statements for tables that present the estimated fair value and gross unrealized losses for securities that have estimated fair values below amortized cost by class and grade, as well as the length of time the related estimated fair value has remained below amortized cost as of September 30, ~~2022~~2023 and December 31, ~~2021.~~2022.

As of September 30, ~~2022~~2023 and December 31, ~~2021,~~2022, the Company classified approximately ~~11.0%~~11.1% and ~~8.5%~~10.8%, respectively, of its fixed maturity securities in the Level 3 category (refer to Note 613 – “Fair Value of Assets and Liabilities” in the Notes to Condensed Consolidated Financial Statements for additional information). These securities primarily consist of private placement corporate and asset-backed securities.

Funds Withheld at Interest

For reinsurance agreements written on a modified coinsurance basis and certain agreements written on a coinsurance basis, assets equal to the net statutory reserves are withheld and legally owned and managed by the ceding company and are reflected as funds withheld at interest on the Company’s condensed consolidated balance sheets. In the event of a ceding company’s insolvency, the Company would need to assert a claim on the assets supporting its reserve liabilities. However, the risk of loss to the Company is mitigated by its ability to offset amounts it owes the ceding company for claims or allowances against amounts owed by the ceding company. Interest accrues to the total funds withheld at interest assets at rates defined by the treaty terms. The Company is subject to the investment performance on the withheld assets, although it does not directly control them. These assets are primarily fixed maturity investment securities and pose risks similar to the fixed maturity securities the Company owns. To mitigate this risk, the Company helps set the investment guidelines followed by the ceding company and monitors compliance. Ceding companies with funds withheld at interest had an average financial strength rating of “A” as of September 30, ~~2022~~2023 and December 31, ~~2021.~~2022. Certain ceding companies maintain segregated portfolios for the benefit of the Company.

Other Invested Assets

Other invested assets include ~~limited partnership interests, joint ventures (other than operating joint ventures),~~ lifetime mortgages, derivative contracts, FHLB common stock, unit-linked investments, and ~~unit-linked investments.~~real estate held for investment. See “Other Invested Assets” in Note 411 – “Investments” in the Notes to Condensed Consolidated Financial Statements for a table that presents the carrying value of the Company’s other invested assets by type as of September 30, ~~2022~~2023 and December 31, ~~2021.~~2022.

Table of Contents

The Company utilizes derivative financial instruments to protect the Company against possible changes in the fair value of its investment portfolio as a result of interest rate changes, to hedge against risk of changes in the purchase price of securities, to hedge liabilities associated with the reinsurance of variable annuities with guaranteed living benefits and to manage the portfolio’s effective yield, maturity and duration. In addition, the Company utilizes derivative financial instruments to reduce the risk associated with fluctuations in foreign currency exchange rates. The Company uses exchange-traded, centrally cleared, and customized over-the-counter derivative financial instruments.

See Note 512 – “Derivative Instruments” in the Notes to Condensed Consolidated Financial Statements for a table that presents the notional amounts and fair value of investment related derivative instruments held as of September 30, ~~2022~~2023 and December 31, ~~2021.~~2022.

The Company manages its credit risk related to over-the-counter derivatives by entering into transactions with creditworthy counterparties, maintaining collateral arrangements and through the use of master agreements that provide for a single net payment to be made by one counterparty to another at each due date and upon termination. As exchange-traded futures are affected through regulated exchanges, and positions are marked to market on a daily basis, the Company has minimal exposure to credit-related losses in the event of nonperformance by counterparties. See Note 512 – “Derivative Instruments” in the Notes to Condensed Consolidated Financial Statements for more information regarding the Company’s derivative instruments.

The Company holds ~~$786~~$900 million and ~~$758~~$868 million of beneficial interest in lifetime mortgages in the UK, net of allowance for credit losses, as of September 30, ~~2022~~2023 and December 31, ~~2021,~~2022, respectively. Investment income includes $9$11 million and ~~$15~~$9 million in interest income earned on lifetime mortgages for the three months ended September 30, ~~2022~~2023 and ~~2021,~~2022, respectively, and ~~$28~~$29 million and ~~$41~~$28 million in interest income earned on lifetime mortgages for the nine months ended September 30, ~~2022~~2023 and ~~2021,~~2022, respectively. Lifetime mortgages represent loans provided to individuals 55 years of age and older secured by the

~~Table of Contents~~

borrower’s residence. Lifetime mortgages are comparable to a home equity loan by allowing the borrower to utilize the equity in their home as collateral. The amount of the loan is dependent on the appraised value of the home at the time of origination, the borrower's age and interest rate. Unlike a home equity loan, no payment of principal or interest is required until the death of the borrower or sale of the home. Lifetime mortgages may also be either fully funded at origination, or the borrower can request periodic funding similar to a line of credit. Lifetime mortgages are subject to risks, including market, credit, interest rate, liquidity, operational, reputational and legal risks.

New Accounting Standards

~~Financial Services – Insurance~~

In August 2018, the FASB issued amendments that will significantly change the recognition and measurement of long-duration insurance contracts and expand disclosure requirements. The guidance is effective for the Company on January 1, 2023. The Company established a team to support the implementation of the updated guidance, which requires significant changes to policies, reporting and processes. The Company’s achievements as of the balance sheet date include, but are not limited to, the following:

•~~Established preliminary key accounting policies;~~

•~~Updated chart of accounts to support enhanced financial statement presentation and disclosures;~~

•~~Implemented a data management system and process for grouping treaties into cohorts;~~

•~~Established valuation analytics and reporting foundation;~~

•~~Established an assumption governance process for assumption review, changes and approvals; and~~

•~~Conducted dry runs and end to end system testing.~~

~~The Company continues to make progress on the following items (includes, but not limited to):~~

•~~Evaluating and finalizing key accounting policies;~~

•~~Evaluating the impact to the consolidated financial statements at transition;~~

•~~Determining and documenting key risks and appropriate internal controls; and~~

•~~Conducting parallel valuation runs.~~

See Note 142 – ~~“New~~“Impact of Adoption of New Accounting ~~Standards”~~Standard” in the Notes to Condensed Consolidated Financial Statements for ~~additional~~information on the Company’s adoption of ASU 2018-12 on January 1, 2023. See Note 19 – “New Accounting Standards Not Yet Adopted” in the Notes to Condensed Consolidated Financial Statements for information on new accounting pronouncements and their impact, if any, on the Company’s results of operations and financial position.

Cybersecurity Incident

As previously disclosed on October 26, 2023, the Company experienced a cybersecurity incident in which an unauthorized third party gained access to certain technology systems of the Company. Following detection of the incident, the Company initiated response protocols, launched an investigation, engaged the services of cybersecurity and forensics experts and advisors, and notified certain insurance regulatory authorities, law enforcement authorities and clients. Based on its investigation to date, the Company does not believe that any client policy holder data was accessed or extracted.

The Company has incurred, and may continue to incur, certain incremental expenses related to this incident, including expenses to respond to, remediate and investigate this incident.

Based on information currently known, the Company does not believe this incident will have a material adverse effect on its business, operations or financial results.

Table of Contents

ITEM 3. Quantitative and Qualitative Disclosures About Market Risk

Market risk is the risk of fluctuations in the value of financial instruments as a result of absolute or relative changes in interest rates, foreign currency exchange rates, equity prices or commodity prices. To varying degrees, the Company products and services, and the investment activities supporting them, generate exposure to market risk. The market risk incurred, and the Company’s strategies for managing this risk, vary by product. As of September 30, ~~2022,~~2023, there have been no material changes in the Company’s economic exposure to market risk or the Company’s Enterprise Risk Management function from December 31, ~~2021,~~2022, a description of which may be found in its Annual Report on Form 10-K, for the year ended December 31, ~~2021,~~2022, Item 7A, “Quantitative and Qualitative Disclosures about Market Risk,” filed with the Securities and Exchange Commission.

ITEM 4. Controls and Procedures

The Chief Executive Officer and the Chief Financial Officer have evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures as defined in Exchange Act Rule 13a-15(e) as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that these disclosure controls and procedures were effective.

There was no change in the Company’s internal control over financial reporting as defined in Exchange Act Rule 13a-15(f) during the quarter ended September 30, ~~2022,~~2023, that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

6798

Table of Contents

PART II - OTHER INFORMATION

ITEM 1. Legal Proceedings

The Company is subject to litigation and regulatory investigations or actions from time to time. Based on current knowledge, management does not believe that loss contingencies arising from pending legal, regulatory and governmental matters will have a material adverse effect on the financial condition, results of operations or cash flows of the Company. However, in light of the ~~normal course~~inherent uncertainties involved in future or pending legal, regulatory and governmental matters, some of ~~its business. The Company currently has no~~which are beyond the Company’s control, and indeterminate or potentially substantial amount of damages sought in any such matters, an adverse outcome could be material ~~litigation.~~to the Company’s financial condition, results of operations or cash flows for any particular reporting period. A legal reserve is established when the Company is notified of an arbitration demand, litigation or ~~litigation~~regulatory action or is notified that an arbitration demand, litigation or ~~litigation~~regulatory action is imminent, it is probable that the Company will incur a loss as a result and the amount of the probable loss is reasonably capable of being estimated.

ITEM 1A. Risk Factors

There have been no material changes from the risk factors previously disclosed in the Company’s ~~2021~~2022 Annual Report.

ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds

Issuer Purchases of Equity Securities

The following table summarizes RGA’s repurchase activity of its common stock during the quarter ended September 30, ~~2022:~~2023:

Total Number of Shares
Purchased (1)
Average Price Paid per
Share
Total Number of Shares
Purchased as Part of
Publicly Announced Plans
or Programs (1)
Maximum Number (or
Approximate Dollar
Value) of Shares that May
Yet Be Purchased Under
the Plan or Program
July 1, 2022 – July 31, 2022 — $ — — $ 400,000,000
August 1, 2022 – August 31, 2022 204,103 $ 128.05 195,234 $ 375,000,364
September 1, 2022 – September 30, 2022 1,163 $ 129.55 — $ 375,000,364


	Total Number of Shares Purchased (1)	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (1)	Maximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plan or Program
July 1, 2023 – July 31, 2023	—	$	—	—	$	250,003,610
August 1, 2023 – August 31, 2023	179,141	$	140.28	178,205	$	225,003,733
September 1, 2023 – September 30, 2023	170,410	$	148.68	168,134	$	200,003,862

(1)RGA ~~had 195,234 repurchases~~repurchased 178,205 and 168,134 shares of common stock under its share repurchase program in August ~~2022.~~and September 2023, respectively. The Company net settled – issuing ~~22,426~~2,667 and ~~2,450~~7,298 shares from treasury and ~~repurchased~~repurchasing from recipients ~~8,869~~936 and ~~1,163~~2,276 shares in August and September ~~2022,~~2023, respectively, in settlement of income tax withholding requirements incurred by the recipients of equity incentive awards.

On February 25, 2022, RGA’s board of directors authorized a share repurchase program for up to $400 million of RGA’s outstanding common stock. The authorization was effective immediately and does not have an expiration date. In connection with this authorization, the board of directors terminated the stock repurchase authority granted in 2019. During the nine months ended September 30, ~~2022,~~2023, RGA ~~repurchase 195,234~~repurchased 1,069,113 shares of common stock under this program for ~~$25~~$150 million.

ITEM 5. Other Information

During the three months ended September 30, 2023, (i) none of our directors or executive officers adopted or terminated any contract, instruction or written plan for the purchase or sale of Company securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) (a “Rule 10b-5 Trading Arrangement”) or any “non-Rule 10b5-1 trading arrangement” and (ii) the Company did not adopt or terminate any Rule 10b-5 Trading Arrangement.

ITEM 6. Exhibits

See index to exhibits.

6899

Table of Contents

INDEX TO EXHIBITS



Exhibit Number						Description

3.1						Amended and Restated Articles of Incorporation, effective ~~as of~~ May 21, 2020, incorporated by reference to Exhibit 3.1(i) to Current Report on Form 8-K filed on May 22, ~~2020.~~2020

3.2						Amended and Restated Bylaws, effective ~~as of May 23, 2018,~~December 20, 2022, incorporated by reference to Exhibit ~~3.2~~3.1 to Current Report on Form 8-K filed ~~on May 24, 2018.~~

~~4.1~~						~~Seventh Supplemental Indenture, dated as of September 23,~~December 20, 2022 between the Company and the Bank of New York Mellon Trust Company, N.A., as Trustee (incorporated by reference to Exhibit 4.2 of the Company’s Form 8-A Registration Statement Filed on September 23, 2022).

~~4.2~~						Form of 7.125% Fixed-Rate Reset Subordinated Debenture due 2052 (incorporated by reference from Exhibit A to the Seventh Supplemental Indenture filed as Exhibit A to the Seventh Supplemental Indenture filed as Exhibit 4.2 of the Company 4.2 of the Company’s Form 8-A Registration Statement filed on September 23, 2022).

31.1						Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 302 of the Sarbanes-Oxley Act of ~~2002.~~2002

31.2						Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 302 of the Sarbanes-Oxley Act of ~~2002.~~2002

32.1						Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of ~~2002.~~2002

32.2						Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of ~~2002.~~2002

101.INS						XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

101.SCH						XBRL Taxonomy Extension Schema Document

101.CAL						XBRL Taxonomy Extension Calculation Linkbase Document

101.LAB						XBRL Taxonomy Extension Label Linkbase Document

101.PRE						XBRL Taxonomy Extension Presentation Linkbase Document

101.DEF						XBRL Taxonomy Extension Definition Linkbase Document

104						Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibits 101).

69100

Table of Contents

GLOSSARY OF SELECTED TERMS

Throughout this quarterly report on Form 10-Q, the Company may use certain abbreviations, acronyms and terms which are defined below.

Entities


Term or Acronym						Definition
RGA Reinsurance						RGA Reinsurance Company
Parkway Re						Parkway Reinsurance Company
Rockwood Re						Rockwood Reinsurance Company
Castlewood Re						Castlewood Reinsurance Company
Chesterfield Re						Chesterfield Reinsurance Company
Chesterfield Financial						Chesterfield Financial Holdings LLC
RGA Life and Annuity						RGA Life and Annuity Insurance Company
Timberlake Re						Timberlake Reinsurance Company II
Timberlake Financial						Timberlake Financial L.L.C.
RGA Canada						RGA Life Reinsurance Company of Canada
RGA Barbados						RGA Reinsurance Company (Barbados) Ltd.
RGA Americas						RGA Americas Reinsurance Company, Ltd.
Manor Re						Manor Reinsurance, Ltd.
RGA Atlantic						RGA Atlantic Reinsurance Company Ltd.
RGA Worldwide						RGA Worldwide Reinsurance Company, Ltd.
RGA Global						RGA Global Reinsurance Company, Ltd.
RGA Australia						RGA Reinsurance Company of Australia Limited
RGA International						RGA International Reinsurance Company dac
RGA South Africa						RGA Reinsurance Company of South Africa, Limited
Aurora National						Aurora National Life Assurance Company
Omnilife						Omnilife Insurance Company, Limited
Papara						Papara Financing LLC

Certain Terms and Acronyms


Term or Acronym						Definition
A.M. Best						A.M. Best Company
ABS						Asset-backed securities
Actuary						A specialist in the mathematics of risk, especially as it relates to insurance calculations such as premiums, reserves, dividends, insurance rates and annuity rates.
Allowance						An amount paid by the reinsurer to the ceding company to help cover the ceding company's acquisition and other costs, especially commissions. Allowances are usually calculated as a large percentage (often 100%) of first-year premiums reinsured and smaller percentages of renewal premiums reinsured.
AOCI						Accumulated other comprehensive income (loss)
Asset-Intensive Reinsurance						A transaction (usually coinsurance or funds withheld and often involving reinsurance of annuities) where performance of the underlying assets, more so than any mortality risk, is a key element.
Assumed reinsurance						Insurance risk that a reinsurer accepts (assumes) from a ceding company.
ASU						Accounting Standards Update
ASU 2018-12						Accounting Standards Update Financial Services – Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts
Automatic Reinsurance						Reinsurance arrangement whereby the ceding company and reinsurer agree that all business of a certain description will be ceded to the reinsurer. Under this arrangement, the ceding company performs underwriting decision-making within agreed-upon parameters for all business reinsured.
Bermuda Insurance Act						Bermuda's Insurance Act 1978 which distinguishes between insurers carrying on long-term business, insurers carrying on special purpose business and insurers carrying on general business.
BMA						Bermuda Monetary Authority
BSCR						Bermuda Solvency Capital Requirement
CCPA						California Consumer Privacy Act of 2018
Capital-motivated reinsurance						Reinsurance, including financial reinsurance, whose primary purpose is to enhance the cedant's capital position.
Captive insurer						An insurance or reinsurance entity designed to provide insurance or reinsurance coverage for risks of the entity or entities by which it is owned or to which it is affiliated.
CECL						Accounting for current expected credit losses using the model based on expected losses rather than incurred losses.
Ceding company (also known as cedant)						An insurer that transfers, or cedes, risk to a reinsurer

101

Table of Contents


CEO						RGA’s Chief Executive Officer
Cession						The insurance risk associated with a policy that is reinsured from an insurer to a reinsurer.
CFO						RGA’s Chief Financial Officer
CLOs						Collateralized loan obligations
CMBS						Commercial mortgage-backed securities, a part of our investment portfolio that consists of securities made up of commercial mortgages. Stated on our balance sheet at fair value.
Coinsurance (also known as original terms reinsurance)						A form of reinsurance under which the ceding company shares its premiums, death claims, surrender benefits, dividends and policy loans with the reinsurer, and the reinsurer pays expense allowances to reimburse the ceding company for a share of its expenses.
Coinsurance funds-withheld						A variant on coinsurance, in which the ceding company withholds assets equal to reserves and shares investment income on those assets with the reinsurer.
Counterparty						A party to a contract requiring or offering the exchange of risk.
Counterparty risk						The risk that a party to an agreement will be unable to fulfill its contractual obligations
CPI						Consumer price index
Critical illness (CI) insurance (also known as dread disease insurance)						Insurance that provides a guaranteed fixed sum upon diagnosis of a specified illness or condition such as cancer, heart disease, or permanent total disability. The coverage can be offered on a stand-alone basis or as an add-on to a life insurance policy.
CRO						RGA’s Chief Risk Officer
CVA						Credit valuation adjustment
DAC						Deferred policy acquisition costs: Costs of acquiring new business, which vary with and are directly related to the production of new business, have been deferred to the extent that such costs are deemed recoverable from future premiums or gross profits.
“Directors Plan”						Flexible Stock Plan for Directors
EBITDA						Earnings before interest, taxes, depreciation and amortization
EBS						Economic balance sheet framework as part of the Bermuda Solvency Capital Requirement that forms the basis for an insurer's enhanced capital requirements.
ECR						Enhanced capital requirement in accordance with the provisions of the Bermuda Insurance Act.
EEA						European Economic Area
EIAs						Equity-Indexed Annuities
EMEA						Europe, Middle East and Africa geographic segment
Enterprise Risk Management (ERM)						An enterprise-wide framework used by a firm to assess all risks facing the organization, manage mitigation strategies, monitor ongoing risks and report to interested audiences.
ESG						Environmental, social, and governance
ESTER						Euro Short-term Rate, an alternative to LIBOR being recommended by the European Central Bank
EU						European Union
Expected mortality						Number of deaths predicted to occur in a defined group of people.
FABN						Funding Agreement Backed Notes
Face amount						Amount payable at the death of the insured or at the maturity of the policy.
Facultative reinsurance						A type of reinsurance in which the reinsurer underwrites an individual risk submitted by the ceding company for a risk that is unusual, large, highly substandard or not covered by an automatic reinsurance treaty. Such risks are typically submitted to multiple reinsurers for competitive offers.
FASB						Financial Accounting Standards Board
FCA						Financial Conduct Authority
FHLB						Federal Home Loan Bank
FIA						Fixed indexed annuities
Financial reinsurance (also known as financially-motivated reinsurance)						A form of capital-motivated reinsurance that satisfies all regulatory requirements for risk transfer and is often designed to produce very predictable reinsurer profits as a percentage of the capital provided.
FSB						Financial Stability Board which consists of representatives of national financial authorities of the G20 nations.
FVO						Fair value option
GAAP						U.S. generally accepted accounting principles
GDPR						General Data Protection Regulation which establishes uniform data privacy laws across the European Union.
GICs						Guaranteed investment contracts
GILTI						Global intangible low-taxed income; a provision of U.S. Tax Reform that generally eliminates U.S. Federal income tax deferral on earnings of foreign subsidiaries.
GMAB						Guaranteed minimum accumulation benefits; a feature of some variable annuities that the Company reinsures
GMDB						Guaranteed minimum death benefits; a feature of some variable annuities that the Company reinsures
GMIB						Guaranteed minimum income benefits; a feature of some variable annuities that the Company reinsures
GMWB						Guaranteed minimum withdrawal benefits; a feature of some variable annuities that the Company reinsures
Group life insurance						Insurance policy under which the lives of a group of people, most commonly employees of a single company, are insured in accordance with the terms of one master contract.
Guaranteed issue life insurance						Insurance products that are guaranteed upon application, regardless of past health conditions.
IAIG						Internationally Active Insurance Group
IAIS						International Association of Insurance Supervisors

102

Table of Contents


IBNR						Incurred but not reported; a liability on claims that are based on historical reporting patterns, but have not yet been reported.
IFRS (International Financial Reporting Standards)						Standards and interpretations adopted by the International Accounting Standards Board (IASB).
Individual life insurance						An insurance policy that insures the life of usually one and sometimes two or more related individuals, rather than a group of people.
In-force sum insured						A measure of insurance in effect at a specific date.
Initial public offering (IPO)						The first sale to the public of shares of common stock issued by a private company. IPOs often are issued by smaller companies seeking the capital to expand, but they also can be used by large mutual or privately owned companies seeking to become publicly traded.
LIBOR						London Interbank Offered Rate
Liquidity position						Combination of the company's cash, cash equivalents, and short-term investments
Longevity product						An insurance product that mitigates longevity risk by providing a stream of income for the duration of the policyholder's life.
Loss ratio						Claims and other policy benefits and Future policy benefits remeasurement (gains) losses as a percentage of net premiums
Market risk benefits						Contracts or contract features that provide protection to the policyholder from capital market risk and expose the Company to other-than-nominal capital market risk and are measured at fair value.
MDCI						Missouri Department of Commerce and Insurance
MMS						Minimum margin of solvency required to be maintained by the Company's Bermuda subsidiaries.
Modco						Modified coinsurance
Modified coinsurance						A variant on coinsurance in which the ceding company retains all the reserves, as well as assets backing reserves, and pays the reinsurer interest on the reinsurer's share of the reserves.
Moody’s						Moody’s Investors Service
Morbidity						A measure of the incidence of sickness or disease within a specific population group.
Mortality experience						Actual number of deaths occurring in a defined group of people.
Mortality risk reinsurance						Reinsurance that focuses primarily on transfer of mortality risk through coinsurance of term products or YRT.
NAIC						National Association of Insurance Commissioners
NAIC SAP						NAIC statutory accounting practices
NAV						Net asset value
NIFO						Net investments in foreign operations
NOL						Net operating loss
Non-traditional reinsurance						Usually synonymous with capital-motivated reinsurance, but includes any reinsurance of non-biometrical risks
Novation						The act of replacing one participating member of a contract with another, with all rights, duties and terms being transferred to the new party upon consent of all parties affected.
NYSE						New York Stock Exchange: the exchange where RGA is traded under the symbol “RGA”
OCI						Other comprehensive income (loss)
OTC						Derivatives that are privately negotiated contracts, which are known as over-the-counter derivatives
OTC Cleared						OTC derivatives that are cleared and settled through central clearing counterparties.
PBR						Principles-based reserves
PCAOB						Public Company Accounting Oversight Board (United States)
PCS						Performance Contingent Shares
Pension Plans						The Company's sponsored or administrated qualified and non-qualified defined benefit pension plans
PRT						Pension Risk Transfer
Portfolio						The totality of risks assumed by an insurer or reinsurer.
Preferred risk coverage						Coverage designed for applicants who represent a better-than-average risk to an insurer.
Premium						Amount paid to insure a risk.
Primary insurance (also known as direct insurance)						Insurance business relating to contracts directly between insurers and policyholders. The insurance company is directly responsible to the policyholder.
Production						New business produced during a specified period.
PSU						Performance Share Units
Quota share (also known as 'first dollar' quota share)						A reinsurance arrangement in which the reinsurer receives a certain percentage of each risk reinsured.
RBC						Risk-Based Capital, which are guidelines promulgated by the NAIC and identify minimum capital requirements based upon business levels and asset mix.
Recapture						The right of the ceding company to cancel reinsurance under certain conditions.
Regulation XXX/Regulation A-XXX						U.S. Valuation of Life Policies Model Regulation implemented beginning in 2002 for various types of life insurance business, significantly increased the level of reserves that U.S. life insurance and life reinsurance companies must hold on their statutory financial statements for various types of life insurance business, primarily certain level premium term life products.
Reinsurance						The transfer of insurance risk from an insurer, referred to as the ceding company, to a reinsurer, in conjunction with the payment of a reinsurance premium. Through reinsurance, a reinsurer 'insures' an insurer.

103

Table of Contents


Reserves						The amount required to be carried as a liability in the financial statement of an insurer or reinsurer to provide for future commitments under outstanding policies and contracts.
Retakaful						A form of reinsurance that is acceptable within Islamic law. See Takaful.
Retention limit						The maximum amount of risk a company will insure on one life.
Retrocession						A transfer of reinsurance risk from a reinsurer to another reinsurer, referred to as the retrocessionaire, in conjunction with the payment of a retrocession premium. Through retrocession, a retrocessionaire reinsures a reinsurer.
Retrocessionaire						A reinsurer that reinsures another reinsurer; see Retrocession.
RMBS						Residential mortgage-backed securities, a part of our investment portfolio that consists of securities made up of residential mortgages. Stated on our balance sheet at fair value.
RMSC						The Company's Risk Management Steering Committee
RSUs						Restricted Stock Units
S&P						Standard & Poor's
SARs						Stock Appreciation Rights
SEC						Securities and Exchange Commission
Securitization						The structuring of financial assets as collateral against which securities can be issued to investors.
Simplified issue life insurance						Insurance products with limited face amounts that require no or minimal underwriting.
SOFR						Secured Overnight Financing Rate, an alternative to LIBOR proposed by the Federal Reserve Board
SPLRC						Special Purpose Life Reinsurance Captives
Statutory capital						The excess of statutory assets over statutory reserves, both of which are calculated in accordance with standards established by insurance regulators.
“Stock Plans”						The RGA flexible stock plan and the Flexible Stock Plan for Directors, collectively
Takaful						A form of insurance that is acceptable within Islamic law, and that is devised upon the principles of mutual advantage and group security.
TDR						Troubled Debt Restructuring
Tele-underwriting						A telephone interview process, during which an applicant's qualifications to be insured are assessed.
The “County”						The County of St. Louis, Missouri
The “Plan”						RGA Flexible Stock Plan
The Board						RGA's board of directors
The CARES Act						The Coronavirus Aid, Relief, and Economic Security Act
The Companies Act						The Bermuda's Companies Act of 1981
The Company						Reinsurance Group of America, Incorporated and its subsidiaries, all of which are wholly owned, collectively
Treaty (also known as a contract)						A reinsurance agreement between a reinsurer and a ceding company. The three most common types of reinsurance treaties are YRT (yearly renewable term), coinsurance and modified coinsurance. The three most common methods of accepting reinsurance are automatic, facultative and facultative-obligatory.
TVaR						Tail Value-at-Risk used for calculated capital requirement for Bermuda subsidiaries.
U.S. Tax Reform						The U.S. Tax Cuts and Jobs Act of 2017
UAE						United Arab Emirates
UK						United Kingdom
UL						Universal life insurance
Underwriting						The process that assesses the risk inherent in an application for insurance prior to acceptance of the policy.
Valuation						The periodic calculation of reserves, the funds that insurance companies are required to hold in order satisfy all future insurance obligations.
Variable life insurance						A form of whole life insurance under which the death benefit and the cash value of the policy fluctuate according to the performance of an investment fund. Most variable life insurance policies guarantee that the death benefit will not fall below a specified minimum.
VII						Variable investment income
VOCRA						Value of customer relationships acquired which represents the present value of the expected future profits associated with the expected future business acquired through existing customers of the acquired company or business.
VODA						Value of distribution agreements which represents the present value of future profits associated with the expected future business derived from distribution agreements.
Webcasts						Presentation of information broadcast over the Internet.
WorkWise						The Company's hybrid approach to flexible work arrangements.
Yearly Renewable Term (YRT)						A type of reinsurance which covers only mortality risk, with each year's premium based on the current amount of risk.

104

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


	Reinsurance Group of America, Incorporated
Date: November ~~4, 2022~~3, 2023	By:	/s/ Anna Manning
		Anna Manning
		~~President &~~ Chief Executive Officer
		(Principal Executive Officer)
Date: November ~~4, 2022~~3, 2023	By:	/s/ Todd C. Larson
		Todd C. Larson
		Senior Executive Vice President &and Chief Financial Officer
		(Principal Financial and Accounting Officer)

70105


Balance, June 30, 2021	$	1	$	2,430	$	8,531	$	(1,559)	$	4,041	$	13,444	$	—	$	13,444


Net income (loss)					(22)						(22)				(22)
Total other comprehensive income (loss)									(458)		(458)				(458)
Dividends to stockholders, $0.73 per share					(50)						(50)				(50)

Purchase of treasury stock							(46)				(46)				(46)
Reissuance of treasury stock			17		(1)		1				17				17
Balance, September 30, 2021	$	1	$	2,447	$	8,458	$	(1,604)	$	3,583	$	12,885	$	—	$	12,885


	September 30, 2022		December 31, 2021
Treaty guarantees	$	1,732	$	2,208
Treaty guarantees, net of assets in trust	1,003		1,281
Securities borrowing and repurchase arrangements	161		134


		September 30, 2022				December 31, 2021
Reinsurer	A.M. Best Rating	Amount		% of Total		Amount		% of Total
Reinsurer A	A-	$	1,607	65.4	%	$	1,626	63.0	%
Reinsurer B	A+	406		16.5		423		16.4
Reinsurer C	A+	194		7.9		212		8.2
Reinsurer D	A	54		2.2		59		2.3
Reinsurer E	A+	40		1.6		44		1.7
Reinsurer F	A++	33		1.3		42		1.6
Other reinsurers		122		5.1		174		6.8
Total		$	2,456	100.0	%	$	2,580	100.0	%